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Summary 
Ricin is a heterodimeric, toxic plant protein.  It is able to deliver its catalytic A chain (RTA) into the cytosol of 
target cells.  RTA crosses the endoplasmic reticulum (ER) membrane into the cytosol, masquerading as a 
substrate of ER-associated degradation (ERAD) to do so.  Therein, RTA inactivates ribosomes.  This thesis 
shows that RTA is prone to lose solubility in vitro near the physiological temperature and pH of target cells.  
This instability is hypothesised to cause RTA to misfold in the ER lumen, promoting chaperone and membrane 
interactions therein.  Fittingly, this thesis shows that Grp94, a lumenal chaperone, promotes the toxicity of RTA, 
and that liposomes constructed of negatively-charged phospholipid interact with RTA in vitro.  This instability 
resembles that of other toxic A chains that exploit ERAD.  Cholera toxin A chain and pertussis toxin A chain, 
for instance, are also relatively unstable (Pande et al., 2007 & 2008).   
The Hrd1 complex now seems the strongest candidate for retrotranslocating RTA from the ER lumen (Li et al., 
2010).  In the cytosol, the proteasomal cap has been shown to be involved in downstream processing of RTA – 
enabling toxicity (Li et al., 2010).  This thesis reports that, in mammals, the balance of cytosolic chaperones and 
their co-factors helps to dictate the success of retrotranslocated RTA, putatively by determining its escape from 
terminal degradation in the proteasomal core.  The effect of these chaperones occurs at a stage beyond access of 
the toxin subunit to the ER, and can result in both activation and inactivation of cytosolic RTA. 
It has been shown that, on one hand, Hsc70 is responsible for activating RTA.  Hsc70 may aid RTA in attaining 
an active conformation in the cytosol after retrotranslocation.  Alternatively, it might supplant the effectors of its 
degradation.  On the other hand, Hsc70 also enters RTA into a sequential triage with Hsp90.  Unlike Hsc70, 
Hsp90 deactivates RTA.  This effect is dependent upon the lysines of this toxin subunit, suggesting Hsp90 may 
participate in the lysine-ubiquitination of RTA.  Supporting this conclusion, Hsc70 and Hsp90 can both 
ubiquitinate RTA in vitro.  This ubiquitination can be promoted if RTA is first incubated with liposomes.  This 
implies that RTA may be particularly vulnerable to ubiquitination during retrotranslocation, where it might also 
be partially solvated by phospholipid.  Contrasting to RTA, Hsp90 actually aids the toxicity and dislocation of 
ER-retrotranslocating cholera toxin A chain (Taylor et al., 2010).  It seems that RTA may have fortuitously 
evolved to exploit Hsc70 rather than Hsp90 to promote its cytosolic activation.  Provocatively, the hydrophobic 
C-terminal tail of RTA demarcates it from a homologous toxin, saporin, which does not exploit ERAD to 
achieve toxicity.  Indeed, this region may be an adaptation RTA has acquired to promote interaction of the toxin 
subunit with Hsc70, which even seems to occur in RTA’s native, folded state.  This interaction may be another 
reason why the region is apparently significant to the cytotoxicity of the protein (Simpson et al., 1995) 
Finally, because the reactivation of RTA after retrotranslocation involves proteins with broad specificity (Hsc70, 
Hsp90), this thesis hypothesises that this pathway may operate for other ERAD substrates.  Prior investigators 
have shown isolated examples of this phenomenon.  For example the degradation-independent retrotranslocation 
of extracellularly-applied luciferase (Giodini & Cresswell, 2008) and of endogenous calreticulin (Afshar et al., 
2006).  This thesis hypothesises that the success of a protein in being reactivated post-dislocation will be 
determined by stringency of the cell’s chaperone network, the propensity of the substrate to be degraded, and its 
propensity to refold.  As a protein which is toxic to the cell when refolded in the cytosol, RTA will be a useful 
tool to investigate this putative, broadly relevant, post-dislocation activation pathway. 
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CHAPTER 1: 
Introduction 
1.0 Ricin: occurrence, mode of action and the original applications of its study 
Ricin is a potently toxic protein of the castor oil plant, Ricinus communis.  The mature protein 
is found throughout the tissues of its native host at low levels.  However, it is especially 
concentrated in the endosperm of the plant‟s seeds, from which commercially valuable castor 
oil can also be extracted (Alexander et al., 2008).  Consumption of as few as four of these 
poisonous seeds can be a mortal dose for an adult (Wedin et al., 1986).  This extreme toxicity 
first provoked Stillmark (1888) to discover the agent responsible: the protein, ricin.  
The protein itself is a heterodimer, comprising a galactose-binding lectin moiety of 34kDa 
disulfide-bonded to an rRNA N-glycosidase of 32kDa (Olsnes & Pihl, 1973).  These are 
denoted ricin toxin B chain (RTB) and ricin toxin A chain (RTA) respectively.  Its bipartite 
structure and function makes ricin analogous to a broad class of two-component complexes 
with similar operational arrangement – known collectively as AB-toxins.  The B chain of 
these complexes generally has a cell-binding role, helping to localise the holotoxin to the site 
where the A chain thereafter exerts a cytotoxic activity.  This arrangement is also true of ricin 
(Lord & Robert, 1998).  Ricin is also member to a large family of ribosome inactivating 
proteins (RIPs), which are subdivided into two main types (I & II) by the presence or absence 
of a B chain.  Type I RIPs do not possess a lectin B chain, whereas type II RIPs, like ricin, do 
(Lord et al, 1994).  It is thought that these proteins serve an integral function in their native 
hosts as they are found in well over 50 different species spread among 13 taxonomic families 
(Hartley et al., 1996).   
RTB binds specifically to β1-4 linked galactosides.  Therefore, it is able to bind glycoproteins 
and perhaps even glycolipids that are abundant on the cell surface (Baenziger & Fitte, 1979).  
This ensures the holotoxin can adsorb to the exterior of target cells, promoting the 
indiscriminate endocytosis of the protein.  A small portion of the internalised holotoxin can 
then find its way into a compartment from where RTA, the ribosome-inactivating N-
glycosidase, can be translocated across the membrane into the cytosol (Hazes & Read, 1997; 
Wesche et al., 1999).  Therein, it may encounter its substrate: the ribosome.  The catalytic 
activity of RTA specifically targets a single, highly-conserved adenine of 28S rRNA, 
cleaving it from the phosphodiester backbone of a short stem-loop structure (Endo et al., 
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1987).  After this depurination, the ribosome irreversibly stalls during translation as it can no 
longer bind mechanistically-essential elongation factors (Stirpe & Battelli, 2006).   
As the production of ribosomal RNA accounts for 70% of all transcription even under 
unstressed conditions (Granneman & Tollervey, 2007), the cell has only a limited capacity to 
compete against the catalytic activity of RTA.  To emphasise the overwhelming extent of this 
burden, a single RTA is able to inactivate 2000 ribosomes per minute in vitro (Sandvig & 
Van Deurs, 2002).  The target cell, unable to maintain its protein complement, nor to adapt its 
protein expression in response to dynamic environmental and internal cues, ultimately dies.  
Indeed, after intoxication of an animal host by any major route, both apoptosis and necrosis 
are observed in affected tissues (Sha et al., 2010).  Rao et al. (2005) show that, in a simplified 
culture of HeLa cells, viability is lost through a primarily apoptotic route.   
Surprisingly, despite their wide distribution among plants and the attention of significant 
research, the physiological role of RIPs in their native hosts remains a subject of debate 
(Hartley et al., 1996).  Foremost, ricin has been suggested to have a role in warding off 
herbivores (Olsnes & Pihl, 1982).  However, it seems inconsistent that as many as 36 hours 
may pass after ingestion of a lethal dose before the first signs of toxicity become manifest 
(Wedin et al., 1986).  By this time a greedy herbivore may have already consumed a 
significant quantity of the plant, although it is possible that toxicity could have influenced 
forager behaviour over a greater timescale.  Nevertheless, why synthesise a large, 
metabolically-costly protein to fulfil this job?  Why not synthesise a more prudent secondary 
plant substance (examples of which are reviewed in Hruska, 1988), which could achieve a 
similar and more immediate reduction in edibility?   
Responding to these quandaries, multiple other reasons have been posed to explain the 
abundance of ricin and other similar toxins (Table 1.1).  For example: they may have roles as 
storage proteins, fuelling the growth of seedlings as they make the transition from 
heterotrophic reliance upon seed reserves to autotrophy (Hartley et al., 1996).  Alternatively, 
it has been suggested that RIPs have antiviral roles, causing localised deactivation of host 
cells at sites of viral infection (Chen et al., 1991).  This might be especially important near to 
the germ-line, where ricin is particularly concentrated.  RIPs may even be important as 
antifungal agents (Jach et al., 1995).  However, these arguments are based upon the effects of 
exogenous RIPs upon non-native hosts (such as dilute pokeweed antiviral protein sprayed 
upon tobacco leaves).  Indeed, often they do not appear to bestow any additional resistance to 
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viruses and fungi in their native contexts (as reviewed in Hartley et al., 1996).  Ultimately, it 
may be that a combination of these activities explains the pervasiveness of RIPs and the 
heavy accumulation of ricin in castor seeds, which can be as much as 5% of total protein 
content (Lord et al., 1994). 
 
Table 1.1 – Examples of ribosome inactivating proteins 
Species Common name RIP name Type Reference 
Adenia digitata Wild granadilla Modeccin II Gasperi-Campani et al., 1978 
Adenia precatorius Rosary pea Abrin II Wei et al., 1974 
Cucurbita pepo Marrow Pepocin I Yoshinari et al., 1996 
Diathus 
caryophyllus 
Carnation Dianthin 30/32 I Stirpe et al., 1981 
Phytolacca 
ameriacana 
Pokeweed Pokeweed antiviral 
protein 
I Irvin, 1975 
Ricinus communis Castor oil plant Ricin II Lord et al., 1994 
Sambucus nigra Elderberry Nigrin b/f II Citores et al., 1996 
 
Regardless of the physiological role of ricin in Ricinus communis, its potent toxicity has been 
exploited by humans in a number of therapeutic, investigative and criminal applications 
(reviewed in both Hartley et al., 1996; and Lord et al., 1994).  Some examples of its use 
include, as: 
(1) An active moiety in antibody-conjugated immunotoxins that are used to destroy 
cancerous cells, or else allogeneic T lymphocytes from donated bone marrow. 
(2) A tool in developmental biology used to ablate cell lineages under the control of 
stage- or tissue-specific promoters. 
(3) A transgenically-expressed antiviral and antifungal agent in plants. 
(4) A tool to investigate the secretory pathway. 
Page 4 
 
(5) An abortifacient. 
(6) A way to kill other humans. 
For these reasons, and because of the potential future uses of the toxin in related contexts, the 
mechanism of ricin is the subject of ongoing scientific interest. 
1.1 Biosynthesis of ricin in its native Ricinus communis 
The overall route by which ricin invades a target cell has been introduced, but the molecular 
mechanisms governing this feat have not been elaborated upon.  To appreciate the 
fortuitously ingenious trafficking route the holotoxin undertakes, the biogenesis of the protein 
should be made clear.  Unlike its heterodimeric, mature form, ricin is initially translated as 
one contiguous chain with a signal peptide – holistically known as „preproricin‟ (Hartley et 
al., 1996).  During its synthesis, the emergence of an N-terminal signal peptide from the exit 
tunnel of the ribosome ensures the translational complex is targeted to the endoplasmic 
reticulum membrane (Martoglio & Dobberstein, 1998).  There, the nascent polypeptide is co-
translationally channelled into the lumen of the endoplasmic reticulum (ER) through the 
Sec61 translocon.  As the translating polypeptide is incrementally driven through this 
membrane pore by the machinations of the ribosome, several modifications occur. 
First, the signal peptide is cleaved by the lumen-facing activity of signal peptidase.  Then, as 
four primary-sequence embedded N-glycosylation sites emerge from the translocon, they 
become core-glycosylated (Lord, 1985)
1
 by a complex adjacent to the translocon, the 
oligosaccharyl transferase, OST, complex.   Finally, the signal peptide-cleaved, glycosylated 
polypeptide folds into its native secondary and tertiary structural elements, which are 
stabilised by the formation of five intra-chain disulfide bonds (Rutenber & Robertus, 1991).   
This folded, signal-peptide cleaved protein, referred to as „proricin‟, exits the ER by vesicular 
flow and is targeted to vacuolar protein bodies by a twelve-residue region linking RTA and 
RTB (Frigerio et al., 2001).  Upon entry to this vacuolar compartment, the targeting sequence 
is proteolytically excised, liberating the familiar, heterodimeric form of the toxin that we 
refer to as ricin (Butterworth & Lord, 1983).  The five disulfide bonds that originally formed 
in the ER lumen persist in the final structure: four stabilise RTB, whilst the fifth maintains 
                                                 
1
 These asparagine-linked oligosaccharides have no impact upon the final toxicity of ricin, as their absence has 
little effect upon the toxin‟s efficacy (Rapak et al., 1997) 
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the only remaining covalent bridge between RTB to RTA.  The differences between these 
three forms are summarised graphically in Figure 1.1. 
This series of post-translational processing events minimises the possibility that the toxic 
activity of RTA is ever accidentally exposed to the cytosol of the host cell.  Not only is the 
protein compartmentally sealed off from host ribosomes at the moment of its synthesis, but 
even if it were inadvertently translated into the cytosol, uncleaved preproricin is unable to 
depurinate the ribosomes which are the substrate of the mature toxin (Richardson et al., 
1989).  This, along with the fact that many plant ribosomes are RIP-resistant (Frigerio et al., 
1998; Hartley et al., 1996), prevents the accidental death of the host organism. 
 
 
Figure 1.1 - The various forms of ricin during biogenesis of the mature holotoxin 
Showing preproricin, proricin and ricin.  Core N-glycosylation is indicated by the chain of attached circles and 
squares.  Disulfide bonds are indicated by “x”.  One of these bridges RTA & RTB.  The 22 amino acid signal 
peptide and the 12 amino acid linker are shown by the white rectangles, which are progressively excised in the 
subsequent maturation.  RTA is shown in purple.  RTB is shown in green.  The graphics for the image below 
were produced using Paintshop Pro X2, Corel. 
 
 RTA  RTB  
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1.2 The three-dimensional structure of ricin holotoxin 
The fully-folded structure of mature ricin was determined to a resolution of 2.5Å by Rutenber 
& Robertus (1991).  A rendering of this structure is printed in Figure 1.2.  The detail in the 
following section provides a summary of this structural information, with interpretation 
derived from it paraphrased from Lord et al. (1994). 
Ricin toxin A chain (RTA) – The enzymatically active, N-glycosidase moiety of the 
holotoxin possesses eight α-helices and a single β-sheet.  These elements account for roughly 
half of the 267 amino acid subunit.  The N-terminal 40% of the polypeptide folds into a 
discrete conformational unit comprising two of these α-helices and the β-sheet.  Adjunct to 
this domain, the polypeptide is arranged into a bundle of five α-helices, which nestles behind 
the N-terminal β-sheet.  The central helix of this α-helical cluster bears the active site 
residues of the N-glycosidase activity (Glu177 and Arg180), to which the appropriate stem-
loop structure of rRNA must be accessible.  The C-terminal portion of the polypeptide folds 
into another, independent conformational unit centred upon the eighth α-helix.  This discrete 
region, apposed to the active site helical bundle, helps produce the binding cleft of the 
enzyme.  Importantly for future reference, the opposite side of this cleft-forming domain (the 
C-terminus) is hydrophobic and interacts with RTB.  This region also houses the disulfide 
bridge which covalently links the two subunits. 
Ricin toxin B chain (RTB) – The lectin moiety of the ricin holotoxin is 262 amino acids 
long, and is divided into two lobes that are both competent for galactoside binding.  These 
lobes are homologous, having arisen from gene duplication, and each comprises three 
repeated sub-regions derived from an archaic galactose-binding motif.  Only two of these 
sub-regions – one in each of the two lobes – retain galactose-binding properties.  However, 
even these sites bind galactose in an attenuated fashion relative to other sugar-binding 
proteins.  This weak-binding (combined with the wide variety of receptors competent to be 
bound on the typical target cell) has meant that it has been difficult to identify significant cell 
surface receptors for the holotoxin.  Indeed, if any are specifically important in the 
intoxication process, they have not yet been found. 
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Figure 1.2 - The three-dimensional structure of the ricin holotoxin 
Showing the three-dimensional structure of ricin, as published by Rutenber & Robertus (1991).  The 
polypeptide chain is coloured so that the C-terminus region of each chain is blue – progressing through the 
spectrum to red at the N-terminal of both RTA and RTB.  This image was produced using the UCSF Chimera 
package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San 
Francisco.  Depth is implied by the fading in colour saturation. 
 
 
 
 
 
First lectin domain 
(comprising 3 
archaic motifs, only 
one of which is 
functional) 
Second lectin (comprised 
as the first) 
The hydrophobic domain of 
RTA that interacts with RTB 
and provides the disulfide 
bridge 
The central helix of 
RTA which possesses 
the active site 
residues. 
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1.3 Intoxication of a target cell 
When mature ricin is exposed to target cells, intoxication proceeds via a series of events that 
can be divided into distinct stages.  These stages are: 
(1) Binding at the target cell‟s surface, followed by indiscriminate endocytosis. 
(2) Retrograde trafficking to an endomembrane compartment where the phospholipid 
bilayer can be crossed. 
(3) Translocation of active RTA across the membrane into the cytosol. 
(4) Inactivation of target ribosomes. 
The novel content of this thesis focuses upon putative molecular interactions the toxin might 
make on either side of the translocated membrane and the ramifications this may have upon 
downstream processing of the protein by the target cell.  To provide appropriate context to 
these unique findings, the earlier stages of toxin trafficking are summarised below. 
1.3.1 Transit of ricin from the cell surface to the translocation-competent compartment 
Estimates suggest that the average HeLa cell possesses as many as ~3107 independent cell-
surface galactosides that may be bound by RTB (Spooner et al., 2004).  This abundance 
causes the holotoxin to be broadly adsorbed to the cell surface, resulting in its internalisation 
by a variety of endocytic routes – both clathrin-dependent and clathrin-independent (Simpson 
et al., 1998).  Some of these routes deliver ricin to the lysosome, wherein it is degraded.  
Others deliver the holotoxin to early and recycling endosomes (EEs & REs, respectively) that 
stain positively for the trafficking molecule, Rab5 (Moisenovich et al., 2004). 
Much of the toxin which accesses these Rab5-positive compartments is still subject to 
recycling to the plasma membrane, or else to being diverted to the lysosome (Van Deurs et 
al., 1986).  However, a small portion is transported from these endosomes to the trans-Golgi 
network (TGN), which is the onward route for toxicity (Van Deurs et al., 1988).  Trafficking 
to the TGN is Rab9-independent (which regulates transport from late endosomes to the 
TGN), implying a direct transport of ricin from specifically early endosomes to the TGN 
(Lauvrak et al., 2002).  Consistently, Ütskarpen et al. (2006) showed that ricin intoxication 
was sensitive to siRNA knockdown of Rab6A and Rab6, which collectively regulate early 
endosome-to-TGN transport.   
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Ricin is subsequently transported from the TGN to the ER, wherein fluorescence can be 
observed if cells are intoxicated with a GFP-ricin construct (Liu et al., 2006).  Only a 
minuscule quantity of toxin eventually achieves a cytosolic destination relative to that which 
is internalised at the cell surface.  Data from Rapak et al. (1997) also corroborated the 
trafficking route described above in a series of elegant experiments.  They produced a 
holotoxin where the constituent RTA was tagged with vacant glycosylation and sulfation 
sites.  After intoxication of mammalian cells with this holotoxin, they observed that 
glycosylated, sulfated RTA could be retrieved from the cytosol.  These modifications are 
performed by oligosaccharyl transferase of the ER (Yan et al., 1999) and tyrosyl-protein 
sulfotransferate (TPST) of the Golgi (Spooner et al., 2008a), respectively.  Thus, it showed 
that toxin which had gained access to the cytosol had, at one stage during intoxication, co-
localised with both of these activities.  Supporting this hypothesis, increasing the transport of 
ricin to the Golgi and the ER under experimentally-controlled conditions increases the 
cytotoxicity of ricin.  Indeed, Morre et al. (1987) observed that mammalian cells were 
sensitised to ricin when pre-treated with monensin (which increases the flow of protein traffic 
into the Golgi cisternae).  Consistent with these findings, addition of a C-terminal Golgi 
retention motif to ricin, YQRL, had a predictably sensitising effect (Zhan et al., 1998), as did 
addition of the ER retrieval motif, KDEL (Wales et al., 1993).  As native ricin lacks these 
sequences, it is unknown how it achieves an ER localisation.  Contrastingly, cholera toxin, 
another example of an AB-toxin where the A chain dislocates from the ER into the cytosol, 
actually possesses a C-terminal KDEL (Majoul et al., 1998).  Curiously, however, cholera 
toxin can also navigate to the ER if its KDEL sequence is removed (Lencer et al., 1995).  In 
such a case it might be transported to the ER in a more serendipitous fashion, like ricin.  For 
instance, these toxins might hitch-hike upon other proteins that, themselves, have appropriate 
retrieval sequences.   
Day et al. (2001) hypothesised that ricin might disengage from its original, cell-surface 
binding partner after endocytosis.  This would enable it to re-engage with escapee residents 
of the ER or Golgi which possess KDEL motifs.  Indeed, Day et al. (2001) demonstrated that 
ricin could bind to an iconic ER chaperone, calreticulin, in vitro.
2
  Curiously, however, cells 
                                                 
2
 N.B. This binding occurred only between holotoxin and calreticulin and not between RTA and calreticulin.  
Furthermore, it could be disrupted by the inclusion of lactose in the incubation, but was not dependent on the 
glycosylation of the ricin holotoxin.  This implied it was the lectin activity of RTB that was responsible for the 
interaction (Day et al., 2001). 
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remain sensitive to ricin when wider KDEL retrieval is prevented by inhibition of the COPI 
apparatus, preventing Golgi to ER transport (Chen et al., 2003).  This suggests that there is a 
significant alternative route to the ER that remains to be investigated.   
1.3.2 Rationalising the ER as the ultimate endomembrane destination 
Whilst the exact nuances of ricin‟s retrograde trafficking remain obscure, the final destination 
of the holotoxin in the secretory pathway seems very likely to be the ER lumen (Rapak et al, 
1997; Liu et al., 2006; Sandvig et al., 1991).  This finding is consistent with a multitude of 
other AB-toxins that are also transported to the ER (e.g. cholera toxin – Majoul et al., 1998; 
Pseudomonas exotoxin A and Shiga toxins – as reviewed in Watson & Spooner 2006).  
Fittingly, there are abundant machineries in the ER which facilitate the translocation of 
polypeptides across the membrane, which is what RTA must do to reach cytosolic ribosomes.  
Foremost among these machineries is the Sec61 translocon and its accessory factors, which 
are responsible for importing proteins into the ER.  Complementing this apparatus are the 
components of endoplasmic reticulum associated degradation (ERAD), which collectively 
promote the export of undesirable polypeptides to the cytosol.  There, they are hydrolysed by 
the 26S proteasome (Meusser et al., 2005; Werner et al., 1996).   
From the perspective of the toxin, the directionality of polypeptide movement during ERAD 
seems the most appropriate to exploit.  However, how could it evade the proteasomal 
destruction which is usually the tacit outcome of the process?  Hazes & Read (1997) were 
first to report that RTA and the active moieties of many other ER-trafficking toxins (e.g. 
cholera toxin; shiga toxin; pseudomonas exotoxin, pertussis toxin) have low lysine 
complements compared to polypeptides of similar length.  This implied the physiological role 
of these toxins exposed them to a situation where the replacement of these residues would be 
of benefit to the protein‟s function.  As proteasomal degradation is greatly promoted by 
lysine-linked polyubiquitination (Thrower et al., 2001), it seemed the toxins had evolved to 
escape this modification.  Perhaps they had done so to evade polyubiquitination during a 
particularly vulnerable, ERAD-like translocation into the cytosol?  Summarily, investigative 
interest grew out of this hypothesis into two areas of research:  
(1) what features of ricin could make it appear like an ERAD substrate; and, 
moreover, 
(2) what factors of the canonical ERAD machinery might ricin exploit? 
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Before experimental observations that probe these quandaries are introduced, this chapter 
continues by providing a background to the physiological role, nature and dynamics of this 
essential quality control pathway. 
1.4 Endoplasmic reticulum associated degradation (ERAD) 
The endoplasmic reticulum is the first endomembrane compartment which proteins of the 
secretory pathway encounter.  Whether these proteins are co- or post-translationally 
translocated into the ER from their site of synthesis, they are all transiently accommodated by 
the narrow aperture of the Sec61 translocon en route to this organelle (Van den Berg et al., 
2004; Tian & Andricioaei, 2006).  This means that all polypeptides that are secreted into the 
lumen emerge into it in a substantially unfolded, translocation-competent state.  In this state 
they transiently expose hydrophobic regions to the lumenal environment.  These regions have 
a tendency to self-aggregate, forestalling the acquisition of native structures, so promoting the 
accumulation of dysfunctional ones.  To mitigate these detrimental side-reactions, there are 
abundant chaperones in the ER lumen that temporarily bind these regions.  This shield of 
chaperones persists until enough contiguous polypeptide has emerged from the translocon to 
enclose hydrophobic stretches within appropriately hydrophilic encasements.  Indeed, the 
lumenal equivalent of the Hsc70 molecular chaperone, BiP (Kar2 in yeast), binds imported 
polypeptides as they emerge, ensuring just that (Hammon & Helenius, 1994). 
Nevertheless, the folding process often goes awry if the capacity of the cell to successfully 
nurture the folding of nascent protein is exceeded.  This occurs under conditions of, for 
instance, heat or oxidative stress, nutrient starvation; or after translational errors and mutation 
(Schröder & Kaufman, 2004; McClellan et al., 2005).  Moreover, under unstressed 
conditions, the subunits of multimeric complexes can be synthesised in incorrect ratios, 
yielding orphan polypeptides that lack the partners that usually complement their native state 
(Vanhove et al., 2001).  Even after having assumed a native state, proteins remain subject to 
varying degrees of regressive unfolding – whether these are stochastic or stress-induced.  
This results in the ongoing potential for terminally-misfolded conformers to be generated. 
To prevent the accumulation of misfolded species in the secretory pathway and to ensure that 
detrimental gain-of-function misfolds are not communicated to neighbouring cells, they are 
degraded.  Some proteins of the secretory pathway are transported to the lysosome, wherein 
they are hydrolysed by proteases (McCracken & Brodsky, 2006).  As a drastic measure at 
times of stress, the entirety of overloaded compartments can be degraded by autophagy 
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(Kincaid & Cooper, 2007).  Often, however, misfolded proteins are isolated in the early 
stages of the secretory pathway, preventing their transmission to downstream organelles and 
neighbouring cells.  These proteins are degraded by cytosolic 26S proteasomes, the process 
which is designated „ERAD‟ (Werner et al., 1996).  
However, removal of unwanted polypeptides from the ER lumen to the cytosol is no trivial 
task.  Indeed, each ERAD client investigated to date is managed by a – sometimes vastly, 
sometimes subtly – distinct retinue of facilitators (as reviewed by Nakatsukasa & Brodsky, 
2008).  Still, there are common procedures that unite all ERAD pathways.  In brief: 
(1) Misfolded substrates have to be recognised, which is usually achieved by a 
combination of membrane factors, lingering associations with chaperones and 
lumenal lectins.   
(2) The recognition factors bridge an interaction of the substrate with the 
retrotranslocation machinery.  This machinery is contributed to by a miscellany of 
membrane-associated and membrane-integral complexes that may accommodate exit 
of the polypeptide from its ER locale (i.e. form a pore).   
(3) Finally, upon the cytosolic side of the ER membrane, there are co- and post-
translocational processing events which effectively drive extraction of the misfolded 
polypeptide from the membrane compartment and prepare it for degradation by the 
26S proteasome. 
The variety of ways in which these steps are achieved is outlined in the following sections. 
1.4.1 How the cell identifies ERAD candidates 
Quality control pathways in the ER must resolve terminally-misfolded polypeptides from 
those which are only transiently unfolded and those which are actually appropriately folded.  
However, the nature of a conformational faults can vary greatly, a corollary to the variety of 
stresses, mutations and chance events a cell may endure.  Moreover, a fault can be localised 
to distinct phases of the ER environment: the lumen, the core of the lipid bilayer itself, or 
even to the cytosolic side of the ER membrane.  Because of this diversity of „symptoms‟, the 
array of factors implicated in the diagnosis of ERAD substrates is complex, providing a 
variety of contingencies (reviewed in Määttänen et al., 2010).  Contrastingly, downstream of 
substrate recognition, the similarity between initially separate pathways increases, converging 
upon the final, rude, step of degradation in the proteasomal core (Carvalho et al., 2006).  
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All the same, detection of ERAD clients relies upon two related, general attributes: chronic 
residence in the ER lumen and chronic exposure of hydrophobic regions (Määttänen et al., 
2010).  Retention in the ER can occur if a conformer fails to display appropriate export 
motifs on its surface (Ellgaard & Helenius, 2003).  Retention would also occur if a client had 
a lingering interaction with ER chaperones, as would be the case when a misfolded protein 
recurrently displays hydrophobic regions to the solvent (Vanhove et al., 2001). 
One of the best-elaborated mechanisms measuring prolonged ER-residency is the so-called 
„mannose timer‟ shown in Figure 1.3.  The information that follows is discussed more 
broadly in reviews by Wang & Ng (2008); Eriksson et al. (2004); and Määttänen et al. 
(2010).  First, nascently secreted proteins with appropriate N-X-(S/T) glycosylation sites 
become core-glycosylated in the ER ([N-acetyl-glucosamine]2[mannose]9[glucose]3).  This 
core glycan is then subjected to the sequential activities of relatively fast-acting ER-resident 
glucosidases.  These trim the two terminal glucose residues of the glycan, which promotes 
interaction of the glycoprotein with the ER lectins: calreticulin (Crt) and calnexin (Cnx).  
These lectin chaperones specifically recognise the monoglucosylated form of the glycan, an 
interaction which a final glucosidase can liberate the client from by removal of the last 
glucosyl moiety.  Freed glycoproteins remain competent to rejoin interactions with 
calreticulin and calnexin if an ER-localised UDP-glucose:glycoprotein transferase (UGGT1) 
restores the terminal glucose residue.  Such is the case if the protein fails to be exported.  
However, if the glycoprotein is misfolded it will stay in the ER for an especially long time.  
This is caused by prolonged chaperone interactions and failure to qualify for export to 
downstream compartments.  In this case, a slow-acting mannosidase (e.g. EDEM1/2/3 in 
mammals, or Htm1/Mns1 in yeast) removes a mannose residue from the glycan.  This 
modification prevents UGGT1 from binding the glycoprotein, and irreversibly removes it 
from the calreticulin/calnexin cycle.  The glycan generated by EDEM is thereafter competent 
for interaction with another ER lectin, OS-9 (in mammals; Yos-9 in yeast), which bridges it 
to downstream ERAD components (Qian et al., 2008).   
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Figure 1.3 – Schematic of the mannose timer.  
The pathway is described in text above.  The large blue circle denoted ‘P’ represents the client protein in the 
ER.  The smaller blue squares attached represent N-acetyl glucosamine residues; blue circles mannose 
residues; blue triangles represent glucose residues.  “Onward transport” can be facilitated by vesicle sorting 
receptors that recognise protein cargoes and interact with the cytosolic COPII machinery.  Note EDEM is a 
mammalian protein; in yeast it is called mannosidase I.     
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Other routes by which clients may be co-opted onto ERAD pathways are less clear.  
However, they must exist to cater for proteins which are not glycosylated.  What is more, not 
every glycoprotein is subjected to the mannose timer mechanism.  Indeed, some 
glycoproteins are able to persist in the ER for long periods of time, in complexes with 
chaperones.  For instance immunoglobulin heavy chains, which are retained in complex with 
BiP until their light chain binding partners are secreted into the lumen (Vanhove et al., 2001).  
Alternative mechanisms determining ERAD candidacy may be stochastically driven like the 
mannose timer.  However, they might rely more simply upon prolonged chaperone 
interaction rather than a deterministic glycan switch.  Indeed, OS-9 – which interacts with 
membrane integral ERAD machinery – can be found in complexes with two lumenal 
chaperones: Grp94 and BiP.  The joint properties of these proteins may form an integral 
client-sensing gating complex to downstream ERAD effectors (Eletto et al., 2010; Kabani et 
al., 2003).   
Unfortunately, it remains difficult to differentiate potential gating functions of lumenal 
chaperones from purely chaperoning activities, given that aggregation prevents ERAD 
(McCracken & Brodsky, 2006).  It is also unclear whether Grp94 has a role in „herding‟ the 
client to the chaperone machinery, or whether it is itself responsible for maintaining the 
complexes involved in handling the client (an argument made in a review by Nakatsukasa & 
Brodsky, 2008).  The line therefore blurs between chaperone, gating arbiter and complex 
maintainer. 
1.4.2 Membrane complexes involved in ERAD – multi-functional pores? 
After recognition, substrates are passed to membrane-integral complexes.  These membrane-
associated assemblies are one of the most interesting aspects of ERAD, given the various 
tasks they must fulfil.  All recognise substrates, accommodate their exit from the ER 
membrane, and recruit cytosolic factors involved in downstream degradation.  In 
Saccharomyces cerevisiae, there are two major complexes centred on two distinctive E3 
protein:ubiquitin ligases: Doa10 and Hrd1 (these complexes and their associates are given a 
pictorial review by Kawaguchi & Ng, 2007).  E3 protein:ubiquitin ligases are responsible for 
the ubiquitination of their substrates, a modification which fosters their interaction with the 
proteasome (Thrower et al., 2001).  Remarkably, the Doa10 and Hrd1 complexes handle 
starkly different substrates. 
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1.4.2.1 ERAD-L & ERAD-M: The Hrd1 complex of Saccharomyces cereivisiae 
Substrates with conformational faults localised to the lumen are directed to the Hrd1 pathway 
(Figure 1.4).  They are initially recognised by a presumptive „gating complex‟ that may 
comprise Yos9, Kar2, and Grp94 (Eletto et al., 2010; Kabani et al., 2003).  This triumvirate 
of factors associates with the lumenal domain of an integral membrane protein, Hrd3, to 
which they are thought to pass clients like a mutant of the soluble protein α1-antitrypsin, i.e. 
α1-antitrypsin null Hong Kong (α1-AT NHK; Christianson et al., 2008), and glycoproteins 
(Eletto et al., 2010).  Hrd3 can also independently recognise and retain misfolded ER 
proteins, e.g. soluble, mutant carboxipeptidase Y (CPY*) without the direct aid of the gating 
complex (Gauss et al., 2006; and references in Hirsch et al., 2009).  However, it seems 
reasonable to think that it works synergistically with the soluble chaperone complex to audit 
the contents of the ER.  Hrd3, in turn, is bound stoichiometrically to the transmembrane E3 
ligase, Hrd1 (Gardner et al., 2000).  The E3 ligase activity of Hrd1 is required for the 
degradation of CPY* in the cytosol (Li et al., 2010; Bordallo & Wolf, 1999).   This shows 
that degradation by other ERAD machinery cannot compensate in this context.  Gardner et al. 
(2000) show that Hrd1 over-expression without the correlate up-regulation of Hrd3 leads to 
the promiscuous degradation of folded lumenal proteins.  This demonstrates that the task of 
selecting misfolded clients is delegated to the other, upstream, factors. 
The Hrd1 complex is also involved in the degradation of proteins with transmembrane 
aberrations, such as the Parkin-associated endothelin-like receptor, Pael-R (Omura et al., 
2008).  Problematic transmembrane domains might precipitate irregular structural phenotypes 
in connected lumenal domains.  These would be recognised by soluble machinery.  However, 
it has also been shown that a transmembrane helix of Hrd1 can detect tell-tale hydrophilic 
residues embedded in the otherwise hydrophobic core of the membrane, facilitating their 
transfer of the offending protein to a degradation pathway (Omura et al., 2008). 
How Hrd1 substrates are channelled through the membrane after their recognition – a process 
known as „dislocation‟ or „retrotranslocation‟ – is unknown.  It has been hypothesised that 
Hrd1 forms part of a conduit through the membrane by merit of its six transmembrane helices 
(Omura et al., 2008).  It could even assemble the true pore components.  Indeed, Hrd1 also 
associates with Usa1, a transmembrane protein which recruits Derlin-1 to the complex 
(Hirsch et al., 2009).  Derlin-1, which also bears six transmembrane helices, is another 
potential pore constituent.  It is required for the degradation of a set of clients with mostly 
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lumenal (rather than intra-membrane) faults, such as the transmembrane human V2 
vasopressin receptor (Schwieger et al., 2008).  It could be that Derlin-1 specifically tailors the 
dimensions of the membrane pore for such clients (Yihong et al., 2004).   
After partially emerging onto the cytoplasmic face of the ER membrane, dislocated proteins 
are thought to be subjected to lysine-ubiquitination by the cytoplasm-facing RING finger 
ubiquitin ligase of Hrd1 (Hirsch et al., 2009).  The ubiquitination cascade that leads to the 
priming of transferred ubiquitin residues is also enabled by membrane-associated proteins.  
An E2 enzyme, Ubc7, is tethered to the membrane by interaction with the transmembrane 
protein called Cue1, which interacts with Hrd1 (Bazirgan & Hampton, 2008).  E2 ubiquitin-
activating enzymes are involved in the sequence of reactions which prime ubiquitin for the 
ligation reaction that is catalysed by an E3 ubiquitin ligase‟s activity.  After ubiquitination, 
the substrates of the pathway converge with those of the Doa10 route, which is outlined next. 
1.4.2.2 ERAD-C: The Doa10 complex of Saccharomyces cerevisiae 
ERAD clients that are embedded in the ER membrane and which have cytosolic faults are 
degraded by a complex including Doa10 (Figure 1.4).  As Doa10 contains fourteen 
transmembrane domains, it has been suggested that it may form a pore (Kreft et al., 2006).  
Membrane integral substrates of this complex include the mutant α-factor transporter, 
designated Ste6*, and the plasma membrane H
+
-ATPase, abbreviated to PMA1 (Ravid et al., 
2006).  Much like Hrd1, Doa10 is accompanied by membrane-integral proteins which 
activate its E3 ligase activity.  These include: Ubc7, Ubc6 & Cue1 (Huyer et al., 2004).  
Interestingly, Doa10 also contributes to the degradation of soluble cytoplasmic proteins, like 
the Mat alpha2 receptor (Swanson et al., 2001).  However, such substrates do not appear to 
require downstream extraction machinery to facilitate this process (Ravid et al., 2006).  
Metzger et al. (2008) studied an example of this pathway, using a soluble, cytosolic orotidine 
5-phosphate decarboxylase with a degradation-promoting C-terminal tag (Ura3-CL).   
Precisely how valid substrates are distinguished by the Doa10 complex is unknown; the 
identification of a simple „switch‟ is lacking.  Still, it has been shown that cytoplasmic 
chaperones, e.g. Hdj1 and Ydj1 (Hsp40s) and Ssa1 (Hsc70), are required for the execution of 
the route (Metzger et al., 2008; and references in Nakatsukasa & Brodksy, 2008).  These 
chaperones might be required at any number of stages during the process (e.g.  in complex 
assembly, or an anti-aggregation role), but it has been proposed that they might gate the 
complex, analogous to the way Yos9/Kar2/Grp94 might gate the Hrd1 pathway in the lumen.   
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Figure 1.4 – The ERAD-C, ERAD-L and ERAD-M complexes 
The following figure is heavily influenced by the Cell Snapshot produced by Kawaguchi & Davis (2007).  Unlike 
their figure, machinery downstream of the E3 ligase is omitted for clarity (as these are discussed in the next 
section of this introduction).  ERAD substrates are the fleshy-pink wiggles and transmembrane domain 
proteins marked with asterisks (the asterisk denotes the topology of the conformational fault the substrates 
bears).  1) Substrates are recognised for ERAD-L by a combination of the mannose timer and the gating 
complex formed by chaperones Kar2, Grp94 & Yos9 (Christianson et al., 2008).  2) Substrates are recognised 
for ERAD-M by a transmembrane domain of Hrd1 (Omura et al., 2008), as well as by the mannose time 
mechanism and Yos9.  3) Substrates are recognised for ERAD-C by a combination of Doa10 and putatively a 
gating complex consisting of Hsp40s (Ydj1 & Hdj1) and Hsc70 (Ssa1) – see Nakatsukasa & Brodksy (2008).  
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1.4.2.3 A role for the Sec61 translocon in polypeptide export? 
Early in the ERAD field it was proposed that the Sec61 translocon might simply be co-opted 
for the retro-translocation process.  With the aid of supplementary, ERAD-specific factors it 
could become a „dislocon‟.  However, as Sec61 is important for the initial translocation of 
these polypeptides into the ER, it has been difficult to differentiate import failure from export 
success.  Nakatsukasa & Brodsky (2008) make a comprehensive review of arguments for and 
against its involvement.  Pilon et al. (1997) note that conditional Sec61 mutants are deficient 
in the retrotranslocation of ERAD clients like CPY* when shifted to Sec61-inactive 
conditions.  Additionally, if the ERAD of a glycoprotein is reconstituted in vitro using 
microsomes, retrotranslocation can be prevented if translating ribosomes are first bound to 
Sec61 (Gillece et al., 2000).   
Hebert et al. (2010) argue against Sec61 involvement because the minimal diameter of a 
glycoprotein is 20Å.  They compare this to the aperture of the related, Archaeal SecY, which 
is too narrow, at 3Å (Van den Berg et al., 2004).  Prior investigators, however, have shown 
that the mammalian translocon may be more flexible, its inner enclosure stretching to a 
diameter of 40-60Å during polypeptide import (Hamman et al., 1997).  Nevertheless, 
Nakatsukasa & Brodsky (2008) review how experimenters have consistently failed to isolate 
Hrd1/Doa10 complexes containing Sec61.  Moreover, they cite numerous studies where 
integral membrane substrates are efficiently degraded even when the translocon has been 
disrupted (using conditional mutants).  One thought they express is that formation of Sec61-
inclusive complexes may be transient, explaining why they may not have been observed to 
date.   
Need there be a physical pore at all for some substrates? Ploegh (2007) speculates that 
misfolded proteins might exit the ER environment attached to lipid droplets.  His model 
suggests that insertion of neutral lipid into the bilayer can form discrete, lens-like domains.  
These could be ejected into the cytosol as lipid droplets.  Microdomains of these droplets 
could possess bilayer-like properties, or „wrinkles‟.  Such domains would permit the 
accommodation of integral membrane proteins, including chaperones like calnexin.
3
  This 
would expose their lumenal domains to the cytosol, where they could be recognised by 
quality control.  Ploegh (2007) argues that it is plausible that soluble lumenal protein could be 
transported as well, piggy-backing upon integral-membrane proteins with chaperoning 
                                                 
3
 Which are consistently found associated with lipid droplets, along with BiP (Ploegh, 2007). 
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properties.  Correct or not, this creative speculation highlights how a definitive pore has not 
yet been identified by the field.  This particular issue, therefore, is in need of both 
clarification and – perhaps – novel thinking like Ploegh‟s. 
1.4.3 Driving extraction from the ER membrane in Saccharomyces cerevisiae 
The components mentioned so far recognise ERAD clients and accommodate them through 
the membrane.  They also ubiquitinate them as they emerge into the cytosol.  However, how 
client proteins are driven through the membrane remains to be explained.  Other modes of 
protein translocation require the expenditure of energy to determine their unidirectionality.  
Indeed, transport is often coupled to the hydrolysis of ATP or GTP by the facilitating 
translocase and client-bound chaperones, or by the coupling of the process to the dissipation 
of an electrochemical gradient (Table 1.2).   
The provision of energy during ERAD falls to different factors according to the substrate in 
question.  Two complexes containing ATPases associated with assorted cellular activities 
(AAA proteins) are generally involved.  These are Cdc48, or else subunits of the 19S 
proteasomal cap (Nakatsukasa & Brodsky, 2008).  It is thought that these might act as 
motors, dragging substrates from the membrane (Figure 1.5).  In some cases, the progressive 
polyubiquitination of client lysines might help ratchet the client into the cytosol.  The same 
modification also improves the ability of Cdc48 and the proteasomal cap subunits to bind the 
substrate (Meusser et al., 2005).  
Cdc48 is a soluble, hexameric protein that is both an „unfoldase‟ and a protein complex 
„segregase‟ (Schuberth & Buchberger, 2005; Ye et al., 2004).  Given these generic properties, 
its role extends beyond ERAD.  It is involved in, for instance: membrane fusion, 
transcriptional activation, cell cycle control, apoptosis and is also functionally implicated as a 
molecular chaperone (Wang et al., 2004).  Tailored to these various roles, Cdc48 has multiple 
co-factors which „plug-in‟ to its fundamental activity.  During ERAD, Cdc48 is tethered 
closely to the Doa10/Hrd1 core membrane complexes by the transmembrane protein, Ubx2 
(Schuberth & Buchberger, 2005).  Beyond Ubx2, there are broadly three classes of Cdc48 
ERAD co-factors: 
(1) Ubiquitin-binding proteins such as Ufd1/Npl4 which help Cdc48 bind clients with 
greater avidity (Schuberth & Buchberger, 2005).   
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(2) A substrate-processing enzyme, PNGase (peptide-N4-(acetyl-β-glucosaminyl)-
asparagine amidase), removes N-linked glycans from glycoproteins.  This is a 
prerequisite for their proteasomal degradation (Fagioli et al., 2001; Kim et al., 
2006).  PNGase and Ufd1/Npl4 can bind to Cdc48 at the same time (Raasi & 
Wolf, 2007), suggesting the tight coupling of binding and deglycosylation.   
(3) The co-factors Rad23/Dsk2 bridge Cdc48 to the proteasome, with built-in 
ubiquitin-like domains (Raasi & Wolf, 2007).   
Holistically, the Cdc48 complex therefore links three processes that facilitate proteasomal 
degradation: substrate binding, substrate processing and, ultimately, substrate transfer to the 
proteolytic complex.  Substrates that use Cdc48 can be any of the three classes of ERAD 
substrate: soluble and lumenal e.g. CPY*; transmembrane with lumenal faults, e.g. Hmg-CoA 
reductase; or transmembrane with cytosolic faults, e.g. CFTR
∆F508
 (Rabinovich et al., 2002; 
Gnann et al., 2004). 
A certain subset of clients can be extracted from the ER by the proteasome alone, e.g. pro-
alpha-factor (Lee et al., 2004; reviewed in Meusser et al., 2005).  Indeed, proteasomes 
associate very closely to Sec61 in vivo (Ng et al., 2007).  Lee et al. (2004) pinpointed that the 
19S cap of the proteasome alone is sufficient to facilitate the extraction of pro-alpha-factor 
from ER-derived microsomes.  Subsequent addition of the 20S core complex caused the 
degradation of the retrotranslocated substrate, reconstituting the ERAD pathway entirely.  
This same finding showed that degradation was not intrinsically coupled to extraction.  The 
cap complex comprises 19 individual proteins.  Nine of these segregate into a polyubiquitin-
binding lid (the first example of a ubiquitin binding protein was mammalian s5a / yeast 
Rpn10 of this lid complex – Van Nocker et al., 1996).  A decameric base unit contacts the 
core particle; 6 of these are AAA proteins, like Cdc48.  This ring helps to unfold substrates, 
an activity which may be useful for prising a protein from the ER membrane (Lee et al., 
2004).     
Recently, Lipson et al. (2008) identified that certain subunits of the 19S cap are ERAD-
specific, e.g. Rpt4.  Other subunits may have a more general role in regulating access to the 
core particle (e.g. Rpt2).  Lipson et al. (2008) also showed that degradation of some 
substrates, like CPY*, depends on both Cdc48 and the proteasomal cap.  They hypothesised 
that they could work redundantly – in parallel – or sequentially during extraction.  Li et al. 
(2010) noted that different versions of the same ERAD substrate (RTA, in fact) depended on 
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one or the other for extraction.  This would support a partially redundant mechanism, where 
Cdc48 and Rpt4 can recognise distinct client features, rather than a sequential one (Figure 
1.5).   
One question that arises is: if the proteasome can extract substrates as Cdc48 does, then why 
duplicate the extraction machinery?  It is thought that the intercession of this protein between 
retrotranslocation and degradation provides useful regulatory properties; properties which the 
cap does not have, such as glycan removal.  Despite this, Kim et al. (2006) review how a 
number of glycoproteins do not actually require PNGase to facilitate their degradation, such 
as CPY*, T cell receptor α chain (TCR-α), and class I major histocompatability complex 
(MHC) proteins. Ironically, a processing buffer like Cdc48 – physically separating client 
extraction and client degradation – might be significant to the toxicity of ricin in the 
mammalian context. 
Figure 1.5 - Cdc48 and the proteasomal cap drive extraction of ERAD substrates. 
The following figure is heavily influenced by the Cell Snapshot produced by Kawaguchi & Davis (2007).  It 
shows the Cdc48 and proteasomal mechanisms of extraction from the ER (Meusser et al., 2005).  Cdc48 is 
recruited to the Doa10 and Hrd1 complexes by Ubx2 (left-most model).  Ubiquitin chains are indicated by the 
contiguous chain of little blue circles.  Some substrates can use proteasomal caps to facilitate extraction 
(centre model).  The proteasome complex binds to Sec61 (Ng et al., 2007).  Some substrates use both Cdc48 
and the proteasomal caps.  Lipson et al. (2008), formulated parallel (leftmost and centre models) and 
sequential (right-most model) modes of extraction.  Purple arrow indicates sequential transfer of substrate. 
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Table 1.2 - Protein Import Pathways and their Driving Forces 
Collated from the sources in the right-hand column.  ‘TAP’ refers to the transporter associated with antigen 
processing, whereby exogenous proteins are translocated into the ER lumen and associated with MHC class I 
molecules. ‘AAA’ stands for ATPase associated with assorted cellular activities.  This table is intended to be 
representative and not comprehensive. ∆pH indicates a proton gradient separated by a selectively-permeable 
membrane.  ∆Ψ indicates an electrochemical gradient across a membrane. 
Pathway Moniker Dominant ‘driving’ forces Further Reading 
ER
 im
p
o
rt
 
Co-translational Ribosome-driven chain extension  Corsi & Schekman, 1996 
Post-translational 
Brownian motion coupled to a BiP-
dependent ratchet. 
Corsi & Schekman, 1996 
TAP transporter ATP hydrolysis by translocases. Ehses et al., 2005. 
M
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o
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o
n
d
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al
 
Im
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o
rt
 
(P
o
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n
sl
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n
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) 
To the inner-membrane 
space 
∆Ψ between inner & outer membranes. 
Wiedemann et al., 2004. 
To the matrix 
∆Ψ and Brownian motion coupled to a 
matrix-localised Hsp70 ratchet. 
C
h
lo
ro
p
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st
 Im
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o
rt
 
(P
o
st
-t
ra
n
sl
at
io
n
al
) To the stroma ATP &  GTP hydrolysis by translocases. Soll & Schleiff, 2004. 
To the thylakoid lumen ∆pH, which controls pore dynamics.   Robinson & Bolhuis, 2004. 
Bacterial secretion 
ATP hydrolysis by SecA upon the cis-
side of the membrane. 
Driessen & Nouwen, 2008. 
ER export 
AAA proteins of Cdc48 and the 
proteasomal cap.  An ubiquitin ratchet 
may also provide synergy. 
Meusser et al., 2005. 
 
 
1.4.4 Unique characteristics of mammalian ERAD 
The machineries of mammalian ERAD are more elaborate than those of yeast (Table 1.3).  
This reflects the broader array of clients and more complex layers of regulation that both 
multi-cellularity and developmental pathways demand.  Indeed, the key apparatuses that 
Saccharomyces cerevisiae possesses are all represented and some are expanded.  However, in 
contrast to Saccharomyces cerevisiae, the mammalian cohort of ERAD-implicated E3 ligases 
is supplemented by a soluble, cytosolic set (reviewed in Nakatsukasa & Brodsky, 2008; 
Ballinger et al., 1999).  The degradation of both the cystic fibrosis transmembrane 
conductance regulator (CFTR) and apolipoprotein B (ApoB) epitomises the participation of 
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these soluble E3 ligases in ERAD.  CFTR is a large, polytopic plasma membrane protein that 
is avidly degraded by ERAD (Alberti et al., 2004).  This degradation occurs to a disease-
causing extent in people who are homozygous for the mutant CFTR
∆F508
.  In this version of 
the protein, the conformation of a cytosolic ATP-binding cassette is disrupted (Alberti et al., 
2004; Hirsch et al., 2009).  Hsc70 detects the prolonged ER-residency this fault causes 
(Albert et al. 2004), much as its yeast ortholog, Ssa1, may recognise clients at the outset of 
the Doa10 pathway (Metzger et al., 2008).  Prolonged association of Hsc70 with CFTR
∆F508
 
leads to an increased chance of polyubiquitination.  This polyubiquitination is promoted by 
the soluble, Hsc70-dependent, Hsc70-binding E3 ligase called CHIP (Alberti et al., 2004).  
CHIP ubiquitinates both client and chaperone, leading to client degradation by localisation of 
the client-bound complex to the proteasome (Minami et al. 1996; Alberti et al., 2003).  This 
pathway is quite distinctive, in that it delegates the entirety of the recognition and 
polyubiquitination processes to soluble, cytosolic factors. 
This functional contribution of CHIP to the ERAD of CFTR
∆F508
 highlights the potential 
significance of another two soluble E3 ligases that have been implicated in ERAD, yet have 
no yeast correlates.  One is FBX2, which recognises and ubiquitinates glycoproteins (Yoshida 
et al., 2002).  The other is Parkin, which is analogous to CHIP in that it selects its substrates 
in an Hsc70-dependent manner (Pratt et al., 2010).  Their exact preference for substrates and 
prevalence of their involvement in ERAD, however, is not well understood.   
Interestingly, a core E3 ligase of yeast, Hrd1, has two homologues in mammals.  One is very 
similar to Hrd1, whilst the other (gp78) has acquired an ubiquitin-binding domain much like 
yeast‟s Cue1.  Morito et al. (2008) showed that this motif gates access of substrates to gp78‟s 
RING-finger domain, which cannot start ubiquitin chains de novo.  They speculate that other 
E3 ligases work upstream of gp78.  Indeed, they show that gp78 co-operates in this manner 
with another mammal-specific transmembrane E3 ligase, RMA1, in the degradation of 
CFTR
∆F508
 (Morito et al., 2008).  
The participation of these three complexes – gp78, RMA1 and Hsc70/CHIP – in the 
degradation of CFTR
∆F508
 highlights a good example of redundancy between E3 ligases 
(Morito et al., 2008).  Adding to this picture, if CFTR
∆F508
 is exogenously expressed in yeast, 
the Doa10 complex facilitates its degradation (Younger et al., 2004).  The homolog of Doa10 
in mammals, TEB4, has only recently been identified (Kreft et al., 2006; Nakatsukasa and 
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Brodsky, 2008).  It therefore remains unclear whether it also handles CFTR
∆F508
 in the 
mammalian context. 
 
Table 1.3 - Select factors implicated in both Yeast and Mammalian ERAD 
This table is much as printed in Nakatsukasa & Brodsky (2008).  Derlin-1 can be immunoprecipitated with those 
proteins which are underlined (with additions made as noted by Hebert et al. 2010).  Additional homologs 
have also been added, as per Raasi & Wolf (2007).   
Mammals Yeast (Saccharomyces cerevisiae) 
Cytosol- and membrane-associated  
P97-UFD1-NPL4 Cdc48-Ufd1-Npl4 
(No obvious correlate) 
(No obvious correlate) 
(No obvious correlate) 
Ufd2 
Rad23 
Png1 
CHIP  
FBX2  
Parkin 
Soluble E3 ligases 
ATX3 
Rad23 
N-glycanase 
Membrane-associated  
HRD1-SEL1L 
gp78 
RMA1, TRC8 & RFP2 (Transmembrane E3 ligases). 
TEB4 
Ubc6e 
Ubc 
HERP 
VCP-interacting membrane protein (VIMP) & ERASIN 
Derlin-1, -2 and -3 
Sec61 
(Incorporated into gp78) 
Hrd1-Hrd3 
(Hrd1-like & Cue1-like domain) 
(No obvious correlates) 
Doa10 
Ubc6 
Ubc7 
Usa1 
Ubx2 
Der1 
Sec61 
Cue1 
ER lumen- and membrane-associated  
OS-9 and XTP3-B 
EDEM-1, -2 and -3 
BiP 
PDI 
Yos9 
Htm1 (now Mns1). 
Kar2 
PDI 
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Apolipoprotein B (ApoB) is the other cited example of a substrate whose ERAD is 
contributed to by CHIP.  However, its ERAD is notable for different reasons as well.  ApoB 
is a core constituent of low-density and very-low density lipoproteins, which are involved in 
cholesterol transport (Shepherd, 1994).  During import into the ER, ApoB is loaded with lipid 
and cholesterol.  However, if either is absent, then the N-terminal domain no longer 
associates with ApoB-specific lumenal factors that facilitate its co-translational translocation 
(Gusarova et al., 2001; Brodsky et al., 2007).  After dissociation of these factors, translation 
in the cytosol continues, but the remaining peptide is not passed through the pore, instead 
distending a misfolded loop into the cytosol.  This loop is subsequently recognised by both 
Hsc70 and Hsp90, which target it for degradation by cooperation with CHIP (Gusarova et al., 
2001). The protein is therefore degraded in a co-translational, co-translocational manner in 
response to regulatory cues from the lumen.   
Interestingly, this “aborted” translocation pathway functions more broadly at times of stress 
(Oyadomari et al., 2006).  That is, when the ER is overcome with unfolded protein.  This 
curtails the escalation of the ER‟s quality control burden (Kawaguchi & Ng, 2007).  Negative 
feedback from the lipid content of the lumen also regulates the ERAD of proteins like HMG-
CoA reductase (Song et al., 2005).  Such feedback appears to be a recurring theme, as there 
exists an ERAD-implicated E3 ligase that directly senses sterols and down-regulates the 
proteins responsible for their synthesis, designated TRC8 (Lee et al., 2010; Nakatsukasa & 
Brodsky, 2008; Brauweiler et al., 2007).  Given Ploegh‟s (2007) speculation about the 
involvement of lipid droplets in the egress of ERAD substrates from the ER, this poorly-
characterised category of lipid-sensing factors may hold greater significance for the field of 
ERAD.  For instance, the wider integration of lipid and protein homeostasis.  This remains to 
be determined. 
1.5 Ricin and the ERAD pathway it might exploit 
Over the years, building experimental evidence has suggested that ricin exploits ERAD to 
dislocate RTA into the cytosol.  Inhibition of the proteasome results in the sensitisation of 
mammalian cells to ricin (Wesche et al., 1999), implying RTA (originally applied at the cell 
surface as part of a holotoxin) is a candidate for degradation by the complex.  However, this 
observation could be descriptive of an ultimately cytosolic location rather than of an ERAD-
style retrotranslocation.  Similarly, Deeks et al. (2002) showed that introducing additional 
lysines into RTA decreased its toxicity, suggesting the subunit was exposed to the 
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ubiquitination machinery of the cell during intoxication.  Whether this was the ubiquitination 
machinery of an ERAD-specific process, or simply of cytosolic quality control remained a 
question.  Clarifying this issue, Li et al. (2010) showed that RTA synthesised in the cytosol 
of yeast, without a signal peptide, is rather stable.  This indicates some process predisposes 
RTA to degradation specifically during intoxication.  Indeed, Argent et al. (2000) report that 
folded RTA is strikingly resistant to protease digestion in vitro. The obvious process that 
might render RTA vulnerable to protease digestion in vivo is an unfolding step associated 
with ERAD (Fagioli et al., 2001; Beaumelle et al., 1997; Argent et al., 1994).   
In the mammalian context, the sensitivity of cells to cholera toxin (which also has a lack of 
lysines and is targeted to the ER) is affected in cells where the ERAD machinery has been 
mutated.  Teter et al. (2003) identified a mutant cell-line which was resistant to cholera toxin 
and which degraded a soluble, lumenal ERAD substrate, α1-AT NHK, more efficiently.  
Teter & Holmes (2002) identified a ricin-resistant cell line which simultaneously exhibited 
the reduced degradation of α1-AT, owing to decreased dislocation rather than a fault in 
cytosolic degradation machinery.  The properties of both cell lines linked the function of 
ERAD to the fate of an ER-dislocating toxin.  Using a different approach, Slominska-
Wojewodzka et al. (2006) showed that targeted interference with a component of mammalian 
ERAD (i.e. EDEM) affected the toxicity of ricin.
4
   
In yeast, convincing evidence has suggested RTA exploits ERAD.  Most comprehensively, 
an entire set of factors was identified by Li et al. (2010).  They showed that both toxicity and 
degradation of lumenally-expressed RTA is strongly inhibited by the following deletion 
strains: ∆hrd1, ∆der1 and ∆hrd3.  Promisingly, these findings corroborate well with the 
finding that (in HeLa cells) the ER-targeted, lysine-deficient cholera toxin uses Derlin-1 and 
Hrd1 (and its orthologue, gp78) to access the cytosol (Bernardi et al., 2008 & 2010).  
Toxicity and degradation of lumenally-expressed RTA in yeast was inhibited in other genetic 
backgrounds as well, albeit less strongly.  These backgrounds included: ∆usa1, ∆ubx2, ∆ubc7 
& ∆cue1, which, consistently, are knockouts of proteins associated with the Hrd1 complex.  
The involvement of these factors was notably independent of lysine-ubiquitination and of the 
E3 ubiquitin ligase activity of Hrd1 (Li et al., 2010).  Speculatively, this indicates that many 
                                                 
4
 In a complex series of observations, Slominska-Wojewodzka et al. (2006) observed that up-regulated EDEM 
protected cells against ricin intoxication.  However, when the EDEM·client interaction was subsequently 
interrupted with kifunensine or puromycin, they observed a relative promotion of toxic activity in these cells 
relative to the wild-type.  They hypothesised that ricin exploits EDEM to gain access to the dislocon. 
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factors ascribed „ubiquitination‟ functions have other roles too, e.g. as scaffolding proteins, or 
even pore components.  Overall, these findings suggest that RTA undertakes a route into the 
cytosol which closely identifies with ERAD-L – that of a soluble lumenal substrate in yeast. 
Downstream of the retrotranslocation complex, candidates for the motor driving extraction 
have also been studied.  Marshall et al. (2008) showed that the efficient extraction of RTA 
from the ER of tobacco protoplasts is dependent upon Cdc48.  Cells expressing dominant-
negative versions of this protein retain much of their protein-synthetic capability when they 
express ER-targeted RTA (whereas wild-type protoplasts do not).  Marking a point of 
difference between tobacco, Li et al. (2010) show that Cdc48 and its cofactor, Npl4, are not 
required for the extraction of RTA
WT
 in Saccharomyces cerevisiae.  This difference 
highlights how alternate ERAD arrangements may be perpetuated in the mammalian context, 
a context which is especially relevant to this thesis.   
Interestingly, the ERAD of a severely misfolded mutant of RTA, RTA∆, was dependent upon 
Cdc48 and its co-factors Png1, Rad23, and Dsk2 in yeast (Li et al., 2010; Kim et al., 2006; 
Hosomi et al., 2010).  Kim et al. (2006) report that Png1 (PNGase) can form a dimeric 
complex with Rad23, helping target glycosylated RTA∆ to the proteasome.  It may be that 
the ERAD machinery can distinguish the two forms of RTA.  Alternatively, an intrinsic 
property of RTA
WT
 may ensure that it exits the ER by a tailored, Cdc48-independent route.  
Li et al. (2010) hypothesise that the extraction motor driving RTA may, instead, be a subunit 
of the proteasomal cap.  
There is yet comparably little clarification of the ERAD machinery which ricin might exploit 
in mammals.  However, investigators have carefully explored how ricin might qualify for 
such a process.  Most ERAD candidates travel across the membrane as monomers, free of 
disulfide bonds (Fagioli et al., 2001).  Thus, it was anticipated that RTA might conform to 
this ideal.  Therefore, RTA would have to lose its connection to RTB somehow during 
intoxication.  Indeed, it is quite clear that RTB is not an absolute requirement for the 
retrotranslocation of RTA, as lumenally-targeted RTA is potently toxic to both yeast and 
plants (Marshall et al., 2008; Li et al., 2010).  Moreover, over-expressing RTB in the ER 
lumen of plant and mammalian cells actually inhibits toxicity by potentially sequestering 
RTA therein (Frigerio et al., 1998; Spooner et al., 2004).  Providing a possible answer for 
how RTA might be released from RTB in vivo, Spooner et al. (2004) showed that it was 
possible to generate monomeric RTA by incubating the holotoxin with protein disulfide 
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isomerase (PDI).  Given PDI is an enzyme of the ER, it is – or its homologues are – ideally 
situated to fulfil this role in vivo. 
After liberation from RTB, RTA more closely resembles an ERAD substrate.  It is technically 
no longer a „native‟ protein, having lost the partner to which it is in complex with for most of 
its lifetime.  This might be recognised by the cell, manifested in the exposed C-terminal patch 
of RTA.  Correspondingly, mutations in this region negatively impact upon cytotoxicity 
(Simpson et al., 1995).  Speculatively, it might be that this hydrophobic stretch in the wild-
type interacts with ERAD-promoting chaperones of the ER.  Alternatively, it has been 
suggested that this region provokes interaction with the ER membrane instead, so inducing 
misfolding, which could thereafter promote ERAD (Day et al., 2002; Mayerhofer et al., 
2009).  Indeed, Mayerhofer et al. (2009) show that incubation of RTA with liposomes 
containing negatively-charged phosphatidyl-serine (POPS) leads to disruption of the toxin 
subunit‟s secondary structure in vitro.  Feasibly, this might contribute to the acquisition of a 
translocation-permissive conformation.  Mayerhofer et al. (2009) show that the C-terminus of 
RTA embeds into microsomal membranes, demonstrating that a functional role for this 
domain might exist in vivo.  
Demonstrating that unfolding of RTA is important to the productive, toxic route, Beaumelle 
et al. (2002) conducted a series of experiments using an RTA-dihydrofolate reductase 
complex (RTA-DHFR).  They observed that holotoxin containing RTA-DHFR was still 
cytotoxic (albeit far less effective than wild-type toxin).  If they co-treated cells intoxicated 
with this adulterated holotoxin with methotrexate (a DHFR-inhibitor), toxicity was reduced 
compared to without.  They hypothesised that this was because of the tight-folding of the 
DHFR whilst bound to methotrexate.  Similarly, when Argent et al. (1994) introduced a 
disulfide bond into RTA, they also observed a reduction in toxicity – and proposed a similar 
explanation.  The acquisition of at least a partially-unfolded state therefore seems integral to 
retrotranslocation. 
Overall, there are tenable ideas that suggest how RTA may ensure its recognition as an 
ERAD substrate (Mayerhofer et al., 2009; Simpson et al., 1995).  Given what is known of 
yeast, there are also good protein candidates to target for investigation (Li et al., 2010). 
Moreover, Bernardi et al. (2010) recently identified that CTA1 retrotranslocation is promoted 
by Hrd1 and gp78 in the mammalian context.  RTA‟s dearth of lysines helps it to escape the 
lysine ubiquitination that would usually be performed by the ERAD complex it uses (Deeks 
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et al., 2002).  This putatively attenuates the sequence of interactions that would otherwise 
deliver the toxin subunit to the proteasome.  However, it remains unclear how RTA might 
attain an active conformation after retrotranslocation, thus resolving itself from the majority 
of proteins which await degradation on the cytosolic face of the membrane.  Indeed, RTA is 
unfolds for the process (Beaumelle et al., 2002; Argent et al., 1994) and is unable to attain an 
active conformation spontaneously (Argent et al., 2000).  A mechanism to fold to a catalytic 
conformation therefore becomes crucial.  Perhaps not without its own significance, this 
refolding must also occur in a cellular compartment which is not native for this fragment of a 
secreted plant protein. 
Experiments have shown that RTA becomes a molten globule at a threshold of around 45°C, 
and that the toxin subunit cannot spontaneously refold from this state (Argent et al., 2000).  
Because of this, it has been speculated that a third-party might be required to ensure that a 
correct folding pathway is assumed in vivo after retrotranslocation (Argent et al., 2000).  
Interestingly, Argent et al. (2000) showed that active RTA could be generated in vitro if the 
molten globule state of the protein was incubated with substrate ribosomes.  It was thus 
proposed that the ribosome could perform this process in vivo.  Nevertheless, it is unclear 
what aspect of the ribosome is responsible for this effect.  It could be that co-purified 
proteins, such as small quantities of cytosolic chaperones bound to ribosomal protein (as 
reported for Hsp90 by Kim et al., 2006), are responsible for the phenomenon.  Indeed, in vivo 
where such chaperones are abundant, they might be expected to intercede before an 
interaction with the ribosome is possible.  These protagonists of cytosolic quality control may 
be responsible for the salvage of RTA during intoxication. 
1.6 Cytosolic quality control & chaperones 
Much like in the ER lumen, the cytosol has to nurture the folding of nascent polypeptides.  
Arguably, the „folding problem‟ in this compartment may be graver because of high local 
concentrations of identical, unfolded nascent polypeptides as they are translated from 
polysomal mRNA (Ellis & Hartl, 1999).  Unique stresses demand unique machinery.  In 
mammalian cells, growing protein chains interact with the ribosomally-localised nascent 
chain associated complex, NAC, which may have chaperoning properties (Young et al., 
2004).  Like the ER, added to the burden of nascent chains is the regressive misfolding of 
mature protein at times of stress (McClellan et al., 2005).  Fittingly, there are abundant 
chaperones that cater to the prophylaxis, amelioration and elimination of the various 
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conformational complaints that can arise (Young et al., 2004).  Interestingly, there is also the 
need to keep proteins destined for other compartments in a translocation-competent – 
unfolded or partially-unfolded – state.  Chaperones are involved in this process too (Young et 
al., 2003).   
Like lumenal chaperones, these protein buffers help polypeptides to avoid non-native states 
without themselves becoming a permanent, covalently-attached component of the final 
structure (Ellis & Hartl, 1999).  Via numerous mechanisms, their transient interaction reduces 
the frequency of off-pathway folding events that lead to permanent loss of function and 
aggregation (Markossian & Kurganov, 2004).  However, there are also times when the 
folding capacity of the cell is exceeded.  Under such conditions, distinct quality control 
compartments consisting of concentrated misfolded protein arise: inclusion bodies.  These 
dynamic structures sequester aberrant proteins, waylaying degradation and refolding.  At the 
same time they mitigate the toxic effect of aberrant conformers which would otherwise be 
soluble (Kaganovich et al., 2008).  They store a „folding debt‟, if you will.  Two qualitatively 
distinct „misfolding compartments‟ exist in both yeast and mammals, suggesting careful 
regulation of their formation in eukaryotes.  First, there is a juxta-nuclear, endoplasmic 
reticulum inclusion for ubiquitinated proteins involved in ERAD.  This compartment is 
studded with proteasomes and chaperones (Kaganovich et al., 2008).  Second, there is a 
perivacuolar compartment that enlarges when the prior is saturated.  It consists of terminally 
misfolded, insoluble protein.  Some proteins, for example amyloidogenic species, are 
immediately sent to the latter compartment rather than being kept in the first (Bagola & 
Sommer, 2008).  This kind of audit is indicative of the careful decisions the quality control 
machinery is capable of. 
It is important to note that chaperones, by definition, do not impose specificity – that is they 
do not fold proteins like origami.  Rather, they increase the efficiency of folding, the exact 
secondary and tertiary qualities of which are encoded by the primary sequence of the client 
(Ellis & Hartl, 1999).  Some exceptional „steric chaperones‟ do impart specific 
conformational cues before being segregated from the final structure, but they usually have a 
dedicated substrate, or are themselves initially part of the protein they chaperone, such as the 
cleavable presequences of zymogens (Ellis & Hartl, 1999).  In all likelihood, these would be 
too specific in function to contribute to the successful refolding of retrotranslocated RTA.  
The more generalised chaperones of the cytosol, however, may be of functional significance 
to RTA.   
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In the cytosol, Hsp90s and Hsc70s and a variety of other „holding-type‟ chaperones (of up to 
~200kDa) bind to misfolded conformers (Ellis & Hartl, 1999; Young et al., 2004; Markossian 
& Kirganov, 2004).  Unique to the cytosol, larger, complex chaperones of greater than 
800kDa actually fully encapsulate folding proteins (or individual protein domains; Young 
J.C., et al., 2004).  This sequesters them from the cytosolic milieu, with which they might 
adversely associate whilst filtering through non-native conformations that converge upon the 
native state (Ellis & Hartl, 1999).  The following sections describe these chaperones in more 
detail. 
1.6.1 Hsc70  
One of the most abundant cytosolic chaperones, Hsc70, binds to short regions of unfolded, 
extended, hydrophobic polypeptide (Flynn et al., 1991).  On average, binding-competent 
motifs arise every thirty-six residues in the mammalian proteome (Bukau & Horwich, 1998).  
This makes the potential clients of Hsc70 very broad indeed.  The chaperone itself is divided 
into two highly-conserved, independently-folded regions: an ATPase domain at the N-
terminus and a peptide-binding domain at the C-terminus (Shaner & Morano, 2007).  
Turnover of the N-terminal ATPase is coupled to a conformational rearrangement that alters 
the affinity of the chaperone for clients.  The ATP-bound state binds clients loosely, whereas 
subsequent ATP hydrolysis leads to a state which binds clients with high affinity 
(Sondermann et al., 2001).  Crucial to the diversity of clients and roles that Hsc70 has, 
cycling between nucleotide-governed conformations is controlled by both the intrinsic 
properties of the chaperone itself and a myriad of regulatory co-factors (Young et al., 2003).  
By such manipulation, co-factors can contribute to the context in which a client is initially 
bound by Hsc70, the timing of client residency, and the interaction of the client with 
downstream cellular machineries.   
Despite functional dependence on co-chaperones in vivo, ATPase turnover by Hsc70 can 
occur in their absence.  Indeed, substrate binding alone stimulates ATP hydrolysis.  However, 
this step in the cycle is rate-limiting unless a J-domain-containing co-chaperone is present 
(Sondermann et al., 2001).  J-domain containing proteins are abundant in the cell and 
stimulate the ATPase activity of Hsc70 (Walsh et al., 2004; Bukau & Horwich, 1998).  These 
proteins have a variety of localisations and their various J domains stimulate Hsc70 with 
different potencies.  Some J-domain proteins also bind prospective Hsc70 clients, like Hsp40 
does, regulating their access to the chaperone‟s peptide binding site (Cintron & Toft, 2006; 
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King et al., 2001).  Thus, in the locality of a J-domain protein the concentration of Hsc70 
chaperoning activity is much increased (Young et al., 2003).   
The client/ADP-bound complex can be stabilised by another co-chaperone, HIP (Sondermann 
et al., 2001; King et al., 2001).  A further class of co-chaperone, those with nucleotide 
exchange factor (NEFs) activities, antagonises HIP by promoting the open conformation of 
Hsc70.  This permits the release of bound clients – especially if they are able to swiftly 
conceal the hydrophobic region that led to the initial chaperone interaction.  If the client is 
not able to do so, then repeated rounds of interaction with the chaperone can occur.  
Examples of NEFs include the BAG-domain proteins (Alberti et al., 2003), HspBP1 (Alberti 
et al., 2004) and the independent chaperone Hsp110, which curiously contains an Hsc70-like 
N-terminus of ambiguous functionality (Hrizo et al., 2007; Shaner & Morano, 2007).  
Exemplifying a final effect upon the N-terminal ATPase, the co-chaperone, CHIP, can 
stabilise the „open‟, ATP-bound conformation (Kampinga et al., 2003).  Thus, at every stage 
of its ATPase cycle, Hsc70 is subjected to regulation, making it a complex machine at the 
heart of protein interactions in the cell. 
Aside from influencing the nucleotide-bound state, co-chaperones can also link Hsc70 to 
parallel quality control machineries operating in the cytosol.  One mammalian J-domain 
protein, Hsj1, bears an ubiquitin-interacting motif and so – for instance – can reiteratively 
load ubiquitinated chaperone clients onto Hsc70 (Westhoff et al., 2005).  The BAG-domain 
proteins in particular have diverse functions: BAG-1 has an ubiquitin-like domain for 
associating with the proteasome (Alberti et al., 2001; Alberti et al., 2003).  BAG-2, on the 
other hand, directly opposes BAG-1 by not having the attached ubiquitin-like domain.  This 
means it blocks un-ubiquitinated Hsc70 clients from interacting with the proteasome, so 
promoting the client to freely diffuse into the cytosol instead (Arndt et al., 2005; Dai et al., 
2005).  Last, the co-chaperone, CHIP, as introduced earlier for its role in ERAD, possesses an 
E3 ligase activity that can be focussed upon chaperone-bound substrates (Ballinger et al., 
1999; Connell et al., 1999; McDonough & Patterson, 2003; Murata et al., 2001).  As such, 
Hsc70 is not just an aid to protein folding.  Pivotally, it is also able to facilitate the 
degradation of substrates if they linger in its binding site (Esser et al., 2004).   
1.6.2 Hsp90  
Hsp90 operates as a dimer.  Each component monomer comprises four conserved regions: an 
N-terminal region; a flexible, highly-charged linker region; a middle domain; and a C-
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terminal domain.  The C-terminal domain is responsible for the persistent dimerisation of the 
chaperone and also a regulatory role (Retzlaff et al, 2009), whilst the N-terminal region 
houses an ATPase (Buchner, 1999).  The turnover of the dimer‟s two ATPase domains is 
mutually inter-dependent and coupled to an interaction between N-termini (Buchner, 1999; 
Vaughan et al., 2008; Hessling et al., 2009).  This results in the oscillation of Hsp90 between 
two over-arching conformations (Figure 1.6a).  First a polarised, deformed ring structure 
(ATP-bound) and second, a V-shaped dimer (while ADP-bound, or vacant of nucleotide).  
Curiously, Mickler et al. (2009) found that the coupling of ATP turnover to conformational 
rearrangement is actually quite weak and that the domain rearrangements of the chaperone 
are governed more strongly by stochastic fluctuations.   
Despite being the most abundant chaperone of the mammalian cytosol and the subject of 
intense study, the qualities which distinguish Hsp90‟s clients have not been precisely 
determined (Prodromou & Pearl, 2006).  Moreover, the mechanistic significance of the 
domain rearrangements described above – with regards to the chaperoning properties of the 
protein – is unknown (Richter et al., 2007).  Nevertheless, suggestions have been made.  For 
instance a hydrophobic patch formed at the interface of the N-termini may be important for 
substrate binding, as well as sites in the middle domains, Figure 1.6a (Richter et al., 2007).  
However, the field still seems vague on the matter.  Placing the question of mechanism aside 
for now, it is thought that Hsp90 recognises proteins that are relatively close to their native 
state (compared to Hsc70, at least).  Indeed, Hsp90 participates in the latter stages of steroid 
hormone receptor maturation (King et al., 2001) and in the quaternary assembly of multi-
component complexes (Imai J. et al., 2003; Kim et al., 2006), as opposed to sensing more 
elemental aspects of protein structure (such as an extended polypeptide chain).  Fittingly, 
rather than „enclosing‟ substrates in any fashion, it is thought that clients are bound on 
Hsp90‟s surface (Buchner 1999). 
Like those of Hsc70, the co-factors contributing to Hsp90‟s function are diverse.  They range 
in purpose from participating directly in protein folding and regulating the chaperone‟s 
ATPase cycle to scaffolding Hsp90 to other factors (Buchner 1999; Vaughan et al., 2008).  
Many are protein prolyl isomerases (Buchner, 1999).  Some are substrate-specific and 
involved in client-recognition.  For example there is Cdc37, which is a co-factor specifically 
implicated in the recognition of client kinases.  Cdc37 also inhibits ATP turnover by Hsp90 
and helps load bound kinases onto the chaperone (Siligardi et al., 2002).  Aha1, on the other 
hand, promotes ATP hydrolysis and the interaction of the dimer‟s N-termini (Hessling et al., 
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2009; Vaughan et al., 2008).  Hsp90 also liaises with CHIP and other E3 ligases like Skp1 
(via the Sgt1 adaptor – Zhang et al., 2008).  This diversity of co-chaperones means cytosolic 
Hsp90 can be organised into versatile, discrete, functionally-differentiated complexes – 
tailored to the needs of disparate clients. 
Figure 1.6 – The conformational cycle of Hsp90. 
a) Hsp90 assumes predominantly an elongated V-structure when ADP-bound, and a circular, distorted ring 
when ATP-bound.  Putative substrate binding domains are highlighted in pink.  One is putatively formed 
between N-terminal domains when they dimerise, as indicated.  The other sites are thought to be located 
upon the middle domains of the protein.  The C-terminal domains (blue) are responsible for dimerisation in 
both the ATP and ADP-bound state.  See text for references. b) The steroid hormone receptor pathway, as 
described in text in section 1.6.3 (from King et al., 2001).  The client is denoted by the red squiggle. 
 
a. The conformational cycle of Hsp90 
 
b. Steroid hormone receptor maturation pathway 
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1.6.3 Hsc70 and Hsp90 working together using HOP 
Distinctively, there is one co-chaperone called HOP (Heat shock protein 70/90 organising 
protein) which can physically scaffold Hsp90 to Hsc70 (Odunuga et al., 2004).  This laterally 
integrates two neighbouring chaperoning machineries in the cytosol, permitting a co-
ordinated response to misfolded protein.  The interaction of HOP with Hsc70 and Hsp90 is 
mediated by dedicated tetratricopeptide (TPR) motifs, which are not inter-changeable (Song 
& Masison, 2005).   
Much work has been produced that showing that HOP promotes the processive transfer of 
substrates from Hsc70 to Hsp90 (Figure 1.6b).  King et al. (2001) reports a „folding pathway‟ 
involving both Hsc70 and Hsp90 that leads to optimal activation of steroid hormone receptors 
in vitro and in vivo.  In this pathway, clients are initially recognised by Hsp40 and Hsc70, a 
complex which is then stabilised by the co-chaperone, HIP (Hsc70 interacting protein).  
Stabilisation by HIP increases the probability of the complex encountering free HOP∙Hsp90, 
which specifically recognises the client-, ADP-bound state of Hsc70.  HIP is displaced, 
resulting in a tripartite chaperone complex of Hsp90∙HOP∙Hsc70 (with bound client).  HOP 
binding promotes Hsc70‟s nucleotide exchange, leading to the transfer of bound steroid 
hormone receptor to the dimeric Hsp90.  After transfer to Hsp90, HOP and Hsc70 dissociate 
from the complex.  Hsp90 undergoes nucleotide exchange and finally associates with p23, 
another co-factor, which prolongs the lifetime of the complex (Morishima et al., 2003) by 
preventing ATP hydrolysis (Vaughan et al., 2008).  This prolonged residency maintains the 
long-term activity of the client receptor.  Dissociation, however, permits the receptor to revert 
to a signalling-incompetent form which can go through successive rounds of „pseudo-
maturation‟ (King et al., 2001).  The chronic requirement for Hsp90 by steroid hormone 
receptors has muddied the chaperone field somewhat; such clients have a protracted 
association with chaperones rather than a transient association, as defined by Ellis & Hartl 
(1999). 
This HOP-mediated pathway, at the time of writing, was given the most recent overview by 
Pratt et al. (2010).  With regards to the mechanism of Hsp90, the authors speculated that the 
chaperone associates with the „cleft‟ elements of multi-domain, multi-protein complexes.  
However, what consistently recognisable themes could unite molecularly-different clefts in 
disparate proteins is unknown.  An observation that was made early in the field is that Hsp90 
homologues are inessential to the survival of prokaryotes, whereas they are essential to the 
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survival of eukaryotes (Caplan et al., 1999).  One big difference between these kingdoms of 
life is how widespread multi-domain proteins are; eukaryotes have accreted many more 
multi-domain proteins in their genomes than prokaryotes (Koonin et al., 2000).  Given the 
implication of Hsp90 in ordering clefts (Pratt et al., 2010), and its involvement in the 
assembly and maintenance of macromolecular complexes (Imai et al., 2003; Kim et al., 
2006), this prevalence might be why Hsp90 is so essential to eukaryotes: i.e. the relative 
arrangement of functionally-associated domains. 
1.6.4 CCT (Hsp60) 
The best studied mammalian chaperone is CCT, which is a large hetero-hexadecameric, 
double-ringed complex.  The two back-to-back rings house central cavities that transiently 
accommodate clients during a strictly-regulated binding cycle co-ordinated to rounds of ATP 
hydrolysis (Kosmaoglou, 2008).  In mammals, the rings each comprise eight different 
subunits (Gómez-Puertas et al., 2004).  Each is also capable of housing a separate client, 
although their cycles of binding are linked in an out of phase manner, meaning the complex 
only ever binds one client at a time (Bukau & Horwich, 1998).  CCT assists in the folding of 
an estimated 10% of newly synthesised mammalian proteins and may have a particular 
preference for proteins with β-strands (Kitamura et al., 2006).  Its mechanism makes it very 
distinct from Hsc70 and Hsp90, in that it can encapsulate entire single-domain proteins, or 
individual domains of much larger structures (Young et al., 2004). 
Most work regarding this chaperonin‟s activity has stemmed from the study of orthologues: 
the Archaeal thermosome and the prokaryotic GroEL/GroES (Gómez-Puertas et al., 2004).  
These differ slightly in mechanism and conformational arrangement to CCT, and so the 
mechanism described here is specific to CCT.  CCT begins its client-binding cycle in an open 
conformation competent to bind clients, which occurs via the apical domains of each ring 
(Gómez-Puertas et al., 2004).  Specific subunits are involved in this interaction, which may 
vary between substrates.  Unlike prokaryotic GroEL, this interaction occurs mainly between 
charged and polar residues rather than hydrophobic ones, and interaction with the substrate 
occurs whilst it is in a partially-ordered state rather than an unstructured one (Kosmaoglou, 
2008; Gómez-Puertas et al., 2004).  The binding of substrate is likely to be multivalent and to 
become progressively more so after the initial interaction (Gómez-Puertas et al., 2004).  Each 
subunit of the ring in which the client is held binds ATP.  ATP hydrolysis leads to the iris-
like convergence of α-helical, lid segments of each subunit, enclosing the client (Zhang et al., 
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2010).  The sequential nature in which ATP-binding and hydrolysis occurs is thought to 
affect the conformation of the domains to which the client is bound, meaning it is 
mechanically re-orientated (Gómez-Puertas et al., 2004).  Nucleotide exchange may then 
occur, which (if CCT is similar to GroEL) results in conformational changes that result in re-
opening of the cavity and disassociation from the client (Zhang et al., 2010).  This 
mechanism of segregation enables the client to pursue the native state encoded by its primary 
sequence without interference from the primary sequences of improperly-folded, neighbour 
proteins.   
1.6.5 p97 
Introduced in the earlier context of ERAD, mammalian p97 (or plant/yeast Cdc48), is a 
homohexameric protein with ATPase activity.  As well as its role in ERAD, it also has a 
chaperoning role (Kobayashi et al., 2007; Markossian & Kirganov, 2004).  It forms an offset, 
concentric ring structure, with monomers fanning out from a central pore.  Misfolded or 
ubiquitinated substrates are thought to bind initially to the periphery of the protein, between 
adjacent subunits (Jentsch & Rumpf, 2006; Halawani & Latterich, 2006).     
Kobayashi et al. (2007) show that p97 is able to both re-solubilise and re-activate heat-
denatured luciferase from insoluble, inactive aggregates.  However, it is unclear exactly how 
the ATPase cycle of the protein and the domain rearrangements it promotes is coordinated to 
this activity.  Multiple competing models are discussed by Pye et al. (2006).  Jentsch & 
Rumpf (2006) speculate that, much like Hsc70, the ATPase cycle of p97 may be regulated by 
coordination with multiple co-factors.  Pye et al. (2006) also speculate that some co-factors 
could even transduce the conformational rearrangements p97 makes into distinct mechanical 
operations.  Indeed, quite unlike the other chaperones discussed, it is thought that p97 works 
actively as an „unfoldase‟ (Halawani & Latterich, 2006).  DeLaBarre et al. (2006) note a high 
local concentration of arginine residues lines the central pore of the protein.  The side chains 
of these residues resemble guanidine, a notable protein denaturant.  They compare the local 
frequency of arginyl residues to “8M guanidine”, a concentration capable of denaturing most 
proteins.  Therefore, p97 could break apart aggregates in a fashion regulated by its ATPase 
cycle, giving misfolded proteins a second chance at acquiring a native state. 
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1.6.5 Small heat shock proteins (sHsps) 
The proteins that make up this divergent class of chaperone range in size from 15-42kDa 
(Kosmaoglou et al., 2008).  They come together to form higher order, oligomeric complexes 
of between 9 and 50 subunits (Cashikar et al., 2005).  Unlike the other chaperones 
mentioned, it is deemed that they are regulated primarily by phosphorylation and temperature 
rather than by cycles of ATP binding and hydrolysis (Kosmaoglou et al., 2008).  Some sHsps 
form into defined oligomeric structures with rotational symmetry, whereas others seem more 
dynamic, stackable and modular.  There are ten such proteins in humans, each sharing a 90-
reside α-crystallin domain (Haslbeck et al., 2005).   
Outlining their fundamental mechanism, Kosmaoglou et al. (2008) state that sHsps 
specifically recognise unfolded stretches of polypeptide.  Cashikar et al. (2005) review that 
some become insoluble after heat shock, co-aggregating in large complexes with misfolded 
proteins.  Indeed, unlike other chaperones, oligomeric sHsps can bind more than one client at 
the same time (Haslbeck et al., 2005).  This incorporation into bodies of misfolded protein 
apparently ensures that aggregation is not irreversible, and facilitates the smoother, lateral co-
operation of such aggregates with other chaperones of the cytosolic matrix (Haslbeck et al., 
2005).  Effectively, sHsps hold denatured proteins in a folding-competent state, collecting a 
„reservoir‟ of unfolded species.  Subsequent „reactivation‟ is the preserve of other proteins, 
such as p97 and the Hsc70/Hsp90 chaperone system (Cashikar et al., 2005). 
1.6.6 Which chaperones are of novel investigational interest in the context of ricin? 
Where a study should begin to discern which chaperones might aid RTA is a good question.  
Which chaperones could resolve RTA from other substrates destined for degradation?  To 
refine this starting point, further questions can be asked, for instance: 
(1) Do these chaperones function in analogous pathways? 
(2) Is their activity localised to the ER membrane? 
(3) Are they likely to recognise RTA? 
And, perhaps more tenuously: 
(4)  Could they feasibly integrate with the mammalian equivalents of the Hrd1 
complex, which is the best candidate for the extraction of RTA in yeast (Li et al., 
2010)? 
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Hsc70 seems a plausible candidate for being able to interact with RTA, given the frequency 
of its binding sites across the proteome.  Its activity is also known to be localised to the ER 
membrane in a regulated manner, given that it is involved in the ERAD of apolipoprotein B 
(Gusarova V. et al., 2005) and CFTR
∆F508
 (Jiang et al., 2001).  In addition, Hsc70 acts as a 
gating complex for yeast Doa10, the homolog of which in mammals is TEB4 (Nakatsukasa & 
Brodksy, 2008).  Hsc70 is also known to promote the insertion of tail-anchored proteins 
directly into the ER (Rabu et al., 2008).  If that role could be reversed under the right 
conditions, in part, it would be interesting to speculate whether RTA might benefit from it.  
Hsc70 has other protein transport roles too, for instance in maintaining proteins destined for 
post-translational import in a translocation competent state.  Mechanistically, Hsc70 can also 
perform “entropic pulling” of translocating proteins, dragging them through the membrane, 
Table 2 (Corsi & Schekman, 1996; Wiedemann et al., 2004).  What we know of Hsc70‟s 
chaperoning abilities and its precedent involvement in protein transport pathways therefore 
make it a very interesting target for study. 
As Hsp90 can work in tandem with Hsc70 by merit of HOP, it also seems like a good 
candidate to investigate.  Its activity is likewise localised to the ER membrane in some 
instances.  The ERAD of ApoB and CFTR
∆F508
 are, again, notable examples of this 
(Gusarova et al., 2005; Loo et al., 1998).  Provocatively, Giodini & Cresswell (2008) also 
identified that Hsp90 was responsible for the cytosolic refolding of an exogenously applied 
protein.  These investigators showed that luciferase is endocytosed and transported to the ER 
of cultured dendritic cells.  Therein it is exported to the cytosol by an ERAD-like 
mechanism.
5
  Whilst this may be a rather specific case study in an immune-specialised cell, it 
vouches for the plausible interruption of Hsp90 in the later stages of ERAD.  This 
„interruption‟ apparently leads to the liberation of folded, functional polypeptide (luciferase) 
rather than degradation.  Thus, Hsp90 is evidently involved in a pathway which uncouples 
retrotranslocation from degradation.  Instead, degradation is apparently supplanted with 
Hsp90-mediated refolding.  This makes it an interesting study as well. 
CCT is an arguably poorer candidate for investigation, given it is implicated in the folding of 
only 10% of newly-synthesised proteins (Kosmaoglou et al., 2008).  Moreover, it is thought 
to recognise mainly β-sheet structures (Kitamura et al., 2006).  RTA, on the other hand, is 
                                                 
5
 In that it was blocked by Pseudomonas exotoxin A (which binds to Sec61) and could be reconstituted using 
ER-derived microsomes and cytosolic Cdc48 (Giodini A. & Cresswell P., 2008). 
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largely α-helical.  Its role also seems to be specific to folding rather than interlinked with a 
pathway leading to degradation (McClellan et al., 2005).  Thus, it would perhaps make sense 
for the cell to segregate it away from localities of the cell where proteins are destined for 
degradation.  Small heat shock proteins, on the other hand, may be interesting targets to 
study, but their role seems to be passive – dependent on downstream factors like Hsc70, 
Hsp90 and p97 to deliver folded structures from the misfolded proteins they buffer (Haslbeck 
et al., 2005).  Therefore, study of the downstream „reactivators‟ seem more likely to yield a 
positive, interesting result.   
Finally, the p97 complex also seems like an interesting candidate for interacting with and 
perhaps reactivating retrotranslocated RTA.   Of course, this protein is integral to a variety of 
ERAD routes, and evidence has already suggested that the plant homologue, Cdc48, 
contributes to extraction of active RTA from the ER of tobacco protoplasts (Marshall et al., 
2008).  In yeast, however, Cdc48 does not seem to be required for the extraction of RTA (Li 
et al., 2010).  As these works have already pursued the involvement of Cdc48/p97 in 
extraction of RTA from the ER membrane, the study of Hsc70 and Hsp90 in particular seems 
to provide the most novel investigational target.   
1.7 Thesis aims 
In light of the information above, this thesis aims to determine whether cytosolic chaperones 
– Hsc70 and Hsp90 – participate in a functional interaction with RTA during intoxication of 
target cells.  It will explore whether these intracellular aids to protein-folding have an impact 
on the cytotoxicity of ricin in a representative mammalian cell line, HeLa cells, which have 
been widely used to characterise the mechanism of ricin before now (Watson & Spooner, 
2006).  The first arm of this investigation will use inhibitors to examine the putative role of 
these chaperones during intoxication in vivo.  As Hsc70 and Hsp90 are integral to the 
function of a cell in a multiplicity of ways (and many inhibitors are pleiotropic to different 
degrees), this will be tested with a number of reagents.   
With the involvement of these chaperones tested, this thesis continues to explore the 
mechanisms by which their impact upon cytotoxicity might be executed in vitro.  This is 
examined first by looking at reconstitutions of the processes that these chaperones are known 
to facilitate in vivo and in vitro for bona fide substrates, and seeing whether RTA is also 
candidate to the same phenomena.  The outcome of these experiments will further clarify the 
possibility that a chaperone∙RTA complex can form and will also be informative of the 
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potentially wider array of fates that might be imposed by such interactions in the cellular 
context, where the chaperones interlink with – for instance – the ubiquitin proteasome system 
(UPS).  Factors which might influence the candidacy of RTA as a client of these chaperones 
are also given consideration, e.g. factors which might potentially demarcate the recognition 
of RTA as a misfolded protein in the ER and those which might promote its stability in the 
cytosol and renaissance as a stable protein. 
Finally, the course of this thesis returns to a genetic approach, by looking at whether the 
normal outcome of the interaction can be changed, predictably, by altering the levels of 
mechanistically-elaborated co-chaperones. 
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CHAPTER 2: 
Materials & Methods 
2.0 Suppliers of reagents 
The reagents used throughout this thesis were acquired from the following suppliers.  
Suppliers are listed in alphabetical order (with reagents purchased from them in alphabetical 
order underneath the title of each supplier).  Proteins are also included if they were not 
purified during the course of study. 
  
Autogen Bioclear Fisher Scientific - continued Invitrogen – continued Sigma-Aldrich - continued 
geldanamycin phenol SeeBlue Plus2 Markers lactose 
 potassium acetate  lithium chloride 
Avanti Polar Lipids potassium chloride Marvel MOPS 
POPC (phospholipid) potassium dihydrogen phosphate milk albumin (fat-free) phenylmethylsulfonyl fluoride 
POPS (phospholipid) sodium acetate  RNase A 
 sodium chloride Merck Biochemicals Ponceau S reagent (solid) 
Bio-Rad sodium dodecyl sulphate tryptone phenol red 
Bradford reagent sodium hydroxide yeast extract polyethylene glycol-8000 
 streptomycin magnesium chloride rubidium chloride 
Cook J., Warwick University TCA  sodium azide 
saporin (S. officinalis) TEMED Nippon Kayaku Co. TNM-FH (medium) 
 Tris deoxyspergualin triton X-100 
Fisher Scientific   Trypan blue 
acetic acid Formedium Ltd. Perkin-Elmer Tween20 
acrylamide galactose [35S]-methionine ubiquitin (bovine source) 
calcium chloride  scintillant (Optiphase S-mix)  
chloroform GE Healthcare  Tocris Life Sciences 
citric acid bromophenol blue Promega CCT018159 
coumaric acid BSA BCIP 4-phenyl butyrate 
disodium hydrogen phosphate  NBT radicicol 
EDTA Helena Biotech   
ethanol agarose Roche Vector Laboratories 
formaldehyde  Complete protease inhibitors ricin toxin B chain 
formamide Höhfeld J., University of Bonn   
glucose E1 (from wheat) Sigma-Aldrich VWR International 
glycerol E2 (UbcH5b; H. sapiens) aniline ammonium 
glycine BAG-5, (H.sapiens) ammonium persulphate manganese chloride 
hydrogen chloride CHIP, (H.sapiens) ATP SF9 cells 
luminol Tau protein (micro-tubule assoc.) β-mercaptoethanol  
magnesium sulfate  dithiothreitol  
methanol Invitrogen ethidium bromide  
NN‟-methylene bis-acrylamide Lipofectamine fetal calf serum  
penicillin pluronic acid glutamine  
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2.1 Antibodies 
The primary antibodies detailed in Table 2.1 were used for immunostaining throughout the 
results sections of this thesis.  Secondary antibodies are detailed in Table 2.2. 
 
Table 2.1 – List of primary antibodies used in this thesis 
‘M’ indicates monoclonal.  ‘P’ indicates polyclonal.  The ‘dilution’ column notes the dilution factor at which 
each antibody was used during staining. 
Antibody Source M P Supplier (Catalogue number) Dilution 
α-BAG-5 mouse x  Höhfeld J., University of Bonn 10
-3
 
α-γ-tubulin mouse x  Sigma-Aldrich (T6557) 10
-4
 
α-Grp94 rat x  Stressgen (SPA-850) 10
-4
 
α-Hsc70 rabbit  x Stressgen (SPA-816) 10
-4
 
α-Hsc70/Hsp70 mouse x  Stressgen (SPA-820) 10
-4
 
α-Hsp90 rabbit  x Stressgen (SPA-846) 10
-4
 
α-HOP mouse x  Stressgen (SRA-1500) 10
-4
 
α-Luciferase mouse x  Höhfeld J., University of Bonn 10
-4
 
α-RTA rabbit  x Spooner R.A., University of Warwick 10
-4
 
α-TAg mouse x  Leppard K.N., University of Warwick 10
-3
 
α-Tau protein mouse x  Höhfeld J., University of Bonn 10
-4
 
 
 
Table 2.2 – List of secondary antibodies used in this thesis 
‘M’ indicates monoclonal.  ‘P’ indicates polyclonal.  The ‘dilution’ column notes the dilution factor at which 
each antibody was used during staining. 
Antibody Conjugate Source  M P Supplier (Catalogue Number) Dilution 
α-mouse / rat AP goat  x Promega (S372B) 10
-4
 
α-rabbit AP mouse x  Sigma-Aldrich (A1949) 10
-4
 
α-mouse HRP donkey  x Fisher Scientific (SA1-100) 10
-4
 
α-rabbit HRP goat  x Sigma-Aldrich (A0545) 10
-4
 
α-rabbit Alexa-Fluor 680nm goat  x Invitrogen (A21076) 10
-3
 
 
  
Page 45 
 
2.2 DNA vectors 
The following DNA vectors were used throughout this thesis.  Note that this table mixes viral 
and plasmid vectors.   
 
Table 2.3 DNA vectors used in this thesis 
The experimental application of each is denoted by the columns labelled ‘P’ (indicates those vectors used for 
purification) and ‘O’ (those vectors used for over-expression studies in HeLa).  The ‘host’ column denotes the 
organism from which the protein’s DNA sequence was originally sourced.  References are given to provide an 
example of the plasmids’ prior uses.  *Indicates work with this plasmid has not yet been published. 
Protein Host Vector P O Reference 
BAG-1S H. sapiens pcDNA  x Alberti  et al., 2002 
BAG-2 H. sapiens pcDNA  x Arndt et al., 2005 
BAG-5 H. sapiens pcDNA  x Höhfeld J. (University of Bonn)* 
CHIP H. sapiens pcDNA  x Arndt et al., 2005 
HIP R. rattus pcDNA  x Demand et al., 1998 
HOP R. rattus pcDNA  x Demand et al., 1998 
Hsc70 R. rattus Baculovirus with pVL1393-hsc70 x  Höhfeld & Jentsch, 1997 
Hsp40 H. sapiens pET x  Höhfeld & Jentsch, 1997 
LacZ E. coli pcDNA  x Ladds G. (University of Warwick) 
RTA 
R. communis pUTA x  Deeks et al., 2002 RTA
0K
 
RTA
6K
 
TAg SV40 virus SV40 virus  x Stubdal et al., 1996 
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2.4 Solution composition 
The following list details the composition of solutions referenced multiple times throughout 
the methods sections. 
 
 
Bradford reagent  
(5× stock) 
 
 
Coomassie Blue 
solution 
 
 
de-stain 
 
 
DMEM 
 
DMEM 
(supplemented) 
 
 
 
 
lysis buffer 
 
 
 
 
 
 
 
PBS 
 
 
 
 
 
PBS-T 
0.05% Coomassie Blue (w/v) 
24% ethanol (v/v) 
43% phosphoric acid (w/v) 
 
0.2% Coomassie Blue (w/v) 
7.5% acetic acid (v/v) 
50% ethanol (v/v) 
 
40% methanol (v/v) 
10% acetic acid (v/v) 
 
See Dulbecco et al. (1959)  
 
As DMEM, plus: 
10% FCS 
0.4mM glutamine 
25 units.mL-1 of penicillin  
189 units.mL-1 of streptomycin. 
 
15mM Tris 
150mM NaCl 
1% triton X-100 (w/v) 
0.1% SDS (w/v) 
2mM NaN3  
15% glycerol (w/v) 
made to pH7.5 with HCl 
 
8g.L-1 NaCl 
0.2g.L-1 KCl 
1.44g.L-1 Na2HPO4.12H2O 
0.24g.L-1 KH2PO4 
made to pH7.4 with HCl.   
 
As PBS, plus:  
0.1% Tween20 
trypsin solution 
 
 
 
 
 
 
 
 
 
TBS 
 
 
 
TBS-T 
 
 
transfer buffer 
 
 
 
 
Terrific broth 
 
 
 
 
 
2YT 
8g.L-1 NaCl 
0.38g.L-1 KCl 
0.1g.L-1 Na2HPO4 
1g.L-1 glucose 
3g.L-1 Tris 
0.0015% phenol red (w/v) 
2.5g.L-1 trypsin 
made to pH7.7 with HCl 
 
 
10mM Tris 
150mM NaCl;  
made to pH8 with HCl 
 
As TBS, plus: 
0.05% Tween20 (w/v) 
 
14.42g.L-1 glycine 
3.03g.L-1 Tris 
0.1g.L-1 SDS 
20% methanol (v/v) 
 
12g.L-1 tryptone 
24 g.L-1 yeast extract 
0.4% glycerol (v/v) 
0.017M KH2PO4 
0.072M K2HPO4 
 
16g.L-1 tryptone 
10g.L-1 yeast extract 
5g.L-1 NaCl 
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2.5 Methods 
The structure of this section is laid out in the order that the reader will encounter these 
methods in the results chapters. 
2.5.1 Culture of HeLa cells 
HeLa cells were grown as a monolayer in supplemented DMEM.  Monolayers were cultured 
in 75mL Falcon flasks, or else flat-bottomed dishes.  Monolayers were incubated at 37 °C 
with an ambient 5% CO2(g).   
Cells were passaged after monolayers reached confluency.  To do this, cells were first washed 
by flushing them with 5mL of trypsin solution.  They were then incubated with a further 5mL 
of trypsin solution for 15 minutes at 37 °C with 5% CO2(g). An appropriate volume of the 
resultant cell suspension was then discarded, and the remainder diluted as desired with 
supplemented DMEM.  Diluted suspensions were transferred to fresh 75mL Falcon flasks. 
2.5.2 Assaying the IC50 of ricin to HeLa cells with respect to protein synthesis 
2.5 × 10
4
 cells in 100μL of DMEM were seeded into each well of a 96-well plate (an 
haemocytometer from Neubauer was used to calculate appropriate dilution factors).  These 
plates were then left overnight at 37 °C with ambient 5% CO2(g). 
Each 96-well plate was typically demarcated in halves, with one half (4 rows × 12 columns) 
constituting a coeval set of negative controls and the second half acting as the positive 
control.  The cells upon one half of the plate will have typically been subjected to some form 
of pre-treatment, as described in the appropriate results section.  After this period of pre-
treatment, medium is removed and cells are treated with one of 11 graded doses of ricin in 
100μL of supplemented DMEM.  The ricin dilutions typically halve from a maximum 
concentration of 100ng mL
-1
 (variations as specified in text).  One column of 1 × 8 wells is 
not treated with ricin, as a control.  Note that, in experiments where the effects of 
pharmacological agents were tested, these agents were included during the ricin treatment as 
well. 
After 4 hours of incubation with the graded doses of ricin (37 °C in 5% CO2(g)), wells were 
washed with 100μL of PBS.  Then, 1μCi of [35S]-methionine in 50μL of PBS was added to 
each well.  This labelled amino acid was incorporated into protein by the residual protein 
synthetic capability of the toxin and toxin-untreated cells.  To enable this labelled, cells were 
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incubated for 30 minutes (37°C, 5% CO2(g)).  After labelling, wells were washed 5 times with 
5% TCA (w/v in H2O) to precipitate protein.  Finally, 50μL of scintillant (Optiphase 
Supermix from Perkin Elmer) was added to each well and the fluorescence intensity across 
the plate measured by a scintillation counter (Microbeta Trilux 1450).   
During data analysis, the fluorescence intensity from wells not treated with ricin was used as 
a standard for 100% protein synthesis.  Note that positive and negative controls (i.e. inhibitor 
treated and inhibitor untreated cells, in most cases) possessed independent standards for this 
value (Figure 2.1).  This accounted for the relative toxicity of different pre-treatments.  The 
fluorescence intensity from wells containing each graded dose of ricin was then related to the 
100% value for protein synthesis.  This enabled the construction of a sigmoidal dose-response 
curve.  A program developed by R.A. Spooner was then used to produce a line of best fit 
through the acquired data.  The IC50 was calculated from the regression of this line.  The IC50 
of the positive control dataset was then compared to the IC50 of untreated cells to yield a fold-
change in ricin sensitivity.  This protocol is derived from that published in Spooner et al. 
(2006).  Note that the overall toxicity of the pre-treatment itself could be determined by 
comparing the fluorescence intensity of ricin-untreated.  The intensity from positive-controls 
was compared to negative-controls to get a percentage effect (Spooner et al., 2008). 
 
Figure 2.1 Setup of the Cytotoxicity Assay  
Diagram of the organisation of a 96-well plate. 
 
 
Negative control (no treatment). 
Positive control (e.g. inhibitor treated). 
Ricin concentration 
100% standards for 
the negative control 
(no ricin) 
100% standards for 
the positive control 
(no ricin) 
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2.5.3 Assaying toxin trafficking time 
Cells were seeded into a Falcon 96-well plate as before. Plates were divided in half, one half 
comprising the negative control and the other the positive (each half pre-treated as described 
in text).  At strictly timed intervals, columns of wells were treated with a standard, killing 
dose of ricin (100ng mL
-1
). As before, one 1 × 8 column of wells was no treated with ricin, to 
provide a standard for 100% protein synthesis.  After incubation (37°C, 5% CO2(g)), cells 
were then labelled with [
35
S]-methionine (as before in section 2.5.2, for 30 minutes).  The 
incorporation of this into acid-precipitable material was then quantified, also as in section 
2.5.2.   
The resultant data were assembled into a time-response curve (as per Hudson T.H. & Neville 
D.J., 1987).  This plots the logarithm of protein synthesis vs. the length of ricin incubation.  
The linear phase of this plot is then regressed back to 100% protein synthesis.  The time at 
which protein synthesis is equal to 100% is defined as the holotoxin‟s trafficking time.  
Positive controls were compared to appropriate negative controls (as described) to get a 
percentage change in trafficking time under various treatments. 
2.5.4 Collection of detergent soluble lysates 
Detergent-soluble lysates were collected from confluent monolayers cultured in 6 well plates.  
First, the plates containing monolayers were removed from the 37 °C incubator and cooled on 
ice for 5 minutes.  The supplemented DMEM in which the monolayers had been cultured was 
then removed.  Each of the wells was then washed twice with 1mL of PBS.  
Lysis buffer containing Triton X-100 (and Complete protease inhibitors; one tablet per 50 
mL) was added to each well (to a volume of 0.5mL).  This was left for a period of 5 minutes, 
shaking on ice (or until cell membranes had dissolved, leaving punctuate nuclei – as observed 
by microscopy).  After this period, the lysis buffer in each well was washed repeatedly over 
the residue of the monolayer until the remaining layer of organic material could be seen to 
detach.  The resulting lysate was then collected in an Eppendorf tube and the 10000 ×g 
supernatant (10 minutes at 4 °C) collected.  This final centrifugation step was to remove cell 
debris. 
2.5.5 Bradford assay 
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The Bradford assay was used to determine the protein concentration of cell lysates.  1, 5 and 
10 μL of the lysed sample was added to 1mL of 20% Bradford reagent (v/v) in water and the 
absorbance at 595nm recorded.  A calibration curve was generated by producing an array of 
solutions at known concentrations of BSA (in an equivalent buffer to the samples tested).  
Absorbance was plotted against known protein concentration in Microsoft Excel, and the 
linear phase of the curve was regressed.  The concentration of samples was then determined 
using the formula for the regressed equation and the absorbance of each sample (and 
appropriate dilution factor, where appropriate). 
2.5.6 SDS-PAGE  
Samples destined for SDS-PAGE were first mixed with loading buffer to make a final 
concentration (with sample) of 0.1% SDS (w/v); 0.0625M pH6.8 Tris/HCl; 1.25% β-
mercaptoethanol (v/v) and 2.5% glycerol (w/v); and bromophenol blue (qs).  These samples 
were boiled at 95°C for 5 minutes.  They were then spun in a micro-centrifuge for 5 seconds 
and loaded onto a polyacrylamide gel. 
The resolving portion of this gel constituted polyacrylamide to the concentration indicated in 
the appropriate results section (w/v; 38:1 with NN‟ methylene bis-acrylamide).  The 
remaining constituents of the gel were as follows: 0.78M Tris/HCl pH9.2; 0.01% SDS (w/v); 
0.01% ammonium persulphate (w/v) and 0.05% TEMED (v/v).  The stacking portion of the 
gel constituted: 3.7% acrylamide (w/v; 38:1 with NN‟ methylene bis-acrylamide); 0.17M 
Tris/HCl pH6.8; 0.06% ammonium persulphate (w/v); 0.01% SDS and 0.3% TEMED (v/v). 
After sample loading, gels were subjected to a current of 30mA through the stacking portion 
of the gel, and 45mA through the resolving portion.  Empty lanes were loaded with an 
equivalent volume of loading buffer to prevent wavefront distortion.   
2.5.7 Blotting of polyacrylamide gels onto nitrocellulose 
After separation by SDS-PAGE, samples were blotted onto nitrocellulose (Hybond-ECL, 
Amersham, GE Healthcare).  Sheets of nitrocellulose were sandwiched with the gel between 
two flat electrodes and filter paper (3mm, Whatman).  The gel and filter paper were doused in 
transfer buffer.  A current of 200mA was passed between the electrodes for 2 hours. 
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2.5.8 Immunostaining of nitrocellulose blots 
Blotted nitrocellulose was first blocked from non-specific binding of antibodies by incubation 
in 5% non-fat Marvel (w/v) in TBS-T for 1 hour, while shaking.  The nitrocellulose was then 
exposed to the primary antibody (at an appropriate dilution) in 1% non-fat marvel (w/v) in 
TBS-T for 1 hour and 30 minutes, while shaking.  The antibody-stained nitrocellulose was 
then washed three times in 1% non-fat marvel TBS-T (w/v), for 15 minutes each time.  The 
secondary antibody was then incubated in the same manner as the first, but in 1% non-fat 
marvel TBS-T for 1 hour and 30 minutes while shaking.  The blot was then washed in 1% 
non-fat marvel TBS (without tween), thre times (for 15 minutes each time).  Blots were 
developed using either ECL or AP protocols depending on the nature of the secondary 
antibody‟s conjugate. 
2.5.8.1 Alkaline phosphatase development of nitrocellulose blots 
Blots stained with secondary antibodies which were conjugated to alkaline phosphatase were 
developed according to the Promega protocol.  The nitrocellulose was bathed in 5mL of 
100mM Tris-HCl pH9.0; 150mM NaCl; 1mM MgCl2; 0.33% (v/v) NBT; 0.165% (v/v) BCIP.  
BCIP and NBT were added last.  Pink colour was allowed to appear on the blot until a 
desired intensity had been reached.  At this point, the colour-producing reaction was stopped 
by the addition of 5mL of 0.2mM EDTA. 
2.5.8.2 ECL development of nitrocellulose blots 
Blots with secondary antibodies conjugated to horseradish peroxidise were developed in 
accord with the GE Healthcare protocol.  Equal volumes of solution 1 (0.1M Tris / HCl 
pH8.5; 2.5mM luminol; 0.4mM coumaric acid) were added to solution 2 (0.1M Tris / HCl 
pH8.5; 0.018% H2O2).  This was incubated for 1 minute at room temperature, shaking.  The 
blots were then exposed to Kodak Biomax Scientific Imaging film for an empirically 
determined length of time.  Exposed films were then processed in an AGFA Curix 60 X-ray 
film developer, as per the operator‟s instructions. 
2.5.8.3 Odyssey imaging of nictrocellulose blots 
The stages leading to visualisation of bands by this method were exactly as for AP and ECL 
protocols.  However, PBS-T and PBS were used rather than TBS-T and TBS respectively.  
Additionally, incubation and washes with the secondary antibody were performed in the dark 
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to prevent bleaching of the fluorophore conjugate.  The blot was dried in the dark between 
sheets of filter paper and scanned using a LICOR scanner. 
2.5.9 Other staining techniques 
2.5.9.1 Ponceau S staining of nitrocellulose blots 
Nitrocellulose blots were washed in 5mL Ponceau S solution (0.1% Ponceau [w/v]; 5% acetic 
acid [v/v]) for 10 minutes.  Background staining was then removed by washing the blot in 
distilled water until a good signal:noise ratio was achieved (as determined by eye).  If this 
blot was to thereafter be used in an immuno-stain, residual Ponceau reagent was washed off 
using TBS before probing with antibody. 
2.5.9.2 Coomassie staining after SDS-PAGE 
After electrophoresis, acrylamide gels were evenly soaked in 10mL of Coomassie Blue 
solution.  At a point where the gel had acquired a deep blue colour, the Coomassie solution 
was poured off and the gel was soaked evenly in de-stain solution (on a shaker).  To achieve 
the appropriate ratio of signal:background staining intensity, the de-stain solution may have 
been replaced multiple times, as determined by eye. 
2.5.9.3 Silver staining after SDS-PAGE 
After electrophoresis, gels were washed in 50% methanol (v/v).  The methanol solution was 
replaced every 30 minutes for a total incubation of 2 hours.  The gel was then exposed to the 
silver stain (0.8% silver nitrate [w/v]; 1.4% ammonium [v/v]; 1.71% NaOH [w/v]; in water) 
for 5 minutes, whilst rocking gently on a shaker.  The silver-loaded gel was then washed 4 
times in distilled water, and left for 10 minutes, still shaking.  Bands were produced by 
flooding the gel with silver stain developer (0.0125% citric acid [w/v]; 0.15% formaldehyde 
[v/v]).  This developed the brown colour of stained bands.  At an empirically determined 
endpoint, the development was halted by submerging the gel in de-stain. 
2.5.10 Transformation of bacterial cultures with plasmid DNA 
An aliquot of competent cells was thawed on ice (DH5α for plasmid amplification; JM101, or 
BL21 for protein expression, as stated).  2μL of plasmid DNA was then added to this aliquot 
and incubated on ice for a further 30 minutes.  This mixture was then heat shocked at 42°C 
for 2 minutes and returned to ice for a further 5 minutes.  If the plasmid contained a 
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kanamycin resistance gene, transformed cultures were then allowed to recover at 37°C for an 
hour before the next step.  After recovery, or if the plasmid did not encode a kanamycin 
resistance gene, the transformed cells were spread on plates with nutrient agar containing the 
appropriate antibiotic (for selection of transformed colonies).  Plates were then incubated 
overnight at 37°C. 
2.5.11 Production of rubidium chloride competent cells 
An aliquot of E.coli cells of the desired strain was thawed on ice and then inoculated into 
10mL of SOB medium (20g.L
-1 
peptone; 5g.L
-1
 yeast extract; 10mM NaCl; 2.5mM KCl).  
This inoculated culture was then grown overnight at 37°C in a shaking incubator.  After 
incubation, 500μL of the culture was used to inoculate 50mL of SOB medium (supplemented 
with 250μL of 1M MgSO4(aq) and 125μL of 2M MgCl2(aq)).  This culture was then incubated 
at 37°C until an optical density of 0.48 was reached (compared to medium alone, at a 
wavelength of 600nm).  The culture was then placed onto ice for 15 minutes and the cell 
aggregate collected by centrifugation. 
The cell aggregate was resuspended in 16.6mL of buffer (constituents: 100mM rubidium 
chloride; 50mM manganese chloride; 30mM potassium acetate; 10mM calcium chloride; 
15% glycerol [w/v]) and put on ice for 15 minutes.  The cell aggregate was, again, collected 
by centrifugation.  This cell pellet was resuspended very carefully in 4mL of a different 
buffer (constituents: 10mM MOPS; 10mM rubidium chloride; 75mM calcium chloride; 15% 
glycerol [w/v]).  The resuspension was then incubated on ice for 15 minutes before aliquoting 
(into 100μL volumes).  Each aliquot was snap-frozen upon dry ice and then transferred to a -
80°C freezer for long-term storage. 
2.5.12 Purification of RTA 
RTA was purified by a method that is described by Deeks et al. (2002).  Appropriate 
plasmids were transformed into E.coli JM101 and grown in 50mL of Terrific Broth 
(overnight at 37°C).  This starter culture was then inoculated into 500mL of 2YT media and 
grown for 2 hours at 30°C.  Expression of ricin A chain was induced by adding IPTG to this 
culture to a final concentration of 1mM.  Cells were then incubated for an additional 4 hours.   
The RTA-expressing cells were finally harvested by centrifugation at 10000 ×g, resuspended 
in sodium phosphate buffer (pH6.4) and lysed by sonication.  Cell debris was removed by 
another 10000 ×g centrifugation.  The supernatant was loaded onto a 50mL carboxymethyl-
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Sepharose CL-6B (Pharmacia) column equilibrated with the sodium phosphate (pH6.4) 
buffer.  After washing with a further 1L of buffer to remove unbound material, 100mL of 
sodium phosphate buffer containing 100mM sodium chloride was passed through the column.  
A gradient of up to 300mM sodium chloride was then used to elute the column.  Fractions 
containing RTA were identified by SDS-PAGE and pooled. 
2.5.13 Reassociation of RTA and RTB 
RTA was associated with RTB by a protocol also described by Deeks et al. (2002).  50μg of 
purified RTA was added to 100μg RTB (Vector Labs) in a total volume of 1mL PBS.  Also 
contained in the PBS buffer was 0.1M lactose and 2% β-mercaptoethanol.  This reducing 
mixture was dialysed overnight against the same buffer without any β-mercaptoethanol.  This 
dialysed sample was then dialysed again, into simple PBS (no lactose; over the course of 
three nights). 
Reassociated RTA and RTB was then purified from RTA by passing the dialysed solution 
down a 1mL agarose-immobilised lactose column (Sigma-Aldrich).  This column was 
washed with PBS to remove unbound RTA.  PBS containing 100mM galactose to elute 
reassociated holotoxin and monomeric RTB.  The concentration of reassociated holotoxin 
was determined by silver-staining of the RTA band (after reducing SDS-PAGE in parallel to 
standards of known concentration).     
2.5.14 The solubility assay 
500ng of RTA was added to a volume of 20μL reaction buffer in an Eppendorf tube.  The 
reaction buffer was 10mM MOPS-HCl; 50mM KCl; pH7.2.  Other components may have 
been added as described in text, e.g. inhibitors, liposomes, cytosolic extracts, chaperones and 
ATP.  This mixture was then centrifuged for 5 seconds in a microfuge to mix the 
components.   Following mixing, samples were incubated at the indicated temperature 
(typically 37 ºC or 45 ºC) for 15 minutes.  Samples were then spun at 16000 ×g for 10 
minutes at 4 ºC.  The supernatant and pellet were both retained. Each fraction was mixed with 
an appropriate quantity of loading buffer and boiled for 5 minutes.  Boiled samples were then 
vortexed and spun in a microfuge for 5 seconds (vortexing and mixing was performed twice).  
Samples were separated in parallel by SDS-PAGE, then silver-stained.  The intensity of 
neighbouring pellet/soluble RTA bands was quantified relative to one another using 
TotalLab.   
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Assays containing liposomes only - Where indicated in assays with liposomes, a 
detergent treatment may have been used after the incubation at the specified 
temperature.  This treatment consisted of putting all samples on ice for 5 minutes after 
the 15 minute incubation.  Triton X-100 was then added to the samples at a 
concentration of 1% (w/v) and left for ten minutes at room temperature (or an 
equivalent volume of buffer, in negative controls).  The rest of the protocol was then 
elicited as normal.   
Assays containing cytosol only - Some assays had a complex mix of proteins in the 
incubation, which posed difficulties in downstream SDS-PAGE analysis.  In such 
cases, it was first determined whether any underlying band ran on the gel in a similar 
fashion to RTA (so determining whether quantification would be possible).  In the 
case of incubations with cytosol, an equivalent concentration of pellet and soluble 
fractions from “cytosol alone” was loaded onto gels alongside pellet and soluble 
fractions from “cytosol with RTA”.  These “cytosol alone” lanes were used 
approximate the background signal emanating from the inclusion of cytosol during 
quantification by TotalLab. 
2.5.15 The aniline assay (for quantifying the catalytic activity of RTA) 
The aniline assays in this thesis were conducted with the same method as described by 
Chaddock et al. (1993).  Yeast ribosomes were kindly provided by Dr. J. Cook, having been 
prepared also as described in Chaddock et al. (1993).  Ribosomes were first incubated in 
buffer (25mM Tris-HCl; 25mM KCl; 5mM MgCl2; at pH7.5) for 5 minutes at 30°C.  The 
indicated concentration of RTA was then added.  RTA and ribosomes were incubated 
together for 2 hours at 30°C to allow depurination.  The reaction was then stopped by the 
addition of 0.5% SDS (w/v) in 50mM Tris-HCl (pH7.6).   Ricin-treated rRNA was then 
phenol/chloroform extracted and treated with acetic aniline, pH4.5 (as described in Chaddock 
et al., 1993).  This cleaves the phosphodiester backbone at the site of specific depurination by 
RTA.  The resultant fragment band can then be visualised by separating the rRNA by 
denaturing agarose:formamide gel electrophoresis (see Chaddock et al., 1993), staining with 
ethidium bromid and quantification relative to untreated controls. 
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2.5.16 Production of liposomes  
All lipids used in this thesis were obtained from Avanti Polar Lipids (Alabaster, Alabama). 
Liposomes containing 100% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or 
100% 1-palmitoyl-2-oleoyl-sn-glycero-3-[phosphor-L-serine] (POPS) were prepared using an 
Avestin Inc. (Ottawa, Canada) Liposofast extruder.  The lipid was first dried of solvent 
(chloroform) by flushing with gaseous nitrogen overnight (at least 12 hours) under vacuum.  
Buffer (10mM MOPS; 50mM KCl) was added to make a final lipid concentration of 1mM.  
This suspension was freeze-thawed (dry ice / 37 ºC) 5× to reduce multilamellar vesicles.  
Vesicles were then flushed, at room temperature (21ºC) through the extruder (fitted with a 
100nm pore size polycarbonate filter) using gaseous nitrogen 10×.  Resulting liposomes were 
stored at 4ºC and used within a day. 
2.5.17 Purification of Hsp40 
Hsp40 was purified as per the method outlined in Minami et al. (1996).  The pET/Hsp40 
plasmid was transformed into E.coli BL21(DE3) cells and grown at 37°C overnight in 
500mL of 2YT.  0.4mM IPTG was then added, and the incubation extended for another 2 
hours.  These Hsp40-expressing cells were lysed by sonication in a buffer (20mM MOPS-
HCl; 20mM KCl; 1mM EDTA; pH7.2; 1mM phenylmethylsulfonyl fluoride).  The 10000 ×g 
supernatant of the sonicate was loaded onto a DEAE-Sepharose column (GE Healthcare) and 
eluted with the MOPS-HCl buffer with an ionic gradient of 20mM to 100mM KCl.  Fractions 
containing Hsp40 were determined by SDS-PAGE and Coomassie staining.  Pooled fractions 
containing Hsp40 were then loaded onto a Source 30S column (GE Healthcare) and eluted 
with a graduated buffer containing 100-300mM KCl.  Fractions were analysed by SDS-
PAGE and Coomassie staining, again, to determine the Hsp40 fractions which were to be 
pooled. 
2.5.18 Purification of Hsc70 
Three 1L flasks of SF9 cells (at a density of 1.2 million cells per millilitre) were infected with 
baculovirus containing pVL1393-hsc70 at a multiplicity of infection of 10:1.  This was left 
shaking at 30°C for 3 days.  Cells were induced to express Hsc70 with the addition of 1mM 
IPTG for 4 hours.  The cell aggregate was then collected by centrifugation.  Hsc70 was 
purified from these cells in a 3-stage process.  Cells were first lysed in Buffer A containing 
1% triton X-100 (this buffer‟s other constituents were as follows: 20mM MOPS-HCl; 20mM 
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KCl; 1mM EDTA; pH7.2; 1mM phenylmethylsulfonyl fluoride).  The homogenate was 
centrifuged for 30 minutes at 14000 rpm in a Beckman JA-14 rotor.  The supernatant from 
this centrifugation was then centrifuged again for a further 60 minutes, this time at 45000 rpm 
in a 45 Ti rotor.  Three sequential columns were used to remove protein impurities.  After 
each column, eluted fractions were analysed by SDS-PAGE and Coomassie staining for 
Hsc70 content and pooled for loading onto the next column.  The columns were, in order: 
DEAE-Sepharose (GE Healthcare), which was eluted with Buffer A, with a gradient of up to 
1M KCl.  The second column was an ATP-agarose column (Sigma-Aldrich), which was 
eluted with Buffer A containing up to 2mM ATP.  The third column used was a Source 30Q 
column (GE Healthcare), which was eluted with Buffer A (containing from 0 to 1M KCl).   
2.5.19 Production of a cytosolic extract 
3×75mL flasks of HeLa cells were incubated until they were occupied by confluent 
monolayers.  The HeLa cells were then made into a suspension using trypsin solution.  The 
cells were collected from this suspension by centrifugation (10000 ×g, 10 minutes).  This was 
resuspended in 5mL of 10mM MOPS-HCl (pH7.2) / 50mM KCl and the cells lysed by being 
passed repeatedly through a narrow, ice-cold metal casing containing metal ball bearings.  
The resultant solution was clarified by an hour centrifugation at 120000 ×g.  The supernatant 
was dialysed into 5L of 10mM MOPS-HCl (pH7.2) / 20mM KCl overnight to remove small 
molecules.  The final cytosol preparation was aliquoted into 20μL volumes and snap-frozen 
on dry ice before storage at -80°C 
2.5.20 Ubiquitination assay (mediated by Hsc70/CHIP) 
The ubiquitination protocol is described in Arndt et al. (2005).  Hsc70, CHIP (E3), Hsp40, E1 
and E2 (UbcH5b) were mixed together in the concentrations indicated in the appropriate 
results sections, with the substrate.  The total reaction volume was made up to 20μL.  The 
constituents of the buffer into which these proteins were diluted was as follows: 20mM 
MOPS-HCl, pH7.2; 100mM KCl; 1mM ATP; 1mM DTT; 1mM MgCl2; 0.001% 
phenylmethylsulfonyl fluoride).  Ubiquitin was supplied at a concentration of 2mg.mL
-1
.  
Reactions were incubated under the indicated conditions (usually 2 hours, 37°C).  The 
reaction was stopped by addition of the reducing running buffer for SDS-PAGE. 
Often, a pre-treatment is given before the addition of E1, E2, ubiquitin and CHIP.  Where this 
is so, it is described in the appropriate results section. 
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2.5.21 Lipofectamine transfection 
As described by the Invitrogen protocol, with the modifications mentioned in text. 
2.5.22 Viral infection of HeLa cells 
HeLa cells were seeded into flat-bottomed dishes at a density of 2.5 × 10
5 
cells per millilitre 
and grown overnight in supplemented DMEM.  In the morning, DMEM was washed off with 
PBS and left bare.  At a multiplicity of infection of 10:1, virus-containing DMEM was added 
to the bare HeLa cell monolayers.  The medium in which the virus was diluted contained no 
fetal calf serum.  Infections in six-well plates used a total volume of virus of 200μL per well.  
In 96-well plates, 25μL was used per well.  This virus solution was rocked over the 
monolayers once every 10 minutes for an hour.  Supplemented DMEM was then added and 
the cells incubated for the desired length of time. 
2.5.23 Measuring the turbidity of an RTA-containing incubation 
Two approaches were used.  In both methods, RTA was added to buffer (10mM MOPS; 
50mM KCl; HCl to pH7.2) at a concentration as indicated.  Depending on the method, this 
solution was then incubated in an Eppendorf floating in a 45°C water bath (20μL aliquots 
were taken at time points and their absorbance at 320nm recorded relative to buffer alone).   
Or else, alternatively, a cuvette with the solution in was placed in a spectrophotometer 
(hooked up to a water bath set to 45°C) and the absorbance at 320nm recorded at each 
timepoint was recorded over time (so negating the need for aliquots being taken).   
2.5.24 Amplification of plasmid DNA 
An aliquot of E.coli DH5α were transformed with the appropriate plasmid (as per 2.5.10) and 
then grown in 50mL of terrific broth overnight.  The cell aggregate from this (the 10000 ×g 
pellet) was collected and resuspended in 5mL of buffer (50mM glucose; 10mM EDTA; 
25mM Tris-HCl pH8.0).  To this, 10mL of a solution containing 1% SDS (w/v) and 0.2M 
NaOH was added.  This was mixed vigorously.  After mixing, 5mL of a solution containing 
250g.L
-1
 potassium acetate and 15% acetic acid (v/v) was added.  This was mixed and then 
centrifuged at 10000 ×g.   
The supernatant was mixed with 20mL of isopropanol and incubated at -20°C for 10 minutes.  
Subsequent to this, the 10000 ×g (4 minutes) pellet was collected and dissolved in 1.5mL of 
TE (10mM Tris-HCl, 1mM EDTA, pH8.0).  2mL of 5M LiCl was added to the resuspension, 
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precipitating the RNA.  RNA was removed by centrifugation at 10000 ×g for 4 minutes.  The 
supernatant was resuspended in ethanol, mixed vigorously, and stored at -20°C for 4 hours.  
The 10000 ×g pellet (4 minutes), containing the plasmid DNA, was then collected and 
washed with 95% ethanol.   
Contaminant RNA was degraded by resuspending the DNA pellet in 0.5mL TE with 
40μg.mL-1 RNase A for 30 minutes at 37°C.  Purified DNA was then precipitated with a 
buffer containing 20% PEG-8000 (w/v) and 2.5M NaCl.  This DNA was collected by a 
5minute spin at 13500 rpm in an Eppendorf micro-centrifuge; the pellet was dissolved in 
0.5mL TE and subjected to phenol/chloroform extraction – twice – to remove contaminant 
protein.  Finally, the DNA was precipitated from the chloroform by addition of 1mL ethanol 
and 50μL of 3M sodium acetate.  The precipitate was collected by a final spin in a micro-
centrifuge (5 minutes; 13500rpm).  The pellet was washed with ethanol, air-dried and then 
dissolved in 0.5mL of TE.  The optical density of this solution at 260nm was then measured 
(relative to TE alone) to determine the DNA concentration of the preparation. 
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CHAPTER 3: 
Pharmacological inhibition of chaperones influences the cytotoxicity of ricin. 
3.0 An introduction to why cytosolic chaperones might interact with RTA 
RTA is thought to exploit an ERAD-like pathway in order to gain access to the cytosol.  The 
pathway which facilitates this process in mammals is largely unknown.  However, a route 
involving Hrd1, like in yeast (Li et al., 2010), is expected to be utilised.  This is particularly 
so because cholera toxin A-chain (CTA1) has been shown to be retrotranslocated by its 
mammalian orthologues gp78/Hrd1 (Bernardi et al., 2010).  More broadly, however, the 
facilitators of RTA‟s retrotranslocation will putatively fall under four classes:  
(1) Recognition proteins. 
(2) Membrane-bound proteins that form a pore. 
(3) Cytoplasmic proteins which drive the extraction of RTA. 
(4) Cytoplasmic proteins responsible for resolving RTA from a proteolytic fate. 
Very little is known about the cytosolic interactions RTA makes in mammalian cells, except 
that the 26S proteasome is responsible for degrading two-thirds of the population which gains 
access to this compartment (Wesche et al., 1998).  As evidence has already been acquired 
which suggests RTA interacts with certain chaperones of the mammalian ER lumen, it may 
be that RTA will also be recognised by chaperones in the cytosol.  Slominska-Wojewodzcka 
et al. (2006) suggests that the ER lectin-like chaperone, EDEM, recognises ricin holotoxin, 
promoting delivery of RTA to the retrotranslocation apparatus.  Their data, however, do not 
imply that EDEM is absolutely necessary for the intoxication process.  It has also been shown 
that ricin holotoxin can be reduced to monomeric RTA and RTB by the ER-resident 
chaperone PDI (Spooner et al., 2004).  However, PDI does not seem to be responsible for 
subsequently unfolding RTA (R.A. Spooner, personal communication).  This differentiates it 
from CTA1, which uses the interaction to induce a translocation-competent, substantially-
unfolded state (Moore et al., 2010). 
More specific reasons exist for why RTA may be stabilised or else recognised by chaperones 
in the cytosol.  RTA is effectively an orphaned subunit when isolated from RTB (Marshall et 
al., 2008) and may no longer constitute a „native‟ protein from the perspective of the 
cytosol‟s quality control machinery.  Monomeric RTA also bears a solvent-exposed 
hydrophobic C-terminus.  This domain is crucial for cytotoxicity (Simpson et al., 1995).   It is 
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thought that this domain could begin the membrane or chaperone interactions in the ER that 
lead to retrotranslocation (Day et al., 2002; Mayerhofer et al., 2009).  These „non-native‟ 
qualities would be transposed to the cytosol after retrotranslocation and could feasibly prompt 
recognition by quality control pathways therein.  Moreover, to traverse the potentially narrow 
aperture of a membrane pore such as that of the Sec61 translocon (Van den Berg et al., 2004; 
Tian & Andricioaei, 2006), RTA is likely to have to be partially-unfolded.  For this reason it 
is thought that impediments to the unfolding of RTA hinder cytotoxicity (Beaumelle et al., 
2002; Argent et al., 1994).  As purified RTA cannot fold to an active conformation from a 
heat-induced molten globule in vitro (Argent et al., 2000), a third party is invoked.  This 
factor would assist RTA in regaining a catalytic conformation after retrotranslocation.  It 
need not be a protein binding partner, but could be another quality of the cytosolic 
environment, such as the redox environment, pH, crowding or other. 
Prior to this study, the only established third party for a putative, cytosolic reactivation 
process was the ribosome itself.  Argent et al. (2000) observed that incubation of partially-
unfolded, molten globule-like RTA with salt-washed ribosomes yielded active A chain.  
Inspired by this observation, it was proposed that the ribosomes studding the cytosolic 
surface of the ER provided a practically-situated scaffold upon which nascently 
retrotranslocated RTA could refold.  However, given that chaperones like Hsc70 and Hsp90 
are abundant and often involved in ERAD, this thesis investigates whether these 
evolutionarily-obligated facilitators of protein folding might supersede an interaction with the 
ribosome in vivo.  
Both Hsc70 and Hsp90 have been ascribed roles in ERAD-like pathways before now (Alberti 
et al., 2004; Gusarova et al., 2001).  Co-operating with them in this function is a cohort of co-
factors which regulate their ability to help clients refold productively.  They also interlink 
them with the ubiquitin-proteasome pathway (Ballinger et al., 1999).  This enables 
Hsc70/Hsp90 to allot conformationally aberrant clients for degradation if they bind 
recurrently (Ballinger et al., 1999).  Two substrates that are subjected to Hsc70- and Hsp90-
dependent degradation and which are localised to the ER membrane are the non-native (albeit 
functional) transmembrane protein, CFTR
∆F508
 (Alberti et al., 2004) and the co-
translationally, co-translocationally stalled ApoB (Gusarova et al., 2001), which were 
introduced earlier in this thesis.  As RTA crosses the ER membrane to get into the cytosol, it 
is possible that the topology of the toxin subunit appears analogous to that of CFTR
∆F508
 or 
ApoB at an intermediate stage in the process.  If this is the case, then RTA might interact 
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with Hsc70 and Hsp90 during its membrane transit in a way that is similar to how CFTR
∆F508
 
or ApoB do during their ERAD.   
Like ApoB and CFTR
∆F508
, it is plausible that the net outcome of this chaperone interaction 
with RTA may, likewise, be degradation.  Indeed, a chaperone interaction could even mediate 
the post-retrotranslocational, lysine-dependent degradation of RTA that Deeks et al. (2002) 
observed.  However, in contrast to ApoB and CFTR
∆F508
,
 
the significant phenotypic 
contribution of this interaction with RTA could be the smaller population that survives it and 
benefits from chaperone binding.  After all, only a single cytosolic molecule of RTA is 
thought to be required to deactivate a cell (Lord & Roberts, 1998).  With these ideas in mind, 
this thesis contemplates two possibilities; that Hsc70/Hsp90 might:  
(1) Aid RTA attain an active conformation in the cytosol. 
(2) Assign RTA to a proteolytic fate. 
It may also be that recognition of RTA by Hsc70 and Hsp90 withstands the retrotranslocation 
process itself.  These chaperones could influence the survival of RTA in a significant, chronic 
fashion as the toxin subunit diffuses between substrate ribosomes.  This prospect is roundly 
considered. 
3.1 Experimental approach 
One of the core techniques used throughout this thesis is the cytotoxicity assay.  This 
procedure is used to determine the IC50 of ricin, which is defined herein as the concentration 
of toxin that inhibits 50% of cellular protein synthesis under standardised culture conditions.  
To calculate this value, a dose-response curve is produced.  This curve is constructed by 
treating parallel cultures of cells with serial dilutions of ricin.  After a subsequent incubation 
to permit intoxication, the rate of residual protein synthesis is measured.  This is achieved by 
labelling the intoxicated cells with [
35
S]-methionine and quantifying the eventual 
incorporation of this radioactive amino acid into acid-precipitable protein (unincorporated 
[
35
S]-methionine is washed away before quantification).   
This technique provides a very sensitive method by which the effects of cytosolic RTA can 
be detected.  Indeed, as RTA inhibits protein synthesis in a catalytic fashion, a single instance 
of cytosolic RTA may be sufficient to significantly compromise the functional ribosomal 
complement of an entire cell (Sandvig & Van Deurs, 2002).  Thus, very small changes in the 
concentration of cytosolic RTA can have a significant effect upon the protein synthetic 
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capability of a cell.  If the cytotoxicity of ricin is helped or hindered by a particular pre-
treatment, or condition, then a shift in the dose-response curve relative to a series of 
untreated, parallel controls will be observed.  On a linear plot of increasing relative protein 
synthesis (y-axis) vs. increasing ricin concentration (x-axis), a protective treatment will shift 
the curve to the right.  Protein synthesis at each concentration of toxin will be bolstered.  On 
the other hand, a sensitising treatment will shift the curve to the left, reducing the protein 
synthesis observed at each dose.  By comparing such relative shifts, it is possible to screen for 
treatments which affect the intoxication process. 
This technique is crucial for research into the mechanisms by which ricin invades the cytosol 
because only a small concentration of enzymatically active RTA ultimately reaches this 
destination relative to that which binds at the cell surface.  To render a sense of proportion, it 
is estimated that a mere 5% of the ricin which is internalised from the cell surface reaches the 
TGN upon endocytosis (Van Deurs et al., 1988).  Thereafter, a much smaller portion of 
TGN-localised holotoxin will gain access to the ER because of vesicular recycling from the 
various intermediary compartments back to the cell surface (Van Deurs et al., 1986).  
Moreover, when in the ER itself, because reduction by PDI and the acquisition of a 
translocation-competent state may be inefficient (Spooner et al., 2004; Hudson & Neville, 
1987), even less is expected to subsequently retrotranslocate.  Finally, even after crossing the 
membrane into the cytosol, Deeks et al. (2002) showed that roughly two-thirds of RTA that 
does so is rapidly degraded by proteasomes. 
This series of filtering steps means that a relatively tiny proportion of RTA eventually 
reaches the cytosol in a soluble, active conformation.  This small yet significant quantity 
makes use of techniques like co-immunoprecipitation problematic.  It is technically difficult 
to differentiate the significant sub-population of cytosolic RTA from the relatively vast 
majority of that which floods the secretory pathway and cell surface.  If the binding with a 
hypothesised interacting protein is transient and the target protein is in huge excess, then the 
problem of identifying its interaction with RTA is multiplied.  Instead, determining the IC50 
of the toxin in a variety of controlled treatments provides a more practical experimental 
approach.   
As inhibitors of Hsc70 and Hsp90 were commercially available and easily supplemented into 
this experimental system, it was immediately possible to test whether these chaperones were 
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important in the cytotoxicity of ricin. Table 3.1 introduces the panel of inhibitors which have 
been utilised throughout this thesis to this end. 
 
Table 3.1 – Chaperone inhibitors and their targets. 
*As primarily assigned to these inhibitors.  Off-target effects do occur, and are evaluated throughout the 
discussion of results. 
Inhibitor Full designation Target* Reference 
DSG 15-deoxyspergualin Hsp70/Hsc70 Nadeau et al., 1994. 
GA geldanamycin Hsp90 Whitesell et al., 1994. 
RA radicicol Hsp90 Sharma et al., 1998. 
C01 C01018195 Hsp90 Sharp et al., 2007. 
NECA N-ethyl-5’-carboxamido adenosine Grp94 Immormino et al., 2004. 
 
At this juncture, it seems pertinent to stress that the IC50 assay measures the average 
difference in toxicity between negative and positive control cells.  That is, the effect is 
averaged over the entire population of intoxicated cells.  This does not allow for the 
differentiation of discrete sub-populations of cells, which might be functioning in an 
operationally distinct manner.  As a complementary or alternative technique, fluorescence-
activated cell sorting (FACS) would allow for the resolution of any such distinct populations 
of cells, rather than an average measure like IC50.  Synthesis of a fluorescent reporter protein 
could be activated during intoxication, and the cells could then be counted after incubation by 
this technique. 
3.2 Deoxyspergualin, an inhibitor of Hsc70, protects HeLa cells from ricin intoxication 
Hsc70-type chaperones are inhibited by the peptidomimetic, deoxyspergualin (DSG), which 
structurally mimics a short peptide (Figure 3.1).  Despite this similarity, DSG is not thought 
to bind to the peptide-binding domain of Hsc70, as a client protein would (Nadler et al., 
1998).  Rather, DSG binds to a C-terminal motif of the chaperone – the tetrapeptide „EEVD‟.  
This interaction stimulates the ATPase activity of Hsc70 in vitro, perturbing the dynamics of 
its normal interaction with clients (Nadler et al., 1998).   
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Figure 3.1 - The molecular structure of the Hsc70 inhibitor, DSG 
 
 
In vivo, it was observed by Jiang et al. (1998) that the disease-causing ERAD of mutant 
CFTR
∆F508
 is rectified by treating host cells with DSG.  This treatment disrupts an 
Hsc70∙CFTR∆F508 complex, permitting the maturation and subsequent delivery of the 
functional protein to the plasma membrane, when it would otherwise be degraded (Jiang et 
al., 1998).  Subsequently, it has been shown that interplay of Hsc70 with specific, pro-
degradation co-factors (i.e. BAG-1 and CHIP) is responsible for this degradation (Alberti et 
al., 2004).  DSG evidently prevents the overly-stringent degradation of CFTR
∆F508
 by 
disrupting these complexes, alleviating the diseased phenotype (Jiang et al., 1998).  For this 
reason, DSG is currently being tested in clinical trials for cystic fibrosis.   
The effect of DSG on the IC50 of ricin intoxication – As published by our laboratory in 
Spooner et al. (2008), when HeLa cells were treated with 50μg.mL-1 DSG6 during 
intoxication with ricin, they were protected ~2-fold relative to untreated cells (Figure 3.2a & 
c).  This implies that, at the IC50, there is 50% less catalytic activity from cytosolic RTA in 
DSG-treated cells than there is in control cells.  This 2-fold effect appears to be the maximum 
the dose can yield, given that pre-treatment for an hour does not yield any additional change 
in protection (as shown by the overlapping error bars in Figure 3.2c).  Similarly, a protracted 
incubation for 16-hours results in little change in protection (Spooner et al., 2008).  This 
implies the effect of DSG results from an acute disruption of Hsc70 rather than an indirect, 
chronically-induced one.  This would suggest that Hsc70 normally promotes the activity of 
RTA in target cells. 
As an aside, it should be noted that DSG-treatments unavoidably included lactose, which is 
the excipient with which the inhibitor is stored after synthesis.  However, any effects of this 
sugar (such as interfering with the binding of the lectin-bearing holotoxin to target receptors) 
have been accounted for by the treatment of control cells with an equivalent concentration of 
lactose.    
                                                 
6
 The concentration used in the rescue of CFTR
ΔF508
 in vivo (Jiang et al., 1998) 
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The effect of DSG on ricin trafficking times – It was possible that treatment of cells with 
DSG could interfere with trafficking of ricin from the plasma membrane to the ER.  This 
could be the case if significant trafficking proteins were Hsc70-dependent.  Thus, a series of 
experiments were conducted which examined the length of toxin-incubation required before 
the first signs of ricin cytotoxicity could be observed (a technique described by Hudson & 
Neville, 1987).  HeLa cells were challenged with a killing dose of ricin for varying lengths of 
time, after which their ability to incorporate [
35
S]-methionine into nascent, acid-precipitable 
protein was examined.  The length of time before the first signs of toxicity could be observed 
was then calculated and compared to parallel controls, giving an estimate of toxin trafficking 
time.  Figure 3.2e shows the time-response curves generated from this assay, and Figure 3.2f 
shows the relative trafficking times that were quantified from them.  These results were 
published in Spooner et al. (2008).  DSG-treated cells have a trafficking time which is 103% 
that of controls (standard deviation, SD ±1%; n=3).  This demonstrates that inhibition does 
not severely delay delivery of RTA to the cytosol. 
The effect of DSG alone upon protein synthesis – Figure 3.2d shows that DSG has little 
effect upon protein synthesis by itself.  Importantly, even if there were such an effect (as is 
the case for other treatments used later in this chapter), this would not contribute to the shift 
in the dose-response curve observed.  This is accounted for: each dose-response curve is 
normalised to internal standards for 100% protein synthesis.  For DSG-treated datasets, the 
100% value for protein synthesis was provided by cells which were treated with DSG/lactose, 
and not with ricin.  Similarly, for lactose-treated cells, the 100% standard was provided by 
cells which were treated with just lactose, but not with ricin.  
Potential off-target effects of DSG - Although DSG affects Hsc70-type chaperones of the 
cytosol, it is important to stress that the lumenal paralogue of these chaperones, BiP, is 
unaffected by DSG.  This is because it does not possess the C-terminus „EEVD‟ motif 
(Brodsky, 1999).  Therefore, if the protection owes to an effect upon the chaperone 
complement of the cell, BiP is probably not that which is affected.  DSG does, however, have 
a putative effect upon the activity of cytosolic Hsp90, as this protein does bear the C-terminus 
„EEVD‟ motif to which DSG binds (Nadeau et al., 1994).7  It was important to clarify 
whether the effects of DSG owed to an interaction with Hsc70 or with Hsp90. 
                                                 
7
 Note that the lumenal paralogue of cytosolic Hsp90, Grp94, is unaffected by DSG as it (like BiP) lacks the C-
terminal „EEVD‟ motif. 
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Figure 3.2 – The Hsc70/Hsp70 inhibitor, deoxyspergualin (DSG), protects cells from ricin.  
HeLa cells were seeded into a 96-well plate at a density of 2.5 x 10
5
 cells per well.  They were then grown 
overnight at 37°C.  Half were subsequently treated (for the time indicated) with: 
 
 100μg.mL-1 lactose and 50μg.mL-1 DSG, and the other half with: 
 100μg.mL-1 lactose alone. 
 
Serial dilutions of ricin were then added and the cells were incubated for 4 hours at 37°C.  Subsequently, cells 
were washed with PBS and incubated with 1μCi of *
35
S]-methionine per well for 30 minutes. Incorporation of 
this into acid-precipitable material was then quantified using a scintillation counter.  a) Dose-response curves 
showing the protective effect of treating cells with DSG coeval to application of toxin (representative from a 
set of three).  b) Shows the protective effect of a 1-hour pre-treatment with DSG before application of ricin 
(representative from a set of three). c) The average protective effect of acute and 1-hour pre-treatments with 
DSG, by comparison of IC50.  Cells treated with DSG coeval to application of toxin were protected 1.90-fold 
(standard deviation, SD: ±0.55; n=3) compared to control cells. Those cells pre-treated (denoted ‘pre’) for one 
hour with DSG were protected 2.02-fold (SD: ±0.38; n=3) relative to control cells. d) Shows the effect of DSG 
upon protein synthesis in the absence of ricin.  In all cases, error bars show the standard error of the mean 
(SEM) between 3 independent sets of experiments. 
 
e) Time-response curves showing the trafficking time of ricin.  HeLa cells were seeded into each well of a 96-
well plate and grown overnight at 37°C.  At time nought, every well was supplemented with fresh medium 
containing 100μg.mL
-1
 lactose and 50μg.mL
-1
 DSG (), or else with medium containing 100μg.mL-1 lactose 
alone ().  Each row of cells was then treated for a different length of time (as indicated) with a lethal dose of 
ricin (100ng.mL
-1
).  Residual protein synthesis in each well was then determined.  Protein synthesis at each 
timepoint was normalised to controls not treated with ricin. Lines of best fit were then drawn through the 
exponential phase of the datasets and this portion of the data was regressed using Microsoft Excel.  The time 
at which this equation satisfied 100% synthesis for each series was then used to compare control and inhibitor-
treated cells.  f) The trafficking time for DSG-treated cells was 103% of lactose-treated controls (SD ±1%; n=3; 
error bars show SEM). 
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(Figure 3.2 – continued.) 
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3.3 Inhibitors of Hsp90 sensitise HeLa cells to ricin intoxication 
To distinguish the potential effect of DSG upon Hsp90 from its well-established effects upon 
Hsc70 (Jiang et al., 2001), inhibitors of Hsp90-type chaperones were used in a similar set of 
assays.  Three Hsp90-inhibitors were used, Figure 3.3.  These were: geldanamycin (GA), 
radicicol (RA) and CCT018159 (C01).  Advantageously, RA and GA are both known to have 
no effect upon the ATPase cycle of Hsc70 (Schulte et al., 1998). 
 
Figure 3.3 - Molecular structures of 
the three Hsp90 inhibitors: radicicol, 
CCT018159 and geldanamycin.   
These chemical structures were rendered 
using two softwares: ISISDraw and 
PaintShopPro PHOTO X2. 
 
 
a. radicicol (RA) 
 
 
b. CCT018159 (C01) c. geldanamycin (GA) 
 
 
 
 
 
Each of these molecules has an affinity for the ATP-binding pocket in the N-terminal 
domains of the Hsp90 dimer (Schulte et al., 1998).  Their binding is therefore completely 
different to DSG.  Despite no obvious, structural similarity each mimics the contacts that are 
made by ADP in the site where they bind (Roe et al., 1999; Sharp et al., 2007).  Thus, they 
compete with nucleotide for occupancy of the site and render Hsp90 in a protractedly „open‟ 
conformation (Roe et al., 1999; Sharp et al., 2007).  Stebbins et al. (1997) proposed another 
mechanism.  Stebbins et al. (1997) remarked upon the similarity of the N-terminal inhibitor-
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binding pockets to substrate (peptide) binding sites.  The authors postulate that clients may 
actually be bound in these sites during their interaction with Hsp90.  If so, the binding of 
inhibitor might also compete with the client.  Thus, the inhibitory effect of these compounds 
upon Hsp90 may be elicited by multiple mechanisms.  The concerted effect would still be 
dissociation of Hsp90·client complexes. 
Model clients which are dissociated from Hsp90 by GA/RA include: luciferase (Schneider et 
al., 1996); the tyrosine kinase, src (Whitesell et al., 1994); glucocorticoid receptors 
(Whitesell & Cook, 1996); and the oncogenic Raf (Sharma et al., 1998).  Importantly, this 
has variable, substrate-dependent outcomes.  In the case of luciferase, dissociation leads to 
increased degradation if the luciferase has been heat-treated.  In this case, the lack of 
interaction with Hsp90 evidently leaves the client in a state vulnerable to proteases 
(Schneider et al., 1996).  In the case of the glucocorticoid receptor, inhibition of Hsp90 
results in the loss of its functional signalling from target cells.  However, it is thought that the 
receptor persists in an immature, non-signalling state rather than being degraded (Whitesell & 
Cook, 1996).    
Similarly, Loo et al. (1998) showed that 0.18μM (0.1μg.mL-1) geldanamycin prevents the 
maturation of the ERAD candidate CFTR
WT
 when applied to cells stably-expressing the 
protein.  The authors infer that an interaction of Hsp90 with CFTR
WT
 is important for its 
maturation from the ER.  This contrasts to the maturation-prohibiting effect that Hsc70 has 
upon CFTR
∆F508
 (Jiang et al., 1998). 
 
3.3.1 The effect of geldanamycin on ricin intoxication 
HeLa cells were treated with 1μM GA whilst challenged with ricin.  Compared to control 
cells, which were simply treated with DMSO (the solvent in which GA was dissolved), GA-
treated cells were unexpectedly sensitised ~2-fold to ricin (Figure 3.4).  GA, itself, appears 
toxic to HeLa cells (Figure 3.4c), but as the dose-response curves for each treatment were 
normalised to internal controls, this effect is compensated for in the determination of the IC50.  
These results were published by our laboratory in Spooner et al. (2008). 
This sensitisation obviously opposes the effect of DSG (a ~2-fold protection), and implies 
that approximately twice as much toxin reaches the cytosol in an active conformation when 
Hsp90 is inhibited in this manner.  First, this evidence helps to clarify that the protection 
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caused by DSG does not result from an inhibitory effect upon Hsp90.  Second, it would seem 
that Hsc70 and Hsp90 antagonise each other‟s role in the intoxication process: 
(1) On one hand, Hsc70 promotes the activity of RTA in the cytosol.   
(2) On the other hand, the action of Hsp90 inhibits the activity of RTA in the cytosol.  
The effect of GA on ricin trafficking times - Like for DSG, it was important to determine 
whether GA had an effect upon the retrograde transport of ricin through the secretory 
pathway.  This was especially important as Hsp90 inhibition reportedly interferes in the 
function of Rab proteins (Barzilay et al., 2004; Liu et al., 2009) and ricin trafficking has been 
shown to be dependent upon Rab proteins, e.g. Rab6A and Rab6A‟ (Utskarpen et al., 2006).  
There was effectively no difference between GA-treated and control cells (GA-treated cells 
had a trafficking time 101% that of controls; SD ±11%; n=3; as published in Spooner et al., 
2008).  The sensitising effect of GA resulted from a post-trafficking event.     
Potential off-target effects of GA - As well as three cytosolic isoforms of Hsp90, mammalian 
cells also possess a lumenal paralogue, Grp94 (Chen et al., 2005).  It is possible that GA 
inhibits this lumenal counterpart, which has been implicated in delivering ERAD substrates 
to the retrotranslocation apparatus.  The ERAD client α1-AT NHK is thought to be one such 
Grp94 client (Eletto et al., 2010).  Because of this potential conflation, it was important to 
investigate whether the effect of geldanamycin resulted from an effect upon cytosolic or 
lumenal Hsp90 paralogues.   
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Figure 3.4 – The Hsp90 inhibitor, geldanamycin (GA), sensitises cells to ricin.  
HeLa cells were treated with 1μM GA coeval to ricin-treatment, but otherwise treated as before.    a) A typical 
set of dose-response curves from a total of three independent experiments, comparing cells treated with 
medium containing DMSO () to medium laden with GA (). b) This yielded a 2.14-fold sensitisation (SD 
±0.80; n=3).  c) Shows the effect of GA incubation alone upon protein synthesis, relative to DMSO-treated cells.  
d) Trafficking times were calculated as before.  Trafficking time of GA-treated cells was 101% (SD ±11%; n=3)  
that of DMSO-treated controls. In all cases, error bars show the SEM between four independent sets of 
experiments. 
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3.3.2 The effect of radicicol on ricin intoxication 
The Hsp90 inhibitor, radicicol (RA), has a five-fold reduced affinity for Grp94 than GA 
(Barzilay et al., 2004; Taylor et al., 2010).   Therefore, its relative effect upon Grp94 will be 
diminished.  Nonetheless, RA is still regarded as an inhibitor of Grp94 (Eletto et al., 2010).  
When HeLa cells were treated with 1μM RA, they were sensitised 1.71-fold (SD ±0.46; n=3) 
to ricin (Figure 3.5a & b).  These results were published in Spooner et al. (2008).  This value 
is approximately equivalent to that of geldanamycin (2.14-fold sensitisation; SD ±0.80; n=3).  
Like GA, it appears that this effect also resulted from a post-trafficking interaction, as the 
trafficking time was similar to control cells, Figure 3.5d (published in Spooner et al., 2008). 
3.3.3 The effect of CCT018159 on ricin intoxication 
Finally, the Hsp90 inhibitor, CCT018159 (C01), was examined for its effects on ricin 
intoxication.  C01 was used at a concentration of 3.2μM (its IC50 with respect to the ATPase 
activity of mammalian Hsp90-β in vitro – Sharp et al., 2007). This treatment sensitised cells 
to ricin (Figure 3.6), but to a greater extent than either GA or RA: 2.36-fold (S.D. ±0.24; 
n=3).  C01 also had demonstrably little effect upon trafficking time (Figure 3.6d).   
Unfortunately, little data exists to show whether C01 possesses off-target effects on lumenal 
Grp94.  However, it has – like GA and RA – no effect upon the ATPase activity of Hsc70 
(Sharp et al., 2007).  The greater sensitisation this chemical causes could obviously result 
from a variety of possibilities: unknown off-target effects; a greater inhibitory effect upon 
Hsp90; or even a reduced rate of removal from the cell by P-glycoprotein (Sharp et al., 
2007).   
Remaining problems with interpreting the results of Hsp90 inhibition - Despite the reliably 
sensitising effects of each Hsp90 inhibitor, problems interrupt the straightforward 
interpretation of these results.  For instance it is possible each inhibitor affects Grp94.  
Moreover, inhibition of Hsp90 leads to the induction of Hsp70 expression in the cytosol 
(Shen et al., 2005; Shu et al., 2005).  The following sections attempt to clarify whether each 
of these effects contribute to the sensitisation observed here.  
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Figure 3.5 – The Hsp90 inhibitor, radicicol (RA), sensitises cells to ricin.  
HeLa cells were treated with 1μM RA coeval to ricin-treatment, but were otherwise treated as before. a) A 
typical set of dose-response curves from a total of three independent experiments, comparing cells treated 
with medium containing DMSO () to medium laden with RA dissolved in DMSO ().  b) This produced a 1.71-
fold sensitisation (SD ±0.46; n=3).  c) Shows the effect of RA incubation alone upon protein synthesis, relative 
to DMSO-treated cells. d) Trafficking times were calculated as before.  Trafficking time of RA-treated cells () 
was 93% (SD ±8%; n=3) that of DMSO-treated controls ().  In all cases, error bars show the SEM between 
three independent sets of experiments. 
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Figure 3.6 – The Hsp90 inhibitor, C01018159 (C01), sensitises cells to ricin.  
HeLa cells were treated with 3.2μM C01 coeval to ricin-treatment, and otherwise treated as before.  Controls 
were treated with DMSO as this was the solvent in which C01 was dissolved. a) A typical set of dose-response 
curves from a total of three independent experiments, showing C01-treated cells () and cells treated with an 
equivalent volume of DMSO (). b) This produced a 2.36-fold sensitisation (SD: ±0.24; n=3). c) Shows the 
effect of C01 incubation alone upon protein synthesis, relative to DMSO-treated cells.  d) Trafficking times 
were calculated as before.  Trafficking time of C01-treated cells () was 97% that of DMSO-treated controls 
().  (SD ±6%; n=3.)  In all cases, error bars show the SEM between three independent sets of experiments.   
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3.4 The effect of N-ethyl-5’-carboxamido-adenosine (NECA) on ricin intoxication 
NECA is a Grp94-specific inhibitor which does not bind to cytosolic Hsp90 (Rosser & 
Nicchitta, 2000; Eletto et al., 2010).  Thus, it may be used as a tool to differentiate the 
activities of cytosolic Hsp90 from Grp94.  As published in Spooner et al. (2008), when HeLa 
cells were treated with 1μM NECA, they were protected 1.48-fold (SD ±0.24; n=5) relative 
to DMSO-treated controls (Figure 3.7a & b).  Much like with the other inhibitors, the 
trafficking time of the ricin holotoxin appeared unaffected (Figure 3.7d).  Feasibly, Grp94 
could aid with the presentation of the RTA to the retrotranslocation apparatus (as it does for 
α1-AT NHK - Eletto et al., 2010).  The low degree of protection could reflect how the 
pathway is redundant with other routes, or that NECA is not a very effective Grp94 inhibitor. 
It may seem odd that paralogues Grp94 and Hsp90 direct opposite outcomes for RTA.  
However, these chaperones are divided by a membrane which demarcates separate 
„ambitions‟ for the toxin subunit.  Lumenal RTA requires recognition as an ERAD substrate 
to attain a cytosolic localisation.  Being recognised as misfolded in the ER is thus a boon for 
the activity of the toxin.  Contrastingly, having attained a cytosolic localisation, being 
recognised as misfolded will retard its activity by increasing the chances it is degraded.  
Therefore, this model suggests Grp94 and Hsp90 have a united tendency to recognise RTA as 
misfolded. 
Unfortunately, it is important to note that NECA possesses off-target effects.  For example, it 
is an agonist of adenosine receptors and inhibits both cAMP and cGMP phosphodiesterases 
(Brambilla et al., 2000).  Intracellular signalling caused by these effects might alter the 
quality of the cytosolic environment into which RTA enters.  The coeval application of the 
inhibitor with the application of toxin would have partially limited such chronic, induced 
effects.  Nevertheless, it stands to reason that the protective effect of NECA could be 
pleiotropic.  
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Figure 3.7 - N-ethylcarboxamidoadenosine (NECA) protects cells from ricin.  
HeLa cells were treated with 1μM NECA coeval to ricin-treatment, and otherwise treated as before.  Controls 
were treated with DMSO as this was the solvent in which NECA was dissolved. a) A typical set of dose-response 
curves from a total of three independent experiments, showing NECA-treated cells () and cells treated with 
an equivalent volume of DMSO (). b) This produced a 1.48-fold protection (SD ±0.34; n=5). c) Shows the 
effect of NECA incubation alone upon protein synthesis, relative to DMSO-treated cells.  d) Trafficking times 
were calculated as before.  Trafficking time of NECA-treated cells () was 96% (SD ±3%; n=3) that of DMSO-
treated controls ().    In all cases, error bars show the SEM between three independent sets of experiments. 
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3.5 Hsp90 inhibitors induce the expression of Hsp70. 
It is consistently observed that inhibition of Hsp90 induces the expression of cytosolic Hsp70, 
even at concentrations of as little as 1μM (Shen et al., 2005), such as is used throughout this 
thesis.  This effect is dependent upon the transcription factor, Heat shock factor 1 (HSF1; see 
Shen et al., 2005).  Normally, Hsp90 interacts with HSF1 and masks nuclear localisation 
sequences on this cytosolically located transcription factor.  However, when Hsp90 is 
inhibited (or binding to a sudden surfeit of unfolded clients), HSF1 sheds its contingent of 
chaperones and is transported to the nucleus.  Therein it trans-activates genes with heat shock 
elements to their promoters, including Hsp70 (Shen et al., 2005). 
As the protective effect of DSG upon ricin intoxication indicated a role for Hsc70-type 
chaperones in the cytotoxicity of ricin, it was important to determine whether the 
phenomenon of Hsp70 up-regulation caused the sensitising effects of GA/RA/C01 
treatments.  Figure 3.8 shows two immunoblots where HeLa cells have been incubated with 
either RA or GA, confirming that induction of Hsp70 occurs under our laboratory conditions 
(published in Spooner et al., 2008).  Inducible Hsp70 is noticeably up-regulated at 4-hours 
post-incubation.
8
  Examination of the same lysates for cytosolic Hsp90 shows no obvious 
change in levels. Grp94, on the other hand, is visibly up-regulated at least 8-16 hours after 
treatment (as shown by very weakly-stained bands marked out be black arrowheads in Figure 
3.8).  Lawson et al. (1998) report that both ER-resident Grp94 and BiP are induced under 
similar conditions. 
In the preceding sections, the sensitising effects of GA, RA and C01 were determined after a 
coeval treatment of ricin and inhibitor.  Because of this it was expected that the change in 
IC50 observed would be a result of acute effects rather than chronic, induced ones such as 
changes in protein expression.  However, residual protein synthesis in prior assays was 
measured after a total period of 4 hours‟ incubation.  It might be, therefore, that the level of 
Hsp70 (or of BiP/Grp94) increases swiftly enough in response to GA/RA to have a 
significant effect upon the intoxication process.  On the other hand, delivery of the significant 
portion of active toxin to the cytosol takes closer to ~1 hour after binding to the cell surface 
                                                 
8
 Reassuringly, these observable changes in expression provide evidence that RA and GA are both functional 
under the conditions used in this thesis.   
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than 4 hours (Hudson & Neville, 1987; Spooner et al., 2008).  Thus, the matter needed 
testing. 
  
 
 
 
Figure 3.8 – Cells incubated with either RA or GA display increased levels of Hsp72 and 
Grp94, but constant expression of Hsp90 
Cells were incubated with 1μM of the indicated inhibitor for the indicated length of time, or with DMSO for 16 
hours (-).  Detergent soluble lysates were then collected, analysed by SDS-PAGE, blotted onto nitrocellulose 
and immunostained for the indicated proteins and γ-tubulin (as a loading control).  Bands were visualised by 
an alkaline phosphatase development.  As Grp94 bands are faintly stained, they have been highlighted using 
black arrowheads. 
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3.5.1 The effect of chronic incubation with Hsp90 inhibitors upon ricin intoxication 
Cells were incubated from 0 to 16 hours with either GA or RA, and then assayed for their 
sensitivity to ricin relative to DMSO-treated controls.  Upon lengthened incubation, the 
sensitising effects observed with RA and GA treatments were found to diminish (Figure 3.9).  
After 16-hours of pre-incubation, cells were even protected from ricin (N.B., „protection‟ is 
any value of less than 1-fold sensitisation).  This transition to protection implies a separate 
effect is induced by the treatment rather than the inhibitor simply becoming ineffective over 
time.  The reciprocal of the sensitisation index gives the protective effect, which is 1.43-fold 
in the case of a 16-hour pre-treatment with RA (SD ±0.21; n=3) and 2.13-fold in the case of 
GA (SD ±0.18, n=4).   
As a rise in Hsp70 levels correlate to this shift from sensitisation to protection, they may 
account for it.  Alternatively, a rise in the expression of ER chaperones Grp94/BiP might be 
the cause.  On the other hand, acute inhibition of Grp94 and Hsc70-type chaperones both 
resulted in protection.  Therefore, another question arises: why would promoting their activity 
by increasing their expression also lead to protection?  Rational suggestions can be made to 
explain such a disparity, if induction of Grp94/Hsp70 is responsible for the chronic effect of 
GA/RA:  
(1) Inducible Hsp70, which is weakly expressed in unstressed conditions (Callahan et al., 
2002), may treat RTA differently from Hsc70.  Indeed, its effects are not strictly 
being examined under DSG-treatments.  Thus, although it is similar to Hsc70, Hsp70 
might hinder RTA.  Such differentiation has precedents:   
a. Hsp70 has increased affinity for clients than does Hsc70 (Callahan et al., 
2002), changing the dynamics of an interaction with RTA.   
b. Hsc70 and Hsp70 have opposite effects upon the maturation and degradation 
of epithelial sodium channels (Goldfarb et al., 2006).   
(1) Increased Hsp70 may dilute a relatively static background of deterministic co-factors.  
Thus, antagonism may exist between co-factor independent activities of Hsc70/Hsp70 
and the impositions made upon them by the quality of the co-chaperone environment. 
(3) Up-regulation of Grp94 (or BiP) might alter the dynamics of the chaperone matrix, 
altering the balance between client sequestration in the ER and client ERAD.   
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The effect of chronic Hsp90 inhibition may not necessarily be associated directly with 
chaperones either.  Imai et al. (2003) showed that prolonged inhibition of Hsp90 leads to the 
reduction of 26S proteasome complexes, and a general reduction in the abundance of the 19S 
cap.   It could be that this modification interferes with retrotranslocation, as the proteasome 
has previously been hypothesised as a motor driving extraction of misfolded polypeptides 
from the ER (Kalies et al., 2005;  Lipson et al., 2008), and has been shown to be involved in 
the retrotranslocation of RTA in yeast (Li et al., 2010). 
 
 
 
 
Figure 3.9 – Chronic pre-treatment with both GA and RA protect cells from ricin.  
HeLa cells were pre-incubated (pre) with 1μM GA for a) 0-, b) 4-, c) 8- and d) 16-hours before ricin-treatment. 
Dose-response curves from each assay are shown, comparing cells treated with medium containing DMSO () to 
medium laden with GA and DMSO (). e) and f) Show, respectively, the tabulated and graphical changes in the IC50 
of ricin under these conditions relative to DMSO-treated controls.  g) - l) Show figures equivalent to a) through f), 
but where 1μM radicicol was used rather than geldanamycin.  Error bars show SEM in all cases. 
 
 
Figures a) through f) are on the next page. 
 
g) through to l) are on the subsequent page. 
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(Figure 3.9 – continued.) 
g. 0-hour (coeval) RA incubation 
 
h. 4-hour RA pre-incubation 
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3.5.2 The effect of chronic incubation with 2mM 4-phenylbutyrate 
It has been reported that chronic (72-hour) treatment of HeLa cells with 2mM 4-
phenylbutyrate (4-PB) in the growth medium leads to down-regulation of Hsc70 mRNA by 
promoting its degradation (Rubenstein & Lyons, 2001).  This results in a subsequent 
reduction in Hsc70 levels (Rubenstein & Lyons, 2001).  When cells were treated in this 
fashion in our laboratory, a small reduction of Hsc70 was observed by the immunostain of 
cell lysates (Figure 3.10a & b).  When cells were treated similarly for 72 hours with 2mM 4-
PB and then challenged with ricin, they were protected relative to cells which were treated 
with the chemical coeval to the time of toxin application (1.55-fold; SD ±0.22; n=3; see 
Figure 3.10c & d).  This small protection implies that when there is less Hsc70, less toxin 
activity is observed in the cytosol.  This is in accord with the hypothesised role of Hsc70 as a 
promoter of ricin toxicity.   
Unfortunately, 4-PB also has off-target effects, including: activation of cell differentiation, 
trans-activation of genes and cell cycle arrest (Wang et al., 2008).  Furthermore, the slight 
reduction in Hsc70 observed may not be significant in a system where it is potentially already 
saturating.  Problematically, a genetic approach to the down-regulation of Hsc70 would be 
just as fraught with off-target effects, resulting from the vital housekeeping role of this 
chaperone.  Indeed, knocking out Hsc70 and its cytosolic paralogues entirely is reported to be 
a nonviable approach (reviewed in Whitesell & Lindquist, 2005).  Therefore, alternative 
methods of investigation have been sought to investigate the role of Hsc70 in vitro (see 
subsequent chapters).   
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Figure 3.10 – Chronic incubation with 4-PB leads to the reduced intensity of Hsc70 
immunostaining & protects cells from intoxication. 
HeLa cells were plated at a density of 2.5 x 10
5
 cells per well in a 6-well plate and then incubated in medium 
with or without 2mM 4-PB for 72 hours.  Detergent-soluble lysates were then collected, electrophoresed, 
blotted onto nitrocellulose and immunostained via an alkaline phosphatase development.  a) Shows the 
average intensity of Hsc70 bands in 4-PB treated cells relative to controls (normalised to 1), as quantified by 
TotalLab.  Independent lanes were corrected for loading inaccuracies via the co-staining of γ-tubulin, the 
levels of which were assumed to be unaffected by the treatment. b) Shows the series of three independent 
experiments from which the quantification in “a” was derived. 10μg of protein is loaded per lane.  Staining 
from α-Hsc70 reactivity is marked with the grey arrowhead; reactivity with α-γ-tubulin is marked with a white 
arrowhead.  c) 72-hour incubation with medium containing 2mM 4-PB down-regulates Hsc70 mRNA 
production in Hela cells (Rubenstein & Lyons, 2001) and garners a 1.55-fold protection (SD: ±0.22, n=3) 
relative to acutely-treated controls. d) Shows example dose-response curves from one assay of three 
independent repeats. e) Shows the effect of the 4-PB alone upon protein synthesis, relative to untreated cells. 
Error bars show SEM in all cases. 
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(Figure 3.10 – continued.) 
 
 72-hour 2mM 4-phenylbutyrate pre-treatment 
 Coeval 2mM 4-phenylbutyrate treatment 
 
 
 
c. Protective Effect (n=3) d.  Dose-response curves 
P
ro
te
ct
io
n
 (
-f
o
ld
) 
 
R
el
. p
ro
te
in
 s
yn
th
es
is
 (
%
) 
 
 4-PB - +  [Ricin] (ng.mL-1) 
 
e. Effect of 4-PB alone (n=3)  
 
R
el
. p
ro
te
in
 s
yn
th
es
is
 (
%
) 
  
 
 4-PB - +   
 
 
 
0
0.5
1
1.5
2
2.5
3
0
10
20
30
40
50
60
70
80
90
100
0.05 0.5 5 50
0
20
40
60
80
100
Page 87 
 
3.5.3 The effect of a heat shock upon the susceptibility of cells to ricin 
If the chronic effects of GA/RA resulted from the up-regulation of Hsp70, then a heat shock 
inducing the same response might also protect cells from ricin intoxication.  Parallel plates of 
cells were either heat-shocked for 10 minutes at 45°C, or incubated at 37°C.  After a 
subsequent period of 2 hours at 37°C, IC50 was determined by the usual protocol.  The lag 
was imposed to ensure that the heat shock response would be induced by the time the toxin 
reaches the cytosol (as reported by Burdon et al., 1982).
9
   
The result of three independent assays (Figure 3.11a & b) showed an average sensitisation of 
1.04-fold (SD ±0.23; n=3), which is essentially the same as controls.  This was unexpected, 
given that manipulation of heat-shock proteins in earlier assays had obvious and consistent 
protective or sensitising effects.  It could be that a number of antagonising responses are 
induced by heat-shock, fortuitously neutralising one other.  Among these responses would be 
various other chaperone levels (e.g. functionally-implicated Hsp90); the configuration of the 
proteasome (Beedholm et al., 2004); and potentially competition from a backlog of ERAD 
candidates.   
Obviously, this study could be broadened by examining a panel of different temperature heat-
shocks, transecting different times post-stress, and by clarifying the expression of Hsp70 and 
Hsp90 in the cytosol in each case.  However, it was deemed more valuable to pursue assays 
which began to refine the broadening array of interpretations the data to this point provoked.  
At this juncture, the following hypotheses seem the strongest: 
(1) Grp94 putatively helps direct lumenal RTA to the retrotranslocation apparatus; 
(2) Hsc70 activates cytosolic RTA; 
(3) Hsp90 inactivates cytosolic RTA; 
(4) Long-term Hsp90 inhibition induces an effect which protects cells from ricin. 
 
 
 
 
                                                 
9
 Note that – unlike previous assays – control and heat-shocked cultures had to be on different plates so that 
their temperatures during the treatment could be independently regulated.   
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Figure 3.11 – A 10 min heat shock at 45°C does not alter the susceptibility of cells to ricin 
Cells were plated into two plates at a density of 2.5105 cells per well and grown overnight at 37°C.  Heat-
treated plates were then incubated at 45°C for 10 minutes and returned to 37°C, whereas control plates were 
left in the incubator for this period.  After 2 hours passed, the IC50 of each set of cells was determined by the 
usual method. a) Shows dose-response curves, heat-shocked () and control ().  b) Shows the average effect 
of this treatment (n=3).  Error bars show SEM.
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3.5.4 The effect of deoxyspergualin dominates that of radicicol 
During the conformational maturation of substrates like luciferase, certain kinases and steroid 
hormone receptors, Hsc70 and Hsp90 are known to work together in a sequential triage (Pratt 
et al., 2010).  This pathway delivers native, functional proteins from non-native, inactive 
conformers (Murphy et al., 2003; Johnson et al., 1996).  In these pathways, the co-chaperone 
HOP dynamically links Hsp90 to Hsc70.  Its binding preferences and effects upon the 
ATPase cycle of each chaperone promotes the passage of substrates from Hsc70 to Hsp90 
(Johnson et al., 1998; Hernandez et al., 2002; Gross & Hessefort 1996).   
To test whether this kind of sequential pathway was commensurate with the observations 
made in this thesis, or whether Hsc70 and Hsp90 competed for binding to RTA, a dual-
treatment approach was used (Figure 3.12).  Cells were treated with both DSG and radicicol 
at the time of toxin addition.  The net effect of this treatment was a protection of 1.85-fold 
(SD ±0.48; n=3), which compares well to the effect of DSG alone (1.90-fold protection; SD 
±0.55, cf. section 3.2).  If Hsc70 and Hsp90 were competing with one another for binding 
RTA, dual inhibition would mitigate the opposite effects of these chaperones.  However, this 
does not seem to be the case.  Rather, it appears that the sensitising effect of radicicol is 
dependent upon the activity of Hsc70.  These findings have been published in Spooner et al., 
2008). 
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Figure 3.12 -  The effect of DSG dominates the effect of radicicol 
The protective effect of treating HeLa cells coevally with 50µg.mL
-1
 DSG, 1µM RA () was determined via 
cytotoxicity assay, as before.  The controls used were treated with an equivalent concentration of DMSO and 
lactose () to account for their inclusion in the DSG and RA preparations.  a) Shows typical dose-response 
curves. b) Shows the average protective effect at the IC50 relative to the controls (n=4).  Error bars show SEM. 
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3.5.5 Ricin itself does not provoke alterations in Hsc70/Hsp70 nor Hsp90 expression 
As an aside to the main direction of this chapter, intoxication of a cell by ricin could itself 
promote changes in protein expression or activity.  It has been hypothesised that ricin may 
have evolved a way of promoting a cytosolic environment that is permissive of its 
intoxication (Spooner & Watson, 2006).   
Spooner & Watson (2006) proposed that, as ricin B-chain is a lectin with two binding sites, 
the holotoxin may be able to dimerise adjacent cell surface receptors.  This could lead to the 
induction of internal signalling cascades, which could alter protein activity (Spooner & 
Watson, 2006).  As binding to the cell surface and access of RTA to the cytosol are separated 
by ~1-hour (Hudson & Neville, 1987), this may be enough time for protein expression (or 
indeed activity) in the cytosol to become significantly affected as well.  Of interest to this 
study is whether Hsc70, Hsp70 and Hsp90 chaperones are affected. 
HeLa cells were incubated with minute doses of ricin for different lengths of time.  Detergent 
soluble lysates were then collected and tested for changes in Hsp90 and Hsp70/Hsc70 
expression (Figure 3.13a).  By the method used, no apparent change in any of these proteins 
was detected.
10
  Figure 13.3b shows corroborating data generated by R.A. Spooner 
(University of Warwick), which was interpreted by L. Zeef (University of Manchester).  As 
part of a transcriptomic approach, HeLa cells were treated with 50 ng.mL
-1
 ricin for up to 4 
hours.  Afterward, global transcriptional changes were measured using a technology from 
Affymetrix.  Figure 3.13b shows the relative levels of Hsp90AA1 mRNA after such 
treatment over time (Hsp90AA1 is one of three cytosolic Hsp90 paralogues - Chen et al., 
2005).  It would appear that, if ricin does affect relative protein expression ahead of entry to 
the cytosol, Hsp90 and Hsc70/Hsp70 are not among those which are affected. 
  
                                                 
10
 Although it may be that a saturating level of Hsc70/Hsp70 staining hides a relatively slight induction of 
Hsc70/Hsp70. 
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Figure 3.13 – The effect of ricin incubation on Hsp90 / Hsp70 expression in HeLa cells. 
a) HeLa cells were seeded into and grown overnight in a 6-well plate at a density of 2.5 × 10
6
 cells per well.  
They were then incubated with the stated concentration of ricin in culture medium for the indicated length of 
time.  Detergent soluble lysates were finally collected and 10μg of protein loaded into each lane for SDS-PAGE.  
The gel was then blotted onto nitrocellulose and immunostained for Hsp90, Hsp70/Hsc70 and γ-tubulin, 
before development by an alkaline phosphatase protocol.  Shown below is a representative assay from a set of 
three independent repeats.  b) The data in the following figure is published here courtesy of R.A. Spooner 
(University of Warwick), who treated HeLa cells with 50 ng.mL
-1
 ricin for up to 4 hours and observed changes in 
mRNA levels by a transcriptomic approach using Affymetrix technology.  Data from these assays were 
interpreted by L. Zeef (University of Manchester). 
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3.6 The effect of altering RTA’s lysine complement upon the sensitising properties of 
radicicol 
The experimental approach undertaken to this point has been constrained by the potentially 
pleiotropic effects of the inhibitors used (and, moreover, the pleiotropic effects of inhibiting 
the chaperones themselves).  To try and better ratify whether the effects of these inhibitors 
resulted from a direct mode of action upon RTA, a new approach was devised.   
I take this opportunity to re-state two of the primary rationales for studying the involvement 
of cytosolic chaperones in ricin cytotoxicity: 
(1) Nascently retrotranslocated, unfolded RTA may benefit from an interaction with 
cytosolic chaperones which promote the acquisition of an active conformation. 
(2) While still unfolded, RTA may be recognised by the same chaperones and targeted for 
proteasomal degradation. 
As Hsc70 and Hsp90 work in concert with the ubiquitin-proteasome pathway, they may be 
able to send RTA to the proteasome directly.  If so, this transfer might be mediated by lysine 
ubiquitination.  As discussed earlier, RTA possesses remarkably few lysines, which help it to 
avoid terminal degradation (Hazes & Read, 1997).  Indeed, Deeks et al. (2002) showed that 
increasing the lysine complement of RTA reduces the potency of the holotoxin.  Therefore, if 
the sensitising effect of Hsp90-inhibition was augmented or diminished for holotoxins whose 
constituent RTA subunit had an altered lysine complement, conclusions could be drawn 
about the physical outcome of its interaction with RTA. 
3.6.1 Purification of RTA
0K
, RTA
WT
 and RTA
6K
 
To produce the holotoxin variants used in the proposed assay, recombinant, monomeric RTA 
and purified RTB had to be acquired. RTB was purchased commercially (Vector labs); the 
RTA variants, however, had to be purified from transformed cultures of E.coli. More explicit 
details on the protocol used can be found in the Chapter 2.  However, a précis on the 
purification procedure is given here for ease of reference.  
Genes for expressing RTA variants: RTA
0K
 (no lysines), RTA
WT
 (bearing two endogenous 
lysines) and RTA
6K
 (six lysines) were each separately transformed into E.coli JM101.  
Cultures of each were grown and RTA expression was induced.  Cultures were then 
centrifuged, lysed by sonication and further clarified by centrifugation.  Clarified sonicates 
were then fractionated by ion-exchange chromatography upon a 50mL CM-Sepharose CL-6B 
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column.  Aliquots from the fractions obtained were analysed by Coomassie staining after 
SDS-PAGE for RTA content (Figure 3.14a-c).  Those fractions containing RTA (and no 
impurities) were pooled. 
 
 
 
Figure 3.14 – Purification of RTA variants. 
Purification of clarified sonicates containing RTA
WT
, RTA
6K
, or RTA
0K
 from an E. coli culture.  Continuous 
fractions (enumerated consecutively) were analysed by SDS-PAGE and Coomassie blue staining.  Fractions 
containing RTA with no impurities were pooled. a) Shows purification of RTA
WT
, b) RTA
0K
 & c) RTA
6K
.  In a), 
lane A comprises 10μL of crude sonicate; B is 10μL of the supernatant after centrifugation of the sonicate, 
whilst C is 10μL of the flow-through from the column as it washed with 100mM NaCl in pH 6.4 sodium 
phosphate.  In all cases, the black triangle indicates bands corresponding to the molecular weight of RTA. 
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(Figure 3.14 - continued.) 
 
b. Purification of RTA0K 
 Δ*NaCl+ 
 
c. Purification of RTA6K 
 Δ*NaCl+ 
 
 
 
 
 
  
Page 96 
 
After pooling RTA-containing fractions, each relatively dilute RTA preparation was 
concentrated by centrifugation in Centricons (protocol as described by Millipore).  The purity 
of each preparation was then analysed by Coomassie staining after SDS-PAGE.  This can be 
observed below (Figure 3.15Figure). 
 
Figure 3.15 – Purity of RTAWT, RTA0K and RTA6K preparations after centrifugal 
concentration.   
20μg of RTA (as estimated by the absorbance of the concentrated solutions at 280nm and the molar extinction 
coefficient, which is 0.77 for a 1mg.mL
-1
 solution in sodium phosphate – Chaudry G.J. et al., 1993) was loaded 
per lane.  For comparison, 20μg of purified RTB (Vector labs) was run in parallel in the final lane.  The gel was 
stained with Coomassie blue. 
 
 
 
3.6.2 Association of recombinant RTA with RTB 
To generate holotoxin from monomeric RTA and RTB, RTA had to be joined to RTB via a 
disulfide bond.  For a full account of the association protocol, please refer to Chapter 2.  
However, a précis is given here.  RTA was added to RTB, with RTA in 2:1 excess (w/w) 
with 2% (v/v) β-mercaptoethanol and 100mM lactose.  The β-mercaptoethanol and lactose 
were then removed by consecutive rounds of dialysis.  The resultant solution was passed 
down an immobilised α-lactose column (Sigma-Aldrich) to remove monomeric RTA.  
Monomeric RTB and holotoxin were eluted with a dilute galactose solution (to which RTB 
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binds in preference to lactose).  Galactose was removed from this solution by dialysis, 
yielding a solution of purified RTB and reassociated holotoxin.   
Reassociated holotoxin solutions were finally concentrated by centrifugation using YM-10 
Microcons (Amicon).  They were quantified by silver-staining (Figure 3.16).  As some free, 
monomeric RTB existed in the final preparations, the concentration of holotoxin was 
calculated by comparison of RTA band intensity to standards of known concentration (40, 80, 
120 & 160ng).  Notice that RTA of the reassociated holotoxin migrates faster as it is not 
subjected to glycosylation when expressed in E. coli. 
 
Figure 3.16 – Quantification of reassociated holotoxin 
Three recombinant RTAs with varying complements of endogenous lysine residues were reassociated with RTB.  
The concentrations of the final aliquots of reassociated holotoxin were compared to standards of known 
concentration using a silver stain.  The indicated volume of each reassociation (0K, WT & 6K RTA) was loaded in 
triplicate. 
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3.6.3 The inhibitory range of the reassociated holotoxins 
With the concentrations of the reassociated holotoxins approximated, it was possible to 
explore whether the reassociated, recombinant proteins shared the same lysine-dependent 
trend in cytotoxicity as reported by Deeks et al. (2002).  The efficacy of each in reducing 
protein synthesis was tested (Figure 3.17).  As would be predicted, the IC50 of holotoxin 
containing RTA
6K
 was greatly increased relative to RTA
0K
 and RTA
WT
.  Again, this is 
presumably due to a greater propensity to become polyubiquitinated upon the cytosolic side 
of the ER membrane (Deeks et al., 2002), reducing the concentration of active RTA in the 
cytosol.   
Quite unlike Deeks et al. (2002) RTA
0K
 is significantly more toxic than RTA
WT
.  This 
suggests that the two endogenous lysines are susceptible to ubiquitination.  By average, 
RTA
WT
 is ~1.4-fold less toxic than RTA
0K
 (a significant difference; p=0.013 by Student‟s 
paired T-test).  RTA
6K
, on the other hand, is ~9.5-fold less toxic than RTA
WT
 (p=0.047 by 
Student‟s paired T-test).  If the lysines of RTA6K were all equally predisposed to 
polyubiquitination, a ~3-fold change in toxicity should be observed between the RTA
WT
 and 
RTA
6K
 variants (as there is a 3-fold difference in lysine complement).  Thus, it seems that the 
four non-native lysines of RTA
6K
 are more accessible to the ubiquitination machinery of the 
cell than its two native lysines.  This may tell us that the two endogenous lysines of RTA are 
specifically placed to avoid them contributing to cytosolic inactivation of the toxin subunit.  
Alternatively, the lysines may alter the activity of the protein in some other significant way, 
such as altering its solubility and retrotranslocation dynamics.  However, Deeks et al. (2002), 
did determine that the catalytic activities of these A-chain variants were unaffected when 
tested in vitro. 
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Figure 3.17 – Increasing the lysine 
complement of RTA reduces holotoxin 
cytotoxicity. 
a) Shows the IC50 determined for each 
preparation of reassociated holotoxin.  b) 
Shows dose-response curves for reassociated 
holotoxins comprising RTB reassociated to 
recombinant:  
 RTA0K  
 RTAWT 
 RTA6K  
Example assays are shown from sets of three 
independent experiments.  Error bars show 
SEM. 
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3.6.4 The effects of radicicol upon the potency of three holotoxins with varying lysine 
complements 
The potency of the three reassociated holotoxins was examined in the presence and absence 
of 1μM RA (Figure 3.18).  In the case of RTAWT and RTA6K, radicicol is convincingly 
sensitising.  The toxicity of RTA
0K
, however, does not appear to be bolstered by Hsp90 
inhibition (p=0.245 by Student‟s paired T-test).  The greatest sensitising effect of radicicol 
was clearly upon holotoxin containing RTA
6K
.  The greater concentration of lysine residues 
in RTA
6K
 presumably predisposes it to degradation.  Radicicol apparently neutralises this 
predisposition.  This result implies that Hsp90 helps to mediate the polyubiquitination of 
RTA in vivo. 
Reassuringly, the sensitising effect of radicicol with respect to reassociated holotoxin 
containing RTA
WT
 is similar in magnitude to wild-type toxin which has not been exposed to 
the rigours of the reassociation process.  Radicicol sensitises cells to reassociated RTA
WT
 
1.71-fold (SD ±0.24; n=3; p=0.016 by Student‟s paired T-test).  Equivalent wild-type 
holotoxin purified from Ricinus communis sensitises cells to ricin 1.87-fold (SD ±0.35; n=3). 
Finally, it is intriguing that the RTA
0K
-containing holotoxin was not at all responsive to 
Hsp90-inhibition.  This might suggest that RTA
0K
 simply does not interact with Hsp90, 
unlike the other variants.  RTA
0K 
might be extracted from the ERAD pathway at an earlier 
stage because of its lack of ubiquitination, preventing a subsequent interaction with Hsp90, 
for instance.  Alternatively, the Hsp90-mediated route to inactivation may be one which 
requires direct, lysine-ubiquitination of RTA.   
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Figure 3.18 – Increasing the lysine complement of RTA augments radicicol-induced 
sensitivity to ricin holotoxin. 
The effect of 1 μM radicicol () upon the IC50 of reassociated ricin holotoxin was determined via cytotoxicity 
assay.  Representative dose-response curves under these conditions are plotted alongside DMSO-treated 
controls (). Reassociated holotoxin comprised RTB disulfide-bonded to a) RTA0K, b) RTAWT or c) RTA6K.  In 
each case, the representative curves come from a set of three independent experiments. d) Shows the 
sensitising effect of radicicol for each holotoxin variant (n=3; error bars show the SEM between the three sets 
of assays). 
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3.7 Discussion 
Manipulating the function of chaperones in vivo using pharmacological agents changes the 
sensitivity of the target cell to ricin.  The role of the chaperone matrix in the cell is inarguably 
complex and will control multitudinous cellular functions by promoting the active 
conformations of various clients (and the degradation of their misfolded forms).  Therefore, 
the effects of inhibiting these chaperones are also likely to be rather complex.  However, 
from the evidence at hand, some tentative models can be proposed. 
The role of Hsc70 - Inhibition of Hsc70 protects cells.  Thus, the uninhibited chaperone 
somehow helps more active RTA reach, or else survive, in the cytosol (Spooner et al., 2008).  
As DSG does not affect BiP (Brodsky, 1999) and trafficking of ricin through the secretory 
pathway is unaffected by this treatment, the inhibitory effect appears to be a cytosolic one.  
That is, Hsc70 effects component involved in intoxication at a stage beyond transport of ricin 
to the ER.  The most direct interpretation of these data is that Hsc70 is responsible for 
activating cytosolic RTA, potentially by helping it to fold into a catalytically active 
conformation.  Alternatively, Hsc70 might be responsible for maintaining a third party which 
promotes the toxicity of RTA.  For this to be feasible, such a third-party would have to be 
prone to denature from its native, functional state to a significant extent within a timeframe 
defined by toxin trafficking.  Because of this proviso, the simplest model to adopt is perhaps 
one of a direct interaction between Hsc70 and RTA (as published in Spooner et al., 2008). 
The role of Hsp90 & the effect of Hsp90 inhibitors - Opposite to Hsc70, inhibition of 
another key cytosolic chaperone, Hsp90, sensitised cells to ricin.  As trafficking times were 
unaffected by treatment with this inhibitor, it seemed that this was also a cytosolic effect.  
These findings implied that Hsp90-type chaperones promote inactivation of RTA in vivo 
(published in Spooner et al., 2008), or else promoted the existence of a third party which 
inactivates RTA (again, for this explanation to be feasible, this third-party would have to be 
prone to denature within a timeframe defined by toxin trafficking).   
One obvious candidate for such a third-party might be the proteasomal core, which degrades 
RTA (Deeks et al., 2002).  Indeed, Imai et al. (2003) shows in yeast that a (much higher) 
dose of 18µM geldanamycin causes incremental loss of the 26S proteasome and up-
regulation of the relative proportion of the uncapped 20S complex after as few as 3 hours of 
incubation (and progressively moreso to a maximum effect at post 16-hours).  In this chapter, 
however, chronic incubations with radicicol and geldanamycin show that this change 
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correlates to protection and not sensitisation.  Therefore, it seems unlikely that the acute 
effects of GA/RA or C01 result from an impact upon the proteasome. 
On the other hand, the chronic effects of GA/RA/C01 in protecting cells from ricin 
intoxication may be associated with loss of the 19S proteasomal cap.  Imai et al. (2003) 
showed that, over time, incubation of cells with GA leads to gradual loss of this lid complex.  
This may be significant, as the proteasomal cap has been posed as a motor driving the 
extraction of ERAD substrates, including RTA, from the lumen (Lee et al., 2004; Kopito et 
al., 1997; Li et al., 2010).  It may be that chronic treatment with GA/RA reduces the cytosolic 
concentration of this complex, so reducing the capacity of the cell to retrotranslocate ERAD 
substrates like RTA, so protecting cells.  Alternatively, the difference between acute and 
chronic Hsp90-inhibition may result from up-regulation of chaperones, e.g. Grp94, or 
cytosolic chaperones like Hsp70.  This might alter the dynamics of ERAD, e.g. retarding 
retrotranslocation (if caused by Grp94), or cytosolic quality control (if caused by Hsp70). 
The role of Hsp90 is dependent upon the lysine content of RTA – Another major finding of 
this chapter is that the inactivation which Hsp90 apparently coordinates is dependent upon 
the lysine content of RTA.  Introducing additional lysines into the toxin subunit increases the 
capability of Hsp90 to facilitate deactivation of it.  That is, the sensitising effect of RA 
increases as the lysine complement of RTA does.  The toxicity of RTA
0K
, indeed, is not 
affected by radicicol.  The most forthright interpretation for these observations is that direct, 
exclusively lysine-targeted polyubiquitination of RTA is involved in this interaction.    Two 
simple models to explain this observation are as follow: 
(1) Hsp90 helps target RTA for ubiquitination by interfacing with a co-factor such as 
CHIP.  This co-chaperone is an E3 ligase that binds to Hsp90 and is able to 
catalyse the formation and extension of polyubiquitin chains upon bound clients 
(Connell et al., 2001); or, 
(2) Hsp90 is responsible for maintaining the structural integrity of another complex 
which ubiquitinates RTA, e.g. a membrane-integral E3 ubiquitin ligase (but which 
must be structurally labile enough for a significant population to be disrupted by 
Hsp90 inhibition in the time taken for toxin trafficking).  
(3) Hsp90 might be responsible for inactivating RTA which is already ubiquitinated – 
perhaps by bridging its interaction to the proteasome. 
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If RTA is a direct client of Hsp90, and is ubiquitinated by it, it seems at odds with bona fide 
clients of the chaperone: for instance the oncoprotein, src (Whitesell et al., 1994), and firefly 
luciferase (Schneider et al., 1996).  If the association of these substrates with Hsp90 is 
disrupted with GA/RA, it results in their loss of function.  Yet, for RTA, disruption of Hsp90 
results in more of its catalytic activity in the cytosol.  This contrast may highlight how the 
interaction of RTA with Hsp90 is a superfluous one.   
Hsc70 and Hsp90 seem to work in a sequential triage of RTA - The effect of dually-
inhibiting Hsc70 and Hsp90 with DSG/RA implies that there may be an ordered sequence to 
the action of Hsc70/Hsp90.  The effects of Hsp90 inhibition are abrogated by inhibition of 
Hsc70.  This result implies that the Hsp90 interaction may be dependent upon a preceding 
one with Hsc70 (as published in Spooner et al., 2008).  This mirrors the folding pathways of 
numerous other substrates of these chaperones (Young et al., 2001). 
Lumenal Grp94 may participate in directing RTA toward retrotranslocation - In the ER 
lumen there exists a homologue of Hsp90-type chaperones, Grp94, which might also be the 
source of the effects observed with GA/RA/C01.  However, this possibility is refuted by the 
protective effect of the Grp94-specific inhibitor, NECA.  If anything, therefore, Grp94 seems 
to have a role opposite that of the Hsp90s of the cytosol with respect to toxicity (as published 
in Spooner et al., 2009).  Eletto et al. (2010) shows that Grp94 may help present certain 
substrates to the Hrd1-associated retrotranslocation complex.  It may function in this way for 
RTA.  However, for RTA, Grp94 does not seem to be an absolute requirement for the 
retrotranslocation process, as GA/RA and C01 affect Hsp90 as well as Grp94.  
Hypothetically, multiple routes directing RTA to the retrotranslocation machinery may well 
exist (e.g. one dictated by EDEM, as proposed by Slominska-Wojewodzcka et al., 2006). 
Differential treatment of RTA by Hsc70 and Hsp70 - The data presented in this chapter are 
suggestive of different roles for inducible Hsp70 and constitutively-expressed Hsc70 in the 
intoxication process.  This seems so because inhibition of Hsc70 (and putative down-
regulation using 4-phenylbutyrate treatment) leads to protection from ricin.  Conversely, up-
regulation of Hsp70 (by chronic Hsp90 inhibition) correlates with protection from ricin.  
Inhibition of Hsp90 with GA/RA is likely to have pleiotropic effects upon the cell, as 
discussed earlier.  However, if this transition to protection results from Hsp70 up-regulation, 
it could be that the dynamics of this chaperone‟s interaction with RTA are different from 
Hsc70‟s.  For example, Hsp70 reportedly binds to hydrophobic stretches more strongly than 
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Hsc70 (Callahan et al., 2002).  This difference might result in degradation rather than 
activation for RTA.  Hsc70 and Hsp70 have similarly opposite effects upon the expression of 
other proteins, e.g. the functional maturation of epithelial sodium channels (Goldfarb et al., 
2006).  Therefore, functional differentiation of Hsc70 and Hsp70 would be consistent.   
Further exploration of these findings - Multiple lines of evidence imply an in vivo role for 
Hsc70 and Hsp90 in the cytotoxicity of ricin.  However, it remains obscure whether these 
effects result from a direct interaction of the chaperones with RTA, or because these 
chaperones are required for the functionality of other factors.  Indeed, it may be possible that 
unknown, off-target effects of the inhibitors used could be the source of the effects observed.  
To clarify whether these pharmacological effects result from direct interactions between RTA 
and Hsc70/Hsp90 is the objective of the succeeding chapters.  The succeeding chapters take 
an in vitro approach, using purified proteins, ensuring there are fewer factors obscuring the 
interpretation of the results. 
Fundamental conclusions – The fundamental findings of this chapter imply that Hsp90 has a 
role in assigning cytosolic RTA for inactivation via a lysine-dependent mechanism.  On the 
other hand, Hsc70 appears to aid the activity of the toxin in the cytosol.  In context of the 
hypotheses laid out at the beginning of this chapter, it could be that Hsc70 participates in the 
sequence of interactions that RTA makes in the cytosol after or during retrotranslocational.  
This interaction with Hsc70 could give partially-unfolded, nascently retrotranslocated RTA 
the chance to re-fold into a state which is regarded as native in the context of the cytosol.  By 
this mechanism, RTA might then simply exit the latter stages of ERAD, i.e. degradation, by 
merit of simply no longer being recognised as a worthy candidate for degradation.  In this 
model, Hsc70 provides an „escape hatch‟ from events that would otherwise lead to 
degradation. 
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CHAPTER 4: 
An in vitro assay for determining factors affecting the solubility of RTA 
4.0 How a direct interaction between Hsc70 and RTA could be important 
It has been hypothesised that RTA exploits Hsc70 at some point proximal to its 
retrotranslocation of the ER membrane.  RTA putatively uses this interaction to increase the 
yield of successfully reactivated toxin in the cytosol.  A subsequent recurrent, transient 
interaction of RTA with Hsc70 after having acquired a cytosolic localisation might also 
significantly extend its toxic half-life therein, enabling the toxin subunit to deactivate more 
ribosomes than it would be able to otherwise.  Often, if a client has a persistent association 
with Hsc70 it would result in its degradation via polyubiquitination (McDonough & 
Patterson, 2003; Jiang et al., 2001), but as RTA has a dearth of lysines this side-effect of the 
interaction might be diminished (Deeks et al., 2002). 
As an alternative suggestion for the observations of the previous chapter, Hsc70 could 
contribute to the mechanism by which the retrotranslocation step itself occurs.  This would 
not be without analogous precedents in the cell, as Hsc70-type chaperones are required in the 
post-translational import of polypeptides across a variety of organelle membranes (Höhfeld & 
Hartl, 1994; Plath & Rapoport, 2000; Young et al., 2003).  In such post-translational import 
pathways, cytosolic Hsc70 binds to clients on the cis-side of the membrane being crossed, 
typically before the cargo polypeptide has completely folded.  This interaction ensures that 
the polypeptide is kept in a conformationally-malleable, transport-competent state (Corsi & 
Schekman, 1996).  Arguably more interesting to this study, however, Hsc70-type chaperones 
are also thought to act as motors operating upon the trans-side of the membrane being 
crossed (Tomkiewicz et al., 2007).  In this position they are the hypothesised mediators of 
“Brownian ratchet” or “power-stroke” mechanisms which are linked to the ATPase cycle of 
the chaperone, and which effectively help to pull the translocating protein through the pore in 
the target membrane (Tomkiewicz et al., 2007; De Los Rios et al., 2006).  In mammals, a 
mitochondrial Hsp70 and the ER-localised BiP have both been proposed to operate in this 
way (Jehnsen & Johnson, 1999; Tomkiewicz et al., 2007).  It is therefore a consideration that 
the cytosolic counterpart of BiP and mitochondrial Hsp70, i.e. cytosolic Hsc70, could exhibit 
such a function in the dislocation of RTA into the cytosol. 
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If cytosolic Hsc70 does help drive extraction of RTA from the ER membrane, it would be an 
unusual mechanism by which an otherwise ERAD-like pathway is resolved.  For many bona 
fide ERAD substrates, including ApoB and CFTR
∆F508
, the AAA protein-containing 19S 
proteasomal cap and the p97-containing complex are thought to drive extraction (reviewed in 
Meusser et al., 2005; for ApoB see Fisher et al., 2008; and see Carlson et al., 2006, for 
CFTR
∆F508
).   Unlike RTA, however, the typical substrates of these putative translocation 
motors become polyubiquitinated during their ERAD, a modification which is thought to 
provide a physical anchor which may be bound and pulled upon (Meusser et al., 2005).  The 
results of Deeks et al. (2002), Li et al., (2010) and the previous chapter, however, clearly 
illustrate that canonical lysine-ubiquitination is not necessary for the retrotranslocation 
process that RTA undertakes.  Previously, Marshall et al. (2008) showed that the p97-
homologue in Nicotiana tabacum (known as Cdc48), can facilitate extraction of RTA
0K
 from 
the ER of tobacco protoplasts.  However, Li et al. (2010) showed that this was not the case in 
yeast.  Speculatively, if RTA
WT
 is extracted by p97 in mammals, its retarded 
polyubiquitination might diminish the avidity with which it is bound.  This attenuated 
interaction might permit chaperones like Hsc70 to displace otherwise typical mediators of 
ERAD.   
If any of the mechanisms hypothesised above were true, then a demonstrable interaction 
between RTA and Hsc70 should exist.  This chapter, therefore, ultimately aims to investigate 
whether Hsc70 interacts with RTA in a direct and functional way. 
4.1 Experimental approach 
As described in the previous chapter, a co-immunoprecipitation approach to this investigation 
was precluded because of the low cytosolic concentrations of RTA that are found during 
intoxication.  Instead, this chapter describes the development of a method to test for an 
interaction of Hsc70 with RTA in vitro.  Ideally, this assay would be facile, reliable and able 
to show a functional association between Hsc70 and RTA amid a myriad of other proteins 
and chemicals.   
In seminal experiments expounding the function of Hsc70, Minami et al. (1996) compared 
the degree to which luciferase irreversibly aggregated in conditions with or without 
chaperones.  They demonstrated that Hsc70 and its loading co-factor, Hsp40, could prevent 
the aggregation of thermally-denatured luciferase during a 42°C heat-treatment in vitro, a feat 
that was maximally effective in the presence of ATP.  They observed this by two methods:  
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(1) In real-time, by measuring the dynamic light scattering from particles of 
aggregated luciferase.  
(2) By separating an incubation of luciferase and chaperones by centrifugation and 
analysing the relative distribution of protein between pellet and soluble fractions. 
If such assays could be recapitulated with RTA, it would provide evidence for a direct 
interaction between the two proteins – with RTA as client and Hsc70 functioning as a bona 
fide chaperone.  These observations could then help to reconcile the in vivo effects of 
chaperone inhibition.  With this intention, this chapter describes a series of experiments 
investigating whether the general parameters known to govern protein stability lead to 
measurable changes in the assays mentioned above, and whether these changes are consistent 
with what would be expected of a good assay for measuring protein folding.   
The parameters tested to this end included: pH, temperature, electrolyte concentration, 
macromolecular crowding and the effect of a small molecule chaperone.  With this 
foundation in place, assays which examined the influence of the Hsc70/Hsp40 chaperone 
pathway were later introduced.   
Mimicking the retrotranslocating or post-retrotranslocation state - As it is hypothesised that 
RTA interacts with Hsc70/Hsp40 in at least a partially-unfolded state after it has crossed the 
ER membrane, thermal denaturation was enlisted as a tool to denature RTA (as per Argent et 
al., 2000).  This would render RTA in a state more representative of a post-retrotranslocation 
conformation (i.e. in which significant hydrophobic stretches may be solvent-exposed).  It is 
worth mentioning, however, that this is not the physiological mechanism by which RTA is 
unfolded during intoxication.  Rather, it is thought that factors in the ER environment 
promote the toxin subunit‟s change in conformation, e.g. negatively-charged phospholipids of 
the ER membrane.  Liposomes comprising such phospholipid induce measurable changes to 
RTA‟s secondary structure when they are co-incubated in vitro (Day et al., 2002).  This same 
effect is thought to promote co-option of the toxin subunit onto an ERAD-like pathway in 
vivo (Day et al., 2002; Mayerhofer et al., 2009). 
Thermal versus lipid-based denaturation - Importantly for the interpretation of data 
presented in this chapter and the next, the ways in which thermal denaturation and interaction 
with negatively-charged phospholipids influence the structure of RTA are certain to be 
qualitatively different.  Thermal denaturation forces the polypeptide chain into a higher-
energy state.  This breaks non-covalent, intra-chain bonds by increasing the kinetic energy of 
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the polypeptide backbone and its side-chains, expanding the diversity of conformations the 
protein population will inhabit.  On the other hand, phospholipid-based disruption of the 
secondary structure would presumably replace non-covalent intra-peptide bonds with non-
covalent phospholipid interactions instead.  This promotes the partial insertion of RTA into 
liposomes in vitro (Mayerhofer et al., 2009).  This insertion of RTA into the ER membrane 
might constrain the polypeptide into a relatively narrower array of conformations, promoting 
a correspondingly finer set of folding outcomes.  These differences may alter the nature of the 
interactions that so-treated RTA can thereafter make in the cell when the polypeptide 
emerges on the cytoplasmic side of the membrane (such as with Hsc70).  This 
physiologically relevant point is given consideration in the development of the assay and in 
the discussion of the results.  
Screens for factors contributing to both unfolding and folding of RTA - Lastly, the folding 
state of RTA is deemed critical to the events which govern both co-option onto an ERAD-
like pathway in the ER and subsequent success of the toxin subunit in the cytosol (Beaumelle 
et al., 2002; Argent et al., 1994; Mayerhofer et al., 2009).  As such, it was a secondary 
hypothesis that RTA may have evolved to exploit qualities of the lumenal and cytosolic 
environments to maximise the success of its retrotranslocation and subsequent reactivation.  
Therefore, a final objective of this chapter was to use the developed assay to screen for 
factors which might contribute to instability of RTA in the ER lumen (promoting co-option 
onto an ERAD pathway), and which might support its relative stability in the cytosol 
(extending its catalytic half-life therein).   
4.2 The temperature dependence of RTA aggregation 
To determine the temperature dependence of RTA aggregation may seem a simplistic initial 
foray, but as the assays proposed were as yet untested for the toxin subunit, it was important 
to determine that the same rules applied to it as had been determined for other experimental 
systems (e.g. Minami et al., 1996; Van den Berg et al., 1999).  A straightforward prediction 
preceded these experiments: at higher temperatures, RTA would misfold, aggregate and so 
lose solubility.  This experiment also tests whether a consistent temperature-dependent 
threshold for RTA unfolding, of around 42°C (as determined by circular dichroism – Argent 
et al. 2000) could be resolved.   
As a subunit of the ricin holotoxin, which is laid down in the endosperm of the developing 
seeds of the castor bean plant (Ricinus communis), RTA is stable over a wide range of 
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temperature (from lows of 0°C in native northern India to highs of 42°C in Kenya – Casey, 
2007).  During trafficking from the plasma membrane to the ER of a target cell as part of the 
holotoxin, it also remains stable at a relatively constant physiological temperature of 37°C.  
Conversely, as an orphan subunit in the ER of target cells, RTA must acquire characteristics 
at this physiological temperature that ensure it is recognised as misfolded, but which are not 
so severe so as to prevent it from being irreversibly degraded or terminally inactivated.   
Correspondingly, orphaned RTA has been shown to approach a threshold for unfolding 
arguably close to the physiological temperature of 37°C.  Argent et al. (2000) showed that the 
secondary structure of monomeric RTA becomes significantly destabilised at temperatures in 
excess of 42°C in vitro (homologous RIPs, such as saporin, are stable at much higher 
temperatures).  Upon a subsequent increase to 45°C, they observed that a molten globule-like 
state could be induced, although the precise threshold was batch-dependent.
11
  Mayerhofer et 
al. (2009) described another relevant temperature-threshold, showing that, at temperatures 
lower than 37°C RTA inserts less efficiently into a reconstitution of the membrane it crosses 
in vivo.  
With these observations in mind, an initial array of temperatures was investigated: 37, 45 and 
95°C.  Figure 4.1 shows that RTA which has been incubated at these temperatures for 15 
minutes can be split into pellet and soluble fractions after a 10 minute, 16000 g 
centrifugation.  At 37°C, RTA was mostly soluble, although much was observed in the pellet.  
At 45°C, a greater proportion was observed in the pellet fraction.  After incubation at 95°C, 
relatively all of the RTA was found in the pellet.   However, the absolute signal size from the 
combined intensity of pellet and soluble bands was diminished, suggesting loss of RTA from 
the experimental system (Figure 4.1a & d).  To determine how RTA was being lost, a more 
comprehensive array of temperatures was first examined.  
  
                                                 
11
 Buffer conditions: 20mM sodium phosphate, pH7.0, with 2mM DTT (Day et al., 2002). 
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Figure 4.1 – RTA can be heated and then split into soluble and aggregated fractions 
500ng RTA in a total volume of 20μL (0.8μM) was incubated in an Eppendorf tube at the indicated temperature for 
15 minutes (in a buffered solution of 10mM MOPS / 50mM KCl, pH7.2).  Samples were then separated into pellet (P) 
and soluble (S) fractions by centrifugation at 16000 g for 10 minutes.  Both fractions were subsequently dissolved 
in loading buffer and separated in parallel by SDS-PAGE.  a) RTA bands (grey arrowhead) were developed via silver 
stain.  Vertical grey and black lines have been added to help demarcate adjacent pellet/soluble pairs. b) Pellet and 
soluble RTA bands were quantified relative to one another (using TotalLab). c) Plots the average intensity of bands 
derived from pellet () and soluble fractions (). d) Plots the average total intensity of the pellet band added to 
the soluble band for each temperature ().  Note loss of signal at 95°C. 
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The effect of increasing temperature in gradual increments from 24°C to 55°C can be 
observed in Figure 4.2a & b.  At temperatures of 37°C and below, RTA is quite uniformly 
divided between pellet and soluble fractions, although there is a marginal decrease in 
solubility as the temperature increases.  This starkly contrasts to a sharp threshold between 
37°C and 45°C.  At this transition, there is a dramatic loss of RTA from the soluble fraction.  
The larger error-bars for the 45°C dataset reflect how this is likely to be near an important 
transition temperature, where small changes in temperature result in relatively gross changes 
in solubility. Encouragingly, these data mirror the 42-45°C threshold observed by Argent et 
al. (2000). 
Just as observed in Figure 4.1, the total amount of RTA in Figure 4.2a & b visibly decreases 
at elevated temperatures, rather than merely shifting from soluble to pellet fractions as 
expected.  It was possible that this might be because of a protease contaminating the 
incubation, the activity of which upon RTA was greatly increased above 45°C.  Such a 
protease could have been co-purified with RTA at low concentrations, or could have 
otherwise contaminated the buffer (although no fragmentation of RTA was observed – Figure 
4.1).  To test this, RTA was incubated at 55°C with or without Complete protease inhibitor 
tablets (Roche; used at the manufacturer‟s recommended concentration).  Figure 4.2c shows 
no difference in the solubility of RTA when the inhibitors are present (quantified in Figure 
4.2d), suggesting that loss of signal does not result from the activity of a protease.   
If not lost to a protease, then two alternative explanations can be proposed for this 
phenomenon: 
(1) When heated, unfolded RTA has a greater propensity to adhere to the side of the 
reaction vessel in which it is incubated (the vessel being made of hydrophobic 
polypropylene).   
(2) If, even at low temperatures, the quantity of RTA in the pellet is already saturated 
with silver-stain, then redistribution of previously soluble matter to this fraction 
will be masked at higher temperatures.  
In either scenario, the results still show the same, informative trend: a relative decrease in 
solubility at higher temperatures, which is consistent with unfolding. 
 
 
Page 113 
 
 
 
Figure 4.2 – Relative intensity of RTA from the pellet increases with temperature 
a) 500ng RTA in a total volume of 20μL (0.8μM) was incubated at the indicated temperature for 15 minutes, and 
b) the pellet/soluble fractions quantified.  Grey vertical lines demarcate pairs of pellet (P) and soluble (S) 
fractions.  b) Shows quantification of RTA band distribution (using TotalLab).  c) RTA was incubated for 15 min at 
55°C, with or without Complete protease inhibitors (“CPI” - Roche).  Samples were split as before and analysed 
by silver stain.  d) Pellet and soluble RTA bands were quantified as before.  In all cases, error bars show the SEM 
between three independent sets of assays. 
a. Silver stains - each panel shows a repeat 
of the same assay. 
b. Quantification of “a”. (n=3) 
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4.2.1 A comparison of the stability of RTA with saporin at 45°C 
As a comparison to RTA, saporin (a type I RIP homologous with RTA) does not aggregate 
with the same distribution between pellet and soluble fractions at 45°C (Figure 4.3).  
Testament to their similarity, the Cα backbones of these proteins can be superimposed upon 
one another to a high degree (Fermani et al., 2009) and their sequence identity is in the region 
of 30% (Vago et al., 2005).  However, saporin lacks the hydrophobic C-terminus that is 
implicated in the cytotoxicity of RTA (Day et al., 2002).  Saporin also has more lysine 
residues.  Correspondingly, the pI of saporin is 9.5, whilst RTA itself has a pI of 7.3 (Li et al., 
1992; Vago et al., 2005).  As the buffer used in the solubility assay is pH7.2, these conditions 
would favour the solubility of saporin. 
From these comparisons it may be inferred that the relative instability of RTA in the soluble 
phase may be associated with both the hydrophobic C-terminus of the toxin subunit and even 
its reduced lysine content.  This difference in stability is interesting given that saporin is not 
thought to co-opt an ERAD pathway to enter the cytosol (Vago et al., 2005).  RTA, on the 
other hand, seems to have paid a conformational penalty to exploit this route, manifested here 
in its relatively low solubility.  Coincidentally, therefore, evolutionary loss of lysine residues 
to avoid polyubiquitination may have also contributed to the candidacy of RTA as an ERAD 
substrate.  Putatively, both of these factors may have contributed to the selective pressure 
which resulted in RTA‟s substitution of lysine residues. 
Also unlike saporin, RTA spends much of its lifetime as the subunit of a holotoxin.  As part 
of this complex, RTA is stabilised by a disulfide linkage to RTB (Day et al., 2002).  This 
association conceals the hydrophobic C-terminus of the A-chain from the solvent (Day et al., 
2002) and ensures that the complex remains stable during vesicular trafficking.  This stability 
persists until the ER is reached, wherein PDI reduces the dimer (Spooner et al., 2004).  Thus, 
only in the ER is monomeric RTA liberated.  This mechanism ensures that the 
“conformational penalty” highlighted here becomes significant only when it will also be of 
use for the toxin in helping it to cross the ER membrane.  Once in the cytosol, however, this 
otherwise latent instability may well persist.  This reinforces why cytosolic chaperones are 
expected to provide a valuable interaction for the toxin subunit. 
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Figure 4.3 – Solubility of saporin after incubation for 15 minutes at 45°C. 
In this assay 500ng saporin (0.8μM) was substituted for RTA in the incubation volume of 20μL, but the protocol 
was otherwise as before.  a) Shows quantification of the saporin distribution between pellet (P) and soluble (S) 
fractions (the data for RTA in this chart is that from Figure 4.2b).  Error bars show SEM. b) Quantification was 
derived from this set of three independent silver stains. Grey arrowheads indicate the saporin band.   
 
 
a. Quantification (n=3) b. Silver stains – each panel shows a repeat of 
the same assay. 
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4.3 A turbidity assay can be used to measure aggregation of RTA over time 
The assay described to this point only measures the aggregation of RTA at an arbitrary end-
point (in all cases described, a 15 minute incubation).   Similar assays measuring the dynamic 
aggregation of RTA over time can also be conducted, for instance by measuring the light 
scattering from a heated sample (Minami et al., 1996).  Such experiments were conducted; 
please see the appendix (Figure 8.2).  Unfortunately, this approach was prohibited from being 
used more extensively in this chapter because of the lack of reliable, accurate temperature 
controls on the spectrophotometers available.  Moreover, limited space available in the 
sampling chambers of these machines precluded the incorporation of parallel controls.  In an 
ideal situation where these were not problems, this method would have been opted for in 
preference to the solubility assay, as it would have permitted the acquisition of more 
comprehensive data. 
4.4 Solubility correlates with enzymatic activity 
It was important to determine that the quality measured by this assay – solubility – correlated 
with the enzymatic activity of RTA.  Otherwise, it would be less relevant to an in vivo 
reactivation process.  The assay typically used to determine the catalytic activity of RTA 
visualises the depurination of ribosomal RNA by the toxin (Endo et al., 1987).  In this assay, 
RTA-treated ribosomes are exposed to acetic-aniline (pH4.5), which causes the 
phosphodiester backbone of the 26s rRNA to be cleaved at the site where the toxin subunit 
has been specifically depurinated.  The proportion of this aniline fragment can then be 
quantified by its apparent intensity on a denaturing formamide:agarose gel relative to the 
intensity of an rRNA that remains unaffected by the treatment (in this case 5.8S rRNA).  The 
formula for relating fragment intensity to relative depurination is shown in Equation 1, and 
accounts for the comparative staining of each fragment according to its base pair length.  
Background from the gel can be removed from this value by subtracting a similar figure 
derived from intact controls which have not been treated with RTA (or, alternatively, which 
have not been treated with aniline).   
RTA was heated to 45°C for 15 minutes and then assayed for catalytic activity by this 
method.  Figure 4.4a shows that RTA which has been heat-treated has little obvious 
depurinating activity (no aniline fragment can be observed in these assays, although TotalLab 
analysis suggests some activity may persist).  As a control, untreated RTA possessed 
observable activity (the aniline fragment can be seen in these assays).  Similar experiments 
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published in Spooner et al. (2008) show that the soluble fraction (16000 ×g) of heat-treated 
RTA has less enzymatic activity than does an equivalent soluble fraction from untreated RTA 
(reprinted in Figure 4.4b).  The assays in Spooner et al. (2008) also show that the soluble 
fraction of heat-treated RTA does possess enzymatic activity; at least some material which is 
soluble at this temperature retains catalytic activity.   
Admittedly, it would have been preferable to consistently couple the results of each solubility 
assay in this chapter with an experiment to confirm the relationship of enzymatic activity to 
the size of the soluble fraction.  However, this RNA-based technique is subject to difficulties 
owing to the complexity of the protocol and the vulnerability of both the ribosomal RNA and 
aniline fragment to contaminant RNases.  These technical difficulties made a more 
comprehensive approach unfeasible, especially as the complex mixes which are used later in 
this chapter potentially contain significant quantities of contaminant RNase. 
 
 
 
 
                          
                          
                    
   
   
   
      
 
Equation 1 – Depurination formula.  
For calculating relative depurination from the relative intensity of aniline-fragment and 
uncleaved 5.8S rRNA bands, as visualised by ethidium-bromide staining after denaturing 
electrophoresis.  The values “160” and “369” account for the different lengths of each fragment, 
which attract different staining intensities. 
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Figure 4.4 - Solubility of RTA correlates to enzymatic activity 
500ng RTA in a total volume of 20μL (0.8μM) was incubated at either 37°C or 45°C for 15 minutes, as before.  
The indicated mass was then added to yeast ribosomes for a total period of 2 hours at 30°C.  Depurination was 
then measured by treating the ribosomal rRNA with acetic aniline and observing the intensity of the drop-out 
band.  a) Shows electrophoresis of rRNA under denaturing conditions (1.2% agarose; 50% formamide).  Gels 
were stained with ethidium bromide. b) Shows quantification of the relative depurination caused by RTA in 
each of the incubations, as calculated by Equation 1.  Relative depurination was normalised to the aniline-
untreated background.  Error bars show the range between the two repeats shown in “a”.  c) Shows results 
published in Spooner et al. (2008) produced by R.A. Spooner. Here, 16000 g soluble fractions from 375ng of 
45°C-treated RTA (or untreated RTA) were added, in the indicated dilution, to the aniline reactions. d) Shows 
quantification of the relative depurination in each of the incubations shown in “c”.  Relative depurination was 
normalised according to RTA-untreated background.  
 
(Figures displayed on subsequent page.) 
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(Figure 4.4 – continued.) 
 
a. Results of Electrophoresis: 
Heat-treated RTA vs. untreated RTA. 
The separate panels show repeats of 
the same experiment. 
c. Data from Spooner et al. (2008) 
Comparison of soluble fractions 
from heat-treated RTA and 
untreated RTA. 
 
 
 
 
         
b. Quantification of “a” (n=2) d. Quantification of “c” (n=1) 
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4.5 The effects of macromolecular crowding, pH, electrolyte concentration and a small 
molecular chaperone 
4.5.1 Macromolecular crowding 
In vivo, macromolecular crowding imposes limits upon the conformational rearrangements a 
polypeptide can make.  Such crowding effects have not been mimicked in this assays shown 
so far.  Notably, the ER lumen is less crowded than the cytosol, as measured by the diffusion 
rates of GFP after photobleaching (Swaminathan et al., 1997; Marguet et al., 1999).  In both 
compartments, however, crowding will putatively increase the chances of RTA interacting 
aberrantly with adjacent polypeptides.  Furthermore, because of spatial confinement, the 
speed of re-folding interactions is also increased under such conditions (Van den Berg et al., 
1999).  As such, crowding would be expected to hinder the solubility of RTA. 
A highly-branched polymer of neutrally-charged polysaccharide, Ficoll-70, was enlisted to 
emulate volume-excluding effects (Van den Berg et al., 1999).  When RTA was incubated 
with 200g.L
-1
 of this crowding agent, little change in solubility was observed at 45°C (Figure 
4.5a & b) and no change was observed at 37°C (Figure 4.5a & c).
12
  Why Ficoll-70 has little 
or no apparent effect upon solubility is curious.  At 37°C, RTA would not be expected to 
unfold significantly (Argent et al., 2000).  Therefore, it may be that crowding from Ficoll-70 
cannot subsequently augment inter-chain interactions, and so cannot promote a loss of 
solubility.  However, at 45ºC, RTA would be expected to assume a molten globule-like state 
(Argent et al., 2000), where it would presumably be more prone to making inter-chain 
associations.  It seems that some other effect already saturates the propensity of RTA to lose 
solubility when the toxin subunit unfolds at this temperature (45°C).  Speculatively, this 
could be an interaction between the functionally-important hydrophobic C-terminus of the 
toxin subunit (Day et al., 2002; Simpson et al., 1995) and the abundant hydrophobic surface 
which may be adsorbed to during the incubation (the polypropylene Eppendorf). 
                                                 
12
 N.B., Figure 4.5 shows little difference between the pellet/soluble distribution at 37°C compared to 45°C, 
unlike has previously been shown (cf. Figure 4.1 and Figure 4.2).  This is because the RTA used for experiments 
at 37°C and 45°C comes from different stocks.  This highlights the batch dependence reported by Argent et al., 
(2000) and how it is crucial to use RTA from the same stock for data which are to be compared.  As Ficoll-70 
was the factor under scrutiny here, however, it was less important to ensure a similar stock was used at both 
37°C and 45°C. 
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Figure 4.5 – The effect of macromolecular crowding upon RTA aggregation at 45°C and 
37°C 
500ng RTA (concentration and buffer as before) was incubated in an Eppendorf tube at the indicated 
temperature for 15 minutes, but with or without 200g.L
-1
 of Ficoll-70.  Samples were collected and divided, as 
before, into pellet (P) and soluble (S) fractions before being analysed in parallel by SDS-PAGE.  a) Shows 
resultant silver stains.  Vertical grey lines demarcate pellet and supernatant pairs. b) Shows quantification of 
RTA band distribution at 45°C (using TotalLab). c) Shows quantification from experiments conducted at 37°C.  
Error bars derived from the standard deviation of the three repeats shown in c).  In all cases, error bars show 
SEM. 
 
a. Silver stains – upper panel shows assays at 37°C, lower panel 45°C. 
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4.5.2 The effect of electrolyte concentration 
Unlike crowding from Ficoll-70, the solubility of RTA was found to respond to the 
electrolyte concentration of the incubation buffer.  Solubility was increased in heat-treated 
incubations which contained more NaCl (Figure 4.6).   Hu et al. (2009) hypothesise that 
increased electrolyte concentration stabilises the solvent structure, making hydration of an 
extended polypeptide backbone less favourable.  This effect would inhibit unfolding by 
causing tight-packing of the protein. 
Previously, the secondary structure of RTA has been shown to be destabilised by an 
interaction with negatively-charged liposomes (Day et al., 2002; Mayerhofer et al., 2009).  
As the pI of RTA is reportedly 7.3 (Li et al., 1992), and the buffer used to demonstrate the 
liposome interaction in vitro was of pH7.1, the toxin subunit would be positively charged 
under those conditions.  Negatively-charged phospholipid and RTA, therefore, would bear 
charges complementary to their mutual binding in vitro as well as in vivo, where pH 
approaches 7.1 to 7.2 (Van Anken & Braakman, 2005).  As introduced earlier, this interaction 
of RTA with negatively charged lipids is thought to be physiologically significant in 
promoting retrotranslocation (Day et al., 2002; Mayerhofer et al., 2009).  In the model 
supported by these papers, RTA is reductively cleaved from RTB in the ER lumen by PDI 
(Spooner et al., 2004).  Monomeric RTA subsequently interacts with the lipid environment of 
the ER, leading to a conformational change that is permissive of both its recognition as an 
ERAD substrate and retrotranslocation (Day et al., 2002; Mayerhofer et al., 2009).   
Pertinent to the stabilising effect of electrolyte, Day et al. (2002) observed that the initial 
stages of RTA‟s interaction with liposomes can be prevented at increased concentrations of 
NaCl.  Conversely, pre-formed complexes of RTA and liposomes cannot be disrupted with 
NaCl.  Day et al. (2002) concluded that the initial stages dictating the unfolding of RTA were 
caused by electrostatic interactions with which the electrolyte competed.  Thereafter, their 
model suggests RTA embeds itself in the membrane in a hydrophobic manner, producing an 
interaction with which electrolyte cannot compete.  In addition to these hypotheses, it could 
be added that high concentrations of NaCl restrains the “thermal breathing” of RTA by 
stabilisation of the water structure (Hu et al., 2009).  This would constrain the initial 
unfolding events which lead to embedding in the liposome.  Adding NaCl subsequent to the 
interaction could thus also hinder unfolding events that would allow the two species to 
subsequently separate.   
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Figure 4.6 – The effect of [NaCl] upon RTA aggregation at 45°C 
500ng RTA was incubated as before for 15 minutes at 45°C with the indicated concentration of NaCl (aq).  Pellet 
(P) and soluble (S) fractions were collected as previous and analysed in parallel by SDS-PAGE. a) Shows 
resultant silver stains.  b) Shows the quantification of RTA band distribution (using TotalLab). Error bars show 
SEM. 
 
a. Silver stains – each panel 
represents an independent assay. 
 
b. Quantification (n=3) 
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4.5.2.1 The effect of ionic calcium on the solubility of RTA 
Unlike sodium ions, there is a heavily-polarised difference in the concentration of calcium 
ions between the ER and the cytosol (Van Anken & Braakman, 2005).  This results from the 
activity of the sarcoplasmic / endoplasmic reticulum Ca
2+
 ATPase (SERCA) pump (Van 
Anken & Braakman, 2005).  As RTA must cross the membrane which divides these 
compartments in a process that is conformation-dependent, the effect of electrolyte 
concentration on the solubility of RTA might pose some mechanistic significance. 
Being technically difficult to measure, the total [Ca
2+
] of the mammalian ER has been 
estimated very broadly to be between 0.3mM and 50mM by (comprehensively reviewed in 
Meldolesi & Pozzan, 1998).  This additional calcium is sequestered and buffered largely by 
the protein matrix, the function of which it modulates (Van Anken & Braakman, 2005).  
Unsequestered [Ca
2+] in the ER is even more widely estimated to be between 1μM and 3mM 
depending on the tissue examined and the experimental technique used, reflecting its more 
dynamic nature.  For HeLa in particular, an ER concentration of 1.5mM to 3mM 
unsequestered Ca
2+
 has been shown (Meldolesi & Pozzan, 1998).  From the kinetics of the 
SERCA pump, the gradient to the cytosol is expected to involve a difference of around 10
5
 
units (Meldolesi & Pozzan, 1998).   
The effect of [Ca
2+
] concentration upon the solubility of RTA was examined in vitro (Figure 
4.7).  At 45°C, only the highest concentration of Ca
2+
(aq)
 
(10mM) visibly stabilises RTA in the 
soluble fraction.  At lower concentrations, little soluble RTA is apparent (Meldolesi & 
Pozzan, 1998).  This is at odds with a preceding hypothesis regarding what ER and cytosolic 
conditions would promote, which was: RTA would be more soluble in conditions equivalent 
to the cytosol (to extend its toxic lifetime), whilst in the ER it would be less so (so as to be 
recognised for ERAD).  It would therefore seem that other factors in the ER environment 
dominate the acquisition of ERAD-permissive traits.  
To extend these studies, the experimenter has access to both thapsigargin (which inhibits the 
SERCA pumps responsible for the gradient) and ionomycin (which is used to neutralise 
∆[Ca2+] across biological membranes). However, both of these commonly used agents also 
affect the endocytosis and trafficking of ricin through the secretory pathway (Llorente et al., 
2000; Lauvrak et al., 2002), likely complicating the interpretation of their effects.  Therefore, 
the use of these reagents has not been pursued herein. 
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Figure 4.7 – The effect of [CaCl2] upon RTA aggregation at 45°C 
500ng RTA was incubated, as before, at 45°C with the indicated concentration of CaCl2(aq).  Pellet (P) and 
soluble (S) fractions were collected as before and analysed in parallel by SDS-PAGE. a) Shows silver stains with 
vertical grey lines demarcating pellet/soluble pairs; b) shows the quantification of RTA band distribution (using 
TotalLab). Pellet intensity is shown in grey, with soluble band intensity shown in white.  Error bars show SEM. 
 
 
a. Silver stains – each panel represents 
an independent assay. 
 
 
b. Quantification (n=3) 
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4.5.3 The effect of pH 
The effect of different pH buffers on the solubility of RTA was examined (Figure 4.8).  
Buffers ranging from pH6.4 to 8.0 were tested, centred upon pH 7.2 (the pH otherwise used 
in all solubility assays throughout this thesis, and also as used by Minami et al., 1996).  
Under these conditions, RTA was most prone to lose solubility at pH 7.0-7.4.  This is as 
predicted from recombinant RTA‟s pI of 7.3 (Li et al., 1992).13 Around this pH, the net 
charge of RTA would be neutralised and it would thus become less hydrophilic, accounting 
for its loss of solubility.   
Although RTA is evidently unstable at pH7.2, this was the default pH for other solubility 
assays undertaken throughout this thesis.  Significantly, it is at this pH that Hsc70 and Hsp40 
are observed to optimally protect luciferase from thermal denaturation (Minami et al., 1996).  
It is also a fair approximation of the pH in the ER and cytosol of HeLa cells (Kim et al., 
1998; Llopis et al., 1998; Van Anken & Braakman, 2005).  Coincidentally, these findings 
highlight the importance of storing RTA at a pH that is removed from the physiological 
norm.  Indeed, in our laboratory RTA is stored at pH6.4 to limit aggregation. 
The inherent instability of RTA at the physiological pH consistently highlights how RTA is 
finely-tuned to unfold during its lifetime as an orphan subunit.  This is a feature that will 
likely promote its candidacy as an ERAD substrate.  However, as there is no difference in the 
cytosolic and ER pH (Anken & Braakman, 2005), the same instability would persist after the 
toxin subunit has gained access to the cytosol.  A stabilising factor such as a cytosolic 
chaperone, might provide a beneficial interaction for the toxin. 
  
                                                 
13
 Curiously, the pI of recombinant RTA is spuriously reported to be between 6.1 and 6.5 using a variety of 
bioinformatic approaches (Kozlowski, 2008; Gasteiger et al., 2005).   
Page 127 
 
 
Figure 4.8 – The effect of pH upon RTA aggregation at 37°C 
500ng RTA was incubated, as before, at the indicated temperature with the buffer adjusted to the indicated 
pH.  Pellet (P) and soluble (S) fractions were collected as before and analysed in parallel by SDS-PAGE. a) Shows 
silver stains with vertical grey lines demarcating pellet/soluble pairs; shown are three representative gels from 
a series of six total; b) shows the quantification of RTA band distribution (using TotalLab).  Error bars show 
SEM. 
 
a. Silver stains – each panel represents an independent assay. 
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4.6 Glycerol improves the solubility of RTA  
Numerous so-called „small molecular chaperones‟ promote the solubility of proteins like 
RTA by inhibiting the unfolding that leads to their aggregation (Van den Berg et al., 1999).  
Glycerol is one such chemical, able to prevent RTA from aggregating at both 37°C and 45°C 
(Figure 4.9a & b).  Peek et al. (2006) showed that this was by increasing the midpoint 
thermal transition temperature for unfolding (as determined by measuring changes in intrinsic 
tryptophan fluorescence with or without glycerol) rather than by sites that would propagate 
aggregation.  For this reason, glycerol is often supplemented into the buffer in which RTA is 
stored to promote long-term solubility. 
Figure 4.9 – The effect of glycerol on the solubility of RTA 
0.3μM RTA was incubated in 10mM MOPS / 50mM KCl (pH7.2) for 15 minutes at the temperature indicated 
with the shown concentration of glycerol (w/v).  Pellet (P) and soluble (S) fractions were then collected and 
quantified as before. a) Shows silver stains.  b) Shows quantifications made using TotalLab, with error bars 
showing the SEM. 
 
a.. Silver stains – each panel represents a separate assay, 3 at each temperature. 
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4.6.1 Glycerol reduces the cytotoxicity of ricin 
It was introduced earlier that impediments to the unfolding of RTA such as additional 
disulfide bonds (Argent et al., 1994) or the conjugation of tightly-folded species like DHFR 
(Beaumelle et al., 2002) reduce its cytotoxicity.  Therefore, it was predicted that treatment of 
cells with a small molecular chaperone such as glycerol might also inhibit toxicity, stabilising 
RTA in the ER lumen.  Cells were incubated with or without 10% glycerol (w/v) and the IC50 
of ricin was determined in each context (Figure 4.10a & b).  This treatment protected cells 
8.96-fold (SD ±1.45; n=3), a similar effect to that reported by Sandvig et al. (1984), who 
used a concentration of 9.2% (w/v) glycerol in experiments using Vero cells.  Contrastingly, 
Sandvig et al., (1984) hypothesised that this effect was because glycerol increased the rigidity 
of the target ER membrane, prohibiting insertion of RTA into it, rather than from affecting 
RTA directly. 
 
Figure 4.10 – The effect of glycerol on the cytotoxicity of ricin 
HeLa cells were treated with 10% glycerol coeval to ricin-treatment and then examined for the IC50 with 
respect to ricin, as has been shown before.  Control cells did not include glycerol in the incubation.    a) A 
typical set of dose-response curves from a total of three independent experiments, comparing cells treated 
with medium containing no glycerol () to medium laden with 10% glycerol at the time of toxin application 
(w/v) (). b) This yielded an 8.96-fold protection (SD: ±1.45; n=3) compared to untreated controls.  Error bars 
show SEM. 
 
a. Dose-response curves 
 
b. Protective effect (n=3) 
R
el
. p
ro
te
in
 s
yn
th
es
is
 (
%
) 
[Ricin] (ng.mL-1) 
P
ro
te
ct
io
n
 (
-f
o
ld
) 
 
 
Glycerol - + 
 
 
 
0
20
40
60
80
100
120
0.03 0.3 3 30
0
2
4
6
8
10
12
Page 130 
 
4.6.2 Glycerol increases the lag observed before the cytotoxicity of ricin is exhibited 
Sandvig et al. (1984) showed that glycerol treatment did not interfere with endocytosis nor 
binding of the holotoxin to the cell surface.  However, they did not exclude any other 
interaction beyond this stage of holotoxin trafficking.  As such, time-response assays were 
conducted to determine whether the effect of glycerol resided at a stage before entry of RTA 
into the retrotranslocation-competent compartment (Figure 4.11a & b).  The results of these 
assays confirm that, in incubations with glycerol, there is an increase in trafficking time 
before the log-linear portion of the profile is reached.
14
  According to the regression of these 
log-linear profiles (Hudson & Neville, 1987), the relative lag before the first signs of toxicity 
is increased by an average of 57% (SD ±5%; n=3).  Furthermore, the rate of delivery after 
this point is reached is much lower, as shown by the gentler slope of the log-linear region.   
These data clarify that glycerol delays the entry of RTA into the cytosol in an active state.  To 
determine whether glycerol could interfere with the interaction of RTA and the ER 
membrane, so also preventing co-option of the toxin subunit onto an ERAD pathway, was 
one of the objectives of the next section. 
  
                                                 
14
 This also provides a positive example of this particular assay being used to measure a factor retarding delivery 
of the toxin to the cytosol.  This was not demonstrated previously as none of the factors tested had an effect. 
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Figure 4.11 – The effect of glycerol on the trafficking time of ricin 
The protocol used to produce this figure was similar to trafficking assays in the previous chapter.  However, 
cells were treated (at time nought) with medium containing 10% glycerol (w/v), or with medium containing no 
glyercol.  Data was interpreted as before: protein synthesis at each timepoint was normalised to controls not 
treated with ricin (100% protein synthesis). Lines of best fit were then drawn through the exponential phase of 
the datasets and regressed (Microsoft Excel).  The time at which this equation satisfied 100% synthesis for 
each series was then used to compare control and glycerol-treated cells.  c) Shows time-response curves 
comparing cells treated with medium containing no glycerol () to cells treated with medium laden with 10% 
glycerol (w/v) (). d) Shows trafficking times relative to controls (n=3; error bars show SEM).   
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4.6.2 The effect of POPS liposomes on the solubility of RTA 
In vivo, it is thought that the interaction of RTA with the ER membrane is initiated by 
negatively-charged phospholipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine, 
POPS.  This phospholipid is native to the bilayer (Zachowski, 1993).   Its interaction with 
RTA is hypothesised to promote the co-option of the toxin subunit onto an ERAD-like 
pathway (Mayerhofer et al., 2002), or else to promote the acquisition of a conformational 
state which permits retrotranslocation.  As of yet, few data exist to confirm that this is a 
significant process in vivo.  The hypotheses of Sandvig et al. (1984) and those of the previous 
sections posit that glycerol inhibits the toxicity of ricin by interfering with this interaction.  A 
series of experiments were conducted to investigate the following possibilities: 
(1) whether a liposomal interaction could be observed by a change in solubility in 
vitro;  
(2) whether this could be interfered with by glycerol.   
POPS liposomes induce a dramatic loss of solubility - RTA was incubated with or without 
negatively-charged POPS liposomes for 15 minutes at 37°C.  These were constructed in the 
same manner as that used by Heuck et al. (2003).  The relative distribution of RTA between 
insoluble and soluble fractions was then analysed by silver-stain (Figure 4.12).  Incubation of 
RTA with negatively-charged liposomes evidently caused a large shift of RTA to the pellet 
fraction (compare pellet/soluble pairs 1 & 2).   
To test whether this loss of solubility was caused by RTA merely adhering to the surface of 
sedimentable liposomes, detergent was added after the incubation to see whether dissolution 
of the phospholipid vesicles would restore solubility.  Comparing assays with liposomes 
alone to those where triton had been added afterward, it is apparent that the tendency of RTA 
to sediment persists even after the liposomes causing it have been disrupted (cf. pairs 2 and 3 
of Figure 4.12a & b).  This would imply that their interaction with RTA results in an 
irreversible series of structural changes that result in sedimentation, consistent with a process 
that leads to aggregation.  Two explanations could be suggested for this collection of 
observations: 
(1) Interaction with POPS leads to outright aggregation in both cases (i.e. with or 
without triton), so increasing the pellet fraction.   
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(2) Alternatively, the interaction leads to embedding of RTA in the liposomes, 
causing it to sediment with them (without triton).  When the liposomes are 
dissolved by the addition of triton, these structural changes might then cause 
irreversible aggregation (as hydrophobic regions of polypeptide otherwise 
solvated by lipid become exposed and subsequently self-associate). 
As an essential control, incubation of RTA with triton alone had little effect on the solubility 
of RTA (cf. pairs 1 and 4 of Figure 4.12).   
Glycerol does not prevent the interaction - To continue investigation of the hypotheses made 
in the previous section, 10% glycerol (w/v) was added to the incubation before the liposomes 
were added.  These experiments show that this small molecule chaperone has no effect upon 
the interaction under the conditions of this assay (cf. pairs 3 with 5, & 2 with 6).   
These effects are just as pronounced at 45°C - When these assays were repeated at 45°C, 
incubation with the liposomes caused a similar shift to the pellet fraction (Figure 4.12c & d).  
Just as at 37°C, the reduction in solubility was not negated by dissolving the liposomes 
afterward with detergent, and glycerol could not prevent the interaction.  It is also more 
apparent in these assays that glycerol functions as a small molecule chaperone under these 
conditions, promoting the solubility of RTA in isolation (cf.  pairs 1 and 7 of Figure 4.12c & 
d).   
Taken as a whole, these results are of interest because they corroborate the conclusion that 
the interaction of RTA with negatively-charge liposomes is more than a superficial one 
(Mayerhofer et al., 2009; and Day et al., 2002).  In this case, it causes structural 
rearrangement resulting in loss of solubility even if the liposomes are subsequently dissolved 
with triton.  Importantly, however, the physiological membrane will bear significant 
differences from the liposomes used in this assay (such as protein content and the presence of 
other lipids, which will dilute POPS).  Therefore, in vivo, glycerol might still compete with 
such an interaction. 
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Figure 4.12 – The effect of POPS liposomes upon the solubility of RTA 
500ng RTA was incubated in 10mM MOPS / 50mM KCl (pH7.2) buffer for 15 minutes at 37°C with or without 
7.5μM POPS liposomes and 10% (w/v) glycerol.  After this incubation, mixtures were transferred to ice for 5 
minutes and then 10% (w/v) Triton-X100 detergent (or an equivalent volume of water) was added as indicated.  
All samples were then incubated on ice for a further 10 minutes before separation into pellet and supernatant 
fractions at 16000  g for 10 minutes.  a) Pellet and soluble fraction were then run in parallel on SDS-PAGE 
(pairs are demarcated by grey lines) and b) Quantified by TotalLab.  Error bars show the standard deviation 
between 9 independent experiments.  c) and d) Shows equivalents to a) and b) respectively, but where the 
temperature of incubation was 45°C. 
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(Figure 4.12 – continued.) 
 
 
c. Silver stains – each panel represents an independent assay conducted at 45°C. 
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4.6.3 Neutrally-charged liposomes have little effect on the solubility of RTA 
Mayerhofer et al. (2009) and Day et al. (2002) showed that it was specifically negatively-
charged phospholipid which disrupted the secondary structure of RTA and which 
accommodated the insertion of the toxin subunit into the bilayer.  To clarify that this 
observation was reflected in these assays, further experiments were undertaken using the 
neutral phospholipid, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocysteine (POPC; Figure 
4.13).  POPC liposomes displayed strikingly different effects in the assay.  At both 37°C and 
45°C POPC induced little loss of solubility (cf. pairs 1 & 2); the error-bars between 
treatments overlap.  However, unlike with POPS, where glycerol is present, there is 
noticeably more soluble RTA at both 37°C and 45°C (cf. pairs 2 & 6).       
Therefore it appears that the negatively-charged character of POPS-containing liposomes is 
crucial to the dramatic loss of solubility they induce in co-incubated RTA.  Contrasting to 
POPS, in the context of POPC, glycerol can also stabilise RTA from losing solubility.  
Therefore, in vivo, where negatively-charged phospholipids of the ER membrane like POPS 
will be diluted by POPC and other bilayer constituents, glycerol may be able to prevent the 
membrane interaction.  
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Figure 4.13 – The effect of POPC liposomes upon the solubility of RTA 
500ng RTA was incubated in 10mM MOPS / 50mM KCl (pH7.2) buffer for 15 minutes at 37°C with or without 
7.5μM POPC liposomes and 10% (w/v) glycerol.  Samples were otherwise treated as before.  a) Three 
representative silver stains from a set of 6 independent).  b) Quantification derived from the silver stains 
(TotalLab).  Error bars show the standard deviation between the 6 experiments.  c) and d) Shows equivalents 
to a) and b) respectively, but where the temperature of incubation was 45°C. 
 
a. Silver stains – each panel represents an independent assay conducted at 37°C. 
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 (Figure 4.13 – continued.) 
 
 
c. Silver stains – each panel represents an independent assay conducted at 45°C. 
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4.7 The effect of Hsc70/Hsp40 upon the thermal denaturation of RTA 
The experiments conducted to this point persuade us that the effect of factors which are 
expected to influence protein aggregation and misfolding can be observed by measuring the 
solubility of RTA.  The observations made can be reconciled with documented phenomena: 
(1) Increased salt concentration salvages RTA from unfolding events that lead to 
reduced solubility, much as it rescues RTA from initiating interactions with 
negatively-charged liposomes (Day et al., 2002). 
(2) A threshold around 45°C delimits a marked change in RTA solubility, unlike for 
the homologous toxin, saporin, which does not co-opt an ERAD-like pathway.  
This results from differences between the two toxins, for example the hydrophobic 
C-terminus of RTA and its lesser lysine content (Vago et al., 2005). 
(3) Volume-excluding effects by Ficoll-70 do not hinder solubility at 37°C nor 45°C, 
showing that some other factor dominates loss of solubility rather than crowding 
from a hydrophilic crowding agent.  Again, this may potentially be the C-terminus 
of RTA. 
(4) RTA is predictably least soluble in buffers of pH7.0 to 7.4, a range straddling its 
reported pI of 7.3 (Li et al., 1992). 
(5) A small molecule chaperone, glycerol, can rescue RTA from losing solubility 
during heat-treatment. 
(6) Liposomes composed of negatively-charged POPS induce conformational changes 
in RTA that lead to a loss of solubility (corroborating changes to secondary 
structure observed under similar treatments - Mayerhofer et al., 2009; Day et al., 
2002).  This phenomenon may be interfered with in vivo by the small molecule 
chaperone, glycerol, where strongly-denaturing POPS will be diluted by neutral 
phospholipids like POPC (Zachowski, 1993) and other membrane components. 
As these trends could be explained rationally and related well to earlier literature accounts, it 
seemed likely that any solubilising activity of chaperones like Hsp40/Hsc70 might also be 
observed in a meaningful way by this assay.  As such, the next section of this chapter 
discusses the effects of Hsp40/Hsc70 on the solubility of RTA.   
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4.7.1 Purification of Hsp40 
A précis of the Hsp40 purification procedure is given here for ease of reference.  A more 
comprehensive review of the protocol can be found in Chapter 2.  Hsp40 was over-expressed 
in an E. coli BL21 culture using an IPTG-inducible system.  The culture was then centrifuged 
and cells resuspended in 20mM KCl / 20mM MOPS-HCl pH7.2 buffer, before sonication.  
This sonicate was clarified by centrifugation, and Hsp40 was purified in a two-step process 
via column chromatography.  A DEAE-Sepharose column was used first (GE Healthcare).  
Fractions were eluted from this column with buffer containing increasing concentrations of 
KCl (up to 100mM).  Sequential fractions from this elution were analysed by SDS-PAGE and 
stained with Coomassie Blue (Figure 4.14a).  Those fractions containing fewest impurities 
were pooled and loaded onto a Source 30S column (GE Healthcare).  This column was then 
eluted with a graduated buffer containing from 100mM to 300mM KCl.  Serial fractions 
were, again, collected and compared via Coomassie staining after SDS-PAGE (Figure 4.14b).  
Fractions containing Hsp40 and the fewest impurities were pooled and quantified by silver 
stain, where they were compared to standards of known Hsp40 concentration to determine 
their protein content per unit volume (Figure 4.14c). 
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Figure 4.14 – Purification of Hsp40. 
Clarified sonicates from E. coli containing over-expressed Hsp40 were purified via sequential DEAE Sepharose 
and 30S source columns.  a)  Shows the fractions collected from the DEAE Sepharose column. The lane marked A 
shows 15 μL of the sonicate loaded onto the column.  Numbered lanes represent 15L of consecutive fractions 
from the column as it was eluted.  Fractions 1-3 were pooled and loaded onto a 30S source column.  B) Shows 
fractions collected after 30S source column chromatography.  Enumerated are consecutive elutions.  The lane 
marked A shows 15 μL of the partially purified Hsp40 from the previous DEAE column.  Of the enumerated 
fractions, 2-4 were pooled.  C) Shows the quantification of the resultant solutions by silver stain. 0.875μg of 
Hsp40, a kind gift from Jörg Höhfeld (Institute for Cell Biology, Bonn) was loaded alongside 10, 5 & 1μL of the 
Hsp40 purification.  The relative intensity of Hsp40 bands were quantified by TotalLab. 
 
a. DEAE-Sepharose fractions (stained with Coomassie Blue) 
 
 
b. Source 30S fractions (stained with Coomassie Blue) c. Quantification 
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4.7.2 Purification of Hsc70 
SF9 (insect) cells were transformed with a plasmid encoding Hsc70 using a baculovirus 
vector.  After infection and incubation, cultures were induced with IPTG and centrifuged.  
The cell aggregate was lysed using a buffer containing 1% triton X-100.  Lysates were then 
fractionated, in order, with: a DEAE-Sepharose column (GE Healthcare; eluted with 
increasing concentrations of KCl), then an ATP-agarose column (Sigma-Aldrich; eluted with 
up to 2mM ATP) and finally a Source 30Q column (from GE Healthcare, which was also 
eluted with up to 1M KCl).  As fractions were eluted from each column, the A280 was 
observed.  Those fractions showing absorbance in excess of the buffer alone were pooled, 
separated by SDS-PAGE and analysed by Coomassie staining for Hsc70 content (Figure 
4.15).  Only those fractions containing the 70kDa Hsc70 band were collected and transferred 
to a subsequent column.
15
  After the Source 30Q column, the purified fractions were 
concentrated using Centricons (Millipore).  
Please note that in Figure 4.15b, an impurity can be seen at 60kDa.  This is a breakdown 
product of Hsc70, where the C-terminus has been cleaved off.  This is often observed in the 
purification of the chaperone, and it lacks any regulatory modulation owing to the C-terminal 
EEVD motif which is usually bound by co-chaperones and inhibitors like DSG (Höhfeld J. – 
personal communication).  Importantly, Figure 4.15c shows that there is no remnant of this 
moiety in the final Hsc70 preparation.  Thus, it is not interfering in the assay hereafter. 
  
                                                 
15
 For the DEAE-Sepharose column, fractions from which were analysed for Hsc70 content by determining 
peaks in A280 absorbance alone. 
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Figure 4.15 – Purification of Hsc70 
Hsc70 was purified by a three-stage process.  The Coomassie analyses of the latter two of these stages are 
shown here.  a) The pooled fractions from the DEAE-Sepharose column (10μL of which was loaded in the lane 
marked “A”) were loaded onto an ATP-agarose column.  The column was then washed extensively before 
Hsc70 was eluted with a buffer containing ATP.  Sequential fractions were collected and analysed by SDS-PAGE 
and Coomassie staining.  All those fractions containing Hsc70 and no impurities were then loaded onto a 
Source 30Q column.  10μL of these pooled fractions is loaded in lane “A” of b), which shows the fractions were 
eluted using a gradient of KCl.  Fractions containing only the 70kDa band were collected (numbers 4 through 6) 
and concentrated by centricon.  c) Shows 2μg of the final Hsc70 preparation per lane, as determined by biorad.  
Grey arrowheads mark the Hsc70 band.  White arrowheads mark a 60kDa C-terminally truncated Hsc70, 
lacking the EEVD regulatory motif.  All gels are stained with Coomassie blue. 
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4.7.3 Hsc70/Hsp40 bolster the solubility of RTA 
After purification, Hsc70 and Hsp40 could be tested for their effect upon the solubility of 
RTA, which would help to determine:  
(1) Whether they could form a complex. 
(2) Whether they had a predictably functional association. 
The effects of Hsc70/Hsp40 at 45°C - RTA was heated to 45°C and incubated for 15 minutes 
with or without Hsc70, Hsp40 and ATP in the indicated combinations (Figure 4.16).  The 
pellet and soluble distribution of RTA was then analysed by silver-stain after a 10 minute 
centrifugation at 16000 g.  Figure 4.16a shows that including Hsc70 in the incubation 
during the heat treatment boosts the solubility of RTA.  Presumably, this is because the 
chaperone reversibly masks regions of transiently-exposed hydrophobic polypeptide during 
the heat-treatment, preventing aggregation between neighbouring RTA molecules. 
Minami et al. (1996) observed an obvious synergy between Hsp40 and Hsc70 in keeping 
luciferase from aggregating.  However, this is not strongly shown in the case of RTA, where 
there is no significant additional increase in solubility in Hsp40-containing incubations 
compared to assays containing Hsc70 alone.  However, assays shown in Spooner, et al. 
(2008) clearly do show the cooperation of Hsp40 and Hsc70 in keeping RTA soluble.  This 
disparity may reflect batch-dependent differences in the conformational stability of RTA, or 
the activity of Hsp40 (all other things being the same between these assays).  Results 
published in Spooner et al. (2008) also clearly show that chaperone-stabilised RTA retains 
catalytic activity with respect to ribosomal RNA, whereas heat-treated RTA does not. 
Importantly, the inclusion of ATP in similar incubations increased the ability of Hsc70 and 
Hsp40 to maintain the solubility of RTA, by average (Figure 4.16a).  This demonstrates the 
ATP-dependence of Hsc70 (Beissinger & Buchner, 1998) and that the ATPase cycle of the 
chaperone contributes to the optimal preservation of solubility.  This provides more 
convincing evidence that RTA can be actively bound by the chaperone, in a functional way.   
It should be recalled that DSG, which was used in vivo in the previous chapter, stimulates the 
ATPase activity of Hsc70 in vitro, perturbing the chaperone‟s normal association with clients 
(Brodsky, 1999; Nadler et al., 1998).  As rescue of RTA from aggregation in vitro seems to 
be at least partially ATP-dependent, interfering with the ATPase cycle of Hsc70 in vivo may 
affect the same process. 
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The effects of Hsc70/Hsp40 at 37°C – To check whether the interaction observed at 45°C 
resulted from attributes of thermally-denatured RTA, rather than some attribute of the native 
polypeptide, the above assays were repeated at 37°C (Figure 4.16b).  At this temperature, an 
unexpectedly similar effect of the chaperones upon the solubility of RTA was observed, with 
a less pronounced difference between assays with and without ATP.  The relatively large 
error bars correspond to differences in solubility between the batches of RTA used in 
independent assays rather than to variability in the effects of Hsc70/Hsp40. 
According to Argent et al. (2000), the secondary structure of RTA is relatively intact until a 
temperature threshold of 42°C is reached.  Therefore, it would seem that at 37°C there is 
some feature of the native RTA monomer that Hsc70 and Hsp40 can have an effect upon to 
render it more soluble.  A pre-eminent candidate for this is the hydrophobic C-terminus of the 
toxin subunit.  This hydrophobic domain is solvent-exposed (Mayerhofer et al., 2009).  
Therefore it is also exposed to the hydrophobic surface of the polypropylene incubation 
vessel, to which it might adsorb.  Hsc70 could bind to this domain at 37°C, masking it. 
Arguably, this apparent effect of Hsc70 and Hsp40 on the solubility of RTA at 37°C could 
result from a phenomenon which is independent of direct binding to the toxin subunit.  
Interactions made between RTA and the hydrophobic surface of the incubation vessel might 
instead be displaced by the chaperones, which cling to the tube instead.  The immediate 
question to answer, then, is: do the chaperones displace Hsc70 from binding to the incubation 
vessel by binding to RTA directly, or do they block binding by themselves saturating the 
hydrophobic surface of the incubation vessel?  To clarify this issue, a series of experiments 
were conducted in which BSA was included instead of the chaperone complex. 
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Figure 4.16 – The effect of Hsc70 and Hsp40 upon the solubility of RTA after incubations at 
45°C and 37°C 
500ng RTA (0.8μM) was incubated at a) 45°C or b) 37°C, but otherwise as before, with the indicated mixture of 
chaperones and ATP.  Gels were silver-stained and quantified (using TotalLab).  RTA bands are highlighted with 
a grey arrowhead and Hsc70 is highlighted with an asterisk. Hsp40 is only present in catalytic quantities and is 
thus not clearly visible.  Error bars show SEM in all cases. 
 
Concentration of the chaperone components were as follows: 4.7μM Hsc70; 3.2μM Hsp40.  Where used, ATP 
was included at a concentration of 5mM.  (In all cases the standard 10mM MOPS / 50mM KCl buffer of pH7.2 
was supplemented with 5mM MgCl2 to ensure solubility of the ATP.) 
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(Figure 4.16 – continued.) 
 
b. Assays conducted at 37°C (panels show a representative assay) 
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4.8 The effect of BSA upon the solubility assay 
To determine whether Hsc70 and Hsp40 were simply binding to the reaction vessel and so 
displacing RTA from doing the same, BSA was used as a comparison.  RTA was incubated 
with a range of BSA concentrations rather than with the chaperones.  The assays presented in 
Figure 4.17 show that increasing the concentration of co-incubated BSA resulted in an 
apparent increase in the relative solubility of RTA.  The maximal effect of this occurs at 
approximately 2.5 mg.mL
-1
 of BSA. This suggested that BSA itself may block RTA from 
adhering to the side of the Eppendorf tube in which it is incubated.  Thus, at least some of the 
effect of Hsc70/Hsp40 may result from a non-specific blocking phenomenon. 
 
Table 4.1 - Conversion of chaperone molarity into absolute concentration 
In previous assays with chaperones, the concentration of each was stated in terms of molarity.  The following 
table shows the equivalent concentration in mg.mL
-1
, using a molecular weight of 40kDa for Hsp40 and 70kDa 
for Hsc70. 
 Concentration 
Protein μM (2s.f.) mg.mL-1 (2d.p.) 
Hsc70 4.7 0.34 
Hsp40 3.2 0.13 
Total N/A 0.47 
 
 
In earlier assays containing chaperones (shown in Figure 4.16a & b) the maximum 
concentration of protein other than RTA was ~0.47mg.mL
-1
.  This chaperone mixture 
contributed to an increase in solubility of 31% at 45°C and of 23% at 37°C (by average) 
compared to incubations without chaperones.  On the other hand, a 0.63mg.mL
-1
 
concentration of BSA results in an increase to solubility of only 5% at 37°C (by average, 
Figure 4.17b).  Indeed, at this concentration of BSA there is significantly less solubilising 
effect (Figure 4.17c; p<0.001 using an unpaired Student‟s T-test).  Moreover, by average the 
maximal contribution of BSA to the solubility of RTA is a mere 11% at 37°C.  Thus, unless 
Hsc70 and Hsp40 have greater preference for the side of the incubation vessel than does 
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BSA, their solubilising effect seems attributable to a different activity.  It seems reasonable to 
suggest that this is a direct interaction between RTA (as client) and Hsc70 (as chaperone). 
Importantly, if the relative increase in pellet fraction at temperatures higher than 37°C is 
because of RTA merely sticking to the edge of the incubation vessel, it is important to ask 
whether this assay is at all measuring protein aggregation or misfolding.  In answer, the side 
of the tube is a hydrophobic material.  An otherwise soluble protein would therefore bind to 
this surface only if it, too, had exposed hydrophobic regions.  Otherwise, it would be repelled, 
being solvated by water molecules in preference.  As the exposure of hydrophobic domains 
will be determined by factors affecting protein folding, this assay still seems appropriate to 
qualify them.  To refine this protocol, however, the reaction vessel could be pre-treated by 
washing with low concentrations of an inert protein to block the binding of RTA.  As the 
availability of purified Hsc70 was limiting, however, it has not yet been possible to do so. 
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Figure 4.17 – Effect of low BSA concentrations on the distribution of RTA between pellet 
and soluble fractions. 
500ng RTA was incubated as before at a) 37°C or b) 45°C and then separated into pellet (P) and soluble (S) 
fractions, separated by SDS-PAGE.  Bands were developed by a silver-stain protocol.  Included in the 
incubation was the indicated concentration of BSA.  Grey arrowheads mark RTA bands, black arrowheads 
mark BSA bands. c) Shows the average pro-solubility effect of the concentration of BSA tested (0.63 mg.mL
-1
) 
which was closest to the absolute concentration of chaperones used in Figure 4.16 (0.47 mg.mL
-1
).  To attain 
the percentage ‘pro-solubility’ effect, the P/S distribution of RTA was compared in BSA and chaperones 
treatments to the P/S distribution of RTA in buffer alone.  Error-bars show the SEM in all cases. 
 
a. Assays conducted at 37°C (n=4) b. Assays conducted at 45°C (n=4) 
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(Figure 4.17 - continued.) 
 
c.   Average pro-solubility effect of BSA and Hsc70/Hsp40 from different experiments 
 conducted at 37°C (n=3) 
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4.8.1 The effect of concentrated BSA upon the solubility assay 
Low concentrations of BSA convincingly promoted the solubility of RTA, potentially by 
displacing it from binding to the reaction vessel.  However, at higher concentrations it was 
expected that BSA might have the opposite effect, promoting misfolding, aggregation and 
loss of solubility by crowding effects (Van den Berg et al., 1996).  This was hinted at in the 
previous section, where the maximal solubilising effect of BSA peaks at 2.5mg.mL
-1
, by 
average. 
The effect of crowding from a polar macromolecule was already tested with the use of Ficoll-
70.  This uncharged, polar molecule had little effect upon solubility, even at high 
concentrations.  However, Van den Berg et al. (1999) observed differential effects of Ficoll-
70 and BSA upon the folding of lysozyme in vitro.  Thus, it was possible that higher 
concentrations of BSA might produce a crowding effect that was detrimental to solubility.  
To this end, RTA was incubated with a range of much higher BSA concentrations than 
previously tested (Figure 4.18).  As the concentration of BSA was increased beyond 5mg.mL
-
1
, the solubility of RTA was shown to decrease.   
Van den Berg et al. (1999) note that the pI of BSA is 4.9.  At the incubation pH of 7.2 BSA 
would be negatively-charged and might provide an interaction analogous to that provided by 
negatively-charged POPS liposomes (i.e. where a charged exterior leads RTA to interact with 
a hydrophobic interior, leading to loss of solubility).  
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Figure 4.18 – Higher concentrations of BSA inhibit the solubility of RTA 
500ng RTA was incubated, as before, at 37°C with a higher concentration of BSA.  Pellet (P) and soluble (S) 
fractions were then analysed in parallel by SDS-PAGE, silver stain and quantification in TotalLab.  Grey 
arrowheads mark RTA bands.  Error bars show the SEM. 
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4.9 The effect of DSG upon the ability of Hsc70 to keep RTA soluble 
The effect of Hsc70 and Hsp40 upon the solubility of RTA during heat-treatment in vitro was 
shown to be more than that of an arbitrary protein, BSA.  Furthermore, the optimal conditions 
were dependent upon the presence of ATP (cf. Figure 4.16).  To help link the effect of 
inhibiting Hsc70 in vivo to the activity of Hsc70 in vitro, the influence of an Hsc70 inhibitor 
(DSG) upon this rescue of soluble RTA was examined.  To this end, RTA was incubated with 
Hsc70/Hsp40 and a concentration of DSG equivalent to that used in vivo was added. 
As DSG was packaged with a lactose excipient, it was important to provide controls which 
showed this chemical was not responsible for any change in solubility the incubation showed 
(Figure 4.19c, cf. pairs 1 & 2).  These data show that lactose increases the solubility of RTA.  
Likewise, DSG also promotes solubility in isolation from the chaperone complex (cf. pairs 1 
& 3).  These properties have to be accounted for when looking at their effects upon the 
chaperone complex.  With this in mind, the most appropriate comparison to discern the 
effects of DSG upon the chaperone complex are incubations which include 
DSG/lactose/Hsc70/Hsp40/RTA and identical incubations which simply lack DSG (Figure 
4.19c, cf. pairs 4 & 6).  For convenience, these datasets have been outlined with red.   
Inclusion of DSG apparently abrogates some of the effect that Hsc70/Hsp40 have upon 
solubility.  The magnitude of this effect is, by average, a ~22% relative shift of RTA to the 
pellet fraction (Figure 4.19c, pairs 4 & 6).  This is an unexpectedly large value given the total 
effect of the chaperones was, by average, a ~31% shift (Figure 4.16a).  Moreover, some of 
this solubilising effect will be caused by non-specific blocking of RTA from binding to the 
Eppendorf‟s interior surface.  Coupled to this, DSG would also have an antagonistic role to 
any explicitly inhibitory effect upon Hsc70, as it itself promotes solubility (Figure 4.19a & c, 
pairs 2 & 3).  Therefore, the effect of DSG upon Hsc70 may actually be larger than the ~22% 
shift observed, but is obscured by these complexities.   
Very unexpectedly, the magnitude of this effect is also clearly larger than any ATP-
dependent chaperoning effect of the chaperone (Figure 4.16), suggesting that this chemical 
also interferes with a passive ability of the chaperone in promoting solubility.  DSG could be 
operating in this fashion in vivo, and by this mechanism protect cells from ricin. 
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Figure 4.19 – Silver-stained gels showing the effect of DSG upon the ability of Hsc70 and 
Hsp40 to prevent aggregation of RTA. 
500ng RTA was incubated with the indicated mixture of chaperones, 50μg.mL
-1
 DSG, 100μg.mL
-1
 lactose and 
5mM ATP for 15 minutes at 45°C.  Pellet (P) and soluble (S) fractions were collected as before and analysed by 
SDS-PAGE. a) & b) Resultant gels were silver-stained. Shown below are experiments demonstrating the effect 
of DSG and lactose upon both RTA aggregation and upon the ability of Hsc70/Hsp40 to prevent that 
aggregation.  c) Shows quantification via TotalLab, incorporating data displayed in Figure .  Outlined more 
boldly are the datasets which, when compared, best describe the effect of DSG upon the ability of Hsc70 and 
Hsp40 to rescue RTA from aggregation at 45 °C.  Black arrowheads mark bands which owe to staining of Hsc70.  
All assays presented in this figure contain ATP. 
 
Concentration of the chaperone components were as follows: 4.7μM Hsc70; 3.2μM Hsp40.  Where used, ATP 
was included at a concentration of 5mM.  (In all cases the standard 10mM MOPS / 50mM KCl buffer of pH7.2 
was supplemented with 5mM MgCl2 to ensure solubility of the ATP.) 
 
a. Effect of DSG (separate panels 
show repeats of the same assay). 
 
b. Effect of lactose (separate panels 
show repeats of the same assay). 
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(Figure 4.19 – continued.) 
 
 
c. Quantification (n=3).  This figure quantifies a & b and displays it alongside data from 
Figure 4.16. 
 
 
R
TA
 d
is
tr
ib
u
ti
o
n
 (
%
) 
  
RTA + + + + + + 
Lactose - + + + - + 
DSG - - + + - - 
Hsc70/Hsp40 - - - + + + 
Pairs 1 2 3 4 5 6 
 
  
0
20
40
60
80
100
1 2 3 4 5 6
Pellet
Soluble
Page 157 
 
4.10 The effect of chaperones upon saporin 
To show that Hsc70 and Hsp40 are passive species which do not interact with clients unless 
they show some degree of non-native character, an abridgement of the assay above was 
created with saporin.  As previously determined, saporin is not prone to lose solubility at 
45°C.  In Figure 4.20, it is shown that Hsc70, Hsp40 and DSG do not affect the distribution 
of saporin between pellet and soluble fractions after incubation at 45°C.  However, as the 
dynamic range of this assay is likely to be small (i.e. already ~90% of the saporin is soluble), 
any effect may be beyond the scope of reliable determination.  
Figure 4.20 - The effect of chaperones upon saporin  
In identical assay to those conducted with RTA (conducted at 45°C, 500ng saporin was incubated with lactose, 
DSG and Hsc70/Hsp40 in the indicated combinations.  All reactions also contained ATP. Concentration of the 
chaperone components were as follows: 4.7μM Hsc70; 3.2μM Hsp40.  Where used, ATP was included at a 
concentration of 5mM.  (In all cases the standard 10mM MOPS / 50mM KCl buffer of pH7.2 was supplemented 
with 5mM MgCl2 to ensure solubility of the ATP.) 
 
a. Silver-stains - separate panels show 
repeats of the same assay. 
b. Quantification (n=3) 
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4.11 Effect of cytosol on the aggregation of RTA 
Each of the solubility assays to this point has examined the effect of purified constituents 
upon the solubility of RTA.  It was possible a more complex incubation could recapitulate the 
phenomena observed in isolation, showing that the effect of Hsc70 could be manifest amid a 
mixture of other proteins, e.g. a cytosolic extract.  It was thought that a cytosolic extract 
might be observed to: 
(1) Displace RTA from annealing to the side of the incubation vessel, as the cytosol 
would have a variety of proteins which might compete with RTA in doing so. 
(2) Have crowding effects – a cytosolic extract would be densely populated by proteins 
and other macromolecules. 
(3) Prevent RTA from being thermally denatured – a cytosolic extract would include 
chaperones which might cause this effect. 
(4) If point 3 were demonstrated, then those effects might be interfered with by Hsc70 
inhibitors like DSG, or even Hsp90 inhibitors like GA, RA and C01. 
Production of a cytosolic extract - A cytosolic extract was prepared from a monolayer of 
HeLa cells.  The monolayer was incubated with trypsin solution and then resuspended in 
10mM MOPS / 50mM KCl pH7.2 with Complete protease inhibitors (Roche).  Cells were 
then lysed by grinding with metal ball bearings.
16
  The resulting lysate was clarified of 
remaining membrane-bound material by centrifugation at 120000 g for an hour at 4°C.  
This clarified lysate was then dialysed against 10mM MOPS / 50mM KCl pH7.2 buffer 
overnight to remove small molecules.  Samples were then snap-frozen on dry ice and stored 
at -80°C.  Aliquots of the extract were compared, via silver stain, to a separate extract made 
with a buffer containing 1% triton X-100 (Figure 4.21a).  In the mechanically lysed extract, 
there is a reduction of bands at most molecular weights, and particularly at molecular masses 
above 64kDa relative to detergent-lysed extracts.  This preferential loss of higher-molecular 
weight species suggests the release of lytic enzymes (resulting in universally lower molecular 
weight fragments).  Some membrane-bound protein content may have also been removed 
after being sedimented at 120000 g as well, putatively including lumenal chaperones (e.g. 
Grp94 & BiP).   
                                                 
16
 The use of detergent as the mode of lysis was precluded since detergents might also interfere significantly 
with protein interactions affecting the solubility assay. 
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It was planned that RTA would be incubated with increasing concentrations of this extract at 
45°C and that the resultant solubility of RTA would be assayed by the distribution of protein 
between pellet and soluble fractions.  Initially, an immunostain method was used to visualise 
the distribution of RTA between soluble and pellet fractions, but this approach was 
abandoned as it did not yield reliable results (data not shown).  A silver stain approach was 
opted for instead. Figure 4.21b shows cytosolic extracts stained in this manner, compared in 
parallel to RTA.  This shows that the RTA band appears in a region of the gel that is 
relatively free of obscuring bands.  This is just as true when the cytosol incubation is heated 
to 45°C for 15 minutes and split into pellet and supernatant fractions.  Therefore, it seemed 
that a silver-stain approach might return an interpretable set of data, as the intensity of the 
RTA band could be determined with relatively little background interference. 
Figure 4.21 – Production of cytosol from HeLa cells 
a) Cellular extracts were separated by SDS-PAGE and silver-stained.  Lanes marked “mechanically lysed” show the extracts 
generated from the method discussed in the text.  Lanes marked “lysed by detergent” were lysed in a buffer containing 1% 
Triton X-100 and were not clarified of membrane content.  c) 500ng RTA was loaded into the lane marked “RTA”.  The lane 
marked “Cytosol” was loaded with 10μL of the cytosolic extract as well as 500ng RTA.  Lanes followed by “(P)” or “(S)” are 
the products of heating the indicated mixture of 10μL cytosol and 500ng RTA (in a total volume of 20μL) at 45°C for 15 
minutes followed by 16000 g fractionation into pellet and soluble fractions.  
 
a. Silver-stain of cytosolic extracts b.  Where RTA falls in the cytosol ladder 
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Testing the effect of the cytosolic extract on the solubility of RTA - RTA was incubated with 
increasing concentrations of the cytosolic extract. The quantification of each data-point was 
carefully normalised to a background value.  This background value corresponded to the 
intensity of silver-staining by an equivalent concentration of cytosol alone (at the position 
where RTA would have otherwise migrated to in the protein ladder).  The results of this 
analysis and the silver stains from which they are derived are presented in Figure 4.22a (RTA 
bands are marked with asterisks).   
As the concentrations of cytosol increases above 5%, the total signal size from RTA bands 
decreases (Figure 4.22b).  This trend does not appear to be because the background negation 
is over-compensating, but probably results from proteolytic activity (which persists despite 
Complete protease inhibitors being used in generation of the extract).  Encouragingly, 
incubation with lower concentrations of cytosol (5-10%) appears to conserve the solubility of 
RTA.  However, at a cytosol concentration of 25% the solubilising effect diminishes and a 
greater proportion of the RTA is found in the pellet.  Unfortunately, the total signal size also 
diminishes under these conditions, which makes interpretation difficult: the decrease in the 
soluble fraction may be because of an increase in crowding effects, or the preference for any 
endogenous protease to cleave soluble RTA rather than aggregated RTA of the pellet. 
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Figure 4.22 - The effect of a cytosolic extract upon the aggregation of RTA 
500ng RTA was incubated at 45°C for 15 minutes with ATP and increasing concentrations of the mechanically-
lysed cytosol extract.  After this incubation, it was separated into 16000 g supernatant and pellet. These 
were analysed in parallel via SDS-PAGE. Bands were visualised by silver-staining, and are shown below, in a).  
The concentration of cytosol is given arbitrarily, as a percentage of the extract relative to the entire incubation 
volume.  A 25% concentration, therefore, is equivalent to 25% of the incubation mixture: 5μL of the cytosol 
preparation in a total volume of 20μL.  Marked with both the grey arrowheads and asterisks are RTA bands. b) 
Shows quantification of the entire signal size from both pellet and soluble bands, as determined by TotalLab, 
and normalised arbitrarily to the most intense pair.  c) Shows relative quantification of pellet and soluble 
bands.  The pellet is in gray and the soluble fraction is in white. d) The pellet and soluble signal sizes of RTA 
relative to the maximum total signal size from both.  Error bars on all charts show the standard deviation 
between the three sets of experiments shown in a).  Note that the signals from the RTA bands are normalised 
to the background shown in lanes which include cytosol alone. 
 
a. Silver stains - separate panels show independent repeats of the same experiment. 
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(Figure 4.22 – continued.) 
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4.11.1 The effect of Hsc70 and Hsp90 inhibitors upon the properties of cytosol 
If the effect of cytosol at concentrations of 5-10% was because of the activity of chaperones 
therein, then that activity would be inhibited by the pharmacological agents used in Chapter 
3.  To this end, the effects of DSG and C01 upon 10% cytosol were tested (Figure 4.23c & d).  
Unfortunately, in these assays cytosol alone had no significant effect upon the pellet/soluble 
distribution of RTA.  It is possible that the extract, although frozen in individual aliquots at 
minus 80°C, may have lost some of its potency during protracted storage.  Alternatively, the 
inclusion of DMSO or lactose in the assay may have disrupted pro-solubility interactions 
which would otherwise occur. 
Incidentally, these results seem to vouch against the idea that the increased solubility which 
earlier correlated to concentrations of 5-10% cytosol (Figure 4.22) results from non-specific 
binding of the protein to the incubation vessel (which would displace RTA from doing the 
same).  Such a phenomenon would likely be a consistent feature of the extract, irrespective of 
an activity that could be degraded by a protease upon storage.  Figure 4.23d, however, shows 
that the effect has disappeared upon storage. 
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Figure 4.23 - The effect of C01 and DSG upon the rescue of soluble RTA by cytosol. 
a) 500ng RTA was incubated, as before at 45°C, but with or without 10% cytosol (v/v), and with or without 
3.2μM C01 and DMSO.  b) Shows quantification of the silver stains in a).  Error bars show the standard 
deviation between the three assays.  The intensity coming from RTA bands where cytosol was present was 
normalised to the background from equivalent assays where RTA was absent.  Asterisks help mark RTA bands, 
for ease of reference.  c) & d) Show equivalent assays, but where 50μg.mL
-1
 DSG and the excipient of DSG, 
100μg.mL
-1
 lactose have been substituted for C01 and DMSO respectively. 
 
Experiments using the Hsp90 inhibitor, C01018159 (C01) 
 
a.  Silver stains - separate panels show 
 independent repeats of the same 
 experiment. 
 
b.  Quantification normalised to 
 cytosol background (n=3) 
  
RTA + + - - + + 
Cytosol - + + + + - 
C01 - - - + + + 
DMSO + + + + + + 
 
R
TA
 d
is
tr
ib
u
ti
o
n
 (
%
) 
  
 
 
RTA + + + + 
Cytosol - + + - 
C01 - - + + 
DMSO + + + + 
 
 
 
0
20
40
60
80
100
Pellet
Soluble
* * * * 
* * * * 
* * * 
* 
 
 
 
Page 165 
 
 
 
 
 
 
 
 
(Figure 4.23 – continued.) 
 
Experiments using the Hsc70 inhibitor, deoxyspergualin (DSG) 
 
c.  Silver stains - separate panels show 
 independent repeats of the same 
 experiment. 
 
d.  Quantification normalised to 
 cytosol background (n=3) 
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4.12 Discussion 
This chapter set out to examine a functional interaction of Hsc70 with RTA in vitro.  An 
interaction which resembles such an association has been observed in vitro.  When RTA is 
incubated with Hsc70 and Hsp40 at both 37°C and 45°C, more can be found in a soluble 
condition than in incubations without chaperones.  According to the results published in 
Spooner et al. (2008) and data presented in this chapter, this effect occurs maximally when 
ATP is present, showing that there is an interaction between the two proteins involving the 
ATPase cycle of the chaperone.  In other words, the data in this chapter show that Hsc70 may 
actively bind to RTA.   
Binding of Hsc70 to RTA may contribute to the solubility of the toxin subunit by two 
mechanisms, as determined by the effects of the chaperone at both 37°C and 45°C:  
(1) By masking transiently-exposed hydrophobic regions of RTA that otherwise 
promote loss of solubility by aggregation and association with the incubation 
vessel (accounting for the increased pro-solubility effect of Hsc70 at 45°C). 
(2) By masking the hydrophobic C-terminus of the toxin subunit, which seems to 
promote adherence of the protein to the incubation vessel (accounting for 
unexpected effects at 37°C, at which the protein is not thought to unfold to a 
significant extent – Argent et al., 2000). 
An interaction of Hsc70 with non-native RTA - At 45°C, it was anticipated that Hsc70 and 
RTA would interact.  This is because RTA would be prone to unfold at this temperature 
(Argent et al., 2000), a treatment which would mimic the substantially-unfolded state in 
which RTA is suspected to enter the cytosol (Beaumelle et al., 2002; Argent et al., 1994).  
Fittingly, at this temperature, Hsc70 had the greatest effect in promoting solubility.  Just after 
retrotranslocation a transient Hsc70∙RTA complex similar to that which evidently occurs at 
45°C may exist, helping the toxin subunit thereafter reach an active conformation in the 
cytosol.  Alternatively, Hsc70 might interact with RTA while the toxin subunit is still 
partially-enclosed by the membrane (or the membrane pore it uses).  In this case, Hsc70 
could help promote extraction (akin to roles proposed for homologous BiP and mitochondrial 
Hsc70 during other translocation processes – Tomkiewicz et al., 2007). 
DSG inhibits passive and active effects of Hsc70 - The observation that DSG protects cells 
against ricin intoxication has also been paralleled in this in vitro system.  DSG inhibits Hsc70 
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from keeping RTA soluble, and apparently beyond perturbation of the chaperone‟s ATPase 
cycle.  In vivo, the same effect of this inhibitor may be dominant, interrupting an Hsc70∙RTA 
complex.  This would abandon the polypeptide to an increased likelihood of misfolding, or to 
a longer period embedded in the membrane, potentially permitting other ERAD machinery 
the chance to facilitate its degradation. 
Interestingly, DSG itself was shown to be a small molecule chaperone which promoted the 
solubility of RTA.  Confusingly, in vivo this might cause a partial stabilisation of RTA in the 
ER lumen of target cells.  This could putatively interfere with membrane translocation (and 
so result in a portion of the protection it bestows in vivo against ricin, cf. glycerol).  However, 
DSG‟s inhibitory effect upon Hsc70 results in a ~22% decrease in the pellet/soluble 
distribution of RTA.  On the other hand, its isolated, positive effect upon RTA solubility is a 
mere ~8% (Figure 4.19c).  Thus its greater function, at least in vitro, seems to be inhibition of 
Hsc70 rather than as a pro-solubility factor.  Nevertheless, such composite effects should be 
considered. 
An interaction of native RTA with Hsc70 - At 37°C, a temperature at which RTA is thought 
to be largely “native” (Argent et al., 2000), it was anticipated that Hsc70 would not have an 
effect upon solubility.  However, Hsc70 did have a solubilising effect at this temperature.  As 
an equivalent concentration of an arbitrary protein (BSA) produced a much smaller 
solubilising effect, it seemed that the effects of Hsc70 resulted at least partially from its 
activity as a chaperone.  The eminent quality of the native toxin subunit which could cause 
such an interaction at 37°C seems to be RTA‟s solvent-exposed, hydrophobic C-terminus.   
The hydrophobic C-terminus of native RTA may promote an Hsc70 interaction - That the 
C-terminus might be responsible for chaperone interactions with native RTA during a 37°C 
incubation seems a reasonable connection to make.  In this chapter it was shown that saporin 
– which lacks this domain but is otherwise very similar to RTA (Vago et al., 2005) – does not 
interact with chaperones in the same way as RTA does.  This is interesting as the unique 
hydrophobic C-terminus of RTA is important for its toxicity (Simpson et al., 1995).  In vitro 
it has been postulated to embed into the hydrophobic core of negatively-charged liposomes 
(Day et al., 2002; Mayerhofer et al., 2009).  Therefore, that this portion of the protein might 
lead to a hydrophobic series of interactions in vitro resulting in loss of solubility seems 
congruent.   
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Regardless of which domain of RTA is responsible for the interaction of RTA with Hsc70 at 
37°C, it does seem that even the native toxin subunit is recognised by the chaperone.  
Therefore, this result might indicate refolded RTA would be subjected to continuous 
surveillance by Hsc70 in the cytosol of target cells.  That is unless its native quality is altered 
in some fashion by events surrounding retrotranslocation.   
The effects of the cytosolic extract - Unfortunately, it proved difficult to determine whether 
the inhibitory effects of DSG and the Hsp90 inhibitor, C01, could be recapitulated in a 
cytosolic extract.  While it was shown that low concentrations of cytosol might have a pro-
solubility effect, assays where higher concentrations of cytosol were used proved un-
interpretable.  This was because of a putative proteolytic activity in the extract.   Repeat 
assays were prevented due to the quickly-fading activity of the cytosolic preparation in 
maintaining the solubility of RTA (potentially owing to the same proteolytic activity).  
Repetition with fresh cytosol preparations would also skew the comparability of the data, 
owing to batch-variability in generating the extract. 
Other influences upon the solubility of RTA - When other aspects that could govern protein-
folding were tested, it was evident that charged species affected the unfolding of RTA, 
whereas polar species did not.  Increasing concentration of aqueous CaCl2 and NaCl resulted 
in the greater stability of soluble RTA conformers.  This effect may result from stabilisation 
of the solvent structure, which would constrain the polypeptide from unfolding and so 
promoting aggregation (Hu et al., 2009).  On the other hand, incubation with a charged 
protein, BSA, and liposomes constructed from negatively-charged POPS led to loss of 
solubility.  Much like Day et al. (2002) report: initially electrostatic interactions may lead to 
progressively more hydrophobic ones.   
Consistently, neutral liposomes and high concentrations of the polar crowding agent, Ficoll-
70, did not have a large effect at either 37°C or 45°C.  It seems that electrostatic interactions 
dominate the threshold temperature at which RTA unfolds.  As Ficoll-70 had no effect even 
at 45°C, it seems that when RTA does unfold, another feature (other than crowding) 
dominates loss of solubility.  This could be a combination of the hydrophobic C-terminus of 
the protein and the abundance of a surface to which the protein can be adsorbed (i.e. the 
reaction vessel; or, in other cases, the hydrophobic cores of POPS liposomes and BSA 
molecules).  
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A sharp temperature-dependent threshold for unfolding between 37°C and 45°C was also 
shown.  This threshold coincides with the observations of Argent et al. (2000) who 
pinpointed the threshold more precisely to 42-45°C.  At this threshold secondary structure 
becomes significantly perturbed (although the authors stipulate a batch variation to this 
threshold).  This starkly contrasts to the structurally-related toxin, saporin, which is stable at 
equivalent temperatures and does not undertake an ERAD-like route to achieve toxicity 
(Vago et al., 2005).  This relatively low threshold highlights the conformational malleability 
RTA has attained to exploit ERAD.   
Similarly, RTA seems to be most prone to misfold, losing solubility, near a physiological 
threshold of pH.  Over a range of pH6.4 to 8.0, soluble RTA was found to be least stable 
around pH7.0 to 7.4.  Such as latent instability, which is masked by the stabilising effect of 
RTB until the ER of the target cell is reached (Argent et al., 2000; Spooner et al., 2004), 
might contribute to the co-option of RTA onto an ERAD pathway.   
Incidentally, although recombinant RTA does have a pI that is very close to the physiological 
pH, Di Cola et al. (2001) showed that RTA isolated from Ricinus communis has a relatively 
raised pI.  This results from glycosylation in its wild-type host.  An increased pI would make 
the protein more soluble in the ER.  In the mammalian cytosol, where RTA would likely be 
subjected to de-glycosylation (as it is in yeast – Li et al., 2007), its pI would subsequently be 
reduced to a level akin to recombinant RTA, making it less soluble.  This example, therefore, 
does not conform to a preceding hypothesis: that various inherent qualities of RTA in 
response to physiological conditions might favour stability in the cytosol and instability in the 
ER lumen.   
The effect of negatively-charged liposomes – As predicted from the observations of Day et 
al. (2002) and Mayerhofer et al. (2009), the solubility assay showed that RTA could interact 
with negatively-charged liposomes in vitro.  This interaction caused a loss of solubility which 
was not restored after the liposomes were dissolved with a detergent.  This suggested that 
RTA underwent structural changes after binding which resulted in an irreversible loss of 
solubility.  After initial electrostatic contacts are made between lipid and RTA, hydrophobic 
interactions take over as the toxin subunit embeds itself into the liposome (Day et al., 2002).  
This putatively leads to a state which irreversibly aggregates or else irreversibly adheres to 
the reaction vessel after the detergent treatment disperses the liposome.     
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This same loss of solubility is not observed when RTA is incubated with neutrally-charged 
liposomes.  Furthermore, any effect of POPC upon the solubility of RTA which does occur is 
dominated by the presence of a small molecule chaperone, glycerol, which is not the case for 
negatively-charged lipid.  This reiterates that the charge of the lipid used to construct the 
liposome is essential in inducing the structural rearrangements observed.  This corroborates 
other trends observed in this chapter: i.e. charged species like BSA, pH and electrolyte 
concentration affect solubility, whereas neutral, polar Ficoll-70 – and now POPC – do not. 
4.12.1 Improving upon this assay & potential future uses 
Pre-blocking of the incubation vessel - If these in vitro findings were to be extended, it 
would be advisable to block binding to the incubation vessel beforehand by flushing it with 
low concentrations of a relatively inert protein (Van den Berg et al., 1999).  Alternatively, a 
material which provides a polar rather than a hydrophobic surface could be chosen for the 
incubation vessel.  This would increase the proportion observable in the soluble fraction 
under untreated conditions and would increase the dynamic range of the assay.  This would 
enable material which has truly aggregated to be distinguished from material which has 
adhered to the reaction vessel.  Without such blocking, the assay used in this chapter 
measures both of these phenomena.   
The observation of this tendency of RTA to adhere to hydrophobic surfaces, however, is not 
without meaningful application.  The results presented in this chapter have indicated that the 
C-terminus of RTA is likely to be responsible for this binding and may also interact with 
Hsc70 while the toxin subunit is in its native conformation.  This may well result in an 
ongoing interaction with Hsc70 long after membrane retrotranslocation.  As the C-terminus is 
functionally implicated in the toxicity of RTA (Simpson et al., 1995), judicious experiments 
using unblocked tubes might provide an experimental system useful in its investigation. 
Screening for destabilising ER factors and stabilising cytosolic factors – If a systematic 
way for producing the cytosolic extract could be established which also maintained long-term 
solubilising activity, it would be a useful tool.  The extract could be fractionated and screened 
for proteins with solubilising or pro-aggregation activity.  Fractionation could be repeated 
iteratively (with progressive refinement) until isolated protein species with significant effects 
were identified.  These species could then be identified by mass spectrometry.  By such a 
method, a whole host of other “pro-solubility” or “pro-aggregation” factors could be 
discovered which might be significant interacting partners of RTA in vivo.   
Page 171 
 
It might be expected that the toxin subunit has evolved to exploit the physiological conditions 
of the ER and cytosolic compartments in different ways, tailored to its toxic motives.  
Unfortunately, the complexity of these compartments is difficult to meaningfully disassemble 
using the solubility assay – especially for broadly important factors like calcium ion 
concentration (cf. section 4.5.2.1).  Synergy between one aspect and another in the more 
complex system that undeniably exists in vivo will likely drastically alter otherwise 
simplistically-observed trends.  For instance: the overlaid functionality of the protein matrix 
in response to these chemical factors.  The concentration of calcium in the ER – as a 
particular example – modulates the ERAD of many secretory proteins (Van Anken & 
Braakman, 2005).  So, too, do changes in redox levels and the pH (Sevier & Kaiser, 2008).   
To provide a more exhaustive study of any physiologically relevant chemical factors that 
might affect the conformational stability of RTA, however, would be intriguing.  The most 
obvious candidates for future investigation would be the lipid environment and a comparison 
of the chaperone complements of both the ER and cytosol. 
Screening for antagonism of the negatively-charged liposome interaction – The interaction 
of RTA with liposomes constructed from exclusively POPS could not be countered simply 
with the use of a small molecular chaperone (as predicted from the hypotheses of Sandvig et 
al., 1984).  However, glycerol might be able to compete against liposomes where POPS has 
been diluted with neutral lipid.  Identification of other factors which could counter this 
interaction would be particularly interesting to study.  This is because no such factor has yet 
been proposed to suggest how RTA would be prevented from interacting with the cytosolic 
leaflet of the ER membrane, just as it is proposed to in the ER (Mayerhofer et al., 2009).  
This problem is highlighted by reports that lipid distribution between the two leaflets of the 
ER membrane is highly symmetrical (Pomorski & Menon, 2006).  This precludes the 
enrichment of negatively-charged phospholipids in the ER-leaflet being the mechanism.  It is 
a possibility that chaperones like Hsc70 might be responsible for sustaining the cytosolic 
solubility of RTA and preventing such a regressive membrane interaction.  Intriguingly, 
interactions with the membrane are thought to be caused by the C-terminus of RTA 
(Mayerhofer et al., 2009). That Hsc70 seems to bind this region at 37°C and prevent it from 
associating with a hydrophobic surface in vitro may be an analogous feat.     
Alternatively, the solubility assay could be used to determine if RTA can be removed from a 
liposome-bound state after having already been allowed to interact.  RTA and liposomes 
could be incubated together, and factors added to see if they could subsequently disengage 
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such a complex.  If the supply of Hsc70 had not been limiting, experiments like this would 
have been undertaken to test this possibility.  Other factors that would have been interesting 
to study in this regard include the regulatory 19S proteasomal caps and p97-containing 
complexes, which have a similar role during ERAD (Meusser et al., 2005). 
Identification of potential storage excipients - Incidentally, the methods demonstrated in this 
chapter could also be used as a tool to study potential excipients with which RTA may be 
stored for long periods of time.  Such a study is of special interest to those who wish to 
develop and store vaccines (Peek et al., 2006).  Currently, our laboratory stores RTA in a 
pH6.4, sodium phosphate buffer – often containing KCl or glycerol, which stabilises the 
solubility of RTA.  These conditions could be optimised, using this assay to maximise the 
chronic solubility of RTA.   Peek et al. (2006) used a similar assay, where they studied the 
effect of candidate chemicals on the turbidity of a dilute solution of RTA over time.  
However, they discovered this assay was inappropriate in the case of chemicals which 
themselves contributed to turbidity.  The techniques used herein would not be affected in this 
way and so might prove complementary. 
Alternative assays – Other assays for determining the interaction of two proteins (such as 
Hsc70 with RTA) do exist.  For instance: analytical ultra-centrifugation, gel filtration, 
fluorescence resonance energy transfer (FRET) and surface plasmon resonance.  If the 
experimenter wished to support the data herein, those assays might prove a useful supplement 
to those used herein.  For the interaction of factors such as salt, glycerol and pH, fluorescence 
could even be measured. 
4.12.2 Pursuing the chaperone interaction further 
As Chapter 3 showed, inhibition of Hsc70 protects cells – thus, this chaperone seems 
responsible for providing an interaction which leads to activation of the toxin subunit in the 
cytosol.  Evidence for the potential mechanism by which Hsc70 can aid the toxin has been 
posed by this chapter.  Hsc70 can interact functionally with both thermally-denatured RTA 
and, surprisingly, with non-denatured toxin.  Therefore, Hsc70 may have relevance both 
during the retrotranslocation step and afterward during the toxin subunit‟s lifetime in the 
cytosol.  It may both prevent it from losing catalytic activity by aggregating and prevent it 
from re-engaging with the leaflet of the membrane that envelops the cytosol. 
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Earlier in Chapter 3 it was shown that inhibition of Hsp90 sensitised target cells to ricin in a 
way which responded to the lysine content of the toxin subunit.  Thus, Hsp90 seems to be 
responsible for hindering the toxin in a way which involves lysine-polyubiquitination.  A 
proteasomal route may be the most forthright explanation for such a lysine-dependent effect, 
much as Deeks et al. (2002) theorised.  However, mechanisms for how Hsp90 might 
inactivate RTA or facilitate its polyubiquitination have not yet been investigated.  The next 
chapter continues these studies by examining how such chaperone-mediated routes may be 
executed, with the aid of co-chaperones. 
  
Page 174 
 
CHAPTER 5: 
Co-factors of Hsc70 and Hsp90 modulate their in vitro and in vivo activities 
5.0 How co-chaperones may determine the outcome of RTA’s interaction with Hsp70 or 
Hsp90 
Hsc70 and Hsp90 have vital roles in the mammalian cell (Whitesell & Lindquist, 2005).  To 
optimise their function, they require external modulation, tailoring their activities to the 
diverse array of clients a eukaryotic cell possesses.  This external modulation is provided by 
the co-chaperone environment of the cytosol.  Members of this diverse population of co-
factors provide bespoke „folding pathways‟ for certain subsets of client (Young et al., 2004).  
Some of these co-chaperones change the role of the chaperone·client interaction from a 
nurturing complex to one which actively targets the client for proteolysis (Höhfeld et al., 
2001).  Whilst data presented so far in this thesis indicate that Hsc70 might aid 
retrotranslocated RTA gain an active conformation in the cytosol, it shows that other 
chaperones may hinder toxicity, such as Hsp90 appears to.  An extension of this hypothesis is 
that the native balance of co-chaperones in the cytosol contributes to these different roles. 
If cytosolic chaperones can mediate the inactivation of RTA, this facet of the cytosolic triage 
poses an extremely interesting topic of study.  Hsp90 may be involved in a route by which 
RTA is proteolytically inactivated.  As would be implied from the lysine-dependent effect of 
Hsp90 inhibition upon the cytotoxicity of ricin, the interaction of Hsp90 could convey RTA 
to the proteasome, or bring it into contact with an E3 ubiquitin ligase.  An eminent candidate 
for this E3 ligase would be the chaperone-dependent co-factor, CHIP (Alberti et al., 2004).  
Such a mechanism could account for the two-thirds of cytosolic RTA
WT
 that is apparently 
degraded by proteasomes during intoxication (Deeks et al., 2002; Wesche et al., 1999).     
In addition to an explicitly pro-destruction role such as polyubiquitination, the balance of co-
chaperones in the cytosol could also alter the longevity of a putative RTA·Hsc70 or 
RTA·Hsp90 complex.  In this fashion they could alter the likelihood that chaperone-bound 
RTA successfully finds a native state – by prolonging or shortening residency in the binding 
site of each chaperone.  On one hand, prolonged binding might contribute to the success of 
folding by preventing aggregation.  Conversely, it might also increase the chances of a 
subsequent interaction with a co-factor that promotes degradation.  Thus, a co-chaperone may 
not be destructive in the same explicit way that the E3 ubiquitin ligase, CHIP, is, but may still 
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contribute to an environment which promotes degradation (or inactivation) of chaperone-
bound material.  Table 5.1 notes co-chaperones of Hsc70; Table 5.2 (on the subsequent page) 
reviews co-chaperones of Hsp90.  In brief, these co-factors exert their effects by:  
 Stimulating chaperone nucleotide exchange or ATPase activity, so altering the affinity 
of the chaperone towards its clients. 
 Interacting with clients directly, as anti-aggregation factors. 
 Bringing other cytosolic machinery into close proximity with the client·chaperone 
complex (e.g. the proteasome). 
 Acting as recruitment factors to certain cellular locations.  
 In the case of the Hsp90 co-chaperone, prolyl peptidyl isomerise (PPI), performing 
cis/trans isomerisation of client prolyl residues. 
This thesis maintains that genetically interfering with Hsc70 and Hsp90 is a difficult 
experimental approach because of their vital nature, high concentration and multiple cytosolic 
paralogues (as reviewed in Whitesell & Lindquist, 2005).  The cytosolic concentrations of 
their co-chaperones, however, are relatively minor.  For example, while Hsp90 represents 1-
2% of dry cell mass and is one of the most abundant proteins of the cell (Csermely et al., 
1998), CHIP and HspBP1 each represent only 0.05% of this total (Alberti et al., 2004).  This 
arguably renders experimentally significant changes in their cytosolic concentration more 
attainable.  Thus, the co-chaperones of Hsc70 and Hsp90 provide practical targets to 
experimentally target. 
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Table 5.1 - Co-chaperones of Hsc70. 
Their functions, mode of binding, and some example substrates.   The column labelled “Hsp90” shows whether 
the co-chaperone has a potential interaction with Hsp90 as well.  Ticks indicate a definite interaction. 
Question-marks denote a suspected, or else unclear one.  This list is not exhaustive, but indicative. 
Co-factor 
H
sp
9
0
 
B
in
d
in
g 
D
o
m
ai
n
 
Known functions 
CHIP  TP
R
 
 
 Hsc70/Hsp90-dependent E3 ligase (Murata et al., 2001) 
 Stabilises Hsc70·ATP, enhancing in vivo refolding of luciferase (Kampinga et al., 2003) 
 Conflicting reports suggest CHIP inhibits Hsc70-mediated luciferase refolding in vitro (Ballinger et 
al., 1999) 
Hsp40  
J-
d
o
m
ai
n
 
 
 
 Stimulates the ATPase activity of Hsc70 
 Binds clients and has an independent anti-aggregation activity 
 Binds clients and loads them onto Hsc70 
 
HspBP1  
TP
R
 
 
 Nucleotide exchange factor of Hsc70 (Kabani et al., 2002) 
 Inhibits refolding of luciferase in reticulocyte lysate (McLellan et al., 2003) 
 Inhibits CHIP, stimulating maturation of CFTR∆F508 in vivo (Alberti et al., 2004) 
HIP  
TP
R
 
 
 Stabilises ADP-bound form of Hsc70 (Höhfeld et al., 1995) 
 In vitro, isolated HIP inhibits refolding (Bruce & Churchich, 1997) 
 Promotes steroid hormone receptor maturation in vivo (Prapapanich et al., 1998) 
BAG-1  
B
A
G
 
 
 Nucleotide exchange factor of Hsc70 (Alberti et al., 2003) 
 Inhibits Hsc70-mediated refolding of β-galactosidase in vitro (Takayama et al., 1997) 
 Associates Hsc70·client complexes with the proteasome (Lüders et al., 2000) 
 Promotes Tau protein levels in vivo by aiding folding (Elliott et al., 2007) 
BAG-2  
B
A
G
 
 
 Nucleotide exchange factor of Hsc70 (Takayama & Reed, 2001) 
 Inhibits CHIP, and stimulates maturation of CFTR∆F508 (Arndt et al., 2005) 
 Possesses its own anti-aggregation activity for CFTR∆F508 (Arndt et al., 2005) 
BAG-5  
B
A
G
 
 
 Nucleotide exchange factor of Hsc70 (Takayama & Reed, 2001) 
 Inhibits Hsc70-mediated refolding of luciferase in vivo (Kalia et al., 2004) 
 Inhibits the chaperone-dependent activity of the E3 ligase, Parkin (Kalia et al., 2004) 
HOP  TP
R
 
 
 Binds and stabilises Hsp90·ADP (Johnson et al., 1998) 
 Hsp90·HOP binds Hsc70·client complexes (Hernández et al., 2002) 
 Stimulates Hsc70 nucleotide exchange (Gross & Hessefort, 1996).   
 Promotes in vivo maturation of steroid hormone receptors & various kinases (Murphy et al., 2003)  
 Required for optimal Hsc70/Hsp90-mediated refolding of luciferase in vivo (Johnson et al., 1998).   
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Table 5.2 - Co-chaperones of Hsp90. 
Their functions, mode of binding, and some example substrates.   The column labelled “Hsc70” indicates 
whether the co-chaperone has a potential interaction with Hsc70 as well.  Ticks indicate a definite interaction. 
Question-marks denote a suspected, or else unclear one.  This list is not exhaustive, but indicative. 
Co-factor 
H
sc
7
0
 
B
in
d
in
g 
D
o
m
ai
n
 
Known functions 
HOP  TP
R
 
 
 As previous table. 
Also notable, as reviewed by Prodromou & Pearl (2003): 
 Interacts with Hsp90 early in its ATPase cycle, 
 Inhibits the ATPase activity of Hsp90, 
 Stabilises a conformation of Hsp90 that is open to clients. 
 
p50 / Cdc37  
N
o
 f
am
ily
 
 
As reviewed by Prodromou & Pearl (2003): 
 Interacts with Hsp90 early in its ATPase cycle, 
 Inhibits the ATPase activity of Hsp90, 
 Stabilises a conformation of Hsp90 that is open to clients. 
 
p23  
N
o
 f
am
ily
 
 
As reviewed by Felts & Toft (2003): 
 Stabilises mature client·Hsp90·ATP complexes 
 Promotes maturation of steroid-like hormone receptors, but is not essential 
 Isolated p23 prevents aggregation of citrate synthase in vitro. 
 
Aha1  
N
o
 f
am
ily
 
 
 Activates the ATPase activity of Hsp90  (Prodromou & Pearl, 2003) 
 Stimulates client release (Koulov et al., 2010) 
 Stimulates kinase and hormone receptor maturation in vivo (Harst et al., 2005) 
 Contrastingly, down-regulation stimulates CFTR∆F508 maturation (Wang et al., 2006) 
 
CHIP  TP
R
 
 
 As previous table. 
Cyclo- / 
immuno- 
philins 
? TP
R
 
 
 Bear peptidyl prolyl isomerise activity (Fischer et al., 1984) 
 Cpr6 activates the ATPase cycle of Hsp90 (Prodromou & Pearl, 2006) 
 Cyclophilin 40 may also bind to Hsc70 (Carrello et al., 2004) 
 Cyclophilin 40 binds non-native proteins, preserving their folding competent state (Freeman et 
al., 1996) 
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Of course, Hsc70 and Hsp90 are not always in direct physical contact with these co-
chaperones.  Their respective interactions typically occur at different stages in the 
chaperone‟s client binding cycle, and in different combinations (cf. Figure 1.6b, for instance).  
The nature of their interaction will depend on the substrate protein itself, and perhaps the 
distinct conformational character of a given instance of that client.  The binding of some co-
chaperones are also mutually exclusive (e.g. BAG-2 and BAG-1), and can lead to opposite 
fates for similar substrates (e.g. CFTR, see Arndt et al., 2005).  The decision of Hsc70/Hsp90 
to aid folding or to promote degradation, therefore, is pivotally determined by the relative 
concentration of cytosolic co-chaperones, as well as by the apparent qualities of the client 
itself.   
There are very obvious differences in the conformational qualities defining clients of Hsc70 
and Hsp90.  Hsc70 preferentially associates with extended, unfolded sequences of 
hydrophobic polypeptide (Landry et al., 1992).  On the other hand, Hsp90 is thought to bind 
to the surface of partially-folded proteins, promoting “subtler” changes in conformation 
(Prodromou & Pearl, 2006).  This differentiation is reflected by data presented in this thesis – 
i.e. the distinctly opposite effects of these chaperones upon ricin cytotoxicity.  Their different 
binding specificities are also reflected in the hierarchical order in which they interact with 
substrates like kinases and steroid hormone receptors.  As the conformational adjustments a 
folding client makes become more refined approaching the native state from the unfolded 
one, the client‟s tenure shifts from binding Hsc70 to binding Hsp90 (Murphy et al., 2003).  
This sequential interaction also seems to exist for the cytosolic triage of RTA (as Hsc70 
inhibitor effects dominate Hsp90 inhibitor effects – cf. Chapter 3, Figure 3.12).   
As these kinds of pathway are augmented by a client-dependent co-ordinate of co-
chaperones, it might be expected that a specific subset of these factors is responsible for the 
activation of retrotranslocated RTA in the cytosol.  Owing to the differing effects of 
Hsc70/Hsp90 inhibition on ricin intoxication, it is anticipated that a cohort of pro-folding co-
chaperones might dominate the interaction of Hsc70 with RTA.  On the other hand, a pro-
destruction cohort of co-chaperones might dominate the interaction of Hsp90 with RTA.  
This chapter aims to investigate these balances. 
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5.1 Experimental approach 
First, this chapter investigates whether CHIP can polyubiquitinate RTA in a chaperone-
dependent fashion.  The method uses an in vitro reconstitution of purified chaperones and 
components of the ubiquitination cascade to test conditions under which a client is 
ubiquitinated (as described by Murata et al., 2001).  This would show whether it was feasible 
that RTA could become ubiquitinated during a chaperone audit, which would aid 
interpretation of the observations made in vivo so far.  The results of this experiment would 
also provide additional evidence for whether RTA is bound by these chaperones directly, 
given this is requisite for CHIP-mediated ubiquitination (Murata et al., 2001). 
Second, this chapter used a synthesis of approaches already described in this thesis to 
investigate the role of other co-chaperones in the intoxication of a cell by RTA.  That is, by 
studying: 
(1) The effect of the co-chaperone BAG-5 on the solubility of RTA. 
(2) The effect of over-expressing select co-chaperones on the cytotoxicity of ricin. 
5.2 An introduction to CHIP, a co-chaperone of Hsc70 and Hsp90 
The inactivation of cytosolic RTA by Hsp90 is lysine-dependent (cf. Chapter 3, Figure 3.18).  
It was suggested CHIP could polyubiquitinate Hsp90-bound RTA, which would target it to 
the 26S proteasome.  Inhibition of Hsp90 with radicicol could putatively disrupt this 
interaction, preventing the exposure of RTA to this E3 ligase.  This seemed a reasonable 
hypothesis, given radicicol-induced dissociation of client·Hsp90 complexes is reported for 
many substrates (Sharma et al., 1998; Schneider et al., 1996; Whitesell et al., 1994; Whitesell 
& Cook, 1996).   
As Table 5.1 and Table 5.2 detail, CHIP is a co-factor of both Hsc70 and Hsp90.  It 
associates with these chaperones via its three TPR domains, which bind the C-terminal 
tetrapeptide, „EEVD‟, of both chaperones (Ballinger et al., 1999; Kundrat & Regan, 2010).  
This permits CHIP to ubiquitinate bound clients and inhibits the Hsp40-stimulated ATPase 
activity of Hsc70, antagonising Hsc70-mediated refolding of clients in vitro (Ballinger et al., 
1999).  Curiously, this interaction appears to be a beneficial one for the Hsc70-mediated 
refolding of some clients in vivo.  For instance, cells over-expressing CHIP are better able to 
restore the activity of luciferase after heat denaturation (Kampinga et al., 2003).  However, it 
is quite possible that the situation is more complex.  For example, the degradation promoted 
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by CHIP might clear the chaperone machinery of terminally-misfolded substrates, permitting 
Hsc70 to handle denatured luciferase in a more beneficial way.   Interestingly, CHIP can also 
polyubiquitinate Hsc70/Hsp90, leading to the proteasomal degradation of the targeted 
chaperone (Qian et al., 2006) and of its bound client.  Thus, direct ubiquitination of a client is 
not necessarily required to promote its degradation (Urushitani et al., 2004; Jiang et al., 
2001).  For a client such as RTA, which has few lysines, this is a potentially significant point 
of information.   
Importantly, the quality of the chain which an E3 ligase makes is vital to the network of 
interactions the polyubiquitin attachment fosters in the cell (Kim et al., 2007).  The qualities 
in which an ubiquitin chain may vary include:  
(1) The number of ubiquitin monomers attached. 
(2) Whether or not these are in a contiguous chain. 
(3) Which lysine (of the possible seven in ubiquitin) is used to propagate the chain. 
Table 5.3 provides a summary of the various polyubiquitin linkages that exist and their 
ascribed functions in cells.   
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Table 5.3 - Ubiquitination and its various cellular roles. 
The linkage types are listed in approximate order of abundance (as described in Li & Ye, 2009). The reported 
effects of mono-ubiquitination are described in the final row, but its position does not reflect its relative 
abundance. 
Type Processes involving this linkage type References 
Lys48  Promotion of proteasomal degradation 
 Transcriptional regulation (deactivation of Met4 in S. cerevisiae) 
 Stimulation of p97 “segregase” activity 
 
Kim et al., 2007 
Li & Ye, 2008 
(M
o
st
 a
b
u
n
d
a
n
t.
) 
Lys63  Promotion of proteasomal degradation 
 Promotion of autophagy 
 Promotion of endocytosis 
 DNA repair 
 Transcriptional regulation & signal transduction 
 
Kim et al., 2007 
Li & Ye, 2009 
Hochstrasser, 2006 
Lys11  Promotion of proteasomal degradation 
 
Kim et al., 2007 
Lys33  Inhibition of AMPK-related kinase activity 
 
Li & Ye, 2009 
Lys27  Remodelling of ubiquitination complexes 
 
Hatakeyama et al., 2001 
Lys6  Stabilisation of the BRCA1 complex (an E3 ligase) 
 Remodelling ubiquitination complexes  
 
Li & Ye, 2009 
Hatakeyama et al., 2001 
Lys29  Promotion of lysosomal degradation (of Notch signalling 
modulator, DTX) 
 Inhibition of AMPK-related kinase activity 
 
Li & Ye, 2009 
(S
ca
rc
es
t.
) 
Mono  Promotion of receptor internalisation 
 Vesicle sorting 
 DNA repair 
 Gene silencing 
Sun & Chen, 2004 
 
D
im
in
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h
in
g 
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b
u
n
d
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. 
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It has been shown that the ubiquitin linkages produced by CHIP in a minimal reconstitution 
in vitro are not exclusively those which lead to proteasomal recognition.  Kim et al. (2007) 
observed that CHIP produces highly-branching polyubiquitin chains wherein each of the 
seven possible isopeptide linkages is present.
17
  Substrates linked with these highly-branching 
chains are resistant to degradation by purified proteasomes (Kim et al., 2007).  Thus, to assay 
whether a substrate of interest (such as RTA, in this case) is targeted to the proteasome by 
this system, the quality of the polyubiquitination observed is also an important consideration. 
At odds with these in vitro observations, the CHIP-dependent degradation of clients in vivo 
has been convincingly linked to multiple disease-states.  In amyotrophic lateral sclerosis, 
ubiquitination of Hsc70 contributes to the degradation of SOD1 in motor neurons.  This 
predisposes neurons to damage by oxidative stress (Urushitani et al., 2004).  Another 
example is cystic fibrosis, where CHIP is responsible for the premature degradation of 
aberrant, ER-localised CFTR
∆F508
 (Albert et al., 2004; Dickey et al., 2007).  CHIP has also 
been shown to contribute to the polyubiquitination of densely-tangled microtubule-associated 
Tau protein aggregates in moribund neurons.  This ubiquitination is thought to be involved in 
the aetiology of Alzheimer‟s disease, and occurs via both Hsc70- (Shimura et al., 2004) and 
Hsp90-dependent routes (Dickey et al., 2007).  Reports suggest that up-regulation of CHIP in 
vivo attenuates the formation of these Tau protein tangles, alleviating neurotoxicity by 
increasing their degradation (Sahara et al., 2005; Shimura et al., 2004). 
This schism between the in vitro quality of CHIP ubiquitination and the in vivo role of CHIP 
in client degradation highlights how its E3 ligase activity will be subjected to complex layers 
of regulation in the cytosol.  These layers of regulation have not been fully elucidated.  
However, Kim et al. (2009) recently showed that a soluble ubiquitin-binding protein of the 
yeast 26S proteasome complex, s5a/Rpn10, can temper the linkages made by CHIP in vitro.  
Regardless of the quality of the ubiquitination CHIP might bestow, if it could be shown to 
ubiquitinate RTA in vitro, it would nevertheless elaborate upon the diversity of fates a 
chaperone triage could impose upon RTA.  Indeed, showing any ubiquitination at all would 
be an important observation as there were significant doubts that ubiquitination of RTA 
would be possible by any method in vivo or in vitro.   
                                                 
17
 The linkage types are predominantly Lys
11
, Lys
48
 and Lys
63
.  All of these linkages, at least in homogeneous 
chain-types, have been implicated in the increased proteasomal degradation of substrates bearing them 
(reviewed in Kim et al., 2007). 
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The reasons for these doubts were: first, RTA
WT
 has only two lysines upon which to anchor a 
polyubiquitin chain, which is a small number for a polypeptide of its length (Deeks et al., 
2002).  Furthermore, Chapter 3 reported that the sensitising effect of radicicol did not vary 
greatly between holotoxins containing RTA
WT
 and RTA
0K
, whereas it was disproportionately 
increased for RTA
6K
.  This indicated that the two endogenous lysines of RTA were not pliant 
candidates for a putative Hsp90-dependent inactivation, if they were at all.  Finally, as a 
polypeptide which has evolved to possess relatively few lysines, it might be that RTA has 
experienced selective pressure that has promoted the acquisition of other adaptations to evade 
the proteasome.  Precedents for such evasion exist, for example the transcription factor Met4, 
which possesses a novel ubiquitin-binding domain responsible for cis-regulating chain length 
(Flick et al., 2006).   Another example is the co-chaperone BAG-2, which escapes CHIP-
mediated ubiquitination altogether by binding to Hsc70 in an orientation that prohibits it 
being target (Arndt et al., 2005).  It may be that RTA has a novel activity in this regard.  
5.2.1 Ubiquitination of chaperone-bound clients by CHIP 
Initially, the Hsc70-dependent activity of CHIP was studied rather than the Hsp90-dependent 
activity.  Importantly, our expectations of Hsc70 differ from Hsp90, owing to the fact that 
Hsc70 apparently aids activation of cytosolic RTA in vivo, whereas Hsp90 hinders it.  
Because of this observation, it might be predicted that Hsc70 promotes less CHIP-mediated 
ubiquitination of RTA than Hsp90 does, or even none.  However, as the co-chaperone make-
up of the cytosol is complex and many co-factors are mutually antagonistic, the functionality 
of Hsc70 in a reduced system was unknown.  Factors which would suppress (or else remove) 
this ubiquitination in vivo would presumably be absent.  If Hsc70/CHIP could ubiquitinate 
RTA in this reduced system, it would therefore pose more interesting questions about the 
complexities of the co-chaperone environment in vivo. 
Hsc70 and Hsp40 were purified as has previously been described.  Ubiquitin was purchased 
commercially (Sigma-Aldrich).  CHIP, E1 and E2 (UbcH5b) were kind gifts of Jörg Höhfeld 
(University of Bonn).  So, too, were two example substrates: human microtubule-associated 
Tau protein and firefly luciferase.  The latter two proteins were used to determine that the 
purified components of the ubiquitination cascade and the chaperones were functioning as 
expected after their purification.   
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5.2.1.1 Ubiquitination of a native client 
One client of Hsc70/CHIP which does not have to be unfolded (via thermal denaturation or 
chaotropes) to become ubiquitinated is Tau protein (Petrucelli et al., 2005).  Tau proteins are 
a family of polypeptides which bind to and stabilise microtubules.  The folded, monomeric 
Tau polypeptide displays hydrophobic side chains to the solvent which would otherwise be 
hidden by binding to tubulin.  These exposed hydrophobic side-chains interact with Hsc70 
(Sarkar et al., 2008).  This permits ubiquitination if CHIP is also present (Petrucelli et al., 
2004).  Indeed, these qualities of Tau make it analogous to a monomeric, cytosolic RTA, 
which also has an exposed hydrophobic patch that is masked for most of the protein‟s 
lifetime (by RTB). 
Tau protein was incubated with Hsp40, Hsc70, ATP and components of the ubiquitin cascade 
for two hours at 30°C (Figure 5.1).  In the immunostain for Hsc70, a ladder of oligo-
ubiquitinated Hsc70 is observed only in the complete incubation, showing the requirement 
for each of the components added (E1, E2, CHIP and Hsp40/Hsc70).  In this lane no 
ubiquitin-free Hsc70 is detectable at 70kDa, showing that all observable Hsc70 has been 
subjected to the modification.  Similarly, ubiquitination of the client, Tau, is only observed in 
the final lane, where all components of the cascade and chaperone system are added.  In this 
lane the intensity of the un-ubiquitinated Tau band also decreases, showing the ladder of 
slower-migrating material is derived from it.
18
  Approximately 6 distinctly-ubiquitinated 
species can be observed.  According to Thrower et al. (2000), 4 consecutive lys
48
-linked 
ubiquitin monomers is the minimum chain length required for proteasomal degradation.  
Thus, at least the number of ubiquitin attachments observed here is sufficient for “canonical” 
proteasomal degradation.   
This assay demonstrates that the purified components can efficiently label a substrate with 
polyubiquitin, under conditions like those described by Murata et al. (2001).  Thus, these 
components remained functional after their purification.  Furthermore, a protein with a 
solvent-exposed hydrophobic patch could be bound by Hsc70.  This binding evidently 
enables convincing ubiquitination by CHIP without a prior denaturation step.  
 
                                                 
18
 Notably, the intensity of the un-ubiquitinated Tau band also drops in lanes without Hsc70/Hsp40.  This may 
result from a loss of solubility where these chaperones are absent. 
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Figure 5.1 – Hsc70, Hsp40 and CHIP can target native clients for ubiquitination. 
3μM Hsc70, 3μM Hsp40, 3μM CHIP, 0.1μM E1 and 0.4μM E2 (UbcH5b) were incubated in the indicated 
combinations with 0.3μM of Tau protein, 10mM DTT, 5mM ATP, 5mM MgCl2, and 2 mg.mL
-1
 ubiquitin in 
20mM MOPS / 100mM KCl buffer, pH7.2.  They were then incubated for 2 hours at 30°C before the addition 
of SDS-containing loading buffer ahead of SDS-PAGE.  Samples were split into two equal volumes, 
electrophoresed on separate gels, blotted onto nitrocellulose and finally immunostained for Hsc70 and Tau 
protein respectively.  Grey arrowhead indicates un-ubiquitinated Tau protein; Hsc70 is indicated by the black 
arrowhead. 
 
 
 E1 - + + + + 
 E2 + - + + + 
 CHIP + + - + + 
 Hsc70/Hsp40 + + + - + 
 
 
  
Page 186 
 
5.2.1.2 Ubiquitination of a thermally-denatured client 
The ability of CHIP to polyubiquitinate thermally-denatured clients of Hsc70 can also be 
examined.  A client polypeptide in a conformationally-perturbed state is expected to resemble 
the state in which RTA is thought to emerge from the ER membrane.  That is, it will display 
extended stretches of hydrophobic polypeptide to the cytosol, and so to the binding site of 
Hsc70 as well.  In this case, firefly luciferase was used as the client (Figure 5.2).  Luciferase 
was heated with or without both Hsc70 and Hsp40 (for 15 minutes at 45ºC).  The components 
of the ubiquitination cascade were then added (in combinations as indicated) for a further 2 
hours at 30°C.   Under these conditions, there is a pronounced ubiquitin ladder for both 
luciferase and Hsc70 in reactions where all components of the cascade were provided.  
Curiously, polyubiquitination upon Hsc70 is not as extensive as it is for the substrate, 
implying the client is preferentially targeted in this instance.  Hsc70 might also auto-regulate 
its ubiquitination. 
The polyubiquitination of luciferase clusters predominantly at molecular weights between 
250 and 148kDa.  Loss of the un-ubiquitinated luciferase band in the final lane, where the 
reaction is complete, corroborates that this material is derived from it.  The contiguous ladder 
bridging the two regions of the stain is also consistent with this interpretation.  Under similar 
conditions, Kim et al. (2007) show that only one lysine of luciferase is targeted by CHIP, and 
that the polyubiquitin chain formed upon it is highly branching.
19
  Therefore the two lysines 
of RTA may also be all that is needed for an extensive chain.  Luciferase can also become 
ubiquitinated by CHIP in the absence of Hsc70/Hsp40 (cf. fourth lane, Figure 5.2).  This 
happens to a small degree for particularly susceptible substrates, as CHIP itself has a slight 
affinity for misfolded clients (McClellan et al., 2005). 
Darkly-stained species can be seen at high molecular weights on the immunostain for 
luciferase (Figure 5.2), even when the ubiquitination cascade is incomplete.  These are 
therefore unlikely to be polyubiquitinated species, especially given their uneven distribution 
(Murata et al., 2001).  They may be multimers of luciferase.  Some of these bands (between 
148kDa and 98kDa), can be seen more faintly in preceding lanes where Hsc70/Hsp40 are 
present.  It they are multimers, it seems that Hsc70/Hsp40 may prevent their formation.  
                                                 
19
 Resulting in a loss of electrophoretic mobility under SDS-PAGE that responds disproportionately to 
molecular weight; thus, the precise number of attached ubiquitin residues cannot be estimated.   
Page 187 
 
 
 
 
Figure 5.2 – Hsc70, Hsp40 and CHIP targets denatured clients for ubiquitination. 
0.3μM of luciferase was incubated with 3μM Hsc70 and 3μM Hsp40 in 20mM MOPS / 100mM KCl buffer, 
pH7.2 for 15 minutes at 45 °C.  After this incubation, 3μM CHIP, 0.1μM E1, 0.4μM E2 (UbcH5b) and BAG-5 
were added in the indicated combinations along with 10mM DTT, 5mM ATP, 5mM MgCl2, and 2 mg.mL
-1
 
ubiquitin. A further 2 hour incubation at 30°C was then conducted. Samples were then analysed, as before, by 
immunostaining (for luciferase and BAG-5). 
 
         
 E1 - + + + + 
 E2 + - + + + 
 CHIP + + - + + 
 Hsc70/Hsp40 + + + - + 
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The two substrates examined at this point are ubiquitinated in strikingly different ways.  The 
denatured protein, luciferase, attracts far more ubiquitination than the native one, Tau.  This 
supports the observations of Murata et al. (2001), who showed that thermally-denatured 
luciferase is ubiquitinated more efficiently than native luciferase.  This is elicited by the 
higher affinity of Hsc70 to the solvent-exposed hydrophobic stretches of an unfolded 
substrate.  Indeed, the selectivity of CHIP is thought to be governed by the binding of Hsc70.  
Thus, denatured clients are selected for ubiquitination, stochastically, by the recurrent binding 
of Hsc70 (McDonough & Patterson, 2003; Jiang et al., 2001).  However, luciferase and tau 
protein are not homologous and they were not assayed in parallel, so such interpretations 
should be made cautiously and are only made here in light of prior literature accounts. 
By analogy, RTA is likely to be more vulnerable to ubiquitination when unfolded, such as 
during or directly after membrane transit.  Expeditious refolding in the cytosol thereafter 
would help reduce the risk of degradation, so increasing toxicity.  However, the C-terminus 
of the toxin subunit may promote interaction with Hsc70 even in the toxin subunit‟s native 
state (cf. Chapter 4 and Tau protein).  Therefore, the risk of ubiquitination might never be 
eliminated entirely.   
5.3 Can CHIP ubiquitinate Hsc70-bound RTA? 
To clarify whether the above trends were consistent for RTA, the prior assays were repeated 
using the toxin subunit.  Initially, RTA was incubated at 37°C for 2 hours with the 
Hsc70/Hsp40 chaperone complex and components of the ubiquitination cascade, in 
combinations as indicated (Figure 5.3a).  The higher temperature (37°C rather than 30°C) 
was adopted to reflect the temperature at which intoxication of a mammalian cell would 
occur.  This is especially important given that RTA has a threshold for unfolding near this 
temperature (cf. Chapter 4, Figure 4.2).  In a parallel assay (Figure 5.3b), RTA was first 
denatured at 45°C for 15 minutes in the presence or absence of Hsc70, ATP and Hsp40.  
Components of the ubiquitination cascade were added afterward (in combinations as 
indicated) before subsequent incubation at 37°C for 2 hours.   
In both assays, ubiquitination of Hsc70 was observed, which confirms that the ubiquitination 
cascade is functional at this elevated temperature, in vitro.  Notably, in Figure 5.3b, a 
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ubiquitin-free species of Hsc70 cannot be observed.
20
  The loss of this band vouches for the 
extensive ubiquitination of Hsc70 in this particular assay.  Contrastingly, no ubiquitin ladder 
can be observed on immunostains for RTA – irrespective of whether a denaturation step was 
imposed.  Furthermore, the unmodified RTA band does not alter in intensity visibly, implying 
little or none had been converted into higher molecular-weight species.
21
  Under careful 
examination, the ladder of ubiquitination upon Hsc70 also appears remarkably shortened 
compared to previous assays. 
We expect that Hsc70 interacts with RTA at both 45°C and 37°C.  At 37°C because of its 
hydrophobic patch.  It would also be expected to interact strongly at 45°C because of 
denaturation.  Thus, it seems that RTA is not efficiently ubiquitinated by CHIP despite Hsc70 
being able to bind it.  This would be congruent with the protective effect of the Hsc70 
inhibitor, DSG.  According to that observation, the normal function of Hsc70 is to aid the 
toxicity of RTA in vivo.  Therefore, Hsc70 would not be expected to mediate efficient lysine-
ubiquitination of RTA, which would presumably expedite degradation. 
 
 
 
  
                                                 
20
 Please notice that the fastest-migrating Hsc70 band in the final lane is slightly raised compared to those in 
preceding lanes. 
21
 Importantly, the RTA antibody was polyclonal in nature.  This meaning it is relatively unlikely that a crucial 
immuno-reactive epitope was masked by the ubiquitination process, which might otherwise obscure the staining 
of a ubiquitin ladder. 
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Figure 5.3 – RTA as a substrate of the Hsc70 / CHIP complex 
3μM Hsc70, 0.3μM Hsp40, 3μM CHIP, 0.1μM E1 and 0.4μM E2 (Ubc5hb) were incubated in the indicated 
combinations with 0.3μM RTA, 10mM DTT, 5mM ATP, 5mM MgCl2, and 2 mg.mL
-1
 ubiquitin in 20mM MOPS / 
100mM KCl buffer, pH7.2.  They were then incubated for 2 hours before the addition of SDS-containing loading 
buffer ahead of SDS-PAGE.  Samples were split into two equal volumes, electrophoresed on separate gels, 
blotted onto nitrocellulose and finally immunostained for Hsc70 and RTA.  a) Shows immunostains from 
experiments conducted at 37°C.  b) Shows immunostains from an assay where RTA was first heated to 45°C for 
15 minutes with 3μM Hsc70, 5mM ATP and 3μM of Hsp40.  After this incubation, the remaining components 
were added (as before) and incubated for 2 hours at the normal temperature of 37°C. 
 
a. RTAWT b. RTAWT denatured at 45°C 
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5.3.1 Does altered lysine content alter the candidacy of RTA as substrate of CHIP? 
To clarify whether the lack of ubiquitination resulted from RTA‟s dearth of lysines (Deeks et 
al., 2002), or some other feature of the polypeptide, the lysine variants used in Chapter 3 
were re-enlisted: RTA
0K
 and RTA
6K
.  These were incubated, parallel with RTA
WT
, at 45°C 
with Hsc70/Hsp40 for 15 minutes.  The components of the ubiquitination cascade were then 
added and the incubation extended for another 2 hours at 37°C.  The results from this assay 
can be seen below (Figure 5.4). 
Where all the components of the cascade were included, Hsc70 was observably 
polyubiquitinated and the intensity of the unmodified band was correspondingly reduced.  
This was true in the context of each RTA variant.  In contrast, in no case was any RTA 
variant detectably ubiquitinated.  It was expected that at least RTA
6K
 would be ubiquitinated 
because of its increased lysine content.  From these results, it would seem that RTA escapes 
ubiquitination whilst bound to Hsc70 by a method that is independent of lysine content.
22
 
If such a method for evading ubiquitination does exist, it would be unexpected that this 
quality persists even when the secondary structure of RTA is disrupted by a 45°C thermal 
treatment.  It is possible that Hsc70 has a higher affinity for a portion of the polypeptide 
which orientates the lysines of RTA away from CHIP.  Figure 5.5a shows the relative 
positioning of the two native lysine residues with respect to one another in the primary 
polypeptide sequence.  They occupy opposite ends of the polypeptide.  This distance is 
mirrored in the fully-folded 3D structure, where they occupy diametrically opposed positions 
(Figure 5.5b).  Therefore, both are unlikely to be masked from CHIP by the binding of a 
single Hsc70.   
Again, it is noticeable that the range of the polyubiquitinated Hsc70 ladder is reduced 
compared to what is the case in the context of the test substrates in the prior sections.  If this 
ubiquitination is used as a measure of reaction efficiency (Höhfeld J., personal 
communication), it seems that the reaction is not functioning as well in these assays. This 
may contribute to why no ubiquitinated RTA is observed. 
 
                                                 
22
 This is certainly in contrast to what is expected of the toxin subunit‟s interaction with Hsp90, given the lysine-
dependent sensitising effect Hsp90 inhibition has (cf. Chapter 3, Figure 3.18). 
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Figure 5.4 – The effect of lysine content upon ubiquitination of RTA by the Hsc70 / CHIP 
complex 
RTA variants were heated to 45°C for 15 minutes before addition of the rest of the ubiquitination apparatus (to 
the same concentrations as used before).  From some reactions E1 was omitted and from others, Hsc70 and 
Hsp40 were omitted.  Three different RTA variants were compared: RTA
0K
, RTA
WT
 and RTA
6K
.  Samples were 
then incubated for 2 hours at 37°C.  Afterward, each was split into two equal volumes, electrophoresed on 
separate gels, blotted onto nitrocellulose and finally immunostained for Hsc70 and RTA. 
 
 
 
 E1 - - + - - + - - + 
 E2, E3, Hsp40/Hsc70 - + + - + + - + + 
 RTA0K + + + - - - - - - 
 RTAWT - - - + + + - - - 
 RTA6K - - - - - - + + + 
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Figure 5.5 - Sequence of Ricin A Chain highlighting the relative positions of the native 
lysines 
The accession number of the sequence used (Pubmed) is AAA72820.  a) The primary sequence of RTA.  Lysine 
residues are highlighted in yellow.  The ordinal position of the first amino acid in each line of the printed 
sequence (relative to its situation in the entire polypeptide) is indicated by the number on the left-hand side. 
b) A ribbon diagram of RTA showing the opposite distribution of the native lysines in three dimensional 
structure of the polypeptide.  Generated using Chimera (University of California).  The structure is rainbow-
coloured so that the C-terminus is red and the N-terminus is blue, with relative position along the polypeptide 
indicated by changes in colour.  Lysine residues are ringed in red; their position in the polypeptide backbone is 
indicated by black shading; a written label indicates their ordinal position within the polypeptide. 
 
a. Primary sequence 
 
 
 
b. 3D structure 
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Contrastingly, when colleagues performed similar experiments to those above, slight 
ubiquitination of RTA
WT
 was demonstrated (Spooner et al., 2008).  However, this was only 
noticeable after very prolonged film exposures.  For ease of reference, this figure has been 
reprinted below (Figure 5.6a).  Nevertheless, the ratio of ubiquitinated to un-ubiquitinated 
RTA recorded by this immunostain remains very slight (note the concentration of RTA in 
these experiments was also relatively increased: 0.8μM rather than 0.3μM).  Indeed, the 
intensity of the unmodified RTA band is approximately equivalent in all lanes.  This contrasts 
to the positive controls enlisted earlier: Hsc70, microtubule associated Tau and firefly 
luciferase (cf. Figure 5.1 & Figure 5.2).   
Encouragingly, Spooner et al. (2008) also showed, using similarly extended film exposures, 
that the degree to which RTA
6K
 was ubiquitinated under these conditions was increased 
relative to RTA
WT
 (Figure 5.6b).  However, the relative proportion of the ubiquitinated 
population still seemed small.  The range of the polyubiquitin ladder observed upon RTA
6K
 is 
also not as extensive as for the test substrates, with chains of only up to three ubiquitins being 
visible.  This value is thought to be insufficient for efficient proteasomal degradation, even if 
they are linked in a way which is canonically associated with efficient proteasomal 
degradation (Thrower et al., 2000).  Taken together, these data are not so contrasting to the 
other data presented in this thesis.  They, too, imply that the toxin subunit is not an ideal 
candidate for ubiquitination by the Hsc70/CHIP complex.  Furthermore, the additional 
lysines of RTA
6K
 seem insufficient to render RTA as pliant a substrate of Hsc70/CHIP as 
denatured luciferase or native Tau protein evidently are (cf. Figures 5.6c). 
The low level of ubiquitination observed in all assays may invite another explanation: 
perhaps RTA has an unpredicted, explicitly inhibitory effect upon the ubiquitin reaction in 
excess of its few lysines?  A repeat of these assays with parallel controls where RTA is 
absent would have been useful in clarifying this point.  However, resources were very 
limiting. 
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Figure 5.6 – Hsc70/CHIP-mediated ubiquitination of RTAWT and RTA6K 
 
N.B. Assays a) and b) in this figure were performed by Robert Spooner (University of Warwick) 
 
a) 0.8μM RTA was incubated, “complete”, with Hsp40, Hsc70, E1, E2 and CHIP  for 15 minutes at 45°C (at 
concentrations as used before at this temperature in this thesis).  Parallel incubations lacked E1, E2, CHIP or 
Hsp40/Hsc70 (as indicated).  The ubiquitination cascade was then activated with the addition of ATP and the 
reducing agent required to initiate the cascade, DTT.  Reactions were then incubated for a further 2 hours at 
37°C. b) Shows similar experiments (with a simplified set of controls), comparing the ubiquitination of RTA
6K
 
(“6K”) to RTA
WT 
(“2K”) in parallel experiments.  In both a) & b), reactions were split into equal volumes, 
analysed by SDS-PAGE and stained separately for the proteins indicated.  c) Equivalent “complete” lanes from 
Figure 5.1 and 5.2.  
 
a. RTAWT b. RTA6K and RTAWT c. Luciferase & Tau protein 
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5.3.2 Pre-treatment with POPS liposomes promotes the ubiquitination of RTA 
During the retrotranslocation process from the ER into the cytosol, RTA is thought to be 
denatured by the phospholipid membrane (Mayerhofer et al., 2009).  It is feasible that 
specific features of this denaturation persist until it egresses into the cytosol and refolds.  The 
ways in which thermal denaturation and the way in which RTA might unfold in vivo are 
certainly qualitatively different, leading to possible differences in the network of interactions 
subsequently made in the cell.  One of these differences could be the nature of RTA‟s 
interaction with Hsc70 and CHIP.  Liposome-bound RTA might simply be oriented in a more 
(or less) vulnerable way, altering the efficacy of CHIP-mediated ubiquitination. 
To test whether treatment of RTA with liposomes had an effect upon the propensity of the 
toxin subunit to become ubiquitinated, RTA was incubated with both Hsc70/Hsp40 and with 
(or without) liposomes made of POPS for 15 minutes at 37°C.  Subsequent to this, 
components of the ubiquitination cascade were added and the incubation was extended for 
another 2 hours at 37°C. 
Figure 5.7a shows that Hsc70 is ubiquitinated to an equivalent extent in the presence and 
absence of POPS liposomes.  This indicates that the liposomes have no inhibitory effect upon 
the efficiency of the ubiquitination cascade itself.  Figure 5.7b, on the other hand, shows that 
RTA is more heavily ubiquitinated when it has first been incubated with liposomes.  In the 
first exposure, an obvious reduction in the non-ubiquitinated RTA band can be seen in the 
final lane (where the ubiquitination cascade is complete and liposome-treatment has been 
provided).  Ubiquitination of RTA in the parallel assay, free of liposomes, also occurs (note a 
faint band directly above the non-ubiquitinated RTA band in exposures 1 & 2; if this is too 
faint to observe in print, please see the digital copy of this thesis).  This also informs us that 
RTA can be ubiquitinated without prior denaturation at the physiological temperature of 
37°C.  However, it is still not to an extent which would be canonically associated with 
proteasomal recognition (Thrower et al., 2001). 
These observations may seem counter-intuitive: how would becoming embedded in the 
membrane increase the chances of RTA becoming ubiquitinated?  The presence of the 
liposome membrane might hinder the interaction of RTA with Hsc70, sterically blocking 
sites the chaperone could bind to, so reducing the exposure of the polypeptide to CHIP.  In 
answer: first, the secondary structure of RTA will be disrupted by the interaction (Day et al., 
2002).  This would putative increase the number of exposed hydrophobic regions to which 
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Hsc70 could bind.  Second, circular dichroism and fluorescence data suggests that the 
interaction of RTA with liposomes occurs in a predictable, reproducible way, with certain 
residues of the C-terminal tail directing the hydrophobic interactions which occur 
(Mayerhofer et al., 2009; unpublished data of Cook J.C., University of Warwick).  It may be 
that this directs Hsc70 to interact with RTA in a limited, reproducible array of orientations 
which happen to predispose the interaction to an outcome resulting in ubiquitination.  
Conversely, native RTA would have just one, dominant site for Hsc70-binding: the 
hydrophobic C-terminal tail (cf. Chapter 4), which might restrict ubiquitination.  Incubation 
with liposomes may hide this domain from Hsc70, by embedding it in the hydrophobic core 
(Mayerhofer et al., 2009).  This might permit Hsc70 to bind the toxin subunit in an 
ubiquitination-permissive orientation. 
It is interesting to speculate that a low level of ubiquitination could help mediate extraction of 
the toxin subunit from the ER membrane rather than degradation, but evidence would 
indicate otherwise given that lysine-dependent ubiquitination is not required for this step in 
plant and yeast cells (Di Cola et al., 2005; Li et al., 2010).  Moreover, RTA
0K 
is marginally 
more toxic than RTA
WT
 in mammals (cf. Figure 3.17 and Deeks et al., 2002).   
To extend this finding, it would be interesting to determine whether neutrally-charged 
liposomes have the same effect upon the ubiquitination process.  This would help to clarify 
whether the effects observed here result from the known effects of negatively-charged POPS 
upon RTA (Mayerhofer et al., 2009; Day et al., 2002), or some other effect of the 
phosopholipid.   
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Figure 5.7 – The effect of negatively charged POPS liposomes upon the susceptibility of 
RTA to CHIP-mediated ubiquitination. 
0.3μM of RTA was incubated with 3μM Hsc70 and 0.3μM Hsp40 in 20mM MOPS / 100mM KCl buffer, pH7.2 for 
15 minutes at 37°C with or without a concentration of 7.5μM POPS liposomes.  After this incubation, 3μM 
CHIP, 0.4μM E2 (UbcH5b) and BAG-5 were added along with 10mM DTT, 5mM ATP, 5mM MgCl2, and 2 mg.mL
-
1
 ubiquitin.  Lanes contained 0.1μM E1 to complete the ubiquitination cascade where indicated. These 
mixtures were then incubated for 2 hours at 30°C before the addition of SDS-containing loading buffer.  
Samples were split into two equal volumes, electrophoresed on separate gels, blotted onto nitrocellulose and 
finally immunostained for a) Hsc70, (Hsc70 is indicated by the black arrowhead.) and b) RTA.  Grey arrowheads 
indicate un-ubiquitinated RTA.  ,  and  are separate exposures of the same blot (at consecutively 
increasing times after adding the developer solution). 
 
a. 
 
b. 
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5.4 Hsp90-dependent ubiquitination of RTA 
In vivo and in vitro, Hsc70 can be held in proximity to Hsp90 by a TPR-bearing co-factor 
called HOP.  HOP preferentially binds to ADP-bound Hsp90 in the cytosol (Johnson et al., 
1998).  This association stalls the chaperone in its ADP-bound state, when it is most receptive 
to client binding (Johnson et al., 1998).  Furthermore, in this Hsp90-bound form, HOP 
acquires a greater affinity for client-bound Hsc70, causing the formation of a ternary complex 
containing Hsp90, HOP, Hsc70 and client (Hernández et al., 2002).   In this complex, HOP 
stimulates Hsc70 to undergo nucleotide exchange, permitting release of bound clients (Gross 
& Hessefort, 1996).  This concerted, sequential mode of action means HOP directs clients 
from binding Hsc70 to Hsp90, as has been shown to be the case in the conformational 
maturation of steroid hormone receptors, various kinases (Murphy et al., 2003) and in the 
optimal refolding pathway of substrates like firefly luciferase (Johnson et al., 1998).  A 
sequential triage of RTA like this is thought to occur in vivo because Hsc70 inhibition 
dominates the sensitisation caused by Hsp90 inhibition in vivo when cells are intoxicated 
with ricin (cf. Figure 3.12).   
In results that are published in Spooner et al. (2008) a sequential triage was recreated in vitro 
(using purified Hsp40, Hsc70, HOP and Hsp90).  When all of these components were 
provided, along with CHIP, an increase in the ubiquitination of RTA was observed relative to 
incubations excluding Hsp90 or Hsc70 (Figure 5.8).  Consistent with the concept of a 
sequential triage, these results also show that Hsp90 cannot ubiquitinate RTA without Hsc70 
in the reconstitution.  It appears that co-operation of Hsc70 and Hsp90 allots more RTA to 
the proteasome than either would independently.  In the incubation where Hsc70, HOP and 
Hsp90 are present, CHIP is given two opportunities to act upon RTA.  
Curiously, Spooner et al. (2008) also showed that, in isolation from Hsc70, Hsp90 has an 
apparent solubilising effect upon RTA at 45°C, but none at all at 37°C.  This contrasts to 
Hsc70, which has an effect in this experimental system at both temperatures.  Therefore, 
unlike Hsc70, Hsp90 might be able to bind to a substantially-unfolded state of RTA, but not 
to the native protein.  Thus, if RTA can quickly fold in the cytosol to a state that is no longer 
recognised by Hsp90, it may also no longer endure the threat of polyubiquitination by Hsp90-
dependent CHIP.  This helps contribute to the case for Hsc70 being called an “escape-hatch” 
from a cytosolic chaperone triage.   
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Figure 5.8 – Increased CHIP-mediated ubiquitination of RTAWT in the presence of Hsc70 
and Hsp90, as published by Spooner et al. (2008). 
 
N.B. The experiment in this figure was performed by Robert Spooner (University of Warwick) 
 
RTA was incubated with combinations of CHIP/Hsc70/Hsp40/E1/E2 as in the previous figure.  Where indicated, 
HOP and Hsp90 were also added.  Samples were subjected to SDS-PAGE and blotting, as before, and were 
immunostained for RTA and HOP.  Hsc70 and Hsp90 were visualised by silver-staining.  The asterisk indicates a 
cross-reacting band on the RTA immunostain. 
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5.5 Incubation in a cytosolic extract does not lead to observable polyubiquitination of 
RTA 
If RTA could be ubiquitinated in vitro by Hsp90/Hsc70, it might also be ubiquitinated in a 
more complex scenario where components of the ubiquitination cascade have been provided 
by a cytosolic extract.  As such, RTA was incubated at 45°C for 15 minutes with Hsc70 and 
Hsp40 (concentrations as before).  This would denature the toxin subunit, but keep it soluble.  
Subsequent to this, cytosolic extract was added (produced as before, as in Chapter 4), which 
would supply a co-chaperone environment analogous to what would be present during the 
intoxication process in vivo.  Controls where the proteasome inhibitor, ALLN, was included 
were also produced in case any ubiquitinated RTA was degraded.  Samples were then 
incubated at 37°C for the time indicated.  These reactions were separated by SDS-PAGE, 
blotted onto nitrocellulose and immunostained for RTA (Figure 5.9a).   
No ubiquitinated band can be observed in any of the incubations with cytosol.  The intensity 
of a cross-reacting smear from the RTA preparation decreases especially in the presence of 
cytosol (and less so when cytosol and ALLN are incubated together).  It is also noticeable 
that the intensity of the unmodified RTA band decreases over time in incubations with 
cytosol, and that this appears to be rescued by the inclusion of ALLN.  The ratio of signal 
intensity from RTA in lanes containing cytosol and ALLN to lanes containing cytosol alone 
was plotted against time (Figure 5.9b), giving an indication of the level of this degradation 
over time.  This effect presumably results from inhibition of the proteasome, or else 
cathepsins and calpains of the cytosolic extract, which ALLN also affects (Sasaki et al., 
1990). 
Unfortunately, it is not obvious whether this degradation is ubiquitin-dependent.  The lack of 
observably ubiquitinated bands in lanes containing ALLN would imply that it is not.  
However, in lanes where ALLN is present, it is possible that DUBs might subsequently 
remove any ubiquitination, given degradation of the substrate has been retarded.  To clarify 
this issue, ubiquitin-aldehyde might be employed in future experiments.  This modified 
ubiquitin would stabilise putative ubiquitin-conjugates from the hydrolytic action of DUBs 
(Hershko & Rose, 1987).   
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Figure 5.9 - The effect of cytosol on RTA 
a) RTA was denatured at 45°C for 15 minutes with Hsc70 and Hsp40, as before for ubiquitination experiments, 
with 5mM ATP.  Reactions were then incubated at 37°C with or without 10% (v%/v) cytosol and 100nM ALLN 
for the indicated length of time.  At the timepoint indicated, samples were placed on ice and mixed with SDS-
PAGE loading buffer.  Samples were then electrophoresed and immunostained via the Odyssey system for RTA 
(grey arrowhead).  †Shows lower molecular weight species than RTA which are putatively degradation 
products of the protein during storage.  ‡ Marks species of higher molecular weight from the RTA preparation 
which may be cross-reacting impurities.  b) Shows quantification of the putative degradation – it plots the ratio 
of signal intensity from RTA in lanes containing cytosol and ALLN to lanes containing cytosol alone over time.   
a. Immunostain 
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5.6 Polyubiquitination by CHIP is antagonised by other cytosolic co-chaperones 
Polyubiquitination of Hsc70 and Hsp90 clients by CHIP is affected by the concentration of 
other co-chaperones in the cytosol.  For Hsc70, these include co-factors like HspBP1 and 
BAG-2.  These co-factors bind to Hsc70 alongside CHIP, non-competitively masking the 
client protein from ubiquitination (Arndt et al., 2005; Alberti et al., 2003 & 2005).  BAG-1 
and HspBP1 also promote Hsc70 nucleotide exchange, shifting the chaperone into an open 
conformation that allows a client to dissociate if it is able to refold (Arndt et al., 2005; Alberti 
et al., 2004). 
To test whether a co-chaperone could influence the polyubiquitination of RTA in vitro, Jörg 
Höhfeld kindly provided a preparation BAG-5.  This co-chaperone has four repeats of the 
BAG domain, which is the definitive motif of the eponymous family of proteins 
(schematically compared in Figure 5.10).  Other BAG-domain proteins stimulate Hsc70 
nucleotide exchange (Alberti et al., 2001) and act as bridging factors from Hsc70 to other 
proteins (Takayama and Reed, 2001).  Thus, BAG-5 is anticipated to have similar 
functionality.  Like BAG-2, BAG-5 might also inhibit CHIP from ubiquitinating chaperone-
bound clients (Arndt et al., 2005).   
It is thought that the unusual multiplicity of BAG-5‟s Hsc70 interacting domains helps 
assemble a “work-bench” of chaperones and co-factors with a tailored stoichiometry (Jörg 
Höhfeld, personal communication).  If each BAG domain interacts separately with an 
instance of Hsc70, this would increase the local concentration of Hsc70 and might result in a 
more processive series of interactions with a given client.  This might ensure substrates do 
not escape triage prematurely.  Alternatively, the multiplicity of the BAG-domains might 
ensure the co-factor, itself, has a more processive series of interactions with Hsc70, more 
strongly promoting the release of clients.  In one of the only studies published at the time of 
writing, Kalia et al. (2004) showed that BAG-5 inhibits Hsc70 from aiding client refolding.  
They also showed that BAG-5 inhibited another of Hsc70‟s dependent E3 ligases, Parkin.  
They hypothesise that this might contribute to the accumulation of cytotoxic aggregates in 
neuronal models of Parkinson‟s Disease.   
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Figure 5.10 - A comparison of the domain architecture of human BAG domain proteins. 
Shown below are the relative domain organisations of BAG-family proteins.  The BAG-domain, which interacts 
with Hsc70, is usually at the C-terminus of the protein.  However, in BAG-5, these are spread throughout the 
protein. Other domains are also highlighted, e.g. ubiquitin-like (UBL) domains, nuclear localization signal (NLS), 
the WW domain, TXSEEX repeat and PXXP motifs.   
 
N.B. This figure is from Takayama & Reed, 2001. 
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With the above data in mind, the effect of BAG-5 upon the CHIP/Hsc70-mediated 
ubiquitination of two previously introduced substrates – Tau protein and luciferase – was 
investigated.  In both cases (Figure 5.11), the ubiquitination of Tau protein and luciferase is 
decreased when the BAG-5 concentration is increased.   
Curiously, the mono-ubiquitinated Tau band comprises two distinct species which did not 
separate by 8.6kDa (the molecular weight of ubiquitin).  It is possible that they represent 
mono-ubiquitination at two disparate sites upon the protein, which result in disproportionate 
changes in electrophoretic mobility.  However, these distinct species might alternatively owe 
to heterogeneity in the original Tau protein preparation.  
It was important to clarify that the apparent inhibition of ubiquitination was not by 
competition of BAG-5 with Tau protein or luciferase as substrate of CHIP/Hsc70.  This is 
shown by Figure 5.11, as BAG-5 is not ubiquitinated like a client of Hsc70 is.  This is much 
as is reported for the related co-chaperone, BAG-2 (Arndt et al., 2005) which binds to Hsc70 
independently of the client peptide-binding domain of the chaperone (Takayama et al., 1997).  
This provides evidence that the inhibitory effect of BAG-5 is a specific effect of the co-
factor, and gives another example of a protein that can evade ubiquitination by mechanisms 
other than a dearth of lysines. 
Hsc70 is ubiquitinated in all reactions shown in Figure 5.11.  However, the extent to which 
this ubiquitination responds to the concentration of BAG-5 is not as dramatic as it is for the 
substrate.  The simplest explanation would be that BAG-5 does not effectively mask the 
regions which CHIP targets upon Hsc70. 
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Figure 5.11 - BAG-5 inhibits the Hsc70/CHIP-mediated ubiquitination of clients 
a) Tau protein was incubated, as before, at 30°C for 2 hours with Hsc70, Hsp40, the components of the 
ubiquitination cascade and the indicated concentration of BAG-5 protein.  b) Luciferase was pre-incubated at 
45°C with Hsc70 and Hsp40 before the incubation with the components of the ubiquitination cascade.  Then 
these components were added and the rest of the protocol was as before.  In each case, the incubation 
mixtures were split into three equal volumes and immunostained for BAG-5, the substrate in question, and 
Hsc70.  Asterisks mark a band which may be mono-ubiquitination of BAG-5, but is thought to be a cross-
reacting species in the BAG-5 preparation. 
 
a. Tau protein b. Luciferase 
 
BAG-5 
(μM) 
0 3 6 9 
 
 
BAG-5 
(μM 
0 3 6 9 
 
 
 
  
* 
* 
Page 207 
 
5.7 Effect of BAG-5 upon the Hsc70/CHIP-mediated ubiquitination of RTA 
RTA has already been shown to be a weak candidate for the Hsc70/CHIP complex (cf. Figure 
5.3 and Spooner et al., 2008).  It was hypothesised that co-chaperones of the cytosol might 
further reduce ubiquitination by CHIP.  As such, similar experiments to those above were 
repeated with RTA.  A Ponceau S stain of nitrocellulose blots made of this experiment is 
presented in Figure 5.12, alongside an immunostain for Hsc70.   
If the Ponceau S stain is examined first (Figure 5.12a), an extensive protein ladder can be 
observed in incubations where all the usual components of the cascade have been provided 
(E1, E2, CHIP, Hsc70 & Hsp40).  The formation of this ladder is coincident with the 
reduction in intensity of lower molecular weight bands which are present in prior lanes, 
showing the ladder is derived from these species (e.g. CHIP, Hsc70) rather than from 
contaminants.  When BAG-5 is introduced into the complete incubation, the general intensity 
and range of the protein ladder diminishes as the concentration of BAG-5 increases.  The 
titrated dose of BAG-5 is shown by a band corresponding to a molecular weight of 51kDa 
(Kalia et al., 2004), which is marked with a white arrowhead.   
The reduction of the putative ubiquitination ladder by the addition of BAG-5 is accompanied 
by the congruent increase of non-ubiquitinated progenitor bands, such as Hsc70 (black 
arrowhead) and CHIP (stripy arrowhead).  Interestingly, CHIP appears to be ubiquitinated 
even in controls where Hsc70 and Hsp40 are absent (note a reduction in the intensity of this 
band where the upstream components of the cascade have been provided).  This shows it can 
interact with the E2 conjugating enzyme in the absence of Hsc70.  However, its ligating 
ability remains largely localised to itself in these instances (much as in Murata et al., 2001; 
cf. Figure 5.2 as well).  
In Figure 5.12b, a very striking, dose-dependent inhibition of Hsc70 ubiquitination by BAG-5 
can be observed (note that this immunostain is derived from the blot printed in Figure 5.12a).  
Indeed, the reduction of the ladder observed in Figure 5.12a may result, largely, from this 
effect upon Hsc70.  This stark inhibition of Hsc70-ubiquitination contrasts to Figure 5.11, 
where Tau protein and luciferase were used as substrates.  In the case of these substrates, the 
ubiquitination of Hsc70 did not seem as strongly affected by the dose of BAG-5. 
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Figure 5.12 - The effect of BAG-5 upon ubiquitination by Hsc70/CHIP 
RTA was pre-incubated at 45°C with Hsc70 and Hsp40 before components of the ubiquitination cascade were 
added for a subsequent 2 hour incubation at 37°C.  The rest of the protocol was as before.  In each case, the 
incubation mixture was split into two equal volumes and immunostained.  a) Shows a Ponceau S stain of the 
blot which was eventually used for b), the Hsc70 immunostain.   
 
a. Ponceau stain 
 
E1 - + + + + + + + 
E2 (UbcH5b) + - + + + + + + 
E3 (CHIP) + + - + + + + + 
Hsc70/Hsp40 + + + - + + + + 
BAG-5 (μM) 0 0 0 0 0 3 6 9 
 
 
b. Hsc70 immunostain 
 
 
E1 - + + + + + + + 
E2 (UbcH5b) + - + + + + + + 
E3 (CHIP) + + - + + + + + 
Hsc70/Hsp40 + + + - + + + + 
BAG-5 (μM) 0 0 0 0 0 3 6 9 
 
 
  
CHIP 
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Unfortunately, the immunoblots for RTA from the same reactions have a great deal of 
background (Figure 5.13a, exposures 1 & 2).  Curiously, prior applications of the same 
antibodies yielded noise-free blots (cf. Figure 5.4).  It may be that the development procedure 
in this particular assay worked fortuitously well, highlighting dilute species.  Alternatively, 
the stock of RTA may have formed multimers after repeated freeze/thaw cycles. 
Nonetheless, an attempt at interpretation has been made.  In incubations where the complete 
ubiquitination cascade is provided, putative mono-, di- and tri-ubiquitination of RTA can be 
observed.  Consistent with an inhibitory effect of BAG-5, the intensity of some of these 
bands responds negatively to its increasing concentration. Fittingly, the intensity of the un-
ubiquitinated RTA band is weakest in incubations without Hsc70/Hsp40 and in reactions 
where the ubiquitination cascade is completed.  Where Hsc70/Hsp40 are absent, this would 
be caused by a loss of solubility.  When the ubiquitination cascade is completed, this would 
be because of conversion into slower migrating, ubiquitinated species.   
From the second exposure, it can be seen that the high molecular weight smear results from 
ubiquitination.  It is observably laddered and most intense in incubations where all 
components of the cascade have been provided.  This ladder is likely not derived from the 
RTA band at 33kDa, as no contiguous array of bands bridges the two zones upon the 
immuno-blot.  Instead, the smear may be derived from a multimer of RTA at 98kDa.  
Contamination of incomplete incubations (with small concentrations of the indicated missing 
catalytic enzymes) may have caused the ubiquitination observed in these lanes, accounting 
for the weaker ladders observed therein.     
Importantly, the BAG-5 preparation possesses impurities (marked by asterisks in Figure 
5.13b).  Jörg Höhfeld maintains that partial purification of recombinant protein from a 
prokaryotic host is appropriate for testing the inhibitory effects of co-factors upon CHIP-
mediated ubiquitination (personal communication).
23
  Unfortunately, such contaminant 
species might compete with the probed substrate (for ubiquitination, or Hsc70 binding), 
obscuring an inhibitory effect of BAG-5.  However, as BAG-5 inhibits the chaperone-
dependent E3 ligase, Parkin (Kalia et al., 2004), and is related to BAG-2, which inhibits 
CHIP (Arndt et al., 2005), it does not seem unreasonable that this may be a true inhibition 
rather than a competition effect. 
                                                 
23
 As prokaryotes do not possess endogenous components of the ubiquitination cascade which could interfere 
with the activation and ligation of ubiquitin to a substrate protein. 
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Figure 5.13 - The effect of BAG-5 upon ubiquitination of RTA by Hsc70/CHIP  
RTA was pre-incubated at 45°C with Hsc70 and Hsp40 before components of the ubiquitination cascade were 
added for a subsequent 2 hour incubation at 37°C.  Then these components were added and the rest of the 
protocol was as before.  In each case, the incubation mixture was split into two equal volumes and 
immunostained.  a) Shows the immunostain for RTA.  Two separate exposures.    b) A silver stain of the BAG-5 
preparation and the RTA preparation in parallel (the masses of protein used are equivalent to those loaded on 
the gels in a). 
 
a. RTA immunostain (separate panels show different exposures). 
 
  
 
Lane 1 2 3 4 5 6 7 8 
E1 - + + + + + + + 
E2 (UbcH5b) + - + + + + + + 
E3 (CHIP) + + - + + + + + 
Hsc70/Hsp40 + + + - + + + + 
BAG-5 (μM) 0 0 0 0  3 6 9 
 
 
 
RTA dimer? 
RTA trimer? 
Polyubiquitin smear? 
RTA trimer? 
Polyubiquitin smear derived 
from putative trimer? 
RTA 
Exposure 1: 
Exposure 2: 
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(Figure 5.13 – continued.) 
 
b. Silver stain showing contaminants in the BAG-5 preparation 
 
 
 BAG-5  - + + 
 RTA + + - 
 
 
  
* 
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5.8 The effect of BAG-5 upon RTA solubility 
BAG-5 may have effects other than inhibiting CHIP-mediated ubiquitination.  The related co-
factor, BAG-2, inhibits the chaperoning effect of Hsc70 upon some substrates and has, itself, 
anti-aggregation properties (Arndt et al., 2005).  In a similar fashion, BAG-5 could provide 
an additional regulatory overlay upon Hsc70 activity in vivo.  To test this, BAG-5 was 
supplemented into the solubility assay from the previous chapter to determine whether it 
augmented or interfered with the effect of Hsc70 (Figure 5.14).   
The effects of BAG-5 upon Hsc70/Hsp40 - The apparent effects of BAG-5 upon solubility 
are reasonably consistent.  In these assays the solubilising properties of Hsc70 and Hsp40 
alone can be seen (cf. pairs 1 & 2).  Without ATP in the incubations, BAG-5 alone has a 
solubilising effect equivalent to that of Hsc70 in the parallel assay (compare pairs 2 & 3).  
Thus, both seem to act passively as pro-solubility factors.  However, Hsc70 has a greater 
effect than BAG-5, by average, when ATP is present (compare pairs 8 & 9).  This seems to 
support that Hsc70 has an ATP-dependent mechanism for promoting solubility under these 
conditions in addition to a passive effect.  BAG-5 does not have an equivalent ATP-
dependent mechanism. 
In assays without ATP, BAG-5 does not have much of an effect upon Hsc70‟s solubilising 
effect (at a concentration of 3μM BAG-5 – cf. pairs 2 & 4).  In reactions containing ATP, it 
appears that including 3μM BAG-5 partially abrogates the solubilising effect of Hsc70 (cf. 
pairs 8 & 10).  This shows that the co-chaperone has an effect on the ATP-dependent 
solubilising activity of Hsc70.  In light of what is known about these two factors, it could be 
hypothesised that the following justifies these trends: 
(1) BAG-5 and Hsc70 both have pro-solubility activities independent of ATP; 
(2) Hsc70, alone, has an additional pro-solubility activity dependent on ATP; 
(3) BAG-5 inhibits the ATP-dependent activity of Hsc70. 
An effect of BAG-5 on the ATP-dependent chaperoning activity of Hsc70 would not be 
unexpected, given BAG-5 is a putative nucleotide exchange factor of the chaperone 
(Takayama & Reed, 2001).  Furthermore, Kalia et al. (2004) report that BAG-5 negatively 
affects the Hsc70-mediated refolding of thermally-denatured luciferase in vivo, so a negative 
influence upon Hsc70 is also not unexpected.  Nevertheless, before making such conclusions, 
it is important to remember that the BAG-5 preparation was only “partially purified” from 
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E.coli, and so possesses some contaminants (as in Figure 5.13b).  As these contaminants are 
added during the 45°C denaturation, impurities will compete with RTA for tenure in the 
peptide binding domain of Hsc70 if they denature.  If anything, however, this competition 
would be expected to further hinder solubility as the dose of BAG-5 (and contaminants) was 
increased, rather than to promote it as they are titrated into the incubation. 
The effect of BAG-5 in isolation from Hsc70/Hsp40 - To simplify the previous experiment, 
BAG-5 was incubated with RTA at increasing concentrations without accompanying 
chaperones (Figure 5.15a & b).  In all cases, increasing the dose of BAG-5 increased the 
solubility of RTA.  This effect may be slightly increased when ATP is present.  However, 
given that the nucleotide has a slight solubilising effect itself, the effect of BAG-5 appears to 
be more or less the same in both contexts. 
If the change in solubility as a factor of protein concentration is considered, the effects of the 
BAG-5 preparation are greater than that of BSA, and equivalent to Hsc70/Hsp40 under 
similar conditions.  9μM BAG-5 (0.46mg.mL-1) results in a ~23% shift in solubility.  Under 
similar conditions, BSA caused only a ~5% shift at a marginally higher concentration of 
0.63mg.mL
-1 
(cf. Figure 4.17; for ease of reference the shifts caused by BAG-5, BSA and 
Hsc70/Hsp40 are compared in Figure 5.15c).  Thus, it appears that the BAG-5 preparation is 
able to promote solubility of RTA.  This effect may be contributed to by a blocking effect 
like BSA.  However, its effect is in excess of that of BSA, suggesting an additional 
mechanism: e.g. by stabilising soluble conformations of RTA or by blocking the sites which 
could propagate aggregation. 
  
Page 214 
 
 
 
Figure 5.14 – The effect of BAG-5 upon the ability of Hsc70 / Hsp40 to keep RTA soluble at 
45°C. 
RTA was mixed with varying concentrations of BAG-5 and chaperones, with concentrations and buffers as in 
other solubility assays.  “40/70” indicates a concentration of Hsp40 and Hsc70 as previously used in the 
solubility assay. Pellet / supernatant distributions of RTA were then analysed as normal. a) Shows experiments 
conducted without ATP alongside the relative quantification of pellet/soluble bands; b) Shows the equivalents, 
but with 5mM ATP.  Asterisks indicate a contaminant band from the BAG-5 preparation, particularly visible in 
the final lane.  In all cases error bars show SEM. 
 
 
a.  Without ATP (each panel shows an 
 independent assay). 
 
b.  With ATP (each panel shows an 
 independent assay). 
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Figure 5.15 – The effect of BAG-5 alone upon the aggregation of RTA at 45°C. 
RTA was mixed with varying concentrations of BAG-5, with or without 5mM ATP (as indicated). The solubility of RTA was 
then compared at each concentration. a) Shows silver stains and relative pellet/soluble quantification. b) Shows the 
relative absolute signal size between lanes.  Asterisk shows a contaminant band from the BAG-5 preparation.  c) Compares 
the average pro-solubility effects of BSA, Hsc70/Hsp40 and BAG-5 compared to independent controls of RTA in buffer 
alone.  In all cases error bars show SEM. 
 
a. Silver stains and quantification (each panel shows a separate assay). 
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(Figure 5.15 - continued.) 
 
 
b.  Absolute pellet and soluble signal sizes (n=3) 
 
 
 
 
 
 
c.   Average pro-solubility effect of BSA, Hsc70/Hsp40 and BAG-5 from different 
 experiments conducted at 37°C (n=3) 
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5.9 Over-expression of Hsc70 co-factors 
To extend these findings, the in vivo effect of over-expressing co-chaperones upon ricin 
toxicity was studied.  This would provide evidence for whether the balance of co-chaperones 
in the cytosol contributed to the fate of RTA in vivo.   
5.9.2 Targeted over-expression of Hsc70 co-chaperones 
Jörg Höhfeld kindly provided plasmid vectors for the over-expression of the co-chaperones 
HIP, BAG-1, BAG-2, BAG-5 and HOP in mammalian cells. 
5.9.2.1 Optimisation of over-expression conditions 
HeLa cells were transfected using the lipofectamine protocol (Invitrogen) under a variety of 
conditions.  A plasmid for the over-expression of HOP was used as a standard to optimise 
this process as an antibody for this protein was available.  Figure 5.16 shows that the intensity 
of HOP immunostaining increases with both the mass of vector and the volume of 
Lipofectamine reagent used for the transfection.  However, HOP over-expression is not so 
convincingly seen in total lysates examined by silver stain.  There is a heavily-stained band at 
a similar molecular weight (marked with an asterisk) which possibly dwarfs any staining 
attributable to HOP.  Examination of a band (marked with a black arrowhead) slightly above 
the asterisk-marked one shows a slight rise in intensity as mass of plasmid is increased.  This 
seems a good candidate for HOP.  Reassuringly, the silver stains do show that there are no 
dramatic changes in the remaining protein content of transfected cells.  This is a useful 
observation, as it informs us that the transfection procedure will have relatively few off-target 
effects. 
R.A. Spooner (University of Warwick) previously optimised the transfection efficiency of 
this procedure for the same cell line, reporting that 0.7μg was a sufficient quantity of plasmid 
to use (which is why the plasmid was added in multiples of 0.7μg, Figure 5.16).  Using an 
identical vector for over-expressing cytosolic GFP, it was estimated that, when ~0.7μg of 
plasmid was transfected with 3μL of transfection reagent, ~30% of cells showed clear GFP 
fluorescence when viewed by epifluorescence microscopy (R.A. Spooner, unpublished data).  
This relatively low level may explain why HOP cannot be seen so strongly in the silver-stains 
presented. 
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Figure 5.16 – Optimisation of over-expression conditions 
HeLa cells were plated at a density of 2.5  104 cells per well of a 6-well plate and transfected with the 
indicated mass of plasmid DNA (for over-expression of HOP).  Cells were then grown in normal medium over a 
period of 72 hours.  Detergent soluble lysates were then collected and assayed for protein content.  a) Shows 
transfections using 3μL of lipofectamine (label: “lipofect”).  b) Shows parallel transfections using 6μL of the 
reagent.  In each case, an immunostain for HOP was made (upper panel) alongside a silver stain (lower panel) 
showing even loading of 10μg of protein/lane.  Grey arrowheads mark HOP bands.  Asterisk indicates a heavily 
staining band of slightly increased electrophoretic mobility relative to HOP, obscuring interpretation. 
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5.9.3 The effect of over-expressing HOP on ricin intoxication 
As an increase in HOP was observed via immunostaining at a ratio of 0.7μg plasmid to 3μL 
of lipofectamine, this ratio was used in subsequent assays.  Such a minimal approach would 
reduce stress responses associated with high doses of lipid-based transfection reagents 
(Calvin et al., 2006) which might not have been obvious from the silver stains in the previous 
figure.   
After 48 hours of incubation, HOP-transfected cells and mock-transfected cells (transfected 
with empty vector) were re-plated into 96-well plates so their sensitivity to ricin could be 
compared after an overnight incubation.  The IC50 of such cells with respect to ricin was 
determined using the cytotoxicity assay (Figure 5.17a).  Because the size of the protective 
effect was small, this assay was repeated multiple times (Figure 5.17b), showing a high 
degree of reproducibility.  A consistently protective effect was observed.  These results are 
published in Spooner et al. (2008), where there is also published a dose-response to the HOP 
plasmid.  This suggests the recorded effect result from the DNA of the vector rather than to 
an off-target effect of the lipid-based transfection reagent. 
As discussed previously (cf. Table 5.1 and section 5.4), HOP increases the processivity of the 
Hsc70/Hsp90 triage, aiding transfer of clients from Hsc70 to Hsp90 (Johnson et al., 1998; 
Hernández et al., 2002; Gross & Hessefort, 1996; Murphy et al., 2003).  Over-expressing 
HOP, then, would be expected to increase transfer of clients from Hsc70 to Hsp90.  In such a 
context, any RTA that encounters and binds to Hsc70 would be more likely to subsequently 
interact with Hsp90.  Therefore, increasing the level of this co-chaperone would be predicted 
to be protective, as interactions with Hsp90 have already been shown to inactivate RTA (cf. 
Chapter 3 and Spooner et al., 2008).  Furthermore, as a stimulator of Hsc70 nucleotide 
exchange, HOP over-expression might contribute to premature release of RTA from Hsc70, 
which might disrupt the otherwise beneficial effect that Hsc70 has upon the cytosolic 
reactivation of the toxin subunit.  Notably, the protective effect of over-expressing HOP is 
also consistent with the observation that dual Hsc70/Hsp90 inhibition results in a net 
protection.  Both results vouch for the sequential order of an Hsc70/Hsp90 triage, with an 
interaction of RTA and Hsc70 occurring first. 
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Figure 5.17 – Over-expression of HOP protects cell from ricin 
HeLa cells were plated at a density of 2.5  104 cells per well and transfected with 0.7μg of vector (either 
empty. “mock” or encoding HOP).  Cells were then grown in normal medium over a period of 48 hours.  These 
cells were trypsinised and re-divided equally into 96-well plates and grown for a further 24 hours. The efficacy 
of ricin was then studied via cytotoxicity assay.  a) Shows example dose-response curves from each over-
expression, with the HOP over-expressing dataset represented by “” and mock-transfected dataset by “”.  
b) The IC50 value for cells over-expressing HOP was then compared to the IC50 value of cells which were mock-
transfected.  Error bars show the SEM between sets of independent experiments (n=8). 
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5.9.4 Other co-factors 
Vectors for over-expression of the co-chaperones BAG-1, BAG-5, CHIP, HIP and BAG-2 
were each transfected independently into HeLa cells, as before.  Each of these treatments was 
found to have an effect upon ricin intoxication.  However, they varied as to whether they 
were sensitising or protective. 
5.9.4.1 Protective co-factors 
Over-expression of BAG-1 – protected cells from ricin (Figure 5.18b & e).   Lysates from 
mock-transfected and BAG-1 transfected cells were compared via silver stain after being 
separated in parallel on SDS-PAGE (Figure 5.18f).  In the lysate from BAG-1 transfected 
cells, there is a relatively diffuse band centred on a molecular weight of 33kDa, as would be 
anticipated for this protein.  This staining is much more intense than was ever the case for 
HOP.  
Interactions of BAG-1 with both Hsc70 and the proteasome are well-elaborated, an 
association which is thought to promote degradation of Hsc70-bound clients (Alberti et al., 
2001 & 2002).  BAG-1 is also ubiquitinated by CHIP in an Hsc70-dependent manner, which 
synergistically augments the affinity of a client·chaperone complex for the proteasome 
(Alberti et al., 2001 & 2002).  Fittingly, over-expression of BAG-1 increases the degradation 
of Hsc70-bound clients like the glucocorticoid receptor in vivo (Demand et al., 2001).  
However, reports do exist of proteins which are stabilised in vivo by the over-expression of 
BAG-1, e.g. microtubule-dissociated Tau protein, although the mechanism by which this 
occurs is unclear (Elliott et al., 2007).   
From these results it would be hypothesised that, when RTA enters the cytosol from the ER, 
any subsequent interaction with Hsc70 will be more likely to result in inactivation of the 
toxin subunit if the complex encounters BAG-1.  This effect may be executed ultimately by 
proteasomal degradation.  Alternatively, the co-chaperone might interfere with the 
mechanism by which Hsc70 keeps RTA soluble (by acting as a nucleotide exchange factor), 
much as was demonstrated for BAG-5 in vitro. 
Over-expression of BAG-5 – protected cells against ricin intoxication (Figure 5.18c & e).  
Lysates from BAG-5-transfected and mock-transfected cells can be seen in Figure 5.18f, 
where they have been run in parallel by SDS-PAGE and silver-stained.  The BAG-5 
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transfected lysate possesses an additional band at 51kDa, just underlying a very bold band at 
~52kDa.   
This protective effect is unexpected given the inhibitory effect of BAG-5 upon CHIP-
mediated ubiquitination in vitro, and its apparent pro-solubility activity.  On the other hand, 
BAG-5 has been shown to have an inhibitory effect upon the chaperoning effect of Hsc70 (cf. 
Figure 5.14 and Kalia et al., 2004).  It seems that this inhibitory effect upon Hsc70 may be 
the dominant function of the co-chaperone in vivo, as the other effects would sensitise if they 
were dominant.   
Over-expression of CHIP – is also protective against ricin intoxication (Figure 5.18d & e).  
Lysates from CHIP-transfected and mock-transfected cells can be seen in Figure 5.18f, where 
they have been separated in parallel by SDS-PAGE and silver-stained.  At the expected 
molecular weight for CHIP, ~36kDa – there is bleaching of a band which is intensely stained 
in the control.  This bleaching seems to owe to exclusion of the stain by the over-expressed 
CHIP.  This staining phenomenon is not without precedent; Chuba & Palchaudhuri (1986) 
note the differential colour-staining of proteins based on cysteine content (as well as other, 
unidentified, attributes). 
Previously in this thesis it was shown that CHIP can ubiquitinate Hsc70, Hsp90 and client 
RTA in a manner which can be titrated against inhibitory co-factors in vitro (see also Arndt et 
al., 2004 & 2005).  Given that over-expressing CHIP would change this balance in the cell, a 
congruent increase in degradation of chaperone clients, including RTA, would be expected.  
This is the case for other clients in vivo, such as CFTR (Meacham et al., 2001) and 
microtubule-dissociated Tau protein (Shimura et al., 2004).  Even if RTA is not directly 
ubiquitinated, then the chances of it being carried to the proteasome by ubiquitinated Hsc70 
(Urushitani et al., 2004; Jiang et al., 2001) would presumably be increased under conditions 
of CHIP over-expression. 
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Figure 5.18 – Over-expression of HOP, BAG-1, BAG-5, and CHIP sensitises cells to ricin 
treatment. 
HeLa cells were treated as before, but an array of co-factors was studied independently.  Shown below are 
exemplar dose-response curves from the over-expression of a) HOP and putative over-expression of b) BAG-1 
c) BAG-5 and d) CHIP.   In each case “” denotes the co-chaperone over-expressing datasets and “” denotes 
the mock-transfected datasets.   e) Shows the protective effect of each co-chaperone relative to the mock-
transfected cells at the IC50.  Data for HOP displayed here is identical to that in the previous figure and has 
been transferred here for comparative purposes.  Error bars show the SEM. f) Shows silver stains from cells 
which have been transfected in the same fashion, but which have instead been lysed in a detergent-containing 
buffer and analysed by SDS-PAGE (10μg of protein loaded per lane). 
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(Figure 5.18 – continued.) 
 
e. The protective effects of over-expressing HOP (n=8), BAG-1 (n=8), BAG-5 (n=6) and 
CHIP (n=3). 
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5.9.4.2 Sensitising co-factors 
Over-expression of BAG-2 – sensitised cells to intoxication by ricin (Figure 5.19a & b).  
Over-expression of BAG-2 under the same conditions can be visualised by the appearance of 
a new band at around the expected molecular weight of 24kDa (Figure 5.19d).  Unlike BAG-
1, BAG-2 possesses no ubiquitin-like domain for proteasome binding (Arndt et al., 2005).  
BAG-2 is also known to inhibit ubiquitination by CHIP and to exclude the binding of BAG-1 
to Hsc70 (Arndt et al., 2005).  As such, BAG-2 will compete against the activity of these 
other co-chaperones (and likely BAG-5 as well).   
Precisely why there is a difference between the effects of over-expressing BAG-2 and BAG-5 
is unknown, given that they differ mainly by virtue of the multiplicity of the BAG-domain 
they both possess.  It might result from the altered stoichiometries these two co-chaperones 
are likely to promote in the folding complexes they interact with, or the localised 
concentration of nucleotide exchange factor activity, or some as yet unidentified property of 
either protein. 
Over-expression of HIP – also sensitised cells to ricin (Figure 5.19b & c).  Evidence of the 
over-expression of HIP under these transfection conditions can be seen in the silver stain, 
where a narrow band appears at ~43kDa which is not observable in the control (Figure 
5.19d).  HIP over-expression might induce sensitisation by promoting the refolding of Hsc70-
bound RTA, much as this chaperone promotes refolding of thermally-denatured luciferase in 
vivo (Nollen et al., 2001).  HIP stabilises the ADP-bound conformation of Hsc70 (Höhfeld et 
al., 1995), which increases its affinity for bound clients by inducing conformational changes 
which occlude client exit from the peptide binding domain.   
Unlike BAG-2, then, HIP would cause tight association between RTA and Hsc70.  Whilst 
their effects upon a putative Hsc70·RTA complex are therefore different, both of these 
chaperones displace, or else inhibit destructive co-factors like CHIP and BAG-1 (Höhfeld et 
al., 1995).  HIP, like BAG-2, also possesses an anti-aggregation activity independent of 
Hsc70 (Nollen et al., 2001).  This may also help to sensitise the cell to ricin intoxication, by 
directly stabilising retrotranslocated RTA. 
It can also be noticed that the error-bars for BAG-2 and HIP are rather large, covering most 
of the effect.  This is quite unlike those co-factors which were found to be protective.  The 
error-bars describing those data were markedly smaller.  It is difficult to suggest why this 
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might be.  It could be that promotion of folding might be more weakly determined by co-
factors than is promotion of degradation.  Alternatively, greater variability in the transfection 
efficiency of these constructs might be the cause. 
 
 
Figure 5.19 – Over-expressing BAG-2 and HIP 
sensitise cells to ricin treatment. 
Hela cells were transfected, as before, and assayed for 
their sensitivity to ricin.  a) The IC50 value for cells over-
expressing co-chaperone was compared to the IC50 
value of mock-transfected cells.  Error bars show the 
SEM between sets of independent experiments. b) & c) 
show example dose-response curves from each over-
expression, with co-chaperone over-expressing datasets 
represented by “” and mock-transfected datasets by 
“”.  d) Shows silver stains from cells which have been 
transfected in the same fashion, but which have instead 
been lysed in a detergent-containing buffer and 
analysed by SDS-PAGE (10μg of protein loaded per 
lane). 
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(Figure 5.19 – continued.) 
 
d. Silver-stains of transfected and mock-transfected lysates 
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5.9.5 Transfections with LacZ have no effect 
It was possible that over-expressing any arbitrary protein had an effect upon the intoxication 
of cells by ricin.  For example, over-expression of a protein might lead to cellular aggregates 
which could alter the dynamics of the cytosolic chaperone complement, or upon trafficking.  
To account for this possibility, HeLa cells were tested for whether the over-expression of 
LacZ affected ricin intoxication (Figure 5.20).  Although the over-expression of LacZ has not 
been confirmed by silver stain, this assay shows there is no difference in IC50 between 
transfected and mock-transfected cells.  This starkly contrasts to the results observed when 
over-expressing co-chaperones, suggesting their effect is more specific. 
 
Figure 5.20 – Putative over-expression of an arbitrary protein, LacZ, does not affect ricin 
sensitivity. 
Hela cells were transfected, with empty vector or vector for over-expression of LacZ and assayed for their 
sensitivity to ricin.  a) Shows a single assay from a total of three independent experiments. “” Indicates the 
LacZ transfected dataset.  The empty vector transfected dataset is indicated by “”.   b) The IC50 value for cells 
over-expressing co-chaperone was compared to the IC50 value of mock-transfected cells.  Error bars show the 
SEM between three sets of independent experiments.  
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5.10 Over-expression of a J-domain protein during viral infection 
It is known that some viruses possess in their capsids, or else encode in their genetic material, 
proteins which modulate the functionality of the chaperone matrix for the benefit of their life 
cycle (Brodsky & Pipas, 1998).  Such viruses include Simian vacuolating virus 40 (SV40).  
The circular DNA genome of this virus encodes a protein, Large T Antigen (TAg; DeCaprio 
et al., 1997).  TAg inhibits homologues of the retinoblastoma tumour suppressor (Rb) and the 
pro-apoptotic protein, p53 (DeCaprio et al., 1997).  More specifically, TAg possesses an N-
terminal J-domain motif, similar to that of Hsp40, which stimulates the ATPase of Hsc70 
(Genevaux et al., 2003).  It is thought that this co-chaperone activity is required for its effects 
upon p53 and Rb, preferentially engendering interactions of these proteins and their 
complexes with Hsc70 (Genevaux et al., 2003; Brodsky & Pipas, 1998). 
As such, it was predicted that infection of HeLa cells with SV40 virus would result in 
modulation of Hsc70 function in the cytosol, so altering the dynamics of an RTA triage by it.  
The infection process itself provided a convenient vector for the over-expression of the 
protein, which was one motivation for the experiment.  To this end, cells were infected with 
SV40 virus (K.N. Leppard, University of Warwick), lysed and examined for 
immunoreactivity to TAg.  From Figure 5.21a it can be seen that a ~96kDa species appears 
after 24 hours of infection, peaking at 48 hours.  This is as expected for TAg protein (K.N. 
Leppard – personal communication; Stubdal et al., 1996).   
The IC50 of ricin toward cells expressing TAg versus untreated cells was then compared in 
parallel assays.  It appeared that cells treated with virus for 48 hours were protected from 
ricin intoxication (Figure 5.21b).  It remains unclear whether this is because the virus might 
have an effect on trafficking, or because of another viral protein or a separate function of 
TAg aside from its Hsc70-interaction.  However, it is interesting to speculate that this “viral 
co-chaperone” interferes with the normal interaction of RTA with Hsc70.  Intriguingly, 
Kampinga et al. (2003) show that over-expressing a cytosolic J-domain protein, Hsp40, locks 
Hsc70 onto clients.  This depletes the pool available to help thermally-denatured luciferase if 
the protein is subsequently added to the mix.  This explanation correlates well to what is 
observed here: TAg might decrease the population of Hsc70 available to bind (and thus 
rescue) RTA as it emerges from the ER membrane.  Hsc70 would be locked onto other 
(endogenous) clients.  However, because of the number of potential off-target effects, the 
interpretation of this result must be treated with caution.  
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Figure 5.21 – The effect of SV40 virus infection upon the sensitivity of cells to ricin. 
a) Hela cells were plated out at a density of 2.4  104 cells per well in a 6-well plate and infected with SV40 at 
a multiplicity of infection (MOI) of 10.  At time-points afterward, detergent-soluble extracts were taken and 
run in parallel through SDS-PAGE at a concentration of 10μg of protein per lane.  The gel was blotted onto 
nitrocellulose and immunostained for large tumour antigen (black arrowhead; TAg) and γ-tubulin (white 
arrowhead), which were visualised with an alkaline phosphatase development. γ-Tubulin was stained to 
provide a loading control. DOI: duration of infection. M: markers.  b) Shows dose-response curves comparing 
cells which have been pre-infected for 48 hours versus cells which have not been treated with virus. “” 
represents infected and “” represents negative-control cells.  c) Shows the protective effect of both these 
treatments.  Error bars (which are very small) plot the SEM of three independent assays. 
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5.11 Conclusions 
This chapter has attempted to consolidate a model for the division of fates a chaperone triage 
might impose upon retrotranslocated RTA.  As determined in the previous chapter, the 
solubility of RTA can be stabilised by chaperones.  On the other hand, as presented by this 
chapter, RTA might be allotted for degradation by their interaction – via polyubiquitination, 
for instance.  The propensity of either of these processes to occur appears to be dictated by 
the balance of co-factors in the cytosol. The outcome Hsc70 and Hsp90 tend to promote will 
be a composite of the chaperone‟s inherent properties, the conformational state of a given 
instance of the client in question, and the relative abundance of their co-factors. 
5.11.1 Chaperones may promote degradation of RTA by coordinating with CHIP  
It has been shown that CHIP can polyubiquitinate chaperone-bound RTA in vitro, which 
provides evidence for the destructive fate that might result from the chaperone audit.  In this 
reconstitution, ubiquitination can occur via either Hsc70 or Hsp90 (published in Spooner et 
al., 2008).  However, ubiquitination via Hsp90/CHIP requires Hsc70 and HOP to deliver 
RTA to it first (Spooner et al., 2008).  In both of these contexts it has not been possible to 
positively detect species of RTA with more than three conjoined ubiquitin attachments.  This 
is significant because a length of four contiguous ubiquitin attachments is regarded necessary 
to fulfil the criteria of a “canonical” proteasomal signal – as defined by Thrower et al. (2000).  
However, a definition of the “canonical signal” should be treated with caution because of the 
diversifying array of co-factors that are being shown to supplement catalysis of – and 
response to – these processes in vivo (Kim et al., 2007 & 2009).  For instance, accessory 
factors in vivo could promote the extension of the chain into – or else interpretation of the 
chain as – a bona fide proteasomal signal.  Regardless, the findings herein suggest that 
RTA
WT
 can become ubiquitinated, which is a novel finding in itself. 
A lipid-induced vulnerability of RTA - The apparently increased ubiquitination of RTA after 
treatment with liposomes may pose physiological significance as it may compare to the 
vulnerability of the toxin subunit during retrotranslocation.  Other ER membrane-integral 
proteins are targeted by Hsc70/CHIP activity (e.g. CFTR – Arndt et al., 2005), and so the 
same may be true of RTA at some point in its retrotranslocation.  The cytosolic domains of 
CFTR which promote this interaction, however, are known to be very large.  Whether this is 
strictly analogous to the condition of RTA whilst it is embedded upon the surface of a 
liposome is unknown.  If such an interaction like this does occur in vivo, it appears not to 
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result in the net-degradation or inactivation of RTA by Hsc70, considering that the 
chaperone‟s normal function promotes toxicity (cf. Figure 3.2).  
Ratifying a sequential triage by Hsc70/Hsp90 - It seems likely that there is a sequential 
order to the triage of RTA by Hsc70/Hsp90.  Hsc70 seems to interact first and Hsp90 after, a 
process which promotes the ability of CHIP to ubiquitinate RTA by giving it two junctures at 
which it may polyubiquitinate RTA.  The sequential nature of the triage has been supported 
by multiple observations.  First, the effect of dually-inhibiting Hsc70 and Hsp90 is almost the 
same as for inhibiting Hsc70 alone (cf. Chapter 3, Figure 3.12).  Furthermore, increasing the 
flow of clients from Hsc70 to Hsp90 (by over-expressing HOP) has a correspondingly 
protective effect.  This suggests that there is transfer from Hsc70 to Hsp90, and that the latter 
interaction is dependent on the first, and has a negative influence upon the activation of RTA 
in the cytosol.   
At odds with this, perhaps, it has been observed that Hsp90 can rescue the solubility of 
thermally-denatured RTA in vitro, in isolation from Hsc70 (Spooner et al., 2008).  This 
would suggest that RTA and Hsp90 can interact outside of the triage.  It remains a quandary 
why Hsp90 can rescue solubility independently, but cannot facilitate ubiquitination by CHIP 
without Hsc70/HOP present (Spooner et al., 2008).  It may be that a specific quality that is 
necessary for ubiquitination is imposed upon RTA by its prior interaction with Hsc70, or by 
its transit thereafter to Hsp90.  This quality could be a conformational cue that forms during 
the Hsc70 interaction, which results in a more protracted association with Hsp90, or the 
imposition of a particular binding orientation which renders the lysines of the polypeptide 
more accessible to Hsp90-mounted CHIP. 
5.11.2 The activity of CHIP will be opposed by multiple cytosolic factors in vivo 
When RTA was incubated with a cytosolic extract, it appeared that some was degraded in an 
ALLN-sensitive manner, which might suggest the proteasome degrades RTA in this 
experimental setup.  However, in these incubations, ubiquitin-conjugation could not be 
observed – suggesting that ubiquitination was not necessary for this degradation,24 or that 
such modifications are swiftly removed during conditions of proteasomal inhibition (e.g. by 
                                                 
24
 Ubiquitin-independent routes to the 20S proteasome do exist, especially for disordered or especially denatured 
substrates (Jariel-Encontre et al., 2008).  
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DUBs).  This experiment could be improved by including ubiquitin-aldehyde to block the 
potential de-ubiquitination of RTA, which might thereafter be observed. 
As well as de-ubiquitination, other factors in the cytosol would oppose the ubiquitination of 
RTA by CHIP e.g. HIP (Höhfeld et al., 1995), HspBP1 (Alberti et al., 2004) and BAG-2 
(Arndt et al, 2005).  Here, the inhibitory effect of another co-factor, BAG-5, upon CHIP-
mediated ubiquitination was shown for the first time in vitro.  This compares well with Kalia 
et al. (2004), who report that BAG-5 inhibits another Hsc70-dependent E3 ligase, Parkin.  
Increasing doses of BAG-5 observably prevented CHIP-mediated ubiquitination of Hsc70, 
RTA and other test substrates.  Thus, the already low-level of RTA ubiquitination that might 
occur during intoxication would be further attenuated in vivo.  Arguably, there might equally 
be pro-ubiquitination co-factors in vivo (e.g. E4s) which complicate this scenario.   
5.11.3 Does RTA have a lysine-independent mode of avoiding ubiquitination during its 
interaction with Hsc70? 
Data presented in this chapter shows that RTA
6K
 and RTA
WT
 are not ubiquitinated efficiently.   
In similar experiments with longer exposures, Spooner et al. (2008) showed that 
ubiquitination of RTA
6K
 is increased relative to RTA
WT
.  Curiously, the extensive level of 
Hsc70-ubiquitination in the assays of Spooner et al. (2008), reprinted in Figure 5.6, shows the 
reaction may be working even more efficiently than was the case for the test substrates which 
were relatively efficiently ubiquitinated (Tau protein and luciferase, Figure 5.1 and 5.2).  
Thus, despite being supplemented with non-native lysines, the ubiquitination of RTA
6K
 does 
not approach the level to which positive controls (Tau protein and luciferase) are 
polyubiquitinated.  That RTA
6K
 remains relatively poorly ubiquitinated implies there might 
be some quality about the toxin subunit, surprisingly regardless of lysine content, which 
makes it a poor substrate of Hsc70.  This was unexpected, especially as it contrasts to the 
outcome of the interaction of RTA with the Hsp90∙CHIP complex, which is strongly lysine-
dependent in vivo (cf. Chapter 3, Figure 3.18). 
To clarify this phenomenon, it would be beneficial to produce an experiment analogous to 
that conducted in Chapter 3 (Figure 3.18).  Experiments could be conducted to test whether 
the protective effect of DSG differed between holotoxins consisting of reconstituted RTA and 
RTA
WT
/RTA
0K
/RTA
6K
.  This would help determine whether lysine content has a bearing on a 
potential Hsc70/CHIP mediated ubiquitination in vivo, or whether some other factor 
dominates the process (in which case there would be no difference in effect between 
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holotoxin variants).  Unfortunately, DSG has proved difficult to acquire and degrades swiftly 
in storage (see appendix, Figure 8.1).  For completeness, it would also be interesting to see 
whether RTA
6K
 responds more strongly in vitro to Hsp90/CHIP-mediated ubiquitination than 
it does to that mediated by Hsc70/CHIP.  
Other than a shortage of lysines, it could be that denatured RTA simply does not interact with 
Hsc70 as strongly as denatured luciferase or Tau protein do, thereby reducing CHIP-mediated 
ubiquitination.  It is an enticing notion that evasion of ubiquitination by RTA whilst bound to 
Hsc70 may owe as much to a shortened residence in the peptide binding domain of the 
chaperone as to the reduced lysine content of the toxin subunit.  It might be that RTA refolds 
particularly swiftly in the cytosol with the aid of Hsc70 – subsequently escaping candidacy 
for a protracted triage where it is in a vulnerable state – so as to avoid any negative 
interaction with co-chaperones.  
This hypothesis of “shortened residency”, however, is at odds with an earlier observation: 
that the hydrophobic C-terminal domain of RTA, part of the native structure of the protein, 
seems enough to promote interactions with Hsc70.  This domain was proposed to engender 
interactions with RTA even without prior denaturation (cf. Chapter 4).  It could be speculated 
that the nature of this binding is distinct from the binding that occurs after heat denaturation.  
It could be that, without prior denaturation, the C-terminal tail defines the orientation in 
which RTA binds to Hsc70, ensuring polyubiquitination does not occur efficiently.  In the 
case of liposome treatment, this deterministic, protective C-terminal tail would be hidden in 
the liposomal core (Mayerhofer et al., 2009).  After heating, other stretches of extended 
hydrophobic polypeptide would compete with the C-terminal tail.  These regions would not 
impose the same orientation to the interaction with the chaperone complex, and might 
predispose the toxin subunit to greater ubiquitination.  Indeed, Flynn et al. (1991) showed 
that isoleucine and leucine were favoured for binding in the peptide-binding domain of 
Hsc70.  Encouragingly, the hydrophobic C-terminal domain of ricin is defined as (from V245 
to V256): VSILIPIIALMV (Simpson et al., 1995).  Curiously, however, the proline residue in 
the midst of this region is not favourable for binding Hsc70 (Flynn et al., 1991).  This might 
contribute to the peculiarity of the association, which would be interesting to investigate, 
especially given this residue has been implicated as having an important role in toxicity 
(Simpson et al., 1995). 
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5.11.4 The role of other co-factors in the putative cytosolic triage of RTA 
It was shown that those co-factors which have an explicitly destructive role, e.g. BAG-1 and 
CHIP, protected cells from ricin intoxication.  This fits the model generated so far, as the 
over-expression of these proteins would be expected to increase the chances that an 
interaction of RTA with Hsc70 would result in degradation.   They would thus promote 
clearance of RTA from the cytosol, reducing its toxic action therein.  The co-chaperone, 
HOP, also protected cells when over-expressed.  This is presumably by promoting 
interactions of RTA with Hsp90, which were shown to be detrimental for the toxin subunit 
(Figure 3.4). 
On the other hand, BAG-2 and HIP sensitised cells to ricin intoxication.  Strangely, these two 
co-chaperones have opposite modes of interaction with regard to the ATPase cycle of Hsc70.  
Although they are different in this regard, they are united in their ability to inhibit Hsc70-
associated CHIP and in displacing BAG-1 (Arndt et al., 2005; Höhfeld et al., 1995).  Thus, it 
seems to be this commonality which defines their shared sensitising effect.  Unexpectedly, 
although BAG-5 inhibited Hsc70/CHIP-mediated ubiquitination in vitro and possessed its 
own pro-solubility qualities, over-expression of it protected cells from ricin intoxication.  
Another property that this co-chaperone possesses, which is consistent with these 
observations, is its inhibitory effect upon the ATP-dependent solubilising activity of Hsc70.  
This seems the dominant effect of this co-chaperone in vivo.  As BAG-2 is also a nucleotide 
exchange factor of Hsc70 (Arndt et al., 2005), but has the opposite effect, there must be some 
central difference between the two proteins.  For instance, the multiplicity of BAG-5‟s 
interlinked BAG domains may be responsible for the assembly of a folding complex which 
has a bias toward degrading the RTA the complex encounters. 
5.11.5 Summarising 
Chaperone-based triage of RTA in the cytosol is modulated by the co-chaperone 
concentration.  These co-chaperones determine client ubiquitination and the solubilising 
effect of Hsc70. Additionally, co-factors may act independently as pro-solubility factors (e.g. 
BAG-5).  The diversity of fates that may be imposed by the co-chaperone environment 
reflects the integral housekeeping roles of these proteins in the cytosol.  The homeostatic role 
of the co-chaperone environment is immensely broad: the functional content of the proteome 
is defined as much by what is kept appropriately folded, or degraded by proteases, as by what 
is synthesised at the ribosome.  
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CHAPTER 6: 
Final Discussion 
6.0 RTA unfolds to retrotranslocate and is inherently unstable to achieve this 
The question posed at the start of this thesis was: how does RTA gain a catalytic 
conformation in the cytosol after retrotranslocating across the ER membrane?  Imposing extra 
unfolding constraints upon the toxin subunit inhibits cytotoxicity, which is interpreted as 
evidence that RTA has to unfold substantially during the intoxication process (Beaumelle et 
al., 1998; Argent et al., 1994).  On the other hand, if the stability of RTA is drastically 
reduced, it results in its irreversible misfolding and its incontrovertible degradation by a bona 
fide ERAD route (Li et al., 2010).  RTA is therefore finely-tuned: able to be recognised by 
ERAD, but – critically – also able to resolve itself from the majority of ERAD substrates 
which are degraded in the cytosol. 
This thesis has made observations which, consistently, highlight how RTA is structurally 
poised to unfold near physiological conditions.  This has been demonstrated by observing 
changes in the toxin subunit‟s solubility under various, controlled incubations.  First, the 
toxin subunit is prone to lose solubility at the physiological pH of 7.2 (compared to other pH 
conditions ranging from 6.4 to 8.0).  Second, there is a stark threshold between 37°C and 
45°C where increases in temperature result in a dramatic loss of solubility.  Corroborating 
this finding, Argent et al. (2000) previously pinpointed a batch-dependent threshold of 
around 45°C (using circular dichroism) at which RTA becomes a molten globule.  Small 
temperature increases beyond this threshold temperature result in a dramatic disruption of the 
protein‟s secondary structure and aggregation.  Mayerhofer et al. (2009) also identified that, 
at temperatures of 37°C and above, RTA inserts far more efficiently into microsomal 
membranes.  Thus, a temperature threshold may have significance in vivo during intoxication, 
promoting a membrane interaction that could prompt retrotranslocation. 
A RIP closely related to RTA, saporin, does not share its temperature-dependent instability.  
Moreover, it is not thought to exploit an ERAD route (Vago et al., 2005).  Two major 
differences between these proteins are their respective lysine contents and the presence of 
RTA‟s hydrophobic C-terminus.  These features are likely to be significant during ERAD 
(Simpson et al., 1998; Deeks et al., 2002), and to influence solubility.  Thus, they may 
account for their different routes into the cytosol.  Curiously, Deeks et al. (2002) note that 
engineering RTA
WT
 to contain more lysines, producing RTA
6K
, creates a protein which is 
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7°C more stable than RTA
WT
 (as determined by the midpoint change in intensity of a 208nm 
peak, measured by circular dichroism).  This additional stability could feasibly contribute to 
differing retrotranslocation dynamics from the ER lumen.  Indeed, Deeks et al. (2002) 
showed that RTA
6K
 is 100-fold less toxic than RTA
WT
.  Most of this effect is thought to result 
from increased lysine-ubiquitination, leading to proteasomal degradation.  However, 
according to Deeks et al. (2002), RTA
6K
 is still 2-fold less toxic than RTA
WT
 when the 
proteasome is inhibited.  This difference in toxicity might reflect the stabilising effect of the 
additional lysines, which perhaps retards the toxin subunit‟s exit from the lumen.   
Whilst the structural instability of RTA does not compare well with the related saporin, it 
does share similarity with unrelated cholera toxin and pertussis toxin A chains.  Both of these 
toxic A chains dislocate from the ER of target cells via an ERAD-like mechanism and are 
unstable in isolation from their respective holotoxins (Pande et al., 2007 & 2008).  It is 
thought that this instability promotes their ERAD.  Thus, this thesis reports that A-chain 
instability is a consistent feature of multiple ERAD-dislocating toxins.  The cholera toxin 
field, however, does have a competing argument to explain the co-option of CTA1 onto an 
ERAD route – beyond its inherent instability.  Moore et al., (2010) suggest that PDI helps to 
unfold CTA1, passing it thereafter to the retrotranslocation machinery of the Hrd1 complex.  
Thus, a toxin subunit‟s inherent instability can be coupled to chaperone recognition in the 
lumen.  No such unfolding interaction of RTA with PDI has been reported, beyond the role of 
PDI in reducing the holotoxin (Spooner R.A., personal communication; Spooner et al., 2004).   
Regardless of what factor initiates ERAD in the ER lumen, CTA1 and pertussis toxin A chain 
are both ultimately stabilised by cytosolic targets.  Pertussis toxin A chain is stabilised in the 
cytosol by nicotinamide adenine dinucleotide, a proton acceptor required for its toxic activity 
(Pande et al., 2008).  Cholera toxin A chain (CTA1), on the other hand, is stabilised by 
binding to ADP-ribosylating factor 6, ARF6 (Pande et al., 2007).  In the case of RTA, 
stabilisation may result from a combination of ribosomal binding (Argent et al., 2000) and – 
this thesis reports – the properties of cytosolic chaperones like Hsc70. 
6.1 The role of Hsc70  
Inhibition of cytosolic Hsc70 using deoxyspergualin (DSG) results in a ~2-fold protection of 
HeLa cells from ricin.  Hsc70 could be responsible for promoting a catalytic conformation of 
RTA after dislocation from the ER.  Reassuringly, DSG does not alter the lag before the first 
reduction in protein synthesis is observed during intoxication.  This is also the case for the 
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other chaperone inhibitors used in this thesis.  Transport to the translocation-competent 
compartment is deemed the rate-limiting step of ricin‟s mechanism (Hudson & Neville, 
1987).  Thus, the effect of these inhibitor compounds (C01, NECA, DSG, GA & RA) occurs 
at a point subsequent to this stage.  That is, the effect of the chaperones they inhibit occurs 
after access of the toxin subunit to the translocation-competent compartment.   
It seems feasible that DSG abrogates a direct, cytosolic interaction between RTA and Hsc70 
in vivo.  First, it was shown that Hsc70 can prevent RTA from losing solubility after heat-
treatment (to 45°C).  This in vitro buffering effect can be prevented with DSG.  Colleagues 
showed that the rescue of solubility also correlated to the increased enzymatic activity of 
RTA (Spooner et al., 2008).  This suggests that Hsc70 preserves the toxin subunit in an active 
conformation as well as a soluble one.  Unexpectedly, an interaction between Hsc70 and 
RTA was even observed at 37°C, at which the structure of RTA is regarded as native under 
similar conditions (Argent et al., 2000).  This interaction is putatively associated with the 
hydrophobic C-terminus of the toxin subunit and could result in a more prolonged interaction 
with the chaperone.  It is well-known that cytosolic Hsc70 interacts with the hydrophobic N-
terminal targeting sequences of proteins destined for export to other compartments (Zara et 
al., 2009).  Indeed, the hydrophobic C-terminus of RTA is known to bear some structural 
resemblance to a signal peptide (Chaddock et al., 1995).  In vivo, a persistent or recurrent 
interaction of RTA with Hsc70 might prevent the regressive interaction of the toxin subunit 
with the cytosolic leaflet of the ER membrane.  Such a function may be important, given it is 
thought similar interactions of RTA with the lumenal leaflet of the ER membrane promote its 
ERAD (Mayerhofer et al., 2009).  In this sense, Hsc70 could perform a role as NAD does for 
pertussis toxin A chain, or ARF6 does for CTA1 (Pande et al., 2007 & 2008).    
Notably, DSG has no effect upon the sensitivity of HeLa cells to diphtheria toxin (Spooner et 
al., 2008), which translocates from endosomes into the cytosol.  It could be that the stability 
of diphtheria toxin A chain is simply such that it is not a candidate for being bound by Hsc70 
after its translocation.  Indeed, it relies upon endosomal acidification to promote its 
translocation-competent state, qualities of which will be lost after access to the pH7.2 cytosol 
(Rodnin et al., 2010).  Alternatively, it may be that a local concentration of certain J-domain 
containing proteins at the mammalian ER membrane, like ER-associated Ydj1 or Hlj1 in 
yeast (Beilharz et al., 2003), ensures RTA is subjected to the activity of Hsc70.     
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This thesis also showed that the Hsc70-associated co-factor, CHIP, can ubiquitinate RTA
WT
 
at 37°C, with or without a prior 45°C heat treatment (Spooner et al., 2008).  A maximum of 
3-4 ubiquitin tags was the largest detectable chain length using the techniques in this thesis.  
This contrasts to other CHIP substrates examined herein: Hsc70, firefly luciferase and 
mictrotubule-associated tau protein.  Curiously, addition of further lysines does not restore 
RTA to a level of ubiquitination as intense as that observed for the other substrates examined 
(although it does increase the propensity for ubiquitination slightly – Spooner et al. 2008).  
Explaining this, the frequency of lysines in RTA
6K
 remains only 2.4% of residues, compared 
to 8.4% and 7.3% of Hsc70 and luciferase residues respectively.  Thus, compared to these 
standards, it actually remains lysine-deficient.  Nevertheless, for some substrates only one 
appropriately-placed lysine is necessary for an extensive ubiquitin chain, e.g. luciferase (Kim 
et al., 2007).  Therefore, other features might remain significant in reducing Hsc70∙CHIP-
mediated polyubiquitination.  For example, the frequency and quality of sites which may be 
bound by Hsc70. 
Provocatively, the extent of CHIP-mediated ubiquitination can be increased if RTA
WT 
is first 
pre-incubated with liposomes made from negatively-charged POPS.  These liposomes are 
similar to those which RTA has been shown to insert into, and which disrupts its secondary 
structure (Mayerhofer et al., 2009).  If this lipid-based denaturation plays a role in the 
retrotranslocation of RTA, then it would appear that it also renders the toxin subunit in a 
conformation that is particularly vulnerable to ubiquitination.  Evidently, the extent of 
ubiquitination under these conditions is still small.  Even so, co-factors in vivo might 
modulate the process.  Moreover, the tight association of the proteasome to the ER membrane 
(Ng et al., 2007), where RTA will be transiently localised may substitute for an extensive 
polyubiquitin signal (Janse et al., 2004).  Nevertheless, this thesis is clear in showing that the 
net effect of Hsc70 is to promote the toxicity of RTA rather than its degradation.   
Even a low level of ubiquitination can have significant physiological functions.  In the 
context of some recipients, these processes include plasma membrane receptor internalisation 
and the determination of vesicle sorting (Sun & Chen, 2004).  More speculatively, Feldman 
& van der Goot (2009) hypothesise that low levels of ubiquitination may control iterative 
cycles of ER-associated chaperone binding (reminiscent of the calnexin/calreticulin cycle in 
the ER lumen).  Participation in this chaperone binding cycle would be controlled by 
competition between de-ubiquitinating enzymes and ubiquitin ligases.  The low levels of 
ubiquitination RTA might apparently bear after interacting with Hsc70∙CHIP could even 
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dictate such events in a fashion which benefits its toxicity.  The putative involvement of such 
factors in ricin intoxication may be a good target for future study.  Indeed, many proteins 
could be fine-tuned to auto-regulate their ubiquitination, optimising their chaperone-binding 
properties. 
6.2 The role of Hsp90 
If Hsp90 is inhibited, cells become sensitised to ricin (by ~2-3-fold).  Supporting this 
observation, if the co-chaperone which links Hsc70 and Hsp90 together, HOP, is over-
expressed, cells are protected.  This is putatively because of the increased transfer of clients 
from Hsc70 to Hsp90 – clients which could include RTA.  The idea of Hsc70 working in a 
sequential triage with Hsp90 is supported by the effects of dual Hsc70/Hsp90 inhibition, 
which is the same effect as Hsc70 inhibition alone (Spooner et al., 2008).  An interaction of 
RTA with Hsp90 in vivo may be dependent upon one with Hsc70 first. 
The sensitising effect of Hsp90 inhibition is greatly amplified when RTA is engineered to 
contain additional lysines.  Moreover, it is abrogated when it has none.  This implies that the 
effect of Hsp90 is mediated by lysine-ubiquitination.  RTA could be ubiquitinated by CHIP 
in the context of Hsp90 binding.  Alternatively, Hsp90 might maintain the stability of a third 
party, such as an E3 ligase complex, which ubiquitinates RTA.  If there is such a third-party 
complex, it would have to be sufficiently labile to become dysfunctional within a timeframe 
defined by toxin trafficking (roughly an hour), as sensitisation is observed after coeval 
application of chaperone inhibitor and toxin.  Fitting a direct ubiquitination by Hsp90∙CHIP, 
colleagues have published results showing that, when an incubation of RTA/Hsc70/CHIP 
(with other, essential, components of the ubiquitination cascade) is supplemented with 
additional HOP/Hsp90, more efficient ubiquitination ensues (Spooner et al., 2008).  Hsp90 
may direct RTA to degradation by the 26S proteasome. 
Unexpectedly, these observations contrast to what is known of the A chain of cholera toxin.  
CTA1 has been shown to dislocate into the cytosol assisted by a complex containing Hsp90 
(Taylor et al., 2010).  Thus, in the context of CTA1, Hsp90‟s activity seems to be opposite.  
CTA1 retrotranslocation is diminished in cells inhibited by geldanamycin and is blocked 
when Hsp90 is depleted using RNAi (Taylor et al., 2010).  Either Hsp90 maintains the 
stability of a third-party, such as the pore, or else it participates directly in retrotranslocation.  
This compares well to Giodini & Cresswell‟s (2008) report that Hsp90 assists the ERAD-like 
retrotranslocation of exogenous luciferase into the cytosol of dendritic cells.  The Hsp90-
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regulated routes taken by both RTA and CTA1 contrast to diphtheria toxin.  In the case of 
this endosome-translocating toxin, Hsp90 does not appear to be involved at all, as 
geldanamycin and radicicol have no effect upon intoxication (Spilsberg et al., 2005).  Indeed, 
investigators have shown that diphtheria toxin can dislocate its catalytic activity across 
reconstituted lipid bilayers independently of cytosolic factors (Ren et al., 1999; Oh et al., 
1999).  Conversely, Hsp90 is vital to the translocation of other proteins from endosomes.  
Ratts et al. (2003) show that translocation of a diphtheria toxin and IL-2 construct is assisted 
by Hsp90.  This non-native, engineered construct apparently becomes a candidate for the 
extracting activity of Hsp90.  Another example of an endosome-translocating protein 
dependent on Hsp90 is HIV-1 trans-activating protein, Tat (Vendeville et al., 2004).  
Fibroblast growth factors FGF-1 and FGF-2 also translocate from endosomes into the cytosol 
and are prevented from doing so by pre-treatment of cells with radicicol and geldanamycin 
(Wesche et al., 2006).  Finally, Haug et al. (2004) showed that the toxic activities of two AB-
toxins from Clostridium perfringens (Iota toxin) and Clostridium difficile (an ADP-
ribosyltransferase) are dependent on Hsp90.  They show that radicicol protects cells from 
toxin-induced apoptosis.  These proteins may all become unstable in acidified endosomes, 
leading to their interaction with the membrane of the compartment and dislocation by an 
„endosome-associated degradation‟ route.   
So, why might Hsp90 have such a different, opposite, role in ricin intoxication?  First, RTA 
retrotranslocates from the ER and so the localisation of assisting protein factors will be 
different from those operating at the endosome.  This does not explain the difference between 
RTA and CTA1, however.  Ultimately, it may be that RTA is simply a client which Hsp90 is 
more likely to recognise as terminally misfolded, perhaps because of the context of a prior 
triage by Hsc70.  RTA may have evolved to exploit Hsc70 instead of Hsp90.  Alternatively, 
CTA1 may, itself, be particular in requiring Hsp90 to orientate its assembly into a stable 
complex with cytosolic ARF6 (Pande et al., 2007). 
6.3 Long term Hsp90 inhibition changes the dynamics of cytosolic quality control 
When cells were incubated with Hsp90 inhibitors for longer periods of time (up to 16-hour), 
the effect of the treatment upon ricin intoxication makes a transition from sensitisation to 
protection.  It is unclear what this is caused by, but suggestions can be made, for instance: the 
up-regulation of inducible Hsp70, or potentially the reconfiguration of the proteasome.  Both 
of these explanations provoke new questions.  If the change in effect results from Hsp70 up-
Page 242 
 
regulation, it would appear that it has a discrete activity from Hsc70 in handling RTA.  Such 
a difference would not be without precedent, such as in the case of epithelial sodium channels 
(Goldfarb et al., 2006).  If this is the case, it seems Hsc70 is a positive regulator of RTA 
activity, whilst Hsp70 is a negative regulator.  On the other hand, the protective effect could 
result from reduction in the steady-state level of the proteasomal cap, which is coincident 
with chronic Hsp90 inhibition (Imai et al., 2003).  In yeast, of course, the proteasomal cap is 
thought to facilitate extraction of RTA (Li et al., 2010), and therefore this may be evidence of 
a similar role in mammals. Alternatively, chronic inhibition of Hsp90 may change the 
dynamics of the laterally-integrated chaperone network in other ways.  This could result in 
diversion of RTA to chaperone machineries which promote inactivation rather than 
activation. 
6.4 A role for Grp94 
Inhibition of Grp94 with NECA results in protection of cells from ricin intoxication.  
However, as with Hsp90, it is not apparent whether this results from a direct interaction.  In a 
direct interaction, Grp94 might keep RTA soluble and ready for retrotranslocation, or else 
direct it to downstream effectors of ERAD.  This finding would be consistent with the role 
ascribed to Grp94 in gating substrate access to Hrd1 complexes (Christianson et al., 2008).  It 
would be a pleasing symmetry if lumenal Grp94 recognises RTA as misfolded and directs it 
to an ERAD pathway (leading to toxicity), whilst Hsp90 recognises RTA as misfolded and 
directs it to the proteasome (leading to reduction in toxicity).  However, this is certainly not 
necessarily the case: Taylor et al. (2010) report that Grp94 has no effect upon the Hsp90-
dependent retrotranslocation of CTA1, for instance.  As described previously, PDI is thought 
to have a role in unfolding CTA1 ahead of its ERAD.  It could be that Grp94 fulfils or 
contributes to this role in the context of RTA. 
6.5 Manipulation of Hsc70/Hsp90 co-factors alters the dynamics of the triage 
Demonstrating the dynamism of the cytosolic chaperone network, manipulating the 
concentration of Hsc70 and Hsp90‟s co-factors alters the sensitivity of cells ricin.  Over-
expressing a chaperone-dependent E3 ubiquitin ligase, CHIP, leads to protection of cells from 
ricin.  Presumably this is because it leads to greater ubiquitination of retrotranslocated RTA, 
and complexes of chaperones bound to RTA.  This would result in the attraction of the 
proteasome, which could degrade the toxic A chain.  Consistently, over-expression of a co-
chaperone which co-operates with Hsc70∙CHIP to attract the proteasome, BAG-1 (Alberti et 
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al., 2003; Alberti et al., 2004), also protects cells from ricin.  Over-expressing an antagonist 
of both BAG-1 and CHIP, BAG-2 (Arndt et al., 2005), has an appropriately opposite effect, 
sensitising cells to ricin.  Finally, over-expression of HIP also leads to sensitisation, 
putatively by prolonging an Hsc70∙RTA complex, enhancing the success of the folding it is 
hypothesised to promote.  This is the attributed effect of HIP for Hsc70 clients like the 
archetypal firefly luciferase (Lüders et al., 1998), and so it seems a reasonable suggestion to 
make.   
These results point to the flexibility of the chaperone network, reinforcing the concept that 
the aetiology of many misfolding diseases will be polygenetic (Csermely, 2001).  That is: the 
severity of a disease phenotype will be based upon the nature of a patient‟s chaperone 
network, as well as the nature of the misfolding protein regarded to be at fault.  This could be 
manifest in multiple ways: from overly-stringent degradation to overly-lax recognition of 
conformational faults.  Csermely (2001) also argues that if a chaperone network is too-
efficient at masking the faults of a mutated protein, their negative effects could be manifested 
later at times of stress or old age – producing so-called „civilisation diseases‟.  
6.6 Characterisation of BAG-5, a co-chaperone of Hsc70 
BAG-5 is one of the least well-studied co-chaperones of the BAG-domain family (Kalia et 
al., 2004).  This thesis has demonstrated the inhibitory effect of this protein upon CHIP-
mediated ubiquitination.  BAG-5 can prevent the ubiquitination of both Hsc70 and client.  
This effect is much like what is reported for the related protein, BAG-2.  In isolation, it 
appears that BAG-5 also has a pro-solubility effect upon RTA – a function which might 
translate to other substrates.  However, BAG-5 inhibits the ability of Hsc70 to keep RTA 
soluble.  As BAG-5 increases relative to Hsc70, its own ability to maintain the solubility of 
RTA eclipses this inhibitory effect on Hsc70.  BAG-5 may operate like this in vivo as a 
general regulator of Hsc70 function.  In vivo, however, its concentration will be less than that 
of the abundant Hsc70. 
6.7 Fitting these interactions into a wider context: at what stage would the chaperone 
interaction with RTA occur? 
The results of trafficking assays would imply the effect of chaperone inhibition happens after 
the entry of the toxin into the ER.  Li et al. (2010) showed that when RTA is targeted to the 
cytosol of yeast, without prior import into the ER, it is not degraded to a significant degree.  
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This suggests that a process is required to render RTA vulnerable to degradation – such as ER 
retrotranslocation.  The unfolding involved in such a process might make RTA vulnerable to 
Hsp90-mediated inactivation. 
With reference to Figure 6.1, RTA may be ubiquitinated to a low degree as it emerges from 
the ER membrane.  This could be facilitated by a core E3 ubiquitin ligase-associated complex 
from which the toxin subunit might emerge.  However, this modification is not efficient 
enough to ensure all RTA is degraded by the proteasome.  Moreover, Li et al. (2010) show 
that lysine-ubiquitination is not necessary for retrotranslocation in yeast.  The retarded or 
attenuated ubiquitination that may result from RTA‟s resistance to the modification may 
weaken subsequent interactions of the toxin subunit with both p97 and the proteasome.  This 
may permit de-ubiquitinating enzymes and eventually Hsc70 to intercede instead.  A low 
level of ubiquitination may occur again at this stage (e.g. mediated by CHIP), but this is also 
not enough to ensure all encountered RTA is sent to the proteasome.  Instead, net interactions 
with Hsc70 permit RTA a greater chance to gain a catalytic conformation.  Potentially Hsc70 
could also help to pull the protein away from the membrane – by an entropic-pulling 
mechanism (De Los Rios et al., 2006).  Thereafter, RTA would be entered into a soluble 
phase of audit by cytosolic quality control.  Alternatively, Hsc70 might capture an unfolded 
form of RTA that has been released from the membrane by p97 or the proteasomal cap.  After 
RTA folds into its native state, it has been noted that it is strikingly resistant to proteases 
(Argent et al. 2000), which may prevent the protein from being vulnerable to degradation 
after this stage.  Extending this idea, it remains a possibility that RTA folds in a different way 
after being exposed to a retrotranslocation step.  The ER-dislocation of calreticulin into the 
cytosol from the ER makes an interesting precedent in this regard.  Afshar et al. (2005) 
showed that calreticulin becomes strikingly resistant to proteases after dislocation.  They also 
show that this phenomenon was independent of the different calcium concentrations of the 
ER lumen and the cytosol, suggesting an intrinsic change to the protein was responsible 
rather than the surrounding environment.  A similar phenomenon might be of great benefit to 
the toxic motive of RTA. 
6.8 Broader relevance: escape from ERAD may be a common theme 
 
The wider significance of this recovery pathway potentially extends to substrates beyond 
RTA.  The escape of RTA from ERAD may reflect a more universal antagonism between the 
degradation of protein and the capability to refold it.  Many chaperones of the cytosol have 
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evolved as generalists, with broad specificity by evolutionary design.  Only a few barriers 
may exist to preserve retrotranslocated ER protein from being „reactivated‟ in the cytosol by 
these cytosolic generalists.  One obstruction may be swift degradation by ER-tethered 
proteasomes (Ng et al., 2007).  Another may be the packaging of retrotranslocated protein 
into quality-controlled inclusions whose interface with the cytosolic milieu is carefully 
controlled (Bagola & Sommer, 2008).  Of course, the ultimate barrier will be whether that 
protein was selected for ERAD because of terminal misfolding (such as caused by mutation 
and oxidative damage) rather than transient misfolding (in the case of a kinetically-trapped 
folding intermediate).   
RTA happens to represent a unique example where its liberation from a „masqueraded‟ 
misfolded state after retrotranslocation results in a very toxic activity.  Thus, it highlights the 
presence of a normally obscure pathway allowing a protein‟s escape beyond the barriers 
mentioned.  Multiple routes to reactivation may exist, but one route has been identified: an 
Hsc70-dependent mechanism.  Other retrotranslocated ER proteins with more benign 
activities may, similarly, be reactivated in the cytosol by Hsc70.  Indeed, calreticulin is 
known to retrotranslocate from the ER into the cytosol in physiologically significant 
concentrations (Afshar et al., 2005).  A substrate‟s success in doing this would be determined 
by its propensity to become ubiquitinated, to be degraded, to refold, and the cytosolic context 
of chaperones and co-factors.   Although the contribution of these reactivated proteins to the 
overall composition of the cytosol might be minuscule, this process might not be without 
essential significance.  Needless to say, the role of this process will be especially interesting 
for proteins with exquisite catalytic activities, like RTA.  RTA will remain a very useful toxic 
probe with which to test these putative pathways.  
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Figure 6.1 - A model for the triage of RTA by cytosolic chaperones. 
The following figure borrows some styling from the Cell Snapshot of Kawaguchi & Davis (2007).  It summarises 
the putative interaction of RTA with tested lumenal and cytosolic chaperones during the retrotranslocation 
process.  In the ER lumen, Grp94 may be responsible for preparing RTA (or the pore) for retrotranslocation.  
After dislocation, Hsc70 intercepts RTA which is not immediately sent to the proteasome.  Hsc70 can 
potentially do several things to RTA: ubiquitinate it and send it to the proteasome under the auspices of CHIP 
& BAG-1; release it, folded to the cytosol where it can depurinate ribosomes; or, pass it, via HOP, to Hsp90.  
Hsp90 may then also help RTA to refold or else send it for degradation via CHIP-mediated ubiquitination.  
Presumably, lateral co-operation between other chaperones of the cytosol may also operate, allowing audit of 
RTA by a wide variety of chaperones.  Red indicates factors preventing toxicity of RTA; green indicates factors 
promoting activity.  Broad, forking arrows indicate the proposed sequence of interactions. 
 
? 
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6.9 Further research 
Research derived from the findings of this thesis could go in a number of directions.  Much of 
it could pursue further elaboration of the reactivation pathway which RTA undertakes, using 
different iterations of the inhibitor experiments and targeted manipulation of the chaperone 
machineries involved (knocking-down with RNAi, for instance).  It would be interesting to 
see whether Hsp90 inhibition is redundant with proteasomal inhibition, which would test 
whether the chaperone does direct RTA to this proteolytic machine.  It would also be 
interesting to see whether the effect of DSG upon the cytotoxicity of ricin changes according 
to the lysine content of the holotoxin.   
The solubility assay could be refined by pre-blocking reaction tubes with relatively inert 
protein or silane.  This assay could be re-appropriated to screen for pro-solubility (or pro-
aggregation) factors by incubating an indicator protein (such as RTA) with fractions of 
cytosol.  Fractions could be subjected to iterative rounds of testing and division, eventually 
identifying individual factors.  Cytosolic extracts could also be made from cultures over-
expressing particular co-chaperones.  If the method for producing the extract could be made 
systematic enough, this would allow the cross-comparison of how different co-chaperones (in 
the context of a cytosolic mix) may influence the solubility of an indicator protein in vitro.  A 
similar screening approach could be tailored to examine whether factors of the cytosol could 
bolster or inhibit ubiquitination of RTA.  It would also be interesting to see whether CHIP-
ubiquitinated RTA can be degraded in vitro by 26S proteasomes and whether cytosolic 
factors can be identified which augment that process. 
Examining whether Hsc70 and Hsp90 play different roles in other organisms and for a variety 
of toxins would also be an interesting topic of study and would test how universal the 
pathway is.  As yeast is genetically tractable, it would be an interesting platform upon which 
to base these future experiments.  However, redundancy in the chaperone network may mean 
that the effects of knockouts might not be as convincing as targeting members of the Hrd1 
complex (as in Li et al., 2010).  Moreover, gross qualitative differences might be anticipated.  
The differential involvement of Cdc48 in yeast and plants in the ERAD of RTA, for example, 
is a prime example of the disparate retrotranslocation mechanisms than can exist between the 
kingdoms of life (Li et al., 2010; Marshall et al., 2008).  Essential differentiation would 
therefore be predicted.  The ATPase turnover of mammal Hsp90, for instance, is reportedly 
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10-fold higher than that of yeast (Vaughan et al., 2008) and there is no CHIP in yeast.  These 
disparities would possibly change the dynamics of the reactivation pathway entirely.   
This thesis has also discussed the hydrophobic C-terminus of RTA.  It would be interesting to 
determine specifically what roles this domain has in vivo.  For instance roles in dictating 
chaperone interactions, dictating ubiquitination and promoting membrane insertion.  A 
therapeutic polypeptide might even be designed which binds to this region of RTA, inhibiting 
retrotranslocation and even the Hsc70-interaction.  Although, given RTA can separate itself 
from RTB in the lumen (with the help of PDI - Spooner et al., 2006), it might similarly 
separate from such a polypeptide.  Lastly, the lumenal homologue of Hsp90, Grp94, has been 
suggested to work in the lumen to prepare RTA for retrotranslocation.  If this is the case, BiP 
may also be worth investigating – as the lumenal homolog of Hsc70.  However, in previous 
immuno-precipitation attempts with RTA, BiP has not been identified (Day et al., 2001).  
Moreover, BiP and Hsc70 do not complement each other effectively in reconstitutions of 
ERAD using microsomes (Brodsky et al., 1993).  Therefore, they may have functionally 
differentiated in such a way as not to have a symmetrical operation across the membrane. 
6.10 A Final Summary 
At a stage proximal to its retrotranslocation across the ER membrane, RTA interacts with 
chaperones in a way that differentiates it from ERAD substrates doomed to degradation.  
After RTA has unfolded to cross the membrane, an interaction of it with Hsc70 seems to 
promote its successful cytosolic refolding.  The relative balance of Hsc70‟s cofactors in the 
cytosol determines the success of this step: whether the protein is ubiquitinated, freed in a 
folded conformation, or else transferred to Hsp90 (Figure 6.1). Thereafter, Hsp90 seems to 
promote the toxin subunit being sent to the proteasome, a feat which is reliant upon the 
lysine-ubiquitination of RTA.  This feat may well be indicative of a competition that exists in 
the cytosol between degradation and refolding for other substrates of the ERAD process.  It 
emphasises the possibility that escapees from ERAD may occur more broadly, given the right 
substrate qualities and a permissive context of cytosolic chaperones. 
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Figures showing the chemical structures of small molecule inhibitors were produced using ISISDraw V2.5.4 
(MDL Information Systems).   
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Microsoft‟s Excel was used for linear regression of datasets, Student‟s T-tests (paired and unpaired), where 
stated. 
PaintShopPro Photo X2 
Graphics depicting model pathways were produced using PaintShopPro Photo X2 (CorelDraw).   
TotalLab Quant 
All electrophoretic gels and blots derived from them were quantified using TotalLab Quant, 2003 (GE 
Healthcare).   
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CHAPTER 8: 
Appendix 
 
8.1 The activity of deoxyspergualin degrades on prolonged storage 
As referred to in text in section 5.11.3, the activity of deoxyspergualin degrades after opening 
and protracted storage dissolved in water.  Figure 8.1 compares the effect of an old stock of 
DSG to a freshly dissolved batch. 
8.2 The turbidity of RTA can be measured during a heat treatment 
As referred to in section 4.3, dilute RTA was incubated in a MOPS/KCl buffer (in 10 mM 
MOPS / 50 mM KCl, pH7.2) and the absorbance at 320nm was recorded over time.  Two 
methods were used.  An “aliquot method”, where the absorbance of a 20μL sample from an 
larger incubation (of 700μL) was taken and its absorbance measured.  This method used a 
water bath to heat the sample.  A second approach used a spectrophotometer with a heated 
chamber to measure the absorbance of a “whole sample” in a cuvette, without the need for 
aliquots. 
The whole sample method produces much more reliable results, but the capacity of the heated 
spectrophotometer‟s chamber was limited.  Moreover, the temperature control was unreliable 
over time and varied across the chamber.  The aliquot method, on the other hand, would have 
allowed parallel samples to be taken, but the results it generated seemed too unreliable to 
waste precious purified proteins upon. 
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Figure 8.1 – The activity of deoxyspergualin degrades on prolonged storage 
 
a) & b) Show exemplar dose-response curves from sets of three independent assays.  100 μg.mL
-1
 lactose (); 
100 μg.mL
-1 
lactose and 50 μg.mL
-1
 DSG ().  In a) a stock of DSG which had been frozen at 20°C in water for 6 
months.  In b) a freshly dissolved batch was used. c) Shows the calculated protective effect in each instance 
(from an average of the three assays (error bars show standard deviation). d) Shows the effect of DSG itself 
upon protein synthesis relative to lactose treatment. 
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Figure 8.2 – The increasing turbidity of an RTA solution during a heat treatment 
The absorbance of RTA (in 10 mM MOPS / 50 mM KCl, pH7.2) at 320 nm was measured over time.  Two 
techniques were attempted: using a waterbath to heat the sample, from which aliquots were taken and 
analysed in a spectrophotometer separately (the “aliquot method”).  Alternatively, a spectrophotometer with 
temperature control was used, so the absorbance of the whole sample rather than an aliquot was taken at 
each timepoint (the “whole sample method”).  Experiments were conducted with 1.38 μM RTA, with 0.46 μM 
RTA, or no RTA.  Two temperatures were used: 21°C or 45°C. 
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()  Whole sample method, No RTA, 45°C 
 
A
3
2
0
n
m
 (
ab
.u
.)
 
 
 Time (minutes) 
 
 
0
20
40
60
80
100
0 10 20 30 40 50
Cytosolic chaperones influence the fate of a toxin
dislocated from the endoplasmic reticulum
Robert A. Spoonera,1, Philip J. Harta, Jonathan P. Cooka, Paola Pietronia, Christian Rogonb, Jo¨rg Ho¨hfeldb,
Lynne M. Robertsa, and J. Michael Lorda
aDepartment of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom; and bInstitut fu¨r Zellbiologie, Rheinische Friedrich
Wilhelms-Universita¨t Bonn, Ulrich-Haberland-Strasse 61a, 53121 Bonn, Germany
Communicated by Ellen S. Vitetta, University of Texas Southwestern Medical Center, Dallas, TX, September 24, 2008 (received for review January 30, 2008)
The plant cytotoxin ricin enters target mammalian cells by recep-
tor-mediated endocytosis and undergoes retrograde transport to
the endoplasmic reticulum (ER). Here, its catalytic A chain (RTA) is
reductively separated from the cell-binding B chain, and free RTA
enters the cytosol where it inactivates ribosomes. Cytosolic entry
requires unfolding of RTA and dislocation across the ER membrane
such that it arrives in the cytosol in a vulnerable, nonnative
conformation. Clearly, for such a dislocated toxin to become active,
it must avoid degradation and fold to a catalytic conformation.
Here, we show that, in vitro, Hsc70 prevents aggregation of
heat-treated RTA, and that RTA catalytic activity is recovered after
chaperone treatment. A combination of pharmacological inhibition
and cochaperone expression reveals that, in vivo, cytosolic RTA is
scrutinized sequentially by the Hsc70 and Hsp90 cytosolic chaper-
one machineries, and that its eventual fate is determined by the
balance of activities of cochaperones that regulate Hsc70 and
Hsp90 functions. Cytotoxic activity follows Hsc70-mediated escape
of RTA from an otherwise destructive pathway facilitated by
Hsp90. We demonstrate a role for cytosolic chaperones, proteins
typically associated with folding nascent proteins, assembling
multimolecular protein complexes and degrading cytosolic and
stalled, cotranslocational clients, in a toxin triage, in which both
toxin folding and degradation are initiated from chaperone-bound
states.
Hsc70  Hsp90  ricin
Endoplasmic-reticulum (ER) associated protein degradation(ERAD) comprises coordinated disposal systems that rec-
ognize and remove misfolded and unassembled proteins in the
ER, dislocating them across the ER membrane to the cytosol for
proteasomal destruction. Degradation is normally facilitated by
polyubiquitylation, usually on internal lysyl residues of the target
protein. Both membrane-bound and soluble ER proteins can be
disposed of by ERAD (1, 2).
The plant cytotoxin ricin traffics to the ER lumen of mam-
malian cells where it is reduced to its RTA and RTB subunits
before RTA dislocation (3). RTA does not penetrate the ER
membrane directly; instead it exploits pre-existing protein-
conducting channels as a nonnative species, mimicking ER
proteins dispatched via ERAD (4, 5). Thus, it enters the cytosol
in a form susceptible to proteolysis or aggregation. A proportion
must evade these fates to gain a catalytic conformation that
depurinates target ribosomes, stopping protein synthesis. The
paucity of lysine residues in RTAmay facilitate uncoupling from
ERAD by reducing the potential for polyubiquitylation, thereby
hampering proteasomal degradation (6). This, in turn, may
provide opportunities for spontaneous or chaperone-assisted
folding not normally sanctioned for ERAD substrates.
We show an interaction of RTA with the cytosolic heat shock
(cognate) protein Hsc70. From the chaperone-bound state,
nonnative cytosolic RTA can achieve a catalytic conformation or
can be inactivated. Its ultimate fate depends on the activities of
cochaperones that regulate Hsc70.
Results
Inhibition of Hsc70 Protects HeLa Cells from Ricin. Ricin binds
exposed galactosyl residues, opportunistically exploiting a huge
number of surface glycoproteins (3). Consequently, trafficking
pathways are diverse with 5% of the cell-surface bound toxin
reaching the TGN (7). Of this, only a tiny proportion reaches the
ER (8) and subsequently the cytosol. RTA is not modified in
transit, so the toxic cytosolic fraction cannot be distinguished
from the overwhelming noncytotoxic majority at the cell surface
and in the endomembrane system by immunoblotting, cellular
fractionation, indirect immunofluorescence, or coimmunopre-
cipitation approaches. However, ricin cytotoxicity correlates
strongly with ribosome depurination, so it can be used as a
measure of the relative amount of native RTA in the cytosol (9).
Deoxyspergualin (DSG) alters the ATPase activity of the
cytosolic heat-shock (cognate) protein Hsc70 in vitro, and in vivo
permits expression of functional cystic fibrosis transmembrane
conductance regulator (CFTR) in cells expressing mutant
F508CFTR, presumably by inhibiting interactions with Hsc70
chaperone complexes that target it to proteasomes (10, 11).
When DSG was added with ricin to HeLa cells, the cells became
3-fold more resistant to toxin (Fig. 1 A and B), suggesting that
an increased proportion of toxin remained inactive. DSG alone
had no effect on protein synthesis (Fig. 1C). The ER Hsp70
counterpart BiP is not affected by DSG (12), suggesting that
protection occurred in the cytosol. After ricin challenge, a
distinct lag before the onset of cytotoxicity that represents
trafficking time from cell surface to the first destruction of
ribosomes (13) is unchanged by DSG treatment (Table 1),
confirming that the effect of DSG occurs in the cytosol, and not
by interfering with toxin delivery. Because unfolding is necessary
to render RTA competent for dislocation (5), then folding must
be required for catalytic activity in the cytosol, and this appears
to involve Hsc70. In contrast, DSG had no effect on the potency
of diphtheria toxin (DTx, Fig. 1 A and B), which enters the
cytosol from acidified endosomes, refolding spontaneously in
the cytosol (14).
Inhibition of Hsp90 Sensitizes Cells to Ricin.DSG also interacts with
the cytosolic chaperone Hsp90 (10). To clarify its most upstream
target, we used geldanamycin (GA) and radicicol (RA), com-
petitive inhibitors of the Hsp90 ATP-binding site (15). Treat-
ment with 1 M GA or RA resulted in a 1.5- to 2-fold
sensitization of cells to ricin (Fig. 2 A and B), without altering
toxin trafficking times (Table 1). Treatments with GA or RA
alone have little, if any, effect on protein synthesis (Fig. 2C).
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Prolonged inhibition of Hsp90 by GA up-regulates Hsp72 (16).
We saw the same, confirming activity of GA and RA under our
conditions (Fig. 2D). Our sensitizing effects were obtained by
using acute drug treatments, before up-regulation of Hsp72, but
even with a 4-h drug pretreatment, cells were still sensitized to
ricin (data not shown). Thus, the effects of GA and RA do not
arise through augmented levels of Hsp72. GA and RA also
interact with GRP94, the ER counterpart of Hsp90. NECA
(N-ethylcarboxamidoadenosine), a GRP94 inhibitor that does
not affect Hsp90 (17) protected cells slightly from ricin (1.48 
0.34 -fold, n  5), confirming that the sensitizing effects of GA
and RA arose from inhibition of cytosolic Hsp90 and not GRP94
(Fig. 2B). It also suggests a role for GRP94 in preparing RTA for
dislocation, consistent with its ability to direct the null Hong
Kong variant of 1-antitrypsin to ERAD (18).
These data suggest that the fate of RTA is determined by
cytosolic triage, with an activation arm (toxin-sensitizing) inhib-
ited by DSG and an inactivation arm (protective) inhibited by
GA and RA. Combined treatment with DSG and RA gave a net
protective effect against ricin (Fig. 2B), demonstrating a sequen-
tial process with the step promoted by Hsc70 lying upstream of
the step mediated by Hsp90.
Hsc70 Interacts with RTA in Vitro. Because the minuscule amounts
of cytosolic RTA preclude detection except by monitoring the
consequences of its catalytic action, interactions with Hsp70 and
its cochaperone Hsp40 were examined in vitro. Brief heating to
45°C destabilizes RTA structure (19). RTA became insoluble (P,
pellet) after such treatment (15 min), with 10% remaining
soluble (S) after centrifugation (Fig. 3A, upper panel, upper
graph). Incremental increases in recovery of soluble material
were obtained by adding Hsp40, Hsp70, or both before heating.
Maximal chaperone-mediated solubility required ATP. These
data suggest that a potential role for these chaperones in vivo
could be to prevent vulnerable dislocated RTA from aggregat-
ing. Hsp40 was insoluble after heat treatment, alleviated by
addition of Hsc70. Repeating these assays in the absence of RTA
showed that this is its normal behavior (Fig. 3A, middle panel).
Fig. 1. Deoxyspergualin (DSG) protects HeLa cells from ricin intoxication. (A) Cells were treated for 4 h with graded doses of ricin or diphtheria toxin (DTx) in
growth medium containing 50 g ml1 DSG/100 g ml1 lactose (filled circles) or 100 g ml1 lactose carrier only (open circles), and their subsequent ability to
synthesize proteins was determined by measuring incorporation of [35S]-Met into acid-precipitable material. Typical single assays are shown. (B) Control cells and
cells pretreated (pre) with DSG/lactose were treated as in A, sensitivities to toxin (IC50, toxin concentration required to reduce protein synthesis to 50% that of
nontoxin treated controls) were determined, and fold protection (IC50 DSG-treated cells: IC50 control cells) is displayed. Means of three (DTx, ricin 16-h DSG
pretreatment) or six (ricin, no DSG pretreatment) independent experiments are displayed. (Bars,1 S.D.; broken line, no protective effect over that of treatment
with lactose carrier only). (C) Cells were treated with lactose (lac) or lactose/DSG only as appropriate for 4 h, and remaining protein synthesis ability was
determined. (n  3; bars, 1 S.D.).
Table 1. Ricin cell-surface to cytosol trafficking times
Treatment T, min
100 g ml1 lactose carrier 62.4  1.2
50 g ml1 DSG/ lactose 64.7  1.8
0.001% DMSO vehicle 68.0  6.3
1 M geldanamycin/DMSO 63.4  9.8
1 M radicicol/DMSO 65.2  8.3
T, n  3–6,  1 SD.
Fig. 2. Geldanamycin (GA) and radicicol (RA) sensitize HeLa cells to ricin
challenge. (A) Cells were treated (4 h) with increasing doses of ricin in medium
containing GA/DMSO (black circles), RA/DMSO (gray circles), or DMSO vehicle
only (white circles), and their subsequent ability to synthesize proteins was
determined as in Fig. 1A. Typical single assays are shown. (B) Cells were
challenged as in (A), IC50 values were determined as in Fig. 1B, and the effects
of GA and RA are displayed as fold sensitizations (IC50 GA- or RA-treated cells:
IC50 control DMSO-treated cells). Also shown are the effects of treatment with
NECA, and combined treatments with RA, DSG, and DMSO. Means of three
independent experiments are displayed, except for NECA treatment, where
n 5. (Bars,1 S.D.; broken line, no effect over that of treatment with DMSO
vehicle only) (C) Cells were treated with vehicle DMSO, DMSO/GA, or
DMSO/RA as appropriate for 4 h, and remaining protein synthesis ability was
determined. (n  3; bars, 1 S.D.) (D) Immunoblots of detergent soluble cell
extracts (25 g protein per lane) from cells incubated for various lengths of
time (t) in growth medium containing 1 M GA or 1 M RA were probed for
Hsp72 (upper strip), Hsp90 (middle strip), or -tubulin (lower strip).
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When RTA was heated for 15 min with or without chaperones
at 37°C, the chaperones had a similar although less pronounced
effect (Fig. 3A, lower panel, lower graph). Saporin has a largely
indistinguishable tertiary structure relative to RTA with iden-
tical, superimposable active site residues and has identical
activity against ribosomes (20), but it lacks the C-terminal
hydrophobic stretch that in RTA has been implicated in mem-
brane interactions preceding dislocation (21). Saporin showed
no thermal instability (Fig. 3B) after heating at 45°C. This result
contrasts with the instability of RTA and its recognition by
Hsp40/Hsc70 even at 37°C, and suggests that interactions with
Hsc70 might be a normal feature of folded RTA in the cytosol.
To investigate whether chaperone-treated RTA had cata-
lytic activity, dilutions of the soluble fractions from heat-
treated RTA and chaperone-stabilized RTA were added to
yeast ribosomes, which were subsequently treated with acidi-
fied aniline. Correctly folded RTA specifically depurinates
yeast 26S rRNA, and aniline treatment cleaves the phosphodi-
ester bond at the depurination site, releasing a small diagnostic
fragment of RNA (22). As expected, a small amount of RTA
activity remained after heat-treatment, but almost full activity
was recovered from chaperone-stabilized RTA (Fig. 3C). We
conclude that the major proportion of denatured RTA with
chaperone-mediated solubility is, or can become, competent to
gain catalytic activity.
Hsc70 Cochaperone Activity Determines the Fate of Dislocated RTA in
Vivo. Having established that RTA interacts with Hsc70 in vitro
and that catalytic activity can be recovered from the chaperone-
bound state, we examined the effects of modulating Hsc70
cochaperone activities in vivo.
The dual cochaperone Hsc70-Hsp90 organizing protein (Hop)
recruits Hsp90 to pre-existing Hsc70-client complexes, transfer-
ring client proteins from Hsc70 to Hsp90 (23). Transient over-
expression of Hop protected cells from ricin challenge (Fig. 4 A
and C), suggesting that increased links between Hsc70 and
Hsp90 lead to increased toxin turnover, consistent with the
sensitizing effects of GA/RA that block entry into the Hsp90
cycle. Thus, sequential interaction with Hsc70 and Hsp90 directs
cytosolic RTA toward net inactivation.
BCL2-associated athanogene protein (BAG-1) isoforms are
nucleotide exchange factors that stimulate release of Hsc70-
bound clients and bear a ubiquitin-like (ubl) motif that interacts
with the proteasome (24). Transient overexpression of BAG-1
protected cells against ricin (Fig. 4 B and D). Thus, BAG-1 may
stimulate release of Hsc70-bound RTA on a path toward inac-
tivation, consistent with the increased sensitivity of cells to ricin
reported after inhibition of proteasome activity (25).
Both Hsc70- and Hsp90- complexes can become sorting
machines that promote client destruction. C terminus of Hsp70-
interacting protein (CHIP) is an E3 ubiquitin ligase that interacts
with Hsc70 and Hsp90, and with its partner ubiquitin-
conjugating enzymes initiates proteasomal sorting by ubiquity-
lating chaperone-bound substrates. Transient over-expression of
CHIP resulted in enhanced inactivation of RTA, seen as in-
creased resistance of cells to ricin (Fig. 4 B and E).
To investigate whether Hsc70 can also promote toxin activity
in vivo, we overexpressed Hsp70-interacting protein (Hip), a
Hsc70 cochaperone, which stabilizes ADP-bound Hsc70, in-
Fig. 3. In vitro interactions of RTA and Hsp40 and Hsc70 chaperones. (A) RTA (500 ng) was incubated at the indicated temperatures for 15 min in 20 l of 20
mM Mops pH 7.2, 100 mM KCl, in the presence or absence of Hsp40, Hsc70, or ATP (shown below the panels). Aggregated (P) and soluble (S) fractions were
separated by centrifugation, heated in reducing SDS sample buffer, and analyzed by SDS/PAGE and subsequent silver staining. *, proteolytic fragment of Hsc70
lacking the C-terminal regulatory domain. Proportions (%) of aggregated (gray) and soluble (white) RTA are shown. (Bars,1 S.D.) (B) Reaction mixtures where
RTA was replaced by saporin were treated as in (A). (C) Dilutions of the soluble fractions from 375 ng of heat-treated RTA (upper panel), 375 ng of
chaperone-stabilized RTA (lower panel), and 375 ng of native RTA were added to yeast ribosomes for 2 h at 30°C. After cleavage of any depurinated 28S rRNA
with acetic-aniline, rRNAs were extracted, electrophoresed in denaturing conditions (1.2% agarose, 50% formamide), and gels were stained with ethidium
bromide before quantifying (22).
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creasing client residence and presumably permitting greater
opportunity for productive folding (26). Over-expression of
Hip-sensitized cells to ricin challenge (Fig. 4 B and F); thus, Hip
controls an activation arm of RTA triage.
The BAG-2 nucleotide exchange factor lacks the ubl domain
of BAG-1 and thus, cannot link a client:chaperone complex
directly to the proteasome. It also inhibits CHIP activity (27).
These properties allow it to facilitate maturation of newly
synthesized CFTR, diverting the receptor from the proteasome
pathway (28). Consistent with this, BAG-2 overexpression in-
creased the sensitivity of cells to ricin (Fig. 4 B and G),
demonstrating diversion of RTA from a destructive fate. We
conclude that the ultimate fate of cytosolic RTA is determined
by the relative expression levels of Hsc70 cochaperones.
RTA Can Be a Substrate for CHIP.Our inhibitor and expression data
demonstrate that activation and inactivation arms for RTA
proceed from Hsc70, and suggest that inactivation may require
a ubiquitin signal, either indirectly [via the interlaced ubl domain
of BAG-1 or perhaps in a piggy-back mechanism through Hsc70
ubiquitylation (29)], or directly (as CHIP-mediated RTA ubiq-
uitylation). To examine the latter, purified RTA was added to
reaction mixtures in which CHIP activity can be recapitulated in
vitro (30), which were then incubated for 2 h at 30°C. In complete
reaction mixtures and also when E1 (ubiquitin activating en-
zyme), E2 (ubiquitin conjugating enzyme), CHIP, or Hsp40/
Hsc70 were individually absent from the reconstitutions, no
ubiquitylation of RTA was seen (data not shown). However,
after mild thermal denaturation (45°C, 10 min) followed by
incubation at 30°C in complete reaction mixture not only was
Hsc70 ubiquitylated (Fig. 5A, Ub-Hsc70, upper panel) but so was
a small proportion of RTA (Fig. 5A, Ub-RTA, lower panel). An
even smaller proportion of RTA was a substrate for isolated
CHIP.
The scrutiny of native RTA at 37°C by Hsc70 complexes that
was noted previously (Fig. 3A) was also seen with Hsc70/CHIP
complexes. After incubation at 37°C for 2 h in the absence of E1,
there was no ubiquitylation of Hsc70, CHIP, or RTA (Fig. 5B).
Upon addition of E1, both Hsc70 and CHIP became ubiquity-
lated, events that occur in vivo that reflect regulation of Hsc70
by CHIP (28). Not all proteins are ubiquitylated in these
conditions, for example, BAG-2 inhibits CHIP activity without
becoming ubiquitylated (28). A recombinant version of RTA
containing four extra lysyl residues (RTA 6K) was more heavily
ubiquitylated under these conditions, consistent with its en-
hanced propensity for proteasomal degradation (25). A small
proportion of native wild-type RTA (2K) was also a substrate for
the Hsc70/CHIP cochaperone machinery (Fig. 5B).
Hsp90 also prevented aggregation of heat-treated RTA in
vitro, but in an ATP-independent manner (Fig. 5C, upper panel
and graph), but, unlike Hsc70, had no effect at 37°C (Fig. 5C,
lower panel and graph). Furthermore, in in vitro CHIP-mediated
ubiquitylation assays at 37°C, Hsp90 alone could not direct CHIP
efficiently toward RTA, but in the presence of Hsc70 and HOP,
Hsp90 promoted RTA ubiquitylation, thus providing a rationale
for the net protective effect of Hsp90 in vivo (Fig. 5D). We
conclude that both nonnative and native RTA at the physiolog-
ical temperature for ricin intoxication can be substrates for
Hsc70- and Hsp90-CHIP complexes, and that sequential Hsc70-
Hsp90 interactions lead to net RTA inactivation.
Discussion
Molecular chaperones are widely regarded as cellular protein
folding factors governing folding of nascent and damaged pro-
tein clients, and as protein assembly factors. During ER trans-
location, yeast cytosolic chaperones target ER import-
incompetent proteins to the proteasome (31). In mammalian
cells, roles for Hsc70 have been demonstrated in CFTR triage
(32) and in cotranslocational destruction of apoB that has stalled
in the import translocon (33). Here, we demonstrate that a
luminal protein that exploits the ERAD pathway for dislocation
is also scrutinized by the same machineries. Prevailing concen-
trations of Hsc70 cochaperones determine the proportion of
toxin that can recover catalytic activity and the proportion that
is destroyed. The simplest model to account for our findings is
shown in Fig. 5E, illustrating chaperone-mediated triage of
cytosolic RTA. After dislocation, RTA is recognized by the
Hsc70 chaperone machinery. Cochaperones BAG-2 and Hip
promote RTA activity in vivo, resulting in increased sensitivity of
cells to ricin. Inactivation arms also proceed from Hsc70,
controlled by BAG-1 and CHIP, protecting the cell from ricin
toxicity. In addition, the dual cochaperone Hop coordinates a
sequential Hsc70-Hsp90 triage whose net effect is to render
dislocated RTA inactive. Inactivation may be mediated by
ubiquitylation machineries. Both gain of catalytic conformation
and degradation of RTA proceed from chaperone-bound states.
This is highly reminiscent of the Hsc70-Hsp90 mediated regu-
lation of signaling proteins (34), but may be unprecedented for
a soluble protein that is dislocated from the ER lumen, because
soluble ERAD substrates typically interact with other mem-
brane-associated chaperone machineries (35), whereas cytosolic
domains of misfolded membrane proteins typically interact with
Hsc70 complexes (36). Our findings emphasize the central role
of Hsc70-Hsp90 chaperone machineries in cytosolic protein
triage. A minimal role for Hsc70 appears to be to prevent
aggregation of dislocated RTA in the cytosol, but the possibility
Fig. 4. Hsc70 cochaperone activity determines the fate of dislocated RTA in
vivo. (A) Cells transiently transfected with an expression plasmid expressing
Hop (Hop/Hop), with an equimolar mixture of plasmids expressing LacZ and
Hop (Hop/LacZ), or with a plasmid expressing LacZ (LacZ/LacZ) were assayed
for ricin sensitivity. Values were corrected for transfection efficiency, deter-
mined as 35% by epifluorescent examination of cells transiently transfected
with a plasmid expressing GFP. Dotted line, no effect over that of LacZ
transfection. (B) Cells were transfected, as in (A), with expression plasmids
expressing LacZ, BAG-1S [the small (S) isomer of BAG-1], CHIP, Hip, or BAG-2
and were assayed for ricin sensitivity compared with cells transfected coevally
with vector alone. Dotted line, no protective effect over vector transfection.
(C–G) Interactions of cochaperones with Hsc70 and client protein (red line).
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of Hsc70 supporting the folding of RTA directly cannot yet be
discounted.
Folding of heat-denatured RTA in vitro is favored in the
presence of ribosomes, implicating the toxin’s substrate in its
own activation (19). It remains to be seen whether human
homologues of ribosome-tethered chaperones that assist folding
of nascent proteins (37, 38) also contribute to posttranslational
folding of cytosolic RTA and how significant a role they have
relative to the soluble chaperone complexes.
Materials and Methods
Cytotoxicity Measurements. HeLa cell responses to 4-h challenges with graded
doses of ricin or diphtheria toxin (DTx) were measured as previously described
(3). For pharmacological studies, cells were treated coevally with graded doses
of toxin in medium containing carrier or solvent vehicle (control) and with
toxin dilutions in medium containing both carrier/vehicle and pharmacolog-
ical agent. Each cytotoxicity curve was normalized to controls not treated with
toxin, but containing agent or vehicle as appropriate, so any effects of agent
alone on protein synthesis were accounted for. Toxin trafficking times from
cell surface to first destruction of ribosomes were measured as previously
described (13). DSG was supplied by Worldwide Clinical Development, Nippon
Kayaku Co., Ltd., 31–12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan.
Overexpression Studies. HeLa cells were transfected with vectors expressing
cochaperones, using previously published conditions (3). Two days posttrans-
fection, cells were seeded into 96-well plates and grown overnight for cyto-
toxicity studies. Overexpression of cochaperones was confirmed by using
FLAG-tagged versions of these proteins, and immunoblotting using an anti-
FLAG antibody (data not shown).
In Vitro Ubiquitylation, Aggregation, and RTA Activity Studies. Recombinant
RTA was added to reaction mixtures containing 0.1M E1 ubiquitin activating
enzyme, 0.3 M Hsp40, 3 M Hsc70, 3 M HOP, 3 M Hsp90, 4 M UbcH5 (E2
conjugating enzyme), 3M CHIP, and 2 mg.ml1 ubiquitin in 20 mM Mops, pH
7.2, 100 mM KCl, 5 mM MgCl2, 5 mM ATP, 10 mM DTT buffer as previously
described (28) and to reaction mixtures lacking components as appropriate.
After incubation (2 h) at 30°C or 37°C as appropriate, products were identified
by reducing SDS/PAGE and immunoblot. When required, reaction mixes lack-
ing ATP and MgCl2 were heated to 45°C for 10 min followed by cooling to the
required reaction temperature and activation of the reaction by addition of
ATP and MgCl2. For aggregation studies, reaction mixtures lacking E1, E2,
CHIP, and Ub were used, and RTA was heated to 37°C or 45°C in the presence
or absence of Hsp40, Hsc70, Hsp90, and ATP. Aggregated and soluble fractions
were separated by centrifugation (16,000g, 10 min), solubilized in reducing
SDS sample buffer, and analyzed by SDS/PAGE and silver staining. Catalytic
activity of RTA from soluble fractions was assayed by quantifiying the RNA
Fig. 5. RTA is a substrate for CHIP. (A) RTA was added to a reaction mixture (complete), which can recapitulate CHIP activity (28), and to mixtures lacking E1
ubiquitin activating enzyme, E2 (UbcH5 ubiquitin conjugating enzyme), CHIP, or Hsp40/Hsc70 (40/70) as indicated. After heating (45°C, 10 min), reactions were
activated by addition of 5 mM MgCl2, 10 mM DTT, and 5 mM ATP, incubated (2h, 30°C), and products were identified by reducing SDS/PAGE and immunoblotting
for Hsc70 and RTA. (B) Addition of E1 to a reaction mixture containing RTA, Hsp40, Hsc70, E2, CHIP, and ubiquitin as in A, and incubation at 37°C for 2 h results
in CHIP-mediated ubiquitylation of Hsc70 (upper panel, Ub-Hsc70), CHIP (middle panel, Ub-CHIP), and both RTA 6K and RTA (lower panel, Ub-RTA) as revealed
by immunoblots. (C) RTA (500 ng) was incubated (45°C or 37°C, 15 min) in the presence or absence of Hsp90 or ATP (shown below the panels). Aggregated (P)
and soluble (S) fractions were separated by centrifugation, heated in reducing SDS sample buffer, and analyzed by SDS/PAGE and subsequent silver staining.
Proportions (%) of aggregated (gray) and soluble (white) RTA are shown. (D) RTA was added to CHIP recapitulation mixtures as in A, but containing Hsp40 and
Hsp70 (40/70), HOP, and Hsp90 as indicated below the panels, incubated (2 h, 37°C), and products were identified by reducing SDS/PAGE and immunoblotting
for HOP and RTA, and by silver staining for Hsc70 and Hsp90. *, cross-reacting contaminant. (E) Proposed cytosolic triage of dislocated RTA.
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fragment released from yeast 26S rRNA after RTA-mediated depurination of
intact ribosomes and cleavage with acetic-aniline. rRNA species were resolved
by denaturing gel electrophoresis, and fragments quantified in relation to the
amount of 5.8S rRNA (22). Bands on silver-stained and ethidium bromide
stained gels were quantified by using TotalLab software.
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